CINXE.COM
Spironolactone - Wikipedia
<!DOCTYPE html> <html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-available" lang="en" dir="ltr"> <head> <meta charset="UTF-8"> <title>Spironolactone - Wikipedia</title> <script>(function(){var className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-available";var cookie=document.cookie.match(/(?:^|; )enwikimwclientpreferences=([^;]+)/);if(cookie){cookie[1].split('%2C').forEach(function(pref){className=className.replace(new RegExp('(^| )'+pref.replace(/-clientpref-\w+$|[^\w-]+/g,'')+'-clientpref-\\w+( |$)'),'$1'+pref+'$2');});}document.documentElement.className=className;}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy", "wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"9f6c568e-ab70-4c56-be12-02a0d5422f54","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Spironolactone","wgTitle":"Spironolactone","wgCurRevisionId":1256728327,"wgRevisionId":1256728327,"wgArticleId":732656,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: DOI inactive as of November 2024","All articles with dead external links","Articles with dead external links from January 2023","Articles with permanently dead external links","CS1 German-language sources (de)","Articles with short description","Short description is different from Wikidata","Use dmy dates from October 2021","Drugs with non-standard legal status","ECHA InfoCard ID from Wikidata","Drugboxes which contain changes to watched fields", "All articles lacking reliable references","Articles lacking reliable references from July 2024","All articles with unsourced statements","Articles with unsourced statements from July 2024","All articles with failed verification","Articles with failed verification from July 2024","Articles containing Latin-language text","Articles containing German-language text","Articles containing Spanish-language text","Articles containing Italian-language text","Wikipedia medicine articles ready to translate","Spironolactone","3β-Hydroxysteroid dehydrogenase inhibitors","5α-Reductase inhibitors","11β-Hydroxylase inhibitors","17β-Hydroxysteroid dehydrogenase inhibitors","21-Hydroxylase inhibitors","Acetate esters","Aldosterone synthase inhibitors","Anti-acne preparations","Antimineralocorticoids","Cholesterol side-chain cleavage enzyme inhibitors","CYP17A1 inhibitors","Hair loss medications","Hair removal","Lactones","Pregnane X receptor agonists","Pregnanes","Prodrugs","Progestogens", "Selective estrogen receptor modulators","Spiro compounds","Spirolactones","Steroidal antiandrogens","Thioesters","World Health Organization essential medicines"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Spironolactone","wgRelevantArticleId":732656,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":200000,"wgRelatedArticlesCompat":[],"wgCentralAuthMobileDomain":false,"wgEditSubmitButtonLabelPublish":true, "wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":false,"wgVector2022LanguageInHeader":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q422188","wgCheckUserClientHintsHeadersJsApi":["brands","architecture","bitness","fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.search.codex.styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.tablesorter.styles":"ready","jquery.makeCollapsible.styles":"ready","ext.wikimediamessages.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","wikibase.client.init": "ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","mediawiki.page.media","site","mediawiki.page.ready","jquery.tablesorter","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.switcher","ext.urlShortener.toolbar","ext.centralauth.centralautologin","mmv.bootstrap","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.echo.centralauth","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.checkUser.clientHints","ext.quicksurveys.init","ext.growthExperiments.SuggestedEditSession","wikibase.sidebar.tracking"];</script> <script>(RLQ=window.RLQ||[]).push(function(){mw.loader.impl(function(){return["user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"}); }];});});</script> <link rel="stylesheet" href="/w/load.php?lang=en&modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cext.wikimediamessages.styles%7Cjquery.makeCollapsible.styles%7Cjquery.tablesorter.styles%7Cskins.vector.icons%2Cstyles%7Cskins.vector.search.codex.styles%7Cwikibase.client.init&only=styles&skin=vector-2022"> <script async="" src="/w/load.php?lang=en&modules=startup&only=scripts&raw=1&skin=vector-2022"></script> <meta name="ResourceLoaderDynamicStyles" content=""> <link rel="stylesheet" href="/w/load.php?lang=en&modules=site.styles&only=styles&skin=vector-2022"> <meta name="generator" content="MediaWiki 1.44.0-wmf.4"> <meta name="referrer" content="origin"> <meta name="referrer" content="origin-when-cross-origin"> <meta name="robots" content="max-image-preview:standard"> <meta name="format-detection" content="telephone=no"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/9/98/Spironolactone.svg/1200px-Spironolactone.svg.png"> <meta property="og:image:width" content="1200"> <meta property="og:image:height" content="1014"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/9/98/Spironolactone.svg/800px-Spironolactone.svg.png"> <meta property="og:image:width" content="800"> <meta property="og:image:height" content="676"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/9/98/Spironolactone.svg/640px-Spironolactone.svg.png"> <meta property="og:image:width" content="640"> <meta property="og:image:height" content="541"> <meta name="viewport" content="width=1120"> <meta property="og:title" content="Spironolactone - Wikipedia"> <meta property="og:type" content="website"> <link rel="preconnect" href="//upload.wikimedia.org"> <link rel="alternate" media="only screen and (max-width: 640px)" href="//en.m.wikipedia.org/wiki/Spironolactone"> <link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Spironolactone&action=edit"> <link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"> <link rel="icon" href="/static/favicon/wikipedia.ico"> <link rel="search" type="application/opensearchdescription+xml" href="/w/rest.php/v1/search" title="Wikipedia (en)"> <link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"> <link rel="canonical" href="https://en.wikipedia.org/wiki/Spironolactone"> <link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en"> <link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&feed=atom"> <link rel="dns-prefetch" href="//meta.wikimedia.org" /> <link rel="dns-prefetch" href="//login.wikimedia.org"> </head> <body class="skin--responsive skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Spironolactone rootpage-Spironolactone skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a> <div class="vector-header-container"> <header class="vector-header mw-header"> <div class="vector-header-start"> <nav class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-dropdown" class="vector-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right" > <input type="checkbox" id="vector-main-menu-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-main-menu-dropdown" class="vector-dropdown-checkbox " aria-label="Main menu" > <label id="vector-main-menu-dropdown-label" for="vector-main-menu-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span> <span class="vector-dropdown-label-text">Main menu</span> </label> <div class="vector-dropdown-content"> <div id="vector-main-menu-unpinned-container" class="vector-unpinned-container"> <div id="vector-main-menu" class="vector-main-menu vector-pinnable-element"> <div class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned" data-feature-name="main-menu-pinned" data-pinnable-element-id="vector-main-menu" data-pinned-container-id="vector-main-menu-pinned-container" data-unpinned-container-id="vector-main-menu-unpinned-container" > <div class="vector-pinnable-header-label">Main menu</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button> </div> <div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation" > <div class="vector-menu-heading"> Navigation </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li> </ul> </div> </div> <div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction" > <div class="vector-menu-heading"> Contribute </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> <a href="/wiki/Main_Page" class="mw-logo"> <img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt="" aria-hidden="true" height="50" width="50"> <span class="mw-logo-container skin-invert"> <img class="mw-logo-wordmark" alt="Wikipedia" src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;"> <img class="mw-logo-tagline" alt="The Free Encyclopedia" src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;"> </span> </a> </div> <div class="vector-header-end"> <div id="p-search" role="search" class="vector-search-box-vue vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box"> <a href="/wiki/Special:Search" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle" title="Search Wikipedia [f]" accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span> <span>Search</span> </a> <div class="vector-typeahead-search-container"> <div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width"> <form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button"> <div id="simpleSearch" class="cdx-search-input__input-wrapper" data-search-loc="header-moved"> <div class="cdx-text-input cdx-text-input--has-start-icon"> <input class="cdx-text-input__input" type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput" > <span class="cdx-text-input__icon cdx-text-input__start-icon"></span> </div> <input type="hidden" name="title" value="Special:Search"> </div> <button class="cdx-button cdx-search-input__end-button">Search</button> </form> </div> </div> </div> <nav class="vector-user-links vector-user-links-wide" aria-label="Personal tools"> <div class="vector-user-links-main"> <div id="p-vector-user-menu-preferences" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-userpage" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-dropdown" class="vector-dropdown " title="Change the appearance of the page's font size, width, and color" > <input type="checkbox" id="vector-appearance-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-appearance-dropdown" class="vector-dropdown-checkbox " aria-label="Appearance" > <label id="vector-appearance-dropdown-label" for="vector-appearance-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-appearance mw-ui-icon-wikimedia-appearance"></span> <span class="vector-dropdown-label-text">Appearance</span> </label> <div class="vector-dropdown-content"> <div id="vector-appearance-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <div id="p-vector-user-menu-notifications" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en" class=""><span>Donate</span></a> </li> <li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:CreateAccount&returnto=Spironolactone" title="You are encouraged to create an account and log in; however, it is not mandatory" class=""><span>Create account</span></a> </li> <li id="pt-login-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:UserLogin&returnto=Spironolactone" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o" class=""><span>Log in</span></a> </li> </ul> </div> </div> </div> <div id="vector-user-links-dropdown" class="vector-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out" title="Log in and more options" > <input type="checkbox" id="vector-user-links-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-user-links-dropdown" class="vector-dropdown-checkbox " aria-label="Personal tools" > <label id="vector-user-links-dropdown-label" for="vector-user-links-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span> <span class="vector-dropdown-label-text">Personal tools</span> </label> <div class="vector-dropdown-content"> <div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item" title="User menu" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport" class="user-links-collapsible-item mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en"><span>Donate</span></a></li><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&returnto=Spironolactone" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&returnto=Spironolactone" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li> </ul> </div> </div> <div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor" > <div class="vector-menu-heading"> Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a> </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li> </ul> </div> </div> </div> </div> </nav> </div> </header> </div> <div class="mw-page-container"> <div class="mw-page-container-inner"> <div class="vector-sitenotice-container"> <div id="siteNotice"><!-- CentralNotice --></div> </div> <div class="vector-column-start"> <div class="vector-main-menu-container"> <div id="mw-navigation"> <nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-pinned-container" class="vector-pinned-container"> </div> </nav> </div> </div> <div class="vector-sticky-pinned-container"> <nav id="mw-panel-toc" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark"> <div id="vector-toc-pinned-container" class="vector-pinned-container"> <div id="vector-toc" class="vector-toc vector-pinnable-element"> <div class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned" data-feature-name="toc-pinned" data-pinnable-element-id="vector-toc" > <h2 class="vector-pinnable-header-label">Contents</h2> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button> </div> <ul class="vector-toc-contents" id="mw-panel-toc-list"> <li id="toc-mw-content-text" class="vector-toc-list-item vector-toc-level-1"> <a href="#" class="vector-toc-link"> <div class="vector-toc-text">(Top)</div> </a> </li> <li id="toc-Medical_uses" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Medical_uses"> <div class="vector-toc-text"> <span class="vector-toc-numb">1</span> <span>Medical uses</span> </div> </a> <button aria-controls="toc-Medical_uses-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Medical uses subsection</span> </button> <ul id="toc-Medical_uses-sublist" class="vector-toc-list"> <li id="toc-Heart_failure" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Heart_failure"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.1</span> <span>Heart failure</span> </div> </a> <ul id="toc-Heart_failure-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-High_blood_pressure" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#High_blood_pressure"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.2</span> <span>High blood pressure</span> </div> </a> <ul id="toc-High_blood_pressure-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-High_aldosterone_levels" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#High_aldosterone_levels"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.3</span> <span>High aldosterone levels</span> </div> </a> <ul id="toc-High_aldosterone_levels-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Skin_and_hair_conditions" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Skin_and_hair_conditions"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.4</span> <span>Skin and hair conditions</span> </div> </a> <ul id="toc-Skin_and_hair_conditions-sublist" class="vector-toc-list"> <li id="toc-Comparison" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Comparison"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.4.1</span> <span>Comparison</span> </div> </a> <ul id="toc-Comparison-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Transgender_hormone_therapy" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Transgender_hormone_therapy"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.5</span> <span>Transgender hormone therapy</span> </div> </a> <ul id="toc-Transgender_hormone_therapy-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Forms" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Forms"> <div class="vector-toc-text"> <span class="vector-toc-numb">1.6</span> <span>Forms</span> </div> </a> <ul id="toc-Forms-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Contraindications" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Contraindications"> <div class="vector-toc-text"> <span class="vector-toc-numb">2</span> <span>Contraindications</span> </div> </a> <ul id="toc-Contraindications-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Side_effects" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Side_effects"> <div class="vector-toc-text"> <span class="vector-toc-numb">3</span> <span>Side effects</span> </div> </a> <button aria-controls="toc-Side_effects-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Side effects subsection</span> </button> <ul id="toc-Side_effects-sublist" class="vector-toc-list"> <li id="toc-High_potassium_levels" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#High_potassium_levels"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.1</span> <span>High potassium levels</span> </div> </a> <ul id="toc-High_potassium_levels-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Breast_changes" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Breast_changes"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.2</span> <span>Breast changes</span> </div> </a> <ul id="toc-Breast_changes-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Menstrual_disturbances" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Menstrual_disturbances"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.3</span> <span>Menstrual disturbances</span> </div> </a> <ul id="toc-Menstrual_disturbances-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Mood_changes" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Mood_changes"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.4</span> <span>Mood changes</span> </div> </a> <ul id="toc-Mood_changes-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Lipid_changes" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Lipid_changes"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.5</span> <span>Lipid changes</span> </div> </a> <ul id="toc-Lipid_changes-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Rare_reactions" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Rare_reactions"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.6</span> <span>Rare reactions</span> </div> </a> <ul id="toc-Rare_reactions-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Spironolactone_bodies" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Spironolactone_bodies"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.7</span> <span>Spironolactone bodies</span> </div> </a> <ul id="toc-Spironolactone_bodies-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Pregnancy_and_breastfeeding" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Pregnancy_and_breastfeeding"> <div class="vector-toc-text"> <span class="vector-toc-numb">3.8</span> <span>Pregnancy and breastfeeding</span> </div> </a> <ul id="toc-Pregnancy_and_breastfeeding-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Overdose" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Overdose"> <div class="vector-toc-text"> <span class="vector-toc-numb">4</span> <span>Overdose</span> </div> </a> <ul id="toc-Overdose-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Interactions" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Interactions"> <div class="vector-toc-text"> <span class="vector-toc-numb">5</span> <span>Interactions</span> </div> </a> <ul id="toc-Interactions-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Pharmacology" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Pharmacology"> <div class="vector-toc-text"> <span class="vector-toc-numb">6</span> <span>Pharmacology</span> </div> </a> <button aria-controls="toc-Pharmacology-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Pharmacology subsection</span> </button> <ul id="toc-Pharmacology-sublist" class="vector-toc-list"> <li id="toc-Pharmacodynamics" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Pharmacodynamics"> <div class="vector-toc-text"> <span class="vector-toc-numb">6.1</span> <span>Pharmacodynamics</span> </div> </a> <ul id="toc-Pharmacodynamics-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Pharmacokinetics" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Pharmacokinetics"> <div class="vector-toc-text"> <span class="vector-toc-numb">6.2</span> <span>Pharmacokinetics</span> </div> </a> <ul id="toc-Pharmacokinetics-sublist" class="vector-toc-list"> <li id="toc-Absorption" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Absorption"> <div class="vector-toc-text"> <span class="vector-toc-numb">6.2.1</span> <span>Absorption</span> </div> </a> <ul id="toc-Absorption-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Distribution" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Distribution"> <div class="vector-toc-text"> <span class="vector-toc-numb">6.2.2</span> <span>Distribution</span> </div> </a> <ul id="toc-Distribution-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Metabolism" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Metabolism"> <div class="vector-toc-text"> <span class="vector-toc-numb">6.2.3</span> <span>Metabolism</span> </div> </a> <ul id="toc-Metabolism-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Elimination" class="vector-toc-list-item vector-toc-level-3"> <a class="vector-toc-link" href="#Elimination"> <div class="vector-toc-text"> <span class="vector-toc-numb">6.2.4</span> <span>Elimination</span> </div> </a> <ul id="toc-Elimination-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> </ul> </li> <li id="toc-Chemistry" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Chemistry"> <div class="vector-toc-text"> <span class="vector-toc-numb">7</span> <span>Chemistry</span> </div> </a> <button aria-controls="toc-Chemistry-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Chemistry subsection</span> </button> <ul id="toc-Chemistry-sublist" class="vector-toc-list"> <li id="toc-Names" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Names"> <div class="vector-toc-text"> <span class="vector-toc-numb">7.1</span> <span>Names</span> </div> </a> <ul id="toc-Names-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Analogues" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Analogues"> <div class="vector-toc-text"> <span class="vector-toc-numb">7.2</span> <span>Analogues</span> </div> </a> <ul id="toc-Analogues-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Synthesis" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Synthesis"> <div class="vector-toc-text"> <span class="vector-toc-numb">7.3</span> <span>Synthesis</span> </div> </a> <ul id="toc-Synthesis-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-History" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#History"> <div class="vector-toc-text"> <span class="vector-toc-numb">8</span> <span>History</span> </div> </a> <ul id="toc-History-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Society_and_culture" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Society_and_culture"> <div class="vector-toc-text"> <span class="vector-toc-numb">9</span> <span>Society and culture</span> </div> </a> <button aria-controls="toc-Society_and_culture-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Society and culture subsection</span> </button> <ul id="toc-Society_and_culture-sublist" class="vector-toc-list"> <li id="toc-Generic_names" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Generic_names"> <div class="vector-toc-text"> <span class="vector-toc-numb">9.1</span> <span>Generic names</span> </div> </a> <ul id="toc-Generic_names-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Brand_names" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Brand_names"> <div class="vector-toc-text"> <span class="vector-toc-numb">9.2</span> <span>Brand names</span> </div> </a> <ul id="toc-Brand_names-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Availability" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Availability"> <div class="vector-toc-text"> <span class="vector-toc-numb">9.3</span> <span>Availability</span> </div> </a> <ul id="toc-Availability-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Research" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#Research"> <div class="vector-toc-text"> <span class="vector-toc-numb">10</span> <span>Research</span> </div> </a> <button aria-controls="toc-Research-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Research subsection</span> </button> <ul id="toc-Research-sublist" class="vector-toc-list"> <li id="toc-Prostate_conditions" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Prostate_conditions"> <div class="vector-toc-text"> <span class="vector-toc-numb">10.1</span> <span>Prostate conditions</span> </div> </a> <ul id="toc-Prostate_conditions-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Epstein–Barr_virus" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Epstein–Barr_virus"> <div class="vector-toc-text"> <span class="vector-toc-numb">10.2</span> <span>Epstein–Barr virus</span> </div> </a> <ul id="toc-Epstein–Barr_virus-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Other_conditions" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Other_conditions"> <div class="vector-toc-text"> <span class="vector-toc-numb">10.3</span> <span>Other conditions</span> </div> </a> <ul id="toc-Other_conditions-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-References" class="vector-toc-list-item vector-toc-level-1"> <a class="vector-toc-link" href="#References"> <div class="vector-toc-text"> <span class="vector-toc-numb">11</span> <span>References</span> </div> </a> <ul id="toc-References-sublist" class="vector-toc-list"> </ul> </li> </ul> </div> </div> </nav> </div> </div> <div class="mw-content-container"> <main id="content" class="mw-body"> <header class="mw-body-header vector-page-titlebar"> <nav aria-label="Contents" class="vector-toc-landmark"> <div id="vector-page-titlebar-toc" class="vector-dropdown vector-page-titlebar-toc vector-button-flush-left" > <input type="checkbox" id="vector-page-titlebar-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-titlebar-toc" class="vector-dropdown-checkbox " aria-label="Toggle the table of contents" > <label id="vector-page-titlebar-toc-label" for="vector-page-titlebar-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span> <span class="vector-dropdown-label-text">Toggle the table of contents</span> </label> <div class="vector-dropdown-content"> <div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">Spironolactone</span></h1> <div id="p-lang-btn" class="vector-dropdown mw-portlet mw-portlet-lang" > <input type="checkbox" id="p-lang-btn-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-p-lang-btn" class="vector-dropdown-checkbox mw-interlanguage-selector" aria-label="Go to an article in another language. Available in 34 languages" > <label id="p-lang-btn-label" for="p-lang-btn-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-34" aria-hidden="true" ><span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span> <span class="vector-dropdown-label-text">34 languages</span> </label> <div class="vector-dropdown-content"> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D8%B3%D8%A8%D9%8A%D8%B1%D9%88%D9%86%D9%88%D9%84%D8%A7%D9%83%D8%AA%D9%88%D9%86" title="سبيرونولاكتون – Arabic" lang="ar" hreflang="ar" data-title="سبيرونولاكتون" data-language-autonym="العربية" data-language-local-name="Arabic" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-azb mw-list-item"><a href="https://azb.wikipedia.org/wiki/%D8%A7%D8%B3%D9%BE%DB%8C%D8%B1%D9%88%D9%86%D9%88%D9%84%D8%A7%DA%A9%D8%AA%D9%88%D9%86" title="اسپیرونولاکتون – South Azerbaijani" lang="azb" hreflang="azb" data-title="اسپیرونولاکتون" data-language-autonym="تۆرکجه" data-language-local-name="South Azerbaijani" class="interlanguage-link-target"><span>تۆرکجه</span></a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/Espironolactona" title="Espironolactona – Catalan" lang="ca" hreflang="ca" data-title="Espironolactona" data-language-autonym="Català" data-language-local-name="Catalan" class="interlanguage-link-target"><span>Català</span></a></li><li class="interlanguage-link interwiki-cy mw-list-item"><a href="https://cy.wikipedia.org/wiki/Spironolacton" title="Spironolacton – Welsh" lang="cy" hreflang="cy" data-title="Spironolacton" data-language-autonym="Cymraeg" data-language-local-name="Welsh" class="interlanguage-link-target"><span>Cymraeg</span></a></li><li class="interlanguage-link interwiki-de mw-list-item"><a href="https://de.wikipedia.org/wiki/Spironolacton" title="Spironolacton – German" lang="de" hreflang="de" data-title="Spironolacton" data-language-autonym="Deutsch" data-language-local-name="German" class="interlanguage-link-target"><span>Deutsch</span></a></li><li class="interlanguage-link interwiki-el mw-list-item"><a href="https://el.wikipedia.org/wiki/%CE%A3%CF%80%CE%B5%CE%B9%CF%81%CE%BF%CE%BD%CE%BF%CE%BB%CE%B1%CE%BA%CF%84%CF%8C%CE%BD%CE%B7" title="Σπειρονολακτόνη – Greek" lang="el" hreflang="el" data-title="Σπειρονολακτόνη" data-language-autonym="Ελληνικά" data-language-local-name="Greek" class="interlanguage-link-target"><span>Ελληνικά</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Espironolactona" title="Espironolactona – Spanish" lang="es" hreflang="es" data-title="Espironolactona" data-language-autonym="Español" data-language-local-name="Spanish" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-eo mw-list-item"><a href="https://eo.wikipedia.org/wiki/Spironolaktono" title="Spironolaktono – Esperanto" lang="eo" hreflang="eo" data-title="Spironolaktono" data-language-autonym="Esperanto" data-language-local-name="Esperanto" class="interlanguage-link-target"><span>Esperanto</span></a></li><li class="interlanguage-link interwiki-eu mw-list-item"><a href="https://eu.wikipedia.org/wiki/Espironolaktona" title="Espironolaktona – Basque" lang="eu" hreflang="eu" data-title="Espironolaktona" data-language-autonym="Euskara" data-language-local-name="Basque" class="interlanguage-link-target"><span>Euskara</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%A7%D8%B3%D9%BE%DB%8C%D8%B1%D9%88%D9%86%D9%88%D9%84%D8%A7%DA%A9%D8%AA%D9%88%D9%86" title="اسپیرونولاکتون – Persian" lang="fa" hreflang="fa" data-title="اسپیرونولاکتون" data-language-autonym="فارسی" data-language-local-name="Persian" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Spironolactone" title="Spironolactone – French" lang="fr" hreflang="fr" data-title="Spironolactone" data-language-autonym="Français" data-language-local-name="French" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/%EC%8A%A4%ED%94%BC%EB%A1%9C%EB%86%80%EB%9D%BD%ED%86%A4" title="스피로놀락톤 – Korean" lang="ko" hreflang="ko" data-title="스피로놀락톤" data-language-autonym="한국어" data-language-local-name="Korean" class="interlanguage-link-target"><span>한국어</span></a></li><li class="interlanguage-link interwiki-hy mw-list-item"><a href="https://hy.wikipedia.org/wiki/%D5%8D%D5%BA%D5%AB%D6%80%D5%B8%D5%B6%D5%B8%D5%AC%D5%A1%D5%AF%D5%BF%D5%B8%D5%B6" title="Սպիրոնոլակտոն – Armenian" lang="hy" hreflang="hy" data-title="Սպիրոնոլակտոն" data-language-autonym="Հայերեն" data-language-local-name="Armenian" class="interlanguage-link-target"><span>Հայերեն</span></a></li><li class="interlanguage-link interwiki-hr mw-list-item"><a href="https://hr.wikipedia.org/wiki/Spironolakton" title="Spironolakton – Croatian" lang="hr" hreflang="hr" data-title="Spironolakton" data-language-autonym="Hrvatski" data-language-local-name="Croatian" class="interlanguage-link-target"><span>Hrvatski</span></a></li><li class="interlanguage-link interwiki-id mw-list-item"><a href="https://id.wikipedia.org/wiki/Spironolakton" title="Spironolakton – Indonesian" lang="id" hreflang="id" data-title="Spironolakton" data-language-autonym="Bahasa Indonesia" data-language-local-name="Indonesian" class="interlanguage-link-target"><span>Bahasa Indonesia</span></a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Spironolattone" title="Spironolattone – Italian" lang="it" hreflang="it" data-title="Spironolattone" data-language-autonym="Italiano" data-language-local-name="Italian" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-lv mw-list-item"><a href="https://lv.wikipedia.org/wiki/Spironolaktons" title="Spironolaktons – Latvian" lang="lv" hreflang="lv" data-title="Spironolaktons" data-language-autonym="Latviešu" data-language-local-name="Latvian" class="interlanguage-link-target"><span>Latviešu</span></a></li><li class="interlanguage-link interwiki-hu mw-list-item"><a href="https://hu.wikipedia.org/wiki/Spironolakton" title="Spironolakton – Hungarian" lang="hu" hreflang="hu" data-title="Spironolakton" data-language-autonym="Magyar" data-language-local-name="Hungarian" class="interlanguage-link-target"><span>Magyar</span></a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Spironolacton" title="Spironolacton – Dutch" lang="nl" hreflang="nl" data-title="Spironolacton" data-language-autonym="Nederlands" data-language-local-name="Dutch" class="interlanguage-link-target"><span>Nederlands</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E3%82%B9%E3%83%94%E3%83%AD%E3%83%8E%E3%83%A9%E3%82%AF%E3%83%88%E3%83%B3" title="スピロノラクトン – Japanese" lang="ja" hreflang="ja" data-title="スピロノラクトン" data-language-autonym="日本語" data-language-local-name="Japanese" class="interlanguage-link-target"><span>日本語</span></a></li><li class="interlanguage-link interwiki-no mw-list-item"><a href="https://no.wikipedia.org/wiki/Spironolakton" title="Spironolakton – Norwegian Bokmål" lang="nb" hreflang="nb" data-title="Spironolakton" data-language-autonym="Norsk bokmål" data-language-local-name="Norwegian Bokmål" class="interlanguage-link-target"><span>Norsk bokmål</span></a></li><li class="interlanguage-link interwiki-or mw-list-item"><a href="https://or.wikipedia.org/wiki/%E0%AC%B8%E0%AD%8D%E0%AC%AA%E0%AC%BE%E0%AC%87%E0%AC%B0%E0%AD%8B%E0%AC%A8%E0%AD%8B%E0%AC%B2%E0%AC%BE%E0%AC%95%E0%AD%8D%E0%AC%9F%E0%AD%8B%E0%AC%A8" title="ସ୍ପାଇରୋନୋଲାକ୍ଟୋନ – Odia" lang="or" hreflang="or" data-title="ସ୍ପାଇରୋନୋଲାକ୍ଟୋନ" data-language-autonym="ଓଡ଼ିଆ" data-language-local-name="Odia" class="interlanguage-link-target"><span>ଓଡ଼ିଆ</span></a></li><li class="interlanguage-link interwiki-ps mw-list-item"><a href="https://ps.wikipedia.org/wiki/%D8%B3%D9%BE%D9%8A%D8%B1%D9%88%D9%86%D9%88%D9%84%DA%A9%D9%BC%D9%88%D9%86" title="سپيرونولکټون – Pashto" lang="ps" hreflang="ps" data-title="سپيرونولکټون" data-language-autonym="پښتو" data-language-local-name="Pashto" class="interlanguage-link-target"><span>پښتو</span></a></li><li class="interlanguage-link interwiki-pl mw-list-item"><a href="https://pl.wikipedia.org/wiki/Spironolakton" title="Spironolakton – Polish" lang="pl" hreflang="pl" data-title="Spironolakton" data-language-autonym="Polski" data-language-local-name="Polish" class="interlanguage-link-target"><span>Polski</span></a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/Espironolactona" title="Espironolactona – Portuguese" lang="pt" hreflang="pt" data-title="Espironolactona" data-language-autonym="Português" data-language-local-name="Portuguese" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Spironolacton%C4%83" title="Spironolactonă – Romanian" lang="ro" hreflang="ro" data-title="Spironolactonă" data-language-autonym="Română" data-language-local-name="Romanian" class="interlanguage-link-target"><span>Română</span></a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%A1%D0%BF%D0%B8%D1%80%D0%BE%D0%BD%D0%BE%D0%BB%D0%B0%D0%BA%D1%82%D0%BE%D0%BD" title="Спиронолактон – Russian" lang="ru" hreflang="ru" data-title="Спиронолактон" data-language-autonym="Русский" data-language-local-name="Russian" class="interlanguage-link-target"><span>Русский</span></a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/Spironolakton" title="Spironolakton – Serbian" lang="sr" hreflang="sr" data-title="Spironolakton" data-language-autonym="Српски / srpski" data-language-local-name="Serbian" class="interlanguage-link-target"><span>Српски / srpski</span></a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Spironolakton" title="Spironolakton – Serbo-Croatian" lang="sh" hreflang="sh" data-title="Spironolakton" data-language-autonym="Srpskohrvatski / српскохрватски" data-language-local-name="Serbo-Croatian" class="interlanguage-link-target"><span>Srpskohrvatski / српскохрватски</span></a></li><li class="interlanguage-link interwiki-fi mw-list-item"><a href="https://fi.wikipedia.org/wiki/Spironolaktoni" title="Spironolaktoni – Finnish" lang="fi" hreflang="fi" data-title="Spironolaktoni" data-language-autonym="Suomi" data-language-local-name="Finnish" class="interlanguage-link-target"><span>Suomi</span></a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/Spironolakton" title="Spironolakton – Turkish" lang="tr" hreflang="tr" data-title="Spironolakton" data-language-autonym="Türkçe" data-language-local-name="Turkish" class="interlanguage-link-target"><span>Türkçe</span></a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/%D0%A1%D0%BF%D1%96%D1%80%D0%BE%D0%BD%D0%BE%D0%BB%D0%B0%D0%BA%D1%82%D0%BE%D0%BD" title="Спіронолактон – Ukrainian" lang="uk" hreflang="uk" data-title="Спіронолактон" data-language-autonym="Українська" data-language-local-name="Ukrainian" class="interlanguage-link-target"><span>Українська</span></a></li><li class="interlanguage-link interwiki-vi mw-list-item"><a href="https://vi.wikipedia.org/wiki/Spironolactone" title="Spironolactone – Vietnamese" lang="vi" hreflang="vi" data-title="Spironolactone" data-language-autonym="Tiếng Việt" data-language-local-name="Vietnamese" class="interlanguage-link-target"><span>Tiếng Việt</span></a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E8%9E%BA%E5%86%85%E9%85%AF" title="螺内酯 – Chinese" lang="zh" hreflang="zh" data-title="螺内酯" data-language-autonym="中文" data-language-local-name="Chinese" class="interlanguage-link-target"><span>中文</span></a></li> </ul> <div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q422188#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div> </div> </div> </div> </header> <div class="vector-page-toolbar"> <div class="vector-page-toolbar-container"> <div id="left-navigation"> <nav aria-label="Namespaces"> <div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Spironolactone" title="View the content page [c]" accesskey="c"><span>Article</span></a></li><li id="ca-talk" class="vector-tab-noicon mw-list-item"><a href="/wiki/Talk:Spironolactone" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t"><span>Talk</span></a></li> </ul> </div> </div> <div id="vector-variants-dropdown" class="vector-dropdown emptyPortlet" > <input type="checkbox" id="vector-variants-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-variants-dropdown" class="vector-dropdown-checkbox " aria-label="Change language variant" > <label id="vector-variants-dropdown-label" for="vector-variants-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">English</span> </label> <div class="vector-dropdown-content"> <div id="p-variants" class="vector-menu mw-portlet mw-portlet-variants emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> </div> </div> </nav> </div> <div id="right-navigation" class="vector-collapsible"> <nav aria-label="Views"> <div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Spironolactone"><span>Read</span></a></li><li id="ca-edit" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Spironolactone&action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-history" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Spironolactone&action=history" title="Past revisions of this page [h]" accesskey="h"><span>View history</span></a></li> </ul> </div> </div> </nav> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-dropdown" class="vector-dropdown vector-page-tools-dropdown" > <input type="checkbox" id="vector-page-tools-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-tools-dropdown" class="vector-dropdown-checkbox " aria-label="Tools" > <label id="vector-page-tools-dropdown-label" for="vector-page-tools-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">Tools</span> </label> <div class="vector-dropdown-content"> <div id="vector-page-tools-unpinned-container" class="vector-unpinned-container"> <div id="vector-page-tools" class="vector-page-tools vector-pinnable-element"> <div class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned" data-feature-name="page-tools-pinned" data-pinnable-element-id="vector-page-tools" data-pinned-container-id="vector-page-tools-pinned-container" data-unpinned-container-id="vector-page-tools-unpinned-container" > <div class="vector-pinnable-header-label">Tools</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button> </div> <div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items" title="More options" > <div class="vector-menu-heading"> Actions </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Spironolactone"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Spironolactone&action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Spironolactone&action=history"><span>View history</span></a></li> </ul> </div> </div> <div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb" > <div class="vector-menu-heading"> General </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Spironolactone" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Spironolactone" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Spironolactone&oldid=1256728327" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Spironolactone&action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&page=Spironolactone&id=1256728327&wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-urlshortener" class="mw-list-item"><a href="/w/index.php?title=Special:UrlShortener&url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FSpironolactone"><span>Get shortened URL</span></a></li><li id="t-urlshortener-qrcode" class="mw-list-item"><a href="/w/index.php?title=Special:QrCode&url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FSpironolactone"><span>Download QR code</span></a></li> </ul> </div> </div> <div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export" > <div class="vector-menu-heading"> Print/export </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&page=Spironolactone&action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Spironolactone&printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li> </ul> </div> </div> <div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects" > <div class="vector-menu-heading"> In other projects </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Spironolactone" hreflang="en"><span>Wikimedia Commons</span></a></li><li id="t-wikibase" class="wb-otherproject-link wb-otherproject-wikibase-dataitem mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q422188" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> </div> </div> </div> <div class="vector-column-end"> <div class="vector-sticky-pinned-container"> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-pinned-container" class="vector-pinned-container"> </div> </nav> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-pinned-container" class="vector-pinned-container"> <div id="vector-appearance" class="vector-appearance vector-pinnable-element"> <div class="vector-pinnable-header vector-appearance-pinnable-header vector-pinnable-header-pinned" data-feature-name="appearance-pinned" data-pinnable-element-id="vector-appearance" data-pinned-container-id="vector-appearance-pinned-container" data-unpinned-container-id="vector-appearance-unpinned-container" > <div class="vector-pinnable-header-label">Appearance</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-appearance.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-appearance.unpin">hide</button> </div> </div> </div> </nav> </div> </div> <div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container> <div class="vector-body-before-content"> <div class="mw-indicators"> </div> <div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div> </div> <div id="contentSub"><div id="mw-content-subtitle"></div></div> <div id="mw-content-text" class="mw-body-content"><div class="mw-content-ltr mw-parser-output" lang="en" dir="ltr"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Steroidal antiandrogen and antimineralocorticoid</div> <style data-mw-deduplicate="TemplateStyles:r1236090951">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}@media print{body.ns-0 .mw-parser-output .hatnote{display:none!important}}</style><div role="note" class="hatnote navigation-not-searchable">Not to be confused with <a href="/wiki/Spirolactone" title="Spirolactone">Spirolactone</a>.</div> <p class="mw-empty-elt"> </p> <style data-mw-deduplicate="TemplateStyles:r1257001546">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme) div:not(.notheme){background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table tr{display:table-row!important}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}</style><table class="infobox" style="border-spacing:2px;"><caption class="infobox-title"><span title="International nonproprietary name (INN): Spironolactone">Spironolactone</span></caption><tbody><tr><td colspan="2" class="infobox-image notheme" style="background-color: #f8f9fa;"><span typeof="mw:File"><a href="/wiki/File:Spironolactone.svg" class="mw-file-description"><img alt="Skeletal formula of spironolactone" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/98/Spironolactone.svg/235px-Spironolactone.svg.png" decoding="async" width="235" height="199" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/98/Spironolactone.svg/353px-Spironolactone.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/98/Spironolactone.svg/470px-Spironolactone.svg.png 2x" data-file-width="1290" data-file-height="1090" /></a></span></td></tr><tr><td colspan="2" class="infobox-image notheme" style="background-color: #f8f9fa;"><span typeof="mw:File"><a href="/wiki/File:Spironolactone_3D_ball.png" class="mw-file-description"><img alt="Ball-and-stick model of the spironolactone molecule" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Spironolactone_3D_ball.png/225px-Spironolactone_3D_ball.png" decoding="async" width="225" height="167" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Spironolactone_3D_ball.png/338px-Spironolactone_3D_ball.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Spironolactone_3D_ball.png/450px-Spironolactone_3D_ball.png 2x" data-file-width="2000" data-file-height="1481" /></a></span></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Clinical data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">Pronunciation</th><td class="infobox-data"><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt" lang="en-fonipa"><a href="/wiki/Help:IPA/English" title="Help:IPA/English">/<span style="border-bottom:1px dotted"><span title="/ˌ/: secondary stress follows">ˌ</span><span title="'s' in 'sigh'">s</span><span title="'p' in 'pie'">p</span><span title="/aɪ/: 'i' in 'tide'">aɪ</span><span title="'r' in 'rye'">r</span><span title="/oʊ/: 'o' in 'code'">oʊ</span><span title="'n' in 'nigh'">n</span><span title="/oʊ/: 'o' in 'code'">oʊ</span><span title="/ˈ/: primary stress follows">ˈ</span><span title="'l' in 'lie'">l</span><span title="/æ/: 'a' in 'bad'">æ</span><span title="'k' in 'kind'">k</span><span title="'t' in 'tie'">t</span><span title="/oʊ/: 'o' in 'code'">oʊ</span><span title="'n' in 'nigh'">n</span></span>/</a></span></span> <a href="/wiki/Help:Pronunciation_respelling_key" title="Help:Pronunciation respelling key"><i title="English pronunciation respelling"><span style="font-size:90%">SPY</span>-roh-noh-<span style="font-size:90%">LAK</span>-tone</i></a>,<sup id="cite_ref-LoughlinGenerali2006_1-0" class="reference"><a href="#cite_note-LoughlinGenerali2006-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup> <span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt" lang="en-fonipa"><a href="/wiki/Help:IPA/English" title="Help:IPA/English">/<span style="border-bottom:1px dotted"><span title="/ˌ/: secondary stress follows">ˌ</span><span title="'s' in 'sigh'">s</span><span title="'p' in 'pie'">p</span><span title="/ɪər/: 'ear' in 'near'">ɪər</span><span title="/oʊ/: 'o' in 'code'">oʊ</span><span title="'n' in 'nigh'">n</span><span title="/oʊ/: 'o' in 'code'">oʊ</span><span title="/ˈ/: primary stress follows">ˈ</span><span title="'l' in 'lie'">l</span><span title="/æ/: 'a' in 'bad'">æ</span><span title="'k' in 'kind'">k</span><span title="'t' in 'tie'">t</span><span title="/oʊ/: 'o' in 'code'">oʊ</span><span title="'n' in 'nigh'">n</span></span>/</a></span></span> <a href="/wiki/Help:Pronunciation_respelling_key" title="Help:Pronunciation respelling key"><i title="English pronunciation respelling"><span style="font-size:90%">SPEER</span>-oh-noh-<span style="font-size:90%">LAK</span>-tone</i></a><sup id="cite_ref-ClarkHarvey2011_2-0" class="reference"><a href="#cite_note-ClarkHarvey2011-2"><span class="cite-bracket">[</span>2<span class="cite-bracket">]</span></a></sup> </td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Drug_nomenclature#Trade_names" title="Drug nomenclature">Trade names</a></th><td class="infobox-data">Aldactone, others</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">Other names</th><td class="infobox-data">SC-9420; NSC-150339; 7α-Acetylthiospirolactone; 7α-Acetylthio-17α-hydroxy-3-oxopregn-4-ene-21-carboxylic acid γ-lactone</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">AHFS</a>/<a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a></th><td class="infobox-data"><span title="www.drugs.com"><a rel="nofollow" class="external text" href="https://www.drugs.com/monograph/spironolactone.html">Monograph</a></span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th><td class="infobox-data"><span title="medlineplus.gov"><a rel="nofollow" class="external text" href="https://medlineplus.gov/druginfo/meds/a682627.html">a682627</a></span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">License data</a></th><td class="infobox-data"><style data-mw-deduplicate="TemplateStyles:r1126788409">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style><div class="plainlist"> <ul><li><small><abbr class="country-name" title="United States">US</abbr></small> <a href="/wiki/DailyMed" title="DailyMed">DailyMed</a>: <span title="dailymed.nlm.nih.gov"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Spironolactone">Spironolactone</a></span></li></ul></div> </td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy<br />category</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"> <ul><li><small><abbr class="country-name" title="Australia">AU</abbr>:</small> B3<sup id="cite_ref-Drugs.com_pregnancy_3-0" class="reference"><a href="#cite_note-Drugs.com_pregnancy-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup></li> <li class="mw-empty-elt"></li></ul> </div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes of<br />administration</a></th><td class="infobox-data"><a href="/wiki/Oral_administration" title="Oral administration">By mouth</a>,<sup id="cite_ref-AHFS2015_4-0" class="reference"><a href="#cite_note-AHFS2015-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Topical_administration" class="mw-redirect" title="Topical administration">topical</a><sup id="cite_ref-FARIDDiamanti-Kandarakis2009_5-0" class="reference"><a href="#cite_note-FARIDDiamanti-Kandarakis2009-5"><span class="cite-bracket">[</span>5<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Drug_class" title="Drug class">Drug class</a></th><td class="infobox-data"><a href="/wiki/Antimineralocorticoid" class="mw-redirect" title="Antimineralocorticoid">Antimineralocorticoid</a>; <a href="/wiki/Steroidal_antiandrogen" title="Steroidal antiandrogen">Steroidal antiandrogen</a></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><a href="/wiki/ATC_code_C03" title="ATC code C03">C03DA01</a> (<span title="www.whocc.no"><a rel="nofollow" class="external text" href="https://www.whocc.no/atc_ddd_index/?code=C03DA01">WHO</a></span>) </li></ul></div></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Legal status</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"> <ul><li><small><abbr class="country-name" title="United Kingdom">UK</abbr>:</small> <a href="/wiki/Prescription_drug" title="Prescription drug">POM</a> (Prescription only)<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span class="cite-bracket">[</span>7<span class="cite-bracket">]</span></a></sup></li> <li><small><abbr class="country-name" title="United States">US</abbr>:</small> <a href="/wiki/Boxed_warning" title="Boxed warning"><span style="border:thin solid black;">WARNING</span></a><sup id="cite_ref-FDA-AllBoxedWarnings_6-0" class="reference"><a href="#cite_note-FDA-AllBoxedWarnings-6"><span class="cite-bracket">[</span>6<span class="cite-bracket">]</span></a></sup>Rx-only<sup id="cite_ref-Aldactone_label_8-0" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup></li> <li><small><abbr class="country-name" title="European Union">EU</abbr>:</small> Rx-only<sup id="cite_ref-Qaialdo_EPAR_9-0" class="reference"><a href="#cite_note-Qaialdo_EPAR-9"><span class="cite-bracket">[</span>9<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span class="cite-bracket">[</span>10<span class="cite-bracket">]</span></a></sup></li></ul></div> </td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd"><a href="/wiki/Pharmacokinetics" title="Pharmacokinetics">Pharmacokinetic</a> data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></th><td class="infobox-data">60–90%<sup id="cite_ref-pmid15947888_11-0" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18729003_12-0" class="reference"><a href="#cite_note-pmid18729003-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-CaroneOxberry2017_13-0" class="reference"><a href="#cite_note-CaroneOxberry2017-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Protein binding</a></th><td class="infobox-data">Spironolactone: 88% (to <a href="/wiki/Human_serum_albumin" title="Human serum albumin">albumin</a> and <a href="/wiki/Alpha-1-acid_glycoprotein" class="mw-redirect" title="Alpha-1-acid glycoprotein"><abbr title="alpha-1-acid glycoprotein">AGP</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip alpha-1-acid glycoprotein</span>)<sup id="cite_ref-TakamuraMaruyama1997_14-0" class="reference"><a href="#cite_note-TakamuraMaruyama1997-14"><span class="cite-bracket">[</span>14<span class="cite-bracket">]</span></a></sup><br />Canrenone: 99.2% (to albumin)<sup id="cite_ref-TakamuraMaruyama1997_14-1" class="reference"><a href="#cite_note-TakamuraMaruyama1997-14"><span class="cite-bracket">[</span>14<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></th><td class="infobox-data"><a href="/wiki/Liver" title="Liver">Liver</a>, others:<br />• <a href="/wiki/Deacetylation" class="mw-redirect" title="Deacetylation">Deacetylation</a> via <a href="/wiki/Carboxylesterase" title="Carboxylesterase"><abbr title="carboxylesterase">CES</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip carboxylesterase</span><br />• <i>S</i>-<a href="/wiki/Oxidation" class="mw-redirect" title="Oxidation">Oxygenation</a> via <a href="/wiki/Flavin-containing_monooxygenase" title="Flavin-containing monooxygenase"><abbr title="flavin-containing monooxygenase">FOM</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip flavin-containing monooxygenase</span><br />• <i>S</i>-<a href="/wiki/Methylation" title="Methylation">Methylation</a> via <a href="/wiki/Thiol_S-methyltransferase" title="Thiol S-methyltransferase"><abbr title="thiol S-methyltransferase">TMT</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip thiol S-methyltransferase</span><br />• <a href="/wiki/Dethioacetylation" class="mw-redirect" title="Dethioacetylation">Dethioacetylation</a><br />• <a href="/wiki/Hydroxylation" title="Hydroxylation">Hydroxylation</a> via <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a><br />• <a href="/wiki/Lactone" title="Lactone">Lactone</a> <a href="/wiki/Hydrolysis" title="Hydrolysis">hydrolysis</a> via <a href="/wiki/PON3" title="PON3">PON3</a><sup id="cite_ref-pmid15947888_11-6" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18729003_12-3" class="reference"><a href="#cite_note-pmid18729003-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Parkinson2001_17-0" class="reference"><a href="#cite_note-Parkinson2001-17"><span class="cite-bracket">[</span>17<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Klaassen2007_18-0" class="reference"><a href="#cite_note-Klaassen2007-18"><span class="cite-bracket">[</span>18<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid7895608_19-0" class="reference"><a href="#cite_note-pmid7895608-19"><span class="cite-bracket">[</span>19<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BlackElliott2006_20-0" class="reference"><a href="#cite_note-BlackElliott2006-20"><span class="cite-bracket">[</span>20<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid14579013_21-0" class="reference"><a href="#cite_note-pmid14579013-21"><span class="cite-bracket">[</span>21<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Metabolite" title="Metabolite">Metabolites</a></th><td class="infobox-data"><a href="/wiki/7%CE%B1-Thiospironolactone" title="7α-Thiospironolactone"><abbr title="7α-Thiospironolactone">7α-TS</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip 7α-Thiospironolactone</span>, <a href="/wiki/7%CE%B1-thiomethylspironolactone" class="mw-redirect" title="7α-thiomethylspironolactone"><abbr title="7α-thiomethylspironolactone">7α-TMS</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip 7α-thiomethylspironolactone</span>, <a href="/wiki/6%CE%B2-hydroxy-7%CE%B1-thiomethylspironolactone" class="mw-redirect" title="6β-hydroxy-7α-thiomethylspironolactone"><abbr title="6β-hydroxy-7α-thiomethylspironolactone">6β-OH-7α-TMS</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip 6β-hydroxy-7α-thiomethylspironolactone</span>, <a href="/wiki/Canrenone" title="Canrenone">canrenone</a>, others<sup id="cite_ref-pmid15947888_11-1" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18729003_12-1" class="reference"><a href="#cite_note-pmid18729003-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-SzaszBudvari-Barany1990_15-0" class="reference"><a href="#cite_note-SzaszBudvari-Barany1990-15"><span class="cite-bracket">[</span>15<span class="cite-bracket">]</span></a></sup><br />(All three active)<sup id="cite_ref-McDonaghGardner2011_16-0" class="reference"><a href="#cite_note-McDonaghGardner2011-16"><span class="cite-bracket">[</span>16<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Biological_half-life" title="Biological half-life">Elimination <span class="nowrap">half-life</span></a></th><td class="infobox-data">Spironolactone: 1.4 hrs<sup id="cite_ref-pmid15947888_11-2" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><br /><a href="/wiki/7%CE%B1-thiomethylspironolactone" class="mw-redirect" title="7α-thiomethylspironolactone"><abbr title="7α-thiomethylspironolactone">7α-TMS</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip 7α-thiomethylspironolactone</span>: 13.8 hours<sup id="cite_ref-pmid15947888_11-3" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><br /><a href="/wiki/6%CE%B2-hydroxy-7%CE%B1-thiomethylspironolactone" class="mw-redirect" title="6β-hydroxy-7α-thiomethylspironolactone"><abbr title="6β-hydroxy-7α-thiomethylspironolactone">6β-OH-7α-TMS</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip 6β-hydroxy-7α-thiomethylspironolactone</span>: 15.0 hrs<sup id="cite_ref-pmid15947888_11-4" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><br /><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a>: 16.5 hours<sup id="cite_ref-pmid15947888_11-5" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></th><td class="infobox-data"><a href="/wiki/Urine" title="Urine">Urine</a>, <a href="/wiki/Bile" title="Bile">bile</a><sup id="cite_ref-pmid18729003_12-2" class="reference"><a href="#cite_note-pmid18729003-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Identifiers</th></tr><tr><td colspan="2" class="infobox-full-data"><div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;"> <div style="line-height: 1.6em; font-weight: bold;"><div><a href="/wiki/IUPAC_nomenclature_of_chemistry" title="IUPAC nomenclature of chemistry">IUPAC name</a></div></div> <ul class="mw-collapsible-content" style="margin-top: 0; margin-bottom: 0; line-height: inherit; list-style: none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em;"><li style="line-height: inherit; margin: 0"><div style="font-size: 97%;"><i>S</i>-[(7<i>R</i>,8<i>R</i>,9<i>S</i>,10<i>R</i>,13<i>S</i>,14<i>S</i>,17<i>R</i>)-10,13-Dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1<i>H</i>-cyclopenta[<i>a</i>]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate</div></li></ul> </div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/CAS_Registry_Number" title="CAS Registry Number">CAS Number</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="commonchemistry.cas.org"><a rel="nofollow" class="external text" href="https://commonchemistry.cas.org/detail?cas_rn=52-01-7">52-01-7</a></span><sup> <span typeof="mw:File"><span><img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/PubChem#CID" title="PubChem">PubChem</a> <span style="font-weight:normal"><abbr title="Compound ID">CID</abbr></span></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="pubchem.ncbi.nlm.nih.gov"><a rel="nofollow" class="external text" href="https://pubchem.ncbi.nlm.nih.gov/compound/5833">5833</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Guide_to_Pharmacology" title="Guide to Pharmacology">IUPHAR/BPS</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.guidetopharmacology.org"><a rel="nofollow" class="external text" href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2875">2875</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.drugbank.ca"><a rel="nofollow" class="external text" href="https://www.drugbank.ca/drugs/DB00421">DB00421</a></span><sup> <span typeof="mw:File"><span><img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.chemspider.com"><a rel="nofollow" class="external text" href="https://www.chemspider.com/Chemical-Structure.5628.html">5628</a></span><sup> <span typeof="mw:File"><span><img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Unique_Ingredient_Identifier" title="Unique Ingredient Identifier">UNII</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="precision.fda.gov"><a rel="nofollow" class="external text" href="https://precision.fda.gov/uniisearch/srs/unii/27O7W4T232">27O7W4T232</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/KEGG" title="KEGG">KEGG</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.kegg.jp"><a rel="nofollow" class="external text" href="https://www.kegg.jp/entry/D00443">D00443</a></span><sup> <span typeof="mw:File"><span><img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ChEBI" title="ChEBI">ChEBI</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.ebi.ac.uk"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9241">CHEBI:9241</a></span><sup> <span typeof="mw:File"><span><img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ChEMBL" title="ChEMBL">ChEMBL</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.ebi.ac.uk"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembl/explore/compound/ChEMBL1393">ChEMBL1393</a></span><sup> <span typeof="mw:File"><span><img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/CompTox_Chemicals_Dashboard" title="CompTox Chemicals Dashboard">CompTox Dashboard</a> <span style="font-weight:normal">(<abbr title="U.S. Environmental Protection Agency">EPA</abbr>)</span></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="comptox.epa.gov"><a rel="nofollow" class="external text" href="https://comptox.epa.gov/dashboard/chemical/details/DTXSID6034186">DTXSID6034186</a> <span class="mw-valign-text-top noprint" typeof="mw:File/Frameless"><a href="https://www.wikidata.org/wiki/Q422188#P3117" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></span></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ECHA_InfoCard" class="mw-redirect" title="ECHA InfoCard"><span title="echa.europa.eu">ECHA InfoCard</span></a></th><td class="infobox-data"><a rel="nofollow" class="external text" href="https://echa.europa.eu/substance-information/-/substanceinfo/100.000.122">100.000.122</a> <span class="mw-valign-text-top noprint" typeof="mw:File/Frameless"><a href="https://www.wikidata.org/wiki/Q422188#P2566" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></span></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></th><td class="infobox-data"><span title="Carbon">C</span><sub>24</sub><span title="Hydrogen">H</span><sub>32</sub><span title="Oxygen">O</span><sub>4</sub><span title="Sulfur">S</span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Molar_mass" title="Molar mass">Molar mass</a></th><td class="infobox-data"><span class="nowrap"><span data-sort-value="7002416580000000000♠"></span>416.58</span> g·mol<sup>−1</sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">3D model (<a href="/wiki/JSmol" class="mw-redirect" title="JSmol">JSmol</a>)</th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="chemapps.stolaf.edu (3D interactive model)"><a rel="nofollow" class="external text" href="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC5O%5BC%40%40%5D4%28%5BC%40%40%5D3%28%5BC%40H%5D%28%5BC%40%40H%5D2%5BC%40H%5D%28SC%28%3DO%29C%29C%2FC1%3DC%2FC%28%3DO%29CC%5BC%40%5D1%28C%29%5BC%40H%5D2CC3%29CC4%29C%29CC5">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Melting_point" title="Melting point">Melting point</a></th><td class="infobox-data">134 to 135 °C (273 to 275 °F)</td></tr><tr><td colspan="2" class="infobox-full-data"><div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;"> <div style="line-height: 1.6em; font-weight: bold;"><div><a href="/wiki/Simplified_molecular-input_line-entry_system" class="mw-redirect" title="Simplified molecular-input line-entry system">SMILES</a></div></div> <ul class="mw-collapsible-content" style="margin-top: 0; margin-bottom: 0; line-height: inherit; list-style: none; margin-left: 0; word-break:break-all;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">O=C5O[C@@]4([C@@]3([C@H]([C@@H]2[C@H](SC(=O)C)C/C1=C/C(=O)CC[C@]1(C)[C@H]2CC3)CC4)C)CC5</div></li></ul> </div></td></tr><tr><td colspan="2" class="infobox-full-data"><div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;"> <div style="line-height: 1.6em; font-weight: bold;"><div><a href="/wiki/International_Chemical_Identifier" title="International Chemical Identifier">InChI</a></div></div> <ul class="mw-collapsible-content" style="margin-top: 0; margin-bottom: 0; line-height: inherit; list-style: none; margin-left: 0; word-break:break-all;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">InChI=1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1<sup> <span typeof="mw:File"><span><img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /></span></span><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">Key:LXMSZDCAJNLERA-ZHYRCANASA-N<sup> <span typeof="mw:File"><span><img alt="check" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" decoding="async" width="7" height="7" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /></span></span><span style="display:none">Y</span></sup></div></li></ul> </div></td></tr><tr><td colspan="2" class="infobox-below"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold">  <span class="reflink plainlinks nourlexpansion"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470470172&page2=Spironolactone">(verify)</a></span></span></td></tr></tbody></table> <figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Spironolacton_-_25_mg_%C3%BCberzogene_Tabletten_-_Verpackung_f%C3%BCr_Deutschland_-_Tabletten_mit_Verpackung.jpg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Spironolacton_-_25_mg_%C3%BCberzogene_Tabletten_-_Verpackung_f%C3%BCr_Deutschland_-_Tabletten_mit_Verpackung.jpg/220px-Spironolacton_-_25_mg_%C3%BCberzogene_Tabletten_-_Verpackung_f%C3%BCr_Deutschland_-_Tabletten_mit_Verpackung.jpg" decoding="async" width="220" height="111" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Spironolacton_-_25_mg_%C3%BCberzogene_Tabletten_-_Verpackung_f%C3%BCr_Deutschland_-_Tabletten_mit_Verpackung.jpg/330px-Spironolacton_-_25_mg_%C3%BCberzogene_Tabletten_-_Verpackung_f%C3%BCr_Deutschland_-_Tabletten_mit_Verpackung.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Spironolacton_-_25_mg_%C3%BCberzogene_Tabletten_-_Verpackung_f%C3%BCr_Deutschland_-_Tabletten_mit_Verpackung.jpg/440px-Spironolacton_-_25_mg_%C3%BCberzogene_Tabletten_-_Verpackung_f%C3%BCr_Deutschland_-_Tabletten_mit_Verpackung.jpg 2x" data-file-width="11776" data-file-height="5928" /></a><figcaption>Spironolactone 25 mg</figcaption></figure> <p><b>Spironolactone</b>, sold under the brand name <b>Aldactone</b> among others, is a <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> <a href="/wiki/Medication" title="Medication">medication</a> primarily used to treat <a href="/wiki/Edema" title="Edema">fluid build-up</a> due to <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a>, <a href="/wiki/Hepatic_cirrhosis" class="mw-redirect" title="Hepatic cirrhosis">liver scarring</a>, or <a href="/wiki/Kidney_disease" title="Kidney disease">kidney disease</a>.<sup id="cite_ref-AHFS2015_4-1" class="reference"><a href="#cite_note-AHFS2015-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> It is also used in the treatment of <a href="/wiki/Hypertension" title="Hypertension">high blood pressure</a>, and <a href="/wiki/Hypokalemia" title="Hypokalemia">low blood potassium</a> that does not improve with <a href="/wiki/Potassium#Supplementation" title="Potassium">supplementation</a>, <a href="/wiki/Precocious_puberty" title="Precocious puberty">early puberty</a> in boys, <a href="/wiki/Acne" title="Acne">acne</a> and <a href="/wiki/Hirsutism" title="Hirsutism">excessive hair growth</a> in women.<sup id="cite_ref-AHFS2015_4-2" class="reference"><a href="#cite_note-AHFS2015-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span class="cite-bracket">[</span>22<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span class="cite-bracket">[</span>23<span class="cite-bracket">]</span></a></sup> Spironolactone is taken <a href="/wiki/Oral_administration" title="Oral administration">by mouth</a>.<sup id="cite_ref-AHFS2015_4-3" class="reference"><a href="#cite_note-AHFS2015-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> </p><p>Common <a href="/wiki/Side_effect" title="Side effect">side effects</a> include <a href="/wiki/Electrolyte_abnormalities" class="mw-redirect" title="Electrolyte abnormalities">electrolyte abnormalities</a>, particularly <a href="/wiki/Hyperkalemia" title="Hyperkalemia">high blood potassium</a>, nausea, vomiting, headache, rashes, and a decreased desire for sex.<sup id="cite_ref-AHFS2015_4-4" class="reference"><a href="#cite_note-AHFS2015-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> In those with liver or kidney problems, extra care should be taken.<sup id="cite_ref-AHFS2015_4-5" class="reference"><a href="#cite_note-AHFS2015-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> Spironolactone has not been well studied in pregnancy and should not be used to treat <a href="/wiki/High_blood_pressure_of_pregnancy" class="mw-redirect" title="High blood pressure of pregnancy">high blood pressure of pregnancy</a>.<sup id="cite_ref-Drugs.com_pregnancy_3-1" class="reference"><a href="#cite_note-Drugs.com_pregnancy-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup> It is also a <a href="/wiki/Steroid" title="Steroid">steroid</a> that <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">blocks</a> the effects of the <a href="/wiki/Hormone" title="Hormone">hormones</a> <a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a> and, to a lesser degree, <a href="/wiki/Testosterone" title="Testosterone">testosterone</a>, causing some <a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">estrogen</a>-like effects.<sup id="cite_ref-Burinkul_2021_24-0" class="reference"><a href="#cite_note-Burinkul_2021-24"><span class="cite-bracket">[</span>24<span class="cite-bracket">]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Reliable_sources" title="Wikipedia:Reliable sources"><span title="The material near this tag may rely on an unreliable source. primary (July 2024)">unreliable source?</span></a></i>]</sup><sup id="cite_ref-Sehgal_2023_25-0" class="reference"><a href="#cite_note-Sehgal_2023-25"><span class="cite-bracket">[</span>25<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-ineffectiveness_in_HRT_26-0" class="reference"><a href="#cite_note-ineffectiveness_in_HRT-26"><span class="cite-bracket">[</span>26<span class="cite-bracket">]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may rely on an unreliable or less reliable medical source. (July 2024)">unreliable medical source?</span></a></i>]</sup><sup id="cite_ref-AHFS2015_4-6" class="reference"><a href="#cite_note-AHFS2015-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Deedwania2014_27-0" class="reference"><a href="#cite_note-Deedwania2014-27"><span class="cite-bracket">[</span>27<span class="cite-bracket">]</span></a></sup> Spironolactone belongs to a class of medications known as <a href="/wiki/Potassium-sparing_diuretic" title="Potassium-sparing diuretic">potassium-sparing diuretics</a>.<sup id="cite_ref-AHFS2015_4-7" class="reference"><a href="#cite_note-AHFS2015-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone was discovered in 1957, and was introduced in 1959.<sup id="cite_ref-OttowWeinmann2008_28-0" class="reference"><a href="#cite_note-OttowWeinmann2008-28"><span class="cite-bracket">[</span>28<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Wermuth2008_29-0" class="reference"><a href="#cite_note-Wermuth2008-29"><span class="cite-bracket">[</span>29<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Sittig1988_30-0" class="reference"><a href="#cite_note-Sittig1988-30"><span class="cite-bracket">[</span>30<span class="cite-bracket">]</span></a></sup> It is on the <a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">World Health Organization's List of Essential Medicines</a>.<sup id="cite_ref-WHO23rd_31-0" class="reference"><a href="#cite_note-WHO23rd-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup> It is available as a <a href="/wiki/Generic_medication" class="mw-redirect" title="Generic medication">generic medication</a>.<sup id="cite_ref-AHFS2015_4-8" class="reference"><a href="#cite_note-AHFS2015-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> In 2022, it was the 52nd most commonly prescribed medication in the United States, with more than 12<span class="nowrap"> </span>million prescriptions.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span class="cite-bracket">[</span>32<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span class="cite-bracket">[</span>33<span class="cite-bracket">]</span></a></sup> Spironolactone has a history of use in the trans community.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span class="cite-bracket">[</span>34<span class="cite-bracket">]</span></a></sup> Its use continues despite the rise of various accessible alternatives such as <a href="/wiki/Bicalutamide" title="Bicalutamide">bicalutamide</a> and <a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">cyproterone acetate</a> with more precise action and less side effects.<sup id="cite_ref-Burinkul_2021_24-1" class="reference"><a href="#cite_note-Burinkul_2021-24"><span class="cite-bracket">[</span>24<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Sehgal_2023_25-1" class="reference"><a href="#cite_note-Sehgal_2023-25"><span class="cite-bracket">[</span>25<span class="cite-bracket">]</span></a></sup> </p> <style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc" /></div> <div class="mw-heading mw-heading2"><h2 id="Medical_uses">Medical uses</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=1" title="Edit section: Medical uses"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone is used primarily to treat <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a>, <a href="/wiki/Edema" title="Edema">edematous</a> conditions such as <a href="/wiki/Nephrotic_syndrome" title="Nephrotic syndrome">nephrotic syndrome</a> or <a href="/wiki/Ascites" title="Ascites">ascites</a> in people with <a href="/wiki/Liver_disease" title="Liver disease">liver disease</a>, essential <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, <a href="/wiki/Hypokalemia" title="Hypokalemia">low blood levels of potassium</a>, <a href="/wiki/Secondary_hyperaldosteronism" class="mw-redirect" title="Secondary hyperaldosteronism">secondary hyperaldosteronism</a> (such as occurs with <a href="/wiki/Liver_cirrhosis" class="mw-redirect" title="Liver cirrhosis">liver cirrhosis</a>), and <a href="/wiki/Conn%27s_syndrome" class="mw-redirect" title="Conn's syndrome">Conn's syndrome</a> (primary hyperaldosteronism).<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag needs references to reliable medical sources. (July 2024)">medical citation needed</span></a></i>]</sup> The most common use of spironolactone is in the treatment of heart failure.<sup id="cite_ref-RoncoBellomo2017_35-0" class="reference"><a href="#cite_note-RoncoBellomo2017-35"><span class="cite-bracket">[</span>35<span class="cite-bracket">]</span></a></sup> On its own, spironolactone is only a weak <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> because it primarily targets the <a href="/wiki/Distal_nephron" class="mw-redirect" title="Distal nephron">distal nephron</a> (<a href="/wiki/Collecting_duct_system" title="Collecting duct system">collecting tubule</a>), where only small amounts of <a href="/wiki/Sodium" title="Sodium">sodium</a> are reabsorbed, but it can be combined with other diuretics to increase efficacy.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag needs references to reliable medical sources. (July 2024)">medical citation needed</span></a></i>]</sup> The classification of spironolactone as a "potassium-sparing diuretic" has been described as obsolete.<sup id="cite_ref-pmid10760075_36-0" class="reference"><a href="#cite_note-pmid10760075-36"><span class="cite-bracket">[</span>36<span class="cite-bracket">]</span></a></sup> Spironolactone is also used to treat <a href="/wiki/Bartter%27s_syndrome" class="mw-redirect" title="Bartter's syndrome">Bartter's syndrome</a> due to its ability to raise potassium levels.<sup id="cite_ref-EndouHosoyamada1995_37-0" class="reference"><a href="#cite_note-EndouHosoyamada1995-37"><span class="cite-bracket">[</span>37<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone has antiandrogenic activity. For this reason, it is used to treat a variety of <a href="/wiki/Dermatological_condition" class="mw-redirect" title="Dermatological condition">dermatological conditions</a> in which androgens play a role. Some of these uses include <a href="/wiki/Acne" title="Acne">acne</a>, <a href="/wiki/Seborrhea" class="mw-redirect" title="Seborrhea">seborrhea</a>, <a href="/wiki/Hirsutism" title="Hirsutism">hirsutism</a>, and <a href="/wiki/Pattern_hair_loss" title="Pattern hair loss">pattern hair loss</a> in women.<sup id="cite_ref-pmid2969259_38-0" class="reference"><a href="#cite_note-pmid2969259-38"><span class="cite-bracket">[</span>38<span class="cite-bracket">]</span></a></sup> Spironolactone is used for the treatment of hirsutism in the United States.<sup id="cite_ref-Preedy2012_39-0" class="reference"><a href="#cite_note-Preedy2012-39"><span class="cite-bracket">[</span>39<span class="cite-bracket">]</span></a></sup> High doses of spironolactone, which are needed for considerable antiandrogenic effects, are not recommended for men due to the high risk of <a href="/wiki/Feminization_(biology)" title="Feminization (biology)">feminization</a> and other side effects. Spironolactone can be used to treat <a href="/wiki/Symptom" class="mw-redirect" title="Symptom">symptoms</a> of <a href="/wiki/Hyperandrogenism" title="Hyperandrogenism">hyperandrogenism</a>, such as due to <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a>.<sup id="cite_ref-pmid3143568_40-0" class="reference"><a href="#cite_note-pmid3143568-40"><span class="cite-bracket">[</span>40<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Heart_failure">Heart failure</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=2" title="Edit section: Heart failure"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>While <a href="/wiki/Loop_diuretics" class="mw-redirect" title="Loop diuretics">loop diuretics</a> remain first-line for most people with <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a>, spironolactone has shown to reduce both morbidity and mortality in numerous studies and remains an important agent for treating fluid retention, edema, and symptoms of heart failure. Current recommendations from the <a href="/wiki/American_Heart_Association" title="American Heart Association">American Heart Association</a> are to use spironolactone in patients with NYHA Class II-IV heart failure who have a left ventricular <a href="/wiki/Ejection_fraction" title="Ejection fraction">ejection fraction</a> of less than 35%.<sup id="cite_ref-Yancy_e147-239_41-0" class="reference"><a href="#cite_note-Yancy_e147-239-41"><span class="cite-bracket">[</span>41<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone improves left ventricular <a href="/wiki/Diastolic_function" title="Diastolic function">diastolic function</a> in patients with <a href="/wiki/Heart_failure_with_preserved_ejection_fraction" title="Heart failure with preserved ejection fraction">heart failure with preserved ejection fraction</a>, however it has no effect on mortality and hospitalization.<sup id="cite_ref-Li_2018_42-0" class="reference"><a href="#cite_note-Li_2018-42"><span class="cite-bracket">[</span>42<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Kosmas_2018_43-0" class="reference"><a href="#cite_note-Kosmas_2018-43"><span class="cite-bracket">[</span>43<span class="cite-bracket">]</span></a></sup> </p><p>Due to its antiandrogenic properties, spironolactone can cause effects associated with low androgen levels and <a href="/wiki/Hypogonadism" title="Hypogonadism">hypogonadism</a> in males. For this reason, men are typically not prescribed spironolactone for any longer than a short period of time, e.g., for an acute exacerbation of heart failure. A newer medication, <a href="/wiki/Eplerenone" title="Eplerenone">eplerenone</a>, has been approved by the US <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) for the treatment of heart failure, and lacks the antiandrogenic effects of spironolactone. As such, it is far more suitable for men for whom long-term medication is being chosen. However, eplerenone may not be as effective as spironolactone or the related medication <a href="/wiki/Canrenone" title="Canrenone">canrenone</a> in reducing mortality from heart failure.<sup id="cite_ref-pmid22840667_44-0" class="reference"><a href="#cite_note-pmid22840667-44"><span class="cite-bracket">[</span>44<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="High_blood_pressure">High blood pressure</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=3" title="Edit section: High blood pressure"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>About 1 in 100 people with hypertension have elevated levels of aldosterone; in these people, the antihypertensive effect of spironolactone may exceed that of complex combined regimens of other antihypertensives since it targets the primary cause of the elevated blood pressure. However, a <a href="/wiki/Cochrane_review" class="mw-redirect" title="Cochrane review">Cochrane review</a> found adverse effects at high doses and little effect on blood pressure at low doses in the majority of people with high blood pressure.<sup id="cite_ref-Bat2010_45-0" class="reference"><a href="#cite_note-Bat2010-45"><span class="cite-bracket">[</span>45<span class="cite-bracket">]</span></a></sup> There is no evidence of person-oriented outcome at any dose in this group.<sup id="cite_ref-Bat2010_45-1" class="reference"><a href="#cite_note-Bat2010-45"><span class="cite-bracket">[</span>45<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="High_aldosterone_levels">High aldosterone levels</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=4" title="Edit section: High aldosterone levels"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone is used in the treatment of <a href="/wiki/Hyperaldosteronism" title="Hyperaldosteronism">hyperaldosteronism</a> (high aldosterone levels or mineralocorticoid excess), for instance <a href="/wiki/Primary_aldosteronism" title="Primary aldosteronism">primary aldosteronism</a> (Conn's syndrome).<sup id="cite_ref-pmid30854950_46-0" class="reference"><a href="#cite_note-pmid30854950-46"><span class="cite-bracket">[</span>46<span class="cite-bracket">]</span></a></sup> Antimineralocorticoids like spironolactone and <a href="/wiki/Eplerenone" title="Eplerenone">eplerenone</a> are <a href="/wiki/First-line_treatment" class="mw-redirect" title="First-line treatment">first-line treatments</a> for hyperaldosteronism.<sup id="cite_ref-pmid30854950_46-1" class="reference"><a href="#cite_note-pmid30854950-46"><span class="cite-bracket">[</span>46<span class="cite-bracket">]</span></a></sup> They improve blood pressure and potassium levels, as well as <a href="/wiki/Left_ventricular_hypertrophy" title="Left ventricular hypertrophy">left ventricular hypertrophy</a>, <a href="/wiki/Albuminuria" title="Albuminuria">albuminuria</a>, and <a href="/wiki/Carotid_intima-media_thickness" class="mw-redirect" title="Carotid intima-media thickness">carotid intima-media thickness</a>, in people with primary aldosteronism.<sup id="cite_ref-pmid30854950_46-2" class="reference"><a href="#cite_note-pmid30854950-46"><span class="cite-bracket">[</span>46<span class="cite-bracket">]</span></a></sup> In people with hyperaldosteronism due to unilateral aldosterone-producing <a href="/wiki/Adrenocortical_adenoma" title="Adrenocortical adenoma">adrenocortical adenoma</a>, <a href="/wiki/Adrenalectomy" title="Adrenalectomy">adrenalectomy</a> should be preferred instead of antimineralocorticoids.<sup id="cite_ref-pmid30854950_46-3" class="reference"><a href="#cite_note-pmid30854950-46"><span class="cite-bracket">[</span>46<span class="cite-bracket">]</span></a></sup> Spironolactone should not be used to treat primary aldosteronism in pregnancy due to its antiandrogen-related risk of <a href="/wiki/Teratogen" class="mw-redirect" title="Teratogen">teratogenicity</a> in male fetuses.<sup id="cite_ref-pmid35536535_47-0" class="reference"><a href="#cite_note-pmid35536535-47"><span class="cite-bracket">[</span>47<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid27156905_48-0" class="reference"><a href="#cite_note-pmid27156905-48"><span class="cite-bracket">[</span>48<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid25163723_49-0" class="reference"><a href="#cite_note-pmid25163723-49"><span class="cite-bracket">[</span>49<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid32586668_50-0" class="reference"><a href="#cite_note-pmid32586668-50"><span class="cite-bracket">[</span>50<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Skin_and_hair_conditions">Skin and hair conditions</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=5" title="Edit section: Skin and hair conditions"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Androgens like testosterone and DHT play a critical role in the <a href="/wiki/Pathogenesis" title="Pathogenesis">pathogenesis</a> of a number of <a href="/wiki/Cutaneous_condition" class="mw-redirect" title="Cutaneous condition">dermatological conditions</a> including <a href="/wiki/Oily_skin" class="mw-redirect" title="Oily skin">oily skin</a>, <a href="/wiki/Acne" title="Acne">acne</a>, <a href="/wiki/Seborrhea" class="mw-redirect" title="Seborrhea">seborrhea</a>, <a href="/wiki/Hirsutism" title="Hirsutism">hirsutism</a> (excessive facial/body hair growth in women), and <a href="/wiki/Male_pattern_hair_loss" class="mw-redirect" title="Male pattern hair loss">male pattern hair loss</a> (androgenic alopecia).<sup id="cite_ref-pmid15507105_51-0" class="reference"><a href="#cite_note-pmid15507105-51"><span class="cite-bracket">[</span>51<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28979664_52-0" class="reference"><a href="#cite_note-pmid28979664-52"><span class="cite-bracket">[</span>52<span class="cite-bracket">]</span></a></sup> In demonstration of this, women with <a href="/wiki/Complete_androgen_insensitivity_syndrome" title="Complete androgen insensitivity syndrome">complete androgen insensitivity syndrome</a> (CAIS) do not produce <a href="/wiki/Sebum" class="mw-redirect" title="Sebum">sebum</a> or develop acne and have little to no <a href="/wiki/Body_hair" title="Body hair">body</a>, <a href="/wiki/Pubic_hair" title="Pubic hair">pubic</a>, or <a href="/wiki/Axillary_hair" class="mw-redirect" title="Axillary hair">axillary hair</a>.<sup id="cite_ref-ShalitaRosso2011_53-0" class="reference"><a href="#cite_note-ShalitaRosso2011-53"><span class="cite-bracket">[</span>53<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-ZouboulisKatsambas2014_54-0" class="reference"><a href="#cite_note-ZouboulisKatsambas2014-54"><span class="cite-bracket">[</span>54<span class="cite-bracket">]</span></a></sup> Moreover, men with <a href="/wiki/Congenital_disorder" class="mw-redirect" title="Congenital disorder">congenital</a> <a href="/wiki/5%CE%B1-reductase_deficiency" class="mw-redirect" title="5α-reductase deficiency">5α-reductase type II deficiency</a>, <a href="/wiki/5%CE%B1-reductase" class="mw-redirect" title="5α-reductase">5α-reductase</a> being an <a href="/wiki/Enzyme" title="Enzyme">enzyme</a> that greatly potentiates the androgenic effects of testosterone in the skin, have little to no acne, scanty <a href="/wiki/Facial_hair" title="Facial hair">facial hair</a>, reduced body hair, and reportedly no incidence of male-pattern hair loss.<sup id="cite_ref-pmid16985920_55-0" class="reference"><a href="#cite_note-pmid16985920-55"><span class="cite-bracket">[</span>55<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Sloane2002_56-0" class="reference"><a href="#cite_note-Sloane2002-56"><span class="cite-bracket">[</span>56<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-HannoGuzzo2014_57-0" class="reference"><a href="#cite_note-HannoGuzzo2014-57"><span class="cite-bracket">[</span>57<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Harper2007_58-0" class="reference"><a href="#cite_note-Harper2007-58"><span class="cite-bracket">[</span>58<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Blume-PeytaviWhiting2008_59-0" class="reference"><a href="#cite_note-Blume-PeytaviWhiting2008-59"><span class="cite-bracket">[</span>59<span class="cite-bracket">]</span></a></sup> Conversely, <a href="/wiki/Hyperandrogenism" title="Hyperandrogenism">hyperandrogenism</a> in women, for instance due to <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a> (PCOS) or <a href="/wiki/Congenital_adrenal_hyperplasia" title="Congenital adrenal hyperplasia">congenital adrenal hyperplasia</a> (CAH), is commonly associated with acne and hirsutism as well as <a href="/wiki/Virilization" title="Virilization">virilization</a> (masculinization) in general.<sup id="cite_ref-pmid15507105_51-1" class="reference"><a href="#cite_note-pmid15507105-51"><span class="cite-bracket">[</span>51<span class="cite-bracket">]</span></a></sup> In accordance with the preceding, <a href="/wiki/Antiandrogen" title="Antiandrogen">antiandrogens</a> are highly effective in the treatment of the aforementioned <a href="/wiki/Androgen-dependent_condition" title="Androgen-dependent condition">androgen-dependent</a> skin and hair conditions.<sup id="cite_ref-pmid9420861_60-0" class="reference"><a href="#cite_note-pmid9420861-60"><span class="cite-bracket">[</span>60<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid20082945_61-0" class="reference"><a href="#cite_note-pmid20082945-61"><span class="cite-bracket">[</span>61<span class="cite-bracket">]</span></a></sup> </p><p>Because of the antiandrogenic activity of spironolactone, it can be quite effective in treating acne in women.<sup id="cite_ref-pmid22468178_62-0" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28155090_63-0" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span class="cite-bracket">[</span>64<span class="cite-bracket">]</span></a></sup> In addition, spironolactone reduces oil that is naturally produced in the skin and can be used to treat oily skin.<sup id="cite_ref-pmid28155090_63-1" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26897386_65-0" class="reference"><a href="#cite_note-pmid26897386-65"><span class="cite-bracket">[</span>65<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28979664_52-1" class="reference"><a href="#cite_note-pmid28979664-52"><span class="cite-bracket">[</span>52<span class="cite-bracket">]</span></a></sup> Though not the primary intended purpose of the medication, the ability of spironolactone to be helpful with problematic skin and acne conditions was discovered to be one of the beneficial side effects and has been quite successful.<sup id="cite_ref-pmid28155090_63-2" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26897386_65-1" class="reference"><a href="#cite_note-pmid26897386-65"><span class="cite-bracket">[</span>65<span class="cite-bracket">]</span></a></sup> Oftentimes, for women treating acne, spironolactone is prescribed and paired with a <a href="/wiki/Combined_oral_contraceptive_pill" title="Combined oral contraceptive pill">birth control pill</a>.<sup id="cite_ref-pmid28155090_63-3" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26897386_65-2" class="reference"><a href="#cite_note-pmid26897386-65"><span class="cite-bracket">[</span>65<span class="cite-bracket">]</span></a></sup> Positive results in the pairing of these two medications have been observed, although these results may not be seen for up to three months.<sup id="cite_ref-pmid28155090_63-4" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26897386_65-3" class="reference"><a href="#cite_note-pmid26897386-65"><span class="cite-bracket">[</span>65<span class="cite-bracket">]</span></a></sup> Spironolactone has been reported to produce a 50 to 100% improvement in acne at sufficiently high doses.<sup id="cite_ref-pmid9238337_66-0" class="reference"><a href="#cite_note-pmid9238337-66"><span class="cite-bracket">[</span>66<span class="cite-bracket">]</span></a></sup> Response to treatment generally requires 1 to 3 months in the case of acne and up to 6 months in the case of hirsutism.<sup id="cite_ref-pmid9238337_66-1" class="reference"><a href="#cite_note-pmid9238337-66"><span class="cite-bracket">[</span>66<span class="cite-bracket">]</span></a></sup> Ongoing therapy is generally required to avoid relapse of symptoms.<sup id="cite_ref-pmid9238337_66-2" class="reference"><a href="#cite_note-pmid9238337-66"><span class="cite-bracket">[</span>66<span class="cite-bracket">]</span></a></sup> Spironolactone is commonly used in the treatment of hirsutism in women, and is considered to be a first-line antiandrogen for this indication.<sup id="cite_ref-pmid24889738_67-0" class="reference"><a href="#cite_note-pmid24889738-67"><span class="cite-bracket">[</span>67<span class="cite-bracket">]</span></a></sup> Spironolactone can be used in the treatment of <a href="/wiki/Female-pattern_hair_loss" class="mw-redirect" title="Female-pattern hair loss">female-pattern hair loss</a> (pattern scalp hair loss in women).<sup id="cite_ref-pmid21413648_68-0" class="reference"><a href="#cite_note-pmid21413648-68"><span class="cite-bracket">[</span>68<span class="cite-bracket">]</span></a></sup> There is tentative low quality evidence supporting its use for this indication.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span class="cite-bracket">[</span>69<span class="cite-bracket">]</span></a></sup> Although apparently effective, not all cases of female-pattern hair loss are dependent on androgens.<sup id="cite_ref-pmid20128792_70-0" class="reference"><a href="#cite_note-pmid20128792-70"><span class="cite-bracket">[</span>70<span class="cite-bracket">]</span></a></sup> </p><p>Antiandrogens like spironolactone are male-specific <a href="/wiki/Teratogen" class="mw-redirect" title="Teratogen">teratogens</a> which can feminize male <a href="/wiki/Fetus" title="Fetus">fetuses</a> due to their antiandrogenic effects.<sup id="cite_ref-pmid9420861_60-1" class="reference"><a href="#cite_note-pmid9420861-60"><span class="cite-bracket">[</span>60<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-IswaranImai1997_71-0" class="reference"><a href="#cite_note-IswaranImai1997-71"><span class="cite-bracket">[</span>71<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Smith2013_72-0" class="reference"><a href="#cite_note-Smith2013-72"><span class="cite-bracket">[</span>72<span class="cite-bracket">]</span></a></sup> For this reason, it is recommended that antiandrogens only be used to treat women who are of reproductive age in conjunction with adequate contraception.<sup id="cite_ref-pmid9420861_60-2" class="reference"><a href="#cite_note-pmid9420861-60"><span class="cite-bracket">[</span>60<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-IswaranImai1997_71-1" class="reference"><a href="#cite_note-IswaranImai1997-71"><span class="cite-bracket">[</span>71<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Smith2013_72-1" class="reference"><a href="#cite_note-Smith2013-72"><span class="cite-bracket">[</span>72<span class="cite-bracket">]</span></a></sup> Oral contraceptives, which contain an <a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">estrogen</a> and a <a href="/wiki/Progestin" class="mw-redirect" title="Progestin">progestin</a>, are typically used for this purpose.<sup id="cite_ref-pmid9420861_60-3" class="reference"><a href="#cite_note-pmid9420861-60"><span class="cite-bracket">[</span>60<span class="cite-bracket">]</span></a></sup> Moreover, oral contraceptives themselves are functional antiandrogens and are independently effective in the treatment of androgen-dependent skin and hair conditions, and hence can significantly augment the effectiveness of antiandrogens in the treatment of such conditions.<sup id="cite_ref-pmid9420861_60-4" class="reference"><a href="#cite_note-pmid9420861-60"><span class="cite-bracket">[</span>60<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Ostrzenski2002_73-0" class="reference"><a href="#cite_note-Ostrzenski2002-73"><span class="cite-bracket">[</span>73<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone is not generally used in men for the treatment of androgen-dependent dermatological conditions because of its feminizing side effects, but it is effective for such indications in men similarly.<sup id="cite_ref-pmid21413648_68-1" class="reference"><a href="#cite_note-pmid21413648-68"><span class="cite-bracket">[</span>68<span class="cite-bracket">]</span></a></sup> As an example, spironolactone has been reported to reduce symptoms of acne in males.<sup id="cite_ref-pmid9557251_74-0" class="reference"><a href="#cite_note-pmid9557251-74"><span class="cite-bracket">[</span>74<span class="cite-bracket">]</span></a></sup> An additional example is the usefulness of spironolactone as an antiandrogen in transgender women.<sup id="cite_ref-WPATH2011_75-0" class="reference"><a href="#cite_note-WPATH2011-75"><span class="cite-bracket">[</span>75<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19509099_76-0" class="reference"><a href="#cite_note-pmid19509099-76"><span class="cite-bracket">[</span>76<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid2540730_77-0" class="reference"><a href="#cite_note-pmid2540730-77"><span class="cite-bracket">[</span>77<span class="cite-bracket">]</span></a></sup> </p><p><a href="/wiki/Topical_medication" title="Topical medication">Topical</a> spironolactone has been found to be effective in the treatment of acne as well.<sup id="cite_ref-pmid1387779_78-0" class="reference"><a href="#cite_note-pmid1387779-78"><span class="cite-bracket">[</span>78<span class="cite-bracket">]</span></a></sup> As a result, topical pharmaceutical formulations containing 2% or 5% spironolactone cream became available in Italy for the treatment of acne and hirsutism in the early 1990s.<sup id="cite_ref-pmid8112074_79-0" class="reference"><a href="#cite_note-pmid8112074-79"><span class="cite-bracket">[</span>79<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Benvenga2009_80-0" class="reference"><a href="#cite_note-Benvenga2009-80"><span class="cite-bracket">[</span>80<span class="cite-bracket">]</span></a></sup> The products were discontinued in 2006 when the creams were added to the list of doping substances with a decree of the <a href="/wiki/Ministry_of_Health_(Italy)" title="Ministry of Health (Italy)">Ministry of Health</a> that year.<sup id="cite_ref-Benvenga2009_80-1" class="reference"><a href="#cite_note-Benvenga2009-80"><span class="cite-bracket">[</span>80<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading4"><h4 id="Comparison">Comparison</h4><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=6" title="Edit section: Comparison"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone, the <a href="/wiki/5%CE%B1-reductase_inhibitor" class="mw-redirect" title="5α-reductase inhibitor">5α-reductase inhibitor</a> <a href="/wiki/Finasteride" title="Finasteride">finasteride</a>, and the <a href="/wiki/Nonsteroidal_antiandrogen" title="Nonsteroidal antiandrogen">nonsteroidal antiandrogen</a> <a href="/wiki/Flutamide" title="Flutamide">flutamide</a> all appear to have similar effectiveness in the treatment of hirsutism.<sup id="cite_ref-pmid24889738_67-1" class="reference"><a href="#cite_note-pmid24889738-67"><span class="cite-bracket">[</span>67<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid25918921_81-0" class="reference"><a href="#cite_note-pmid25918921-81"><span class="cite-bracket">[</span>81<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid29522176_82-0" class="reference"><a href="#cite_note-pmid29522176-82"><span class="cite-bracket">[</span>82<span class="cite-bracket">]</span></a></sup> However, some clinical research has found that the effectiveness of spironolactone for hirsutism is greater than that of finasteride but is less than that of flutamide.<sup id="cite_ref-pmid24889738_67-2" class="reference"><a href="#cite_note-pmid24889738-67"><span class="cite-bracket">[</span>67<span class="cite-bracket">]</span></a></sup> The combination of spironolactone with finasteride is more effective than either alone for hirsutism and the combination of spironolactone with a birth control pill is more effective than a birth control pill alone.<sup id="cite_ref-pmid24889738_67-3" class="reference"><a href="#cite_note-pmid24889738-67"><span class="cite-bracket">[</span>67<span class="cite-bracket">]</span></a></sup> One study showed that spironolactone or the <a href="/wiki/Steroidal_antiandrogen" title="Steroidal antiandrogen">steroidal antiandrogen</a> <a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">cyproterone acetate</a> both in combination with a birth control pill had equivalent effectiveness for hirsutism.<sup id="cite_ref-pmid24889738_67-4" class="reference"><a href="#cite_note-pmid24889738-67"><span class="cite-bracket">[</span>67<span class="cite-bracket">]</span></a></sup> Spironolactone is considered to be a first-line treatment for hirsutism, finasteride and the steroidal antiandrogen cyproterone acetate are considered to be second-line treatments, and flutamide is no longer recommended for hirsutism due to <a href="/wiki/Liver_toxicity" class="mw-redirect" title="Liver toxicity">liver toxicity</a> concerns.<sup id="cite_ref-pmid24889738_67-5" class="reference"><a href="#cite_note-pmid24889738-67"><span class="cite-bracket">[</span>67<span class="cite-bracket">]</span></a></sup> The nonsteroidal antiandrogen <a href="/wiki/Bicalutamide" title="Bicalutamide">bicalutamide</a> is an alternative option to flutamide with improved <a href="/wiki/Drug_safety" class="mw-redirect" title="Drug safety">safety</a>.<sup id="cite_ref-pmid24455796_83-0" class="reference"><a href="#cite_note-pmid24455796-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid29211888_84-0" class="reference"><a href="#cite_note-pmid29211888-84"><span class="cite-bracket">[</span>84<span class="cite-bracket">]</span></a></sup> </p><p>The combination of spironolactone with a birth control pill in the treatment of acne appears to have similar effectiveness to a birth control pill alone and the combination of a birth control pill with cyproterone acetate, flutamide, or finasteride.<sup id="cite_ref-pmid28155090_63-5" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> However, this was based on low- to very-low-quality evidence.<sup id="cite_ref-pmid28155090_63-6" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> Spironolactone may be more effective than birth control pills in the treatment of acne, and the combination of spironolactone with a birth control pill may have greater effectiveness for acne than either alone.<sup id="cite_ref-pmid22994662_85-0" class="reference"><a href="#cite_note-pmid22994662-85"><span class="cite-bracket">[</span>85<span class="cite-bracket">]</span></a></sup> In addition, some clinical research has found that flutamide is more effective than spironolactone in the treatment of acne.<sup id="cite_ref-pmid28155090_63-7" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> In one study, flutamide decreased acne scores by 80% within 3 months, whereas spironolactone decreased symptoms by only 40% in the same time period.<sup id="cite_ref-pmid10495361_86-0" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-ShelleyShelley2001_87-0" class="reference"><a href="#cite_note-ShelleyShelley2001-87"><span class="cite-bracket">[</span>87<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BalenFranks2010_88-0" class="reference"><a href="#cite_note-BalenFranks2010-88"><span class="cite-bracket">[</span>88<span class="cite-bracket">]</span></a></sup> However, the use of flutamide for acne is limited by its liver toxicity.<sup id="cite_ref-pmid28379593_89-0" class="reference"><a href="#cite_note-pmid28379593-89"><span class="cite-bracket">[</span>89<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28492054_90-0" class="reference"><a href="#cite_note-pmid28492054-90"><span class="cite-bracket">[</span>90<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-YasaDural2016_91-0" class="reference"><a href="#cite_note-YasaDural2016-91"><span class="cite-bracket">[</span>91<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28274354_92-0" class="reference"><a href="#cite_note-pmid28274354-92"><span class="cite-bracket">[</span>92<span class="cite-bracket">]</span></a></sup> Bicalutamide is a potential alternative to flutamide for acne as well.<sup id="cite_ref-pmid27416311_93-0" class="reference"><a href="#cite_note-pmid27416311-93"><span class="cite-bracket">[</span>93<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid30312645_94-0" class="reference"><a href="#cite_note-pmid30312645-94"><span class="cite-bracket">[</span>94<span class="cite-bracket">]</span></a></sup> Spironolactone can be considered as a first-line treatment for acne in those who have failed other standard treatments such as topical therapies and under certain other circumstances, although this is controversial due to the side effects of spironolactone and its <a href="/wiki/Teratogenicity" class="mw-redirect" title="Teratogenicity">teratogenicity</a>.<sup id="cite_ref-pmid22994662_85-1" class="reference"><a href="#cite_note-pmid22994662-85"><span class="cite-bracket">[</span>85<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid20082945_61-1" class="reference"><a href="#cite_note-pmid20082945-61"><span class="cite-bracket">[</span>61<span class="cite-bracket">]</span></a></sup> </p><p>There is insufficient clinical evidence to compare the effectiveness of spironolactone with other antiandrogens for female-pattern hair loss.<sup id="cite_ref-pmid27225981_95-0" class="reference"><a href="#cite_note-pmid27225981-95"><span class="cite-bracket">[</span>95<span class="cite-bracket">]</span></a></sup> The effectiveness of spironolactone in the treatment of both acne and hirsutism appears to be dose-dependent, with higher doses being more effective than lower doses.<sup id="cite_ref-pmid22994662_85-2" class="reference"><a href="#cite_note-pmid22994662-85"><span class="cite-bracket">[</span>85<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19370553_96-0" class="reference"><a href="#cite_note-pmid19370553-96"><span class="cite-bracket">[</span>96<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Hammerstein1990_97-0" class="reference"><a href="#cite_note-Hammerstein1990-97"><span class="cite-bracket">[</span>97<span class="cite-bracket">]</span></a></sup> However, higher doses also have greater side effects, such as <a href="/wiki/Menstrual_irregularities" class="mw-redirect" title="Menstrual irregularities">menstrual irregularities</a>.<sup id="cite_ref-pmid28155090_63-8" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Transgender_hormone_therapy">Transgender hormone therapy</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=7" title="Edit section: Transgender hormone therapy"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951"><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Feminizing_hormone_therapy#Steroidal_antiandrogens" title="Feminizing hormone therapy">Feminizing hormone therapy § Steroidal antiandrogens</a></div> <p>Despite <a href="/wiki/Paradoxical_reaction" title="Paradoxical reaction">paradoxical reactions</a>, spironolactone is used <a href="/wiki/Off-label_use" title="Off-label use">off-label</a> as a component of <a href="/wiki/Feminizing_hormone_therapy" title="Feminizing hormone therapy">feminizing hormone therapy</a> in <a href="/wiki/Transgender_women" class="mw-redirect" title="Transgender women">transgender women</a>, especially in the United States (where <a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">cyproterone acetate</a> is not available), usually in addition to an <a href="/wiki/Estrogen_(medication)" title="Estrogen (medication)">estrogen</a>.<sup id="cite_ref-Paradoxical_reactions_98-0" class="reference"><a href="#cite_note-Paradoxical_reactions-98"><span class="cite-bracket">[</span>98<span class="cite-bracket">]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Reliable_sources" title="Wikipedia:Reliable sources"><span title="The material near this tag may rely on an unreliable source. primary (July 2024)">unreliable source?</span></a></i>]</sup><sup id="cite_ref-WPATH2011_75-1" class="reference"><a href="#cite_note-WPATH2011-75"><span class="cite-bracket">[</span>75<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19509099_76-1" class="reference"><a href="#cite_note-pmid19509099-76"><span class="cite-bracket">[</span>76<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid2540730_77-1" class="reference"><a href="#cite_note-pmid2540730-77"><span class="cite-bracket">[</span>77<span class="cite-bracket">]</span></a></sup> Alternatives like <a href="/wiki/Bicalutamide" title="Bicalutamide">bicalutamide</a> do not have a similar level of popularity.<sup id="cite_ref-99" class="reference"><a href="#cite_note-99"><span class="cite-bracket">[</span>99<span class="cite-bracket">]</span></a></sup> As spironolactone's antiandrogenic effect appears only in high doses, it can have a wide array of side effects not found in antiandrogens working more exclusively on the androgen receptor.<sup id="cite_ref-Burinkul_2021_24-2" class="reference"><a href="#cite_note-Burinkul_2021-24"><span class="cite-bracket">[</span>24<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Sehgal_2023_25-2" class="reference"><a href="#cite_note-Sehgal_2023-25"><span class="cite-bracket">[</span>25<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-ineffectiveness_in_HRT_26-1" class="reference"><a href="#cite_note-ineffectiveness_in_HRT-26"><span class="cite-bracket">[</span>26<span class="cite-bracket">]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may rely on an unreliable or less reliable medical source. (July 2024)">unreliable medical source?</span></a></i>]</sup> When coupled with estradiol, effects in transgender women include decreased <a href="/wiki/Hirsutism" title="Hirsutism">male pattern body hair</a>, induction of <a href="/wiki/Breast_development" title="Breast development">breast development</a> and of <a href="/wiki/Feminization_(biology)" title="Feminization (biology)">feminization</a> in general, and reduced <a href="/wiki/Spontaneous_erection" class="mw-redirect" title="Spontaneous erection">spontaneous erections</a>.<sup id="cite_ref-pmid2540730_77-2" class="reference"><a href="#cite_note-pmid2540730-77"><span class="cite-bracket">[</span>77<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Forms">Forms</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=8" title="Edit section: Forms"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone is available in the form of <a href="/wiki/Tablet_(pharmacy)" title="Tablet (pharmacy)">tablets</a> (25 mg, 50 mg, 100 mg; brand name Aldactone, others) and <a href="/wiki/Suspension_(chemistry)" title="Suspension (chemistry)">suspensions</a> (25 mg/5 mL; brand name Carospir) for use <a href="/wiki/Oral_administration" title="Oral administration">by mouth</a>.<sup id="cite_ref-Muller1998_100-0" class="reference"><a href="#cite_note-Muller1998-100"><span class="cite-bracket">[</span>100<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-LeeDesai2007_101-0" class="reference"><a href="#cite_note-LeeDesai2007-101"><span class="cite-bracket">[</span>101<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Niazi2016_102-0" class="reference"><a href="#cite_note-Niazi2016-102"><span class="cite-bracket">[</span>102<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-WakelinMaibach2002_103-0" class="reference"><a href="#cite_note-WakelinMaibach2002-103"><span class="cite-bracket">[</span>103<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs@FDA_104-0" class="reference"><a href="#cite_note-Drugs@FDA-104"><span class="cite-bracket">[</span>104<span class="cite-bracket">]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability"><span title="The material near this tag failed verification of its source citation(s). (July 2024)">failed verification</span></a></i>]</sup> It has also been marketed in the form of 2% and 5% <a href="/wiki/Topical" class="mw-redirect" title="Topical">topical</a> <a href="/wiki/Cream" title="Cream">cream</a> in Italy for the treatment of <a href="/wiki/Acne" title="Acne">acne</a> and <a href="/wiki/Hirsutism" title="Hirsutism">hirsutism</a> under the brand name Spiroderm, but this product is no longer available.<sup id="cite_ref-FARIDDiamanti-Kandarakis2009_5-1" class="reference"><a href="#cite_note-FARIDDiamanti-Kandarakis2009-5"><span class="cite-bracket">[</span>5<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-IndexNominum2000_105-0" class="reference"><a href="#cite_note-IndexNominum2000-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup> The medication is also available in combination with other medications, such as <a href="/wiki/Hydrochlorothiazide" title="Hydrochlorothiazide">hydrochlorothiazide</a> (brand name Aldactazide, others).<sup id="cite_ref-Drugs@FDA_104-1" class="reference"><a href="#cite_note-Drugs@FDA-104"><span class="cite-bracket">[</span>104<span class="cite-bracket">]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability"><span title="The material near this tag failed verification of its source citation(s). (July 2024)">failed verification</span></a></i>]</sup><sup id="cite_ref-Drugs.com_106-0" class="reference"><a href="#cite_note-Drugs.com-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup> Spironolactone has poor <a href="/wiki/Water_solubility" class="mw-redirect" title="Water solubility">water solubility</a>, and for this reason, only oral and topical formulations have been developed; other <a href="/wiki/Routes_of_administration" class="mw-redirect" title="Routes of administration">routes of administration</a> such as <a href="/wiki/Intravenous_administration" class="mw-redirect" title="Intravenous administration">intravenous injection</a> are not used.<sup id="cite_ref-pmid15947888_11-7" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup> The only antimineralocorticoid that is available as a <a href="/wiki/Solution_(chemistry)" title="Solution (chemistry)">solution</a> for <a href="/wiki/Parenteral" class="mw-redirect" title="Parenteral">parenteral</a> use is the related medication <a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">potassium canrenoate</a>.<sup id="cite_ref-pmid28634268_107-0" class="reference"><a href="#cite_note-pmid28634268-107"><span class="cite-bracket">[</span>107<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Contraindications">Contraindications</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=9" title="Edit section: Contraindications"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p><a href="/wiki/Contraindication" title="Contraindication">Contraindications</a> of spironolactone include <a href="/wiki/Hyperkalemia" title="Hyperkalemia">hyperkalemia</a> (high potassium levels), <a href="/wiki/End-stage_kidney_disease" class="mw-redirect" title="End-stage kidney disease">severe and end-stage kidney disease</a> (due to high hyperkalemia risk, except possibly in those on <a href="/wiki/Kidney_dialysis" title="Kidney dialysis">dialysis</a>), <a href="/wiki/Addison%27s_disease" title="Addison's disease">Addison's disease</a> (adrenal insufficiency and low aldosterone levels), and concomitant use of <a href="/wiki/Eplerenone" title="Eplerenone">eplerenone</a>.<sup id="cite_ref-Aldactone_label_8-1" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-GoldsmithCovic2014_108-0" class="reference"><a href="#cite_note-GoldsmithCovic2014-108"><span class="cite-bracket">[</span>108<span class="cite-bracket">]</span></a></sup> It should also be used with caution in people with certain <a href="/wiki/Neurological_disorder" title="Neurological disorder">neurological disorders</a>, as well as those who experience or have experienced <a href="/wiki/Anuria" title="Anuria">anuria</a> (lack of urine production), <a href="/wiki/Acute_kidney_injury" title="Acute kidney injury">acute kidney injury</a>, or <a href="/wiki/Kidney_failure" title="Kidney failure">significant impairment of kidney excretory function</a> with risk of hyperkalemia.<sup id="cite_ref-Aldactone_label_8-2" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Side_effects">Side effects</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=10" title="Edit section: Side effects"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>One of the most common side effects of spironolactone is <a href="/wiki/Frequent_urination" title="Frequent urination">frequent urination</a>. Other general side effects include <a href="/wiki/Dehydration" title="Dehydration">dehydration</a>, <a href="/wiki/Hyponatremia" title="Hyponatremia">hyponatremia</a> (low <a href="/wiki/Sodium" title="Sodium">sodium</a> levels), mild <a href="/wiki/Hypotension" title="Hypotension">hypotension</a> (low <a href="/wiki/Blood_pressure" title="Blood pressure">blood pressure</a>),<sup id="cite_ref-pmid10495361_86-1" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Ataxia" title="Ataxia">ataxia</a> (muscle incoordination), <a href="/wiki/Drowsiness" class="mw-redirect" title="Drowsiness">drowsiness</a>, <a href="/wiki/Dizziness" title="Dizziness">dizziness</a>,<sup id="cite_ref-pmid10495361_86-2" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Dry_skin" class="mw-redirect" title="Dry skin">dry skin</a>, and <a href="/wiki/Rash" title="Rash">rashes</a>. Because of its antiandrogenic activity, spironolactone can, in men, cause <a href="/wiki/Breast_tenderness" class="mw-redirect" title="Breast tenderness">breast tenderness</a>, <a href="/wiki/Gynecomastia" title="Gynecomastia">gynecomastia</a> (breast development), <a href="/wiki/Feminization_(biology)" title="Feminization (biology)">feminization</a> in general, and <a href="/wiki/Demasculinization" class="mw-redirect" title="Demasculinization">demasculinization</a>, as well as <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">sexual dysfunction</a> including <a href="/wiki/Loss_of_libido" class="mw-redirect" title="Loss of libido">loss of libido</a> and <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>, although these side effects are usually confined to high doses of spironolactone.<sup id="cite_ref-pmid984618_109-0" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup> At very high doses (400 mg/day), spironolactone has also been associated with <a href="/wiki/Testicular_atrophy" title="Testicular atrophy">testicular atrophy</a> and reversibly <a href="/wiki/Infertility" title="Infertility">reduced fertility</a>, including <a href="/wiki/Semen_abnormalities" class="mw-redirect" title="Semen abnormalities">semen abnormalities</a> such as decreased <a href="/wiki/Sperm_count" class="mw-redirect" title="Sperm count">sperm count</a> and <a href="/wiki/Sperm_motility" title="Sperm motility">motility</a> in men.<sup id="cite_ref-SeldinGiebisch1997_110-0" class="reference"><a href="#cite_note-SeldinGiebisch1997-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Aronson2009_111-0" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup> However, such doses of spironolactone are rarely used clinically.<sup id="cite_ref-Aronson2009_111-1" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup> In women, spironolactone can cause <a href="/wiki/Menstrual_irregularities" class="mw-redirect" title="Menstrual irregularities">menstrual irregularities</a>, <a href="/wiki/Breast_tenderness" class="mw-redirect" title="Breast tenderness">breast tenderness</a>, and <a href="/wiki/Mammoplasia" title="Mammoplasia">breast enlargement</a>.<sup id="cite_ref-pmid2969259_38-1" class="reference"><a href="#cite_note-pmid2969259-38"><span class="cite-bracket">[</span>38<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28155090_63-9" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-CarrellPeterson2010_112-0" class="reference"><a href="#cite_note-CarrellPeterson2010-112"><span class="cite-bracket">[</span>112<span class="cite-bracket">]</span></a></sup> Aside from these adverse effects, the side effects of spironolactone in women taking high doses are minimal, and it is well tolerated.<sup id="cite_ref-pmid28155090_63-10" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid10495361_86-3" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-PescovitzEugster2004_113-0" class="reference"><a href="#cite_note-PescovitzEugster2004-113"><span class="cite-bracket">[</span>113<span class="cite-bracket">]</span></a></sup> </p><p>A potential side effect of spironolactone is <a href="/wiki/Hyperkalemia" title="Hyperkalemia">hyperkalemia</a> (high <a href="/wiki/Potassium" title="Potassium">potassium</a> levels), which, in severe cases, can be life-threatening.<sup id="cite_ref-Aldactone_label_8-3" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> Hyperkalemia can present as a normal anion-gap metabolic acidosis.<sup id="cite_ref-Aldactone_label_8-4" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> It has been reported that the addition of spironolactone to loop diuretics in people with heart failure was associated with a higher risk of hyperkalemia and <a href="/wiki/Acute_kidney_injury" title="Acute kidney injury">acute kidney injury</a>.<sup id="cite_ref-114" class="reference"><a href="#cite_note-114"><span class="cite-bracket">[</span>114<span class="cite-bracket">]</span></a></sup> Spironolactone may put people at a heightened risk for gastrointestinal issues like nausea, vomiting, diarrhea, cramping, and <a href="/wiki/Gastritis" title="Gastritis">gastritis</a>.<sup id="cite_ref-Aldactone_label_8-5" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-115" class="reference"><a href="#cite_note-115"><span class="cite-bracket">[</span>115<span class="cite-bracket">]</span></a></sup> In addition, there has been some evidence suggesting an association between use of the medication and <a href="/wiki/Hemorrhage" class="mw-redirect" title="Hemorrhage">bleeding</a> from the <a href="/wiki/Stomach" title="Stomach">stomach</a> and <a href="/wiki/Duodenum" title="Duodenum">duodenum</a>,<sup id="cite_ref-Aldactone_label_8-6" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> though a causal relationship between the two has not been established.<sup id="cite_ref-116" class="reference"><a href="#cite_note-116"><span class="cite-bracket">[</span>116<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18507655_117-0" class="reference"><a href="#cite_note-pmid18507655-117"><span class="cite-bracket">[</span>117<span class="cite-bracket">]</span></a></sup> Also, spironolactone is <a href="/wiki/Immunosuppression" title="Immunosuppression">immunosuppressive</a> in the treatment of <a href="/wiki/Sarcoidosis" title="Sarcoidosis">sarcoidosis</a>.<sup id="cite_ref-118" class="reference"><a href="#cite_note-118"><span class="cite-bracket">[</span>118<span class="cite-bracket">]</span></a></sup> </p><p>Most of the side effects of spironolactone are dose-dependent.<sup id="cite_ref-pmid22468178_62-1" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> Low-dose spironolactone is generally very well tolerated.<sup id="cite_ref-pmid22468178_62-2" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> Even higher doses of spironolactone, such as 100 mg/day, are well tolerated in most individuals.<sup id="cite_ref-pmid22468178_62-3" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> Dose-dependent side effects of spironolactone include menstrual irregularities, breast tenderness and enlargement, <a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">orthostatic hypotension</a>, and hyperkalemia.<sup id="cite_ref-pmid22468178_62-4" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> The side effects of spironolactone are usually mild and rarely result in discontinuation.<sup id="cite_ref-pmid22468178_62-5" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> </p> <table class="wikitable sortable mw-collapsible mw-collapsed" width="750px" style="margin-left: auto; margin-right: auto; border: none;"> <caption class="nowrap"><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><style data-mw-deduplicate="TemplateStyles:r1239400231">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}html.skin-theme-clientpref-night .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}@media(prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}}@media print{.mw-parser-output .navbar{display:none!important}}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Side_effects_of_spironolactone_in_women_in_clinical_studies_for_acne" title="Template:Side effects of spironolactone in women in clinical studies for acne"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Side_effects_of_spironolactone_in_women_in_clinical_studies_for_acne" title="Template talk:Side effects of spironolactone in women in clinical studies for acne"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Side_effects_of_spironolactone_in_women_in_clinical_studies_for_acne" title="Special:EditPage/Template:Side effects of spironolactone in women in clinical studies for acne"><abbr title="Edit this template">e</abbr></a></li></ul></div> Side effects of spironolactone in clinical studies for acne in women </caption> <tbody><tr> <th rowspan="2"><a href="/wiki/Side_effect" title="Side effect">Side effect</a></th> <th colspan="2"><a href="/wiki/Randomized_controlled_trials" class="mw-redirect" title="Randomized controlled trials"><abbr title="Randomized controlled trials">RCTs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Randomized controlled trials</span> (n (<a href="/wiki/Intention-to-treat_analysis" title="Intention-to-treat analysis"><abbr title="Intention-to-treat analysis">ITT</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Intention-to-treat analysis</span>) = 326)</th> <th colspan="2"><a href="/wiki/Case_series" title="Case series">Case series</a> (n (<a href="/wiki/Intention-to-treat_analysis" title="Intention-to-treat analysis"><abbr title="Intention-to-treat analysis">ITT</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Intention-to-treat analysis</span>) = 663) </th></tr> <tr> <th>Number</th> <th>%</th> <th>Number</th> <th>% </th></tr> <tr> <td><a href="/wiki/Menstrual_irregularities" class="mw-redirect" title="Menstrual irregularities">Menstrual irregularities</a></td> <td>38</td> <td>13.4 (of 283)</td> <td>216</td> <td>33.4 (of 646) </td></tr> <tr> <td><a href="/wiki/Breast_tenderness" class="mw-redirect" title="Breast tenderness">Breast tenderness</a></td> <td>8</td> <td>2.5</td> <td>30</td> <td>4.5 </td></tr> <tr> <td><a href="/wiki/Breast_enlargement" title="Breast enlargement">Breast enlargement</a></td> <td>7</td> <td>2.1</td> <td>13</td> <td>2.0 </td></tr> <tr> <td><a href="/wiki/Dizziness" title="Dizziness">Dizziness</a>/<a href="/wiki/Vertigo" title="Vertigo">vertigo</a>/<a href="/wiki/Lightheadedness" title="Lightheadedness">lightheadedness</a></td> <td>11</td> <td>3.4</td> <td>≥19<sup>a</sup></td> <td>≥2.9 </td></tr> <tr> <td><a href="/wiki/Headache" title="Headache">Headache</a></td> <td>5</td> <td>1.5</td> <td>≥10<sup>a</sup></td> <td>≥1.5 </td></tr> <tr> <td><a href="/wiki/Nausea" title="Nausea">Nausea</a> and/or <a href="/wiki/Vomiting" title="Vomiting">vomiting</a></td> <td>6</td> <td>1.8</td> <td>24</td> <td>3.6 </td></tr> <tr> <td><a href="/wiki/Weight_gain" title="Weight gain">Weight gain</a><sup>b</sup></td> <td>5</td> <td>1.5</td> <td>1</td> <td>0.2 </td></tr> <tr> <td><a href="/wiki/Abdominal_pain" title="Abdominal pain">Abdominal pain</a></td> <td>0</td> <td>0</td> <td>≥11<sup>a</sup></td> <td>≥1.7 </td></tr> <tr> <td><a href="/wiki/Polyuria" title="Polyuria">Polyuria</a></td> <td>2</td> <td>0.6</td> <td>8</td> <td>1.2 </td></tr> <tr> <td><a href="/wiki/Fatigue" title="Fatigue">Fatigue</a>/<a href="/wiki/Lethargy" title="Lethargy">lethargy</a></td> <td>1</td> <td>0.3</td> <td>≥12<sup>a</sup></td> <td>≥1.8 </td></tr> <tr class="sortbottom"> <td colspan="5" style="width: 1px; font-size: small; background-color:#eaecf0; text-align: center;"><b>Footnotes:</b> <sup>a</sup> = Precise values unavailable due to inadequate reporting. <sup>b</sup> = Not monitored in most studies. <b>Description:</b> <a href="/wiki/Side_effect" title="Side effect">Side effects</a> of spironolactone (25–400 mg/day) with ≥1% incidence in a 2017 hybrid <a href="/wiki/Systematic_review" title="Systematic review">systematic review</a> of <a href="/wiki/Clinical_study" class="mw-redirect" title="Clinical study">clinical studies</a> of spironolactone for <a href="/wiki/Acne" title="Acne">acne</a> in women. Side effects with <1% incidence included <a href="/wiki/Postural_hypotension" class="mw-redirect" title="Postural hypotension">postural hypotension</a>, <a href="/wiki/Depression_(mood)" title="Depression (mood)">depression</a>, <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, <a href="/wiki/Muscle_pain" class="mw-redirect" title="Muscle pain">muscle pain</a>, <a href="/wiki/Increased_appetite" class="mw-redirect" title="Increased appetite">increased appetite</a>, <a href="/wiki/Drowsiness" class="mw-redirect" title="Drowsiness">drowsiness</a>, <a href="/wiki/Rash" title="Rash">rashes</a>/<a href="/wiki/Drug_eruption" title="Drug eruption">drug eruptions</a>, <a href="/wiki/Chloasma" class="mw-redirect" title="Chloasma">chloasma</a>-like <a href="/wiki/Skin_pigmentation" class="mw-redirect" title="Skin pigmentation">skin pigmentation</a>, <a href="/wiki/Polydipsia" title="Polydipsia">polydipsia</a>, <a href="/wiki/Weakness" title="Weakness">weakness</a>, <a href="/wiki/Leg_edema" class="mw-redirect" title="Leg edema">leg edema</a>, <a href="/wiki/Change_in_libido" class="mw-redirect" title="Change in libido">libido changes</a>, and <a href="/wiki/Palpitation" class="mw-redirect" title="Palpitation">palpitations</a>. [...] Certain side effects, like <a href="/wiki/Breast_enlargement" title="Breast enlargement">breast enlargement</a>, reduced <a href="/wiki/Premenstrual_syndrome" title="Premenstrual syndrome">premenstrual symptoms</a>, and less <a href="/wiki/Greasy_skin" class="mw-redirect" title="Greasy skin">oily skin</a>/<a href="/wiki/Greasy_hair" title="Greasy hair">greasy hair</a>, could be beneficial. Side effects often could not be unambiguously attributed to spironolactone due concomitant use of other medications, particularly <a href="/wiki/Birth_control_pill" class="mw-redirect" title="Birth control pill">birth control pills</a>. <a href="/wiki/Hyperkalemia" title="Hyperkalemia">Hyperkalemia</a> was rare (14/469; 3.0%) and was "invariably mild and clinically insignificant". Risk of <a href="/wiki/Reporting_bias" title="Reporting bias">bias</a> was high and <a href="/wiki/Quality_of_evidence" class="mw-redirect" title="Quality of evidence">quality of evidence</a> was low to very low. <b>Sources:</b> See template. </td></tr></tbody></table> <div class="mw-heading mw-heading3"><h3 id="High_potassium_levels">High potassium levels</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=11" title="Edit section: High potassium levels"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone can cause hyperkalemia, or high blood potassium levels.<sup id="cite_ref-Aronson2009_111-2" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup> Rarely, this can be fatal.<sup id="cite_ref-Aronson2009_111-3" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup> Of people with heart disease prescribed typical dosages of spironolactone, 10 to 15% develop some degree of hyperkalemia, and 6% develop severe hyperkalemia.<sup id="cite_ref-Aronson2009_111-4" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup> At a higher dosage, a rate of hyperkalemia of 24% has been observed.<sup id="cite_ref-pmid26404748_119-0" class="reference"><a href="#cite_note-pmid26404748-119"><span class="cite-bracket">[</span>119<span class="cite-bracket">]</span></a></sup> An abrupt and major increase in the rate of hospitalization due to hyperkalemia from 0.2% to 11% and in the rate of death due to hyperkalemia from 0.3 per 1,000 to 2.0 per 1,000 between early 1994 and late 2001 has been attributed to a parallel rise in the number of prescriptions written for spironolactone upon the publication of the Randomized Aldactone Evaluation Study (RALES) in July 1999.<sup id="cite_ref-Aronson2009_111-5" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26404748_119-1" class="reference"><a href="#cite_note-pmid26404748-119"><span class="cite-bracket">[</span>119<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid15295047_120-0" class="reference"><a href="#cite_note-pmid15295047-120"><span class="cite-bracket">[</span>120<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-RoncoBellomo2017_35-1" class="reference"><a href="#cite_note-RoncoBellomo2017-35"><span class="cite-bracket">[</span>35<span class="cite-bracket">]</span></a></sup> However, another population-based study in Scotland failed to replicate these findings.<sup id="cite_ref-pmid22942339_121-0" class="reference"><a href="#cite_note-pmid22942339-121"><span class="cite-bracket">[</span>121<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid20483947_122-0" class="reference"><a href="#cite_note-pmid20483947-122"><span class="cite-bracket">[</span>122<span class="cite-bracket">]</span></a></sup> The risk of hyperkalemia with spironolactone is greatest in the elderly, in people with <a href="/wiki/Renal_impairment" class="mw-redirect" title="Renal impairment">renal impairment</a> (e.g., due to <a href="/wiki/Chronic_kidney_disease" title="Chronic kidney disease">chronic kidney disease</a> or <a href="/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">diabetic nephropathy</a>), in people taking certain other medications (including <a href="/wiki/ACE_inhibitor" title="ACE inhibitor"><abbr title="angiotensin-converting-enzyme">ACE</abbr> inhibitors</a>, <a href="/wiki/Angiotensin_II_receptor_blocker" title="Angiotensin II receptor blocker">angiotensin II receptor blockers</a>, <a href="/wiki/Nonsteroidal_anti-inflammatory_drug" title="Nonsteroidal anti-inflammatory drug">nonsteroidal anti-inflammatory drugs</a>, the <a href="/wiki/Antibiotic" title="Antibiotic">antibiotic</a> <a href="/wiki/Trimethoprim" title="Trimethoprim">trimethoprim</a>, and <a href="/wiki/Potassium" title="Potassium">potassium</a> <a href="/wiki/Dietary_supplement" title="Dietary supplement">supplements</a>), and at higher dosages of spironolactone.<sup id="cite_ref-Aronson2009_111-6" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-RoncoBellomo2017_35-2" class="reference"><a href="#cite_note-RoncoBellomo2017-35"><span class="cite-bracket">[</span>35<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid21911446_123-0" class="reference"><a href="#cite_note-pmid21911446-123"><span class="cite-bracket">[</span>123<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid25646289_124-0" class="reference"><a href="#cite_note-pmid25646289-124"><span class="cite-bracket">[</span>124<span class="cite-bracket">]</span></a></sup> </p><p>Although spironolactone poses an important risk of hyperkalemia in the elderly, in those with kidney or cardiovascular disease, and/or in those taking medications or supplements which increase circulating potassium levels, a large retrospective study found that the rate of hyperkalemia in young women without such characteristics who had been treated with high doses of spironolactone for dermatological conditions did not differ from that of controls.<sup id="cite_ref-pmid28155090_63-11" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26897386_65-4" class="reference"><a href="#cite_note-pmid26897386-65"><span class="cite-bracket">[</span>65<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid25796182_125-0" class="reference"><a href="#cite_note-pmid25796182-125"><span class="cite-bracket">[</span>125<span class="cite-bracket">]</span></a></sup> This was the conclusion of a 2017 hybrid systematic review of studies of spironolactone for acne in women as well, which found that hyperkalemia was rare and was invariably mild and clinically insignificant.<sup id="cite_ref-pmid28155090_63-12" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> These findings suggest that hyperkalemia may not be a significant risk in such individuals, and that routine monitoring of circulating potassium levels may be unnecessary in this population.<sup id="cite_ref-pmid28155090_63-13" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26897386_65-5" class="reference"><a href="#cite_note-pmid26897386-65"><span class="cite-bracket">[</span>65<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid25796182_125-1" class="reference"><a href="#cite_note-pmid25796182-125"><span class="cite-bracket">[</span>125<span class="cite-bracket">]</span></a></sup> However, other sources have claimed that hyperkalemia can nonetheless also occur in people with more normal renal function and presumably without such risk factors.<sup id="cite_ref-RoncoBellomo2017_35-3" class="reference"><a href="#cite_note-RoncoBellomo2017-35"><span class="cite-bracket">[</span>35<span class="cite-bracket">]</span></a></sup> Occasional testing on a case-by-case basis in those with known risk factors may be justified.<sup id="cite_ref-pmid28155090_63-14" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> Side effects of spironolactone which may be indicative of hyperkalemia and if persistent could justify serum potassium testing include nausea, fatigue, and particularly muscle weakness.<sup id="cite_ref-pmid28155090_63-15" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> Notably, non-use of routine potassium monitoring with spironolactone in young women would reduce costs associated with its use.<sup id="cite_ref-pmid28155090_63-16" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> </p><p>Among young gender-diverse individuals taking spironolactone, hyperkalemia is rare and (if present) transient and asymptomatic. Larger doses do not appear to increase risks in this population.<sup id="cite_ref-pmid31065620_126-0" class="reference"><a href="#cite_note-pmid31065620-126"><span class="cite-bracket">[</span>126<span class="cite-bracket">]</span></a></sup> A broader retrospective study found that the rate of hyperkalemia in gender-diverse individuals is correlated with age, with those above 45 years old being more at risk. The finding suggests that patients below or at 45 years old without other conditions that affect potassium handling can be spared from routine monitoring.<sup id="cite_ref-pmid36267595_127-0" class="reference"><a href="#cite_note-pmid36267595-127"><span class="cite-bracket">[</span>127<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Breast_changes">Breast changes</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=12" title="Edit section: Breast changes"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone can cause <a href="/wiki/Mastodynia" class="mw-redirect" title="Mastodynia">breast pain</a> and <a href="/wiki/Mammoplasia" title="Mammoplasia">breast enlargement</a> in women.<sup id="cite_ref-Becker2001_128-0" class="reference"><a href="#cite_note-Becker2001-128"><span class="cite-bracket">[</span>128<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-TsioufisSchmieder2016_129-0" class="reference"><a href="#cite_note-TsioufisSchmieder2016-129"><span class="cite-bracket">[</span>129<span class="cite-bracket">]</span></a></sup> This is "probably because of estrogenic effects on target tissue."<sup id="cite_ref-Aronson2009_111-7" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup> At low doses, breast tenderness has been reported in only 5% of women, but at high doses, it has been reported in up to 40% of women.<sup id="cite_ref-ConnJacobs1998_130-0" class="reference"><a href="#cite_note-ConnJacobs1998-130"><span class="cite-bracket">[</span>130<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid22468178_62-6" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> Breast enlargement and tenderness may occur in 26% of women at high doses.<sup id="cite_ref-pmid10495361_86-4" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup> Some women regard spironolactone-induced breast enlargement as a positive effect.<sup id="cite_ref-pmid28155090_63-17" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone also commonly and dose-dependently produces <a href="/wiki/Gynecomastia" title="Gynecomastia">gynecomastia</a> (breast development) as a side effect in men.<sup id="cite_ref-SeldinGiebisch1997_110-1" class="reference"><a href="#cite_note-SeldinGiebisch1997-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-TsioufisSchmieder2016_129-1" class="reference"><a href="#cite_note-TsioufisSchmieder2016-129"><span class="cite-bracket">[</span>129<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Elsevier2014_131-0" class="reference"><a href="#cite_note-Elsevier2014-131"><span class="cite-bracket">[</span>131<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-McInnes2008_132-0" class="reference"><a href="#cite_note-McInnes2008-132"><span class="cite-bracket">[</span>132<span class="cite-bracket">]</span></a></sup> At low doses, the rate is only 5 to 10%,<sup id="cite_ref-McInnes2008_132-1" class="reference"><a href="#cite_note-McInnes2008-132"><span class="cite-bracket">[</span>132<span class="cite-bracket">]</span></a></sup> but at high doses, up to or exceeding 50% of men may develop gynecomastia.<sup id="cite_ref-SeldinGiebisch1997_110-2" class="reference"><a href="#cite_note-SeldinGiebisch1997-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-TsioufisSchmieder2016_129-2" class="reference"><a href="#cite_note-TsioufisSchmieder2016-129"><span class="cite-bracket">[</span>129<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Elsevier2014_131-1" class="reference"><a href="#cite_note-Elsevier2014-131"><span class="cite-bracket">[</span>131<span class="cite-bracket">]</span></a></sup> In the RALES, 9.1% of men taking 25 mg/day spironolactone developed gynecomastia, compared to 1.3% of controls.<sup id="cite_ref-pmid15134800_133-0" class="reference"><a href="#cite_note-pmid15134800-133"><span class="cite-bracket">[</span>133<span class="cite-bracket">]</span></a></sup> Conversely, in studies of healthy men given high-dose spironolactone, gynecomastia occurred in 3 of 10 (30%) at 100 mg/day, in 5 of 8 (62.5%) at 200 mg/day, and in 6 of 9 (66.7%) at 400 mg/day, relative to none of 12 controls.<sup id="cite_ref-pmid8094898_134-0" class="reference"><a href="#cite_note-pmid8094898-134"><span class="cite-bracket">[</span>134<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Wilcox2008_135-0" class="reference"><a href="#cite_note-Wilcox2008-135"><span class="cite-bracket">[</span>135<span class="cite-bracket">]</span></a></sup> The severity of gynecomastia with spironolactone varies considerably, but is usually mild.<sup id="cite_ref-SeldinGiebisch1997_110-3" class="reference"><a href="#cite_note-SeldinGiebisch1997-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup> As with breast enlargement caused by spironolactone in women, gynecomastia due to spironolactone in men is often although inconsistently accompanied by breast tenderness.<sup id="cite_ref-SeldinGiebisch1997_110-4" class="reference"><a href="#cite_note-SeldinGiebisch1997-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup> In the RALES, only 1.7% of men developed breast pain, relative to 0.1% of controls.<sup id="cite_ref-pmid15134800_133-1" class="reference"><a href="#cite_note-pmid15134800-133"><span class="cite-bracket">[</span>133<span class="cite-bracket">]</span></a></sup> </p><p>The time to onset of spironolactone-induced gynecomastia has been found to be 27 ± 20 months at low doses and 9 ± 12 months at high doses.<sup id="cite_ref-pmid15134800_133-2" class="reference"><a href="#cite_note-pmid15134800-133"><span class="cite-bracket">[</span>133<span class="cite-bracket">]</span></a></sup> Gynecomastia induced by spironolactone usually regresses after a few weeks following discontinuation of the medication.<sup id="cite_ref-SeldinGiebisch1997_110-5" class="reference"><a href="#cite_note-SeldinGiebisch1997-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup> However, after a sufficient duration of gynecomastia being present (e.g., one year), <a href="/wiki/Hyalinization" class="mw-redirect" title="Hyalinization">hyalinization</a> and <a href="/wiki/Fibrosis" title="Fibrosis">fibrosis</a> of the tissue occurs and drug-induced gynecomastia may become irreversible.<sup id="cite_ref-pmid18983216_136-0" class="reference"><a href="#cite_note-pmid18983216-136"><span class="cite-bracket">[</span>136<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid11546925_137-0" class="reference"><a href="#cite_note-pmid11546925-137"><span class="cite-bracket">[</span>137<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Menstrual_disturbances">Menstrual disturbances</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=13" title="Edit section: Menstrual disturbances"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone at higher doses can cause <a href="/wiki/Menstrual_irregularities" class="mw-redirect" title="Menstrual irregularities">menstrual irregularities</a> as a side effect in women.<sup id="cite_ref-pmid22468178_62-7" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> These irregularities include <a href="/wiki/Metrorrhagia" class="mw-redirect" title="Metrorrhagia">metrorrhagia</a> (intermenstrual bleeding), <a href="/wiki/Amenorrhea" title="Amenorrhea">amenorrhea</a> (absence of menstruation), and <a href="/wiki/Breakthrough_bleeding" class="mw-redirect" title="Breakthrough bleeding">breakthrough bleeding</a>.<sup id="cite_ref-pmid22468178_62-8" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> They are common during spironolactone therapy, with 10 to 50% of women experiencing them at moderate doses and almost all experiencing them at a high doses.<sup id="cite_ref-pmid10495361_86-5" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Aronson2009_111-8" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup> For example, about 20% of women experienced menstrual irregularities with 50 to 100 mg/day spironolactone, whereas about 70% experienced menstrual irregularities at 200 mg/day.<sup id="cite_ref-pmid22468178_62-9" class="reference"><a href="#cite_note-pmid22468178-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> Most women taking moderate doses of spironolactone develop amenorrhea, and normal <a href="/wiki/Menstruation" title="Menstruation">menstruation</a> usually returns within two months of discontinuation.<sup id="cite_ref-Aronson2009_111-9" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup> Spironolactone produces an <a href="/wiki/Irregular_menstruation" title="Irregular menstruation">irregular</a> and <a href="/wiki/Anovulation" title="Anovulation">anovulatory</a> pattern of <a href="/wiki/Menstrual_cycle" title="Menstrual cycle">menstrual cycles</a>.<sup id="cite_ref-pmid10495361_86-6" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup> It is also associated with metrorrhagia and <a href="/wiki/Menorrhagia" class="mw-redirect" title="Menorrhagia">menorrhagia</a> (heavy menstrual bleeding) in large percentages of women,<sup id="cite_ref-Becker2001_128-1" class="reference"><a href="#cite_note-Becker2001-128"><span class="cite-bracket">[</span>128<span class="cite-bracket">]</span></a></sup> as well as with <a href="/wiki/Polymenorrhea" title="Polymenorrhea">polymenorrhea</a> (short menstrual cycles).<sup id="cite_ref-pmid16076921_138-0" class="reference"><a href="#cite_note-pmid16076921-138"><span class="cite-bracket">[</span>138<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid10792338_139-0" class="reference"><a href="#cite_note-pmid10792338-139"><span class="cite-bracket">[</span>139<span class="cite-bracket">]</span></a></sup> The medication reportedly has no <a href="/wiki/Contraceptive" class="mw-redirect" title="Contraceptive">birth control</a> effect.<sup id="cite_ref-RabeGrunwald2009_140-0" class="reference"><a href="#cite_note-RabeGrunwald2009-140"><span class="cite-bracket">[</span>140<span class="cite-bracket">]</span></a></sup> </p><p>It has been suggested that the weak progestogenic activity of spironolactone is responsible for these effects, although this has not been established and spironolactone has been shown to possess insignificant progestogenic and antiprogestogenic activity even at high dosages in women.<sup id="cite_ref-pmid10495361_86-7" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8144871_141-0" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid2744183_142-0" class="reference"><a href="#cite_note-pmid2744183-142"><span class="cite-bracket">[</span>142<span class="cite-bracket">]</span></a></sup> An alternative proposed cause is inhibition of 17α-hydroxylase and hence <a href="/wiki/Sex_steroid" class="mw-redirect" title="Sex steroid">sex steroid</a> <a href="/wiki/Metabolism" title="Metabolism">metabolism</a> by spironolactone and consequent changes in sex hormone levels.<sup id="cite_ref-SeldinGiebisch1997_110-6" class="reference"><a href="#cite_note-SeldinGiebisch1997-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup> Indeed, <a href="/wiki/CYP17A1" title="CYP17A1">CYP17A1</a> <a href="/wiki/Genotype" title="Genotype">genotype</a> is associated with polymenorrhea.<sup id="cite_ref-pmid32038990_143-0" class="reference"><a href="#cite_note-pmid32038990-143"><span class="cite-bracket">[</span>143<span class="cite-bracket">]</span></a></sup> Regardless of their mechanism, the menstrual disturbances associated with spironolactone can usually be controlled well by concomitant treatment with a <a href="/wiki/Birth_control_pill" class="mw-redirect" title="Birth control pill">birth control pill</a>, due to the <a href="/wiki/Progestin" class="mw-redirect" title="Progestin">progestin</a> component.<sup id="cite_ref-pmid10495361_86-8" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-JemecRevuz2006_144-0" class="reference"><a href="#cite_note-JemecRevuz2006-144"><span class="cite-bracket">[</span>144<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Mood_changes">Mood changes</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=14" title="Edit section: Mood changes"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Research is mixed on whether antimineralocorticoids like spironolactone have positive or negative effects on <a href="/wiki/Mood_(psychology)" title="Mood (psychology)">mood</a>.<sup id="cite_ref-pmid25459896_145-0" class="reference"><a href="#cite_note-pmid25459896-145"><span class="cite-bracket">[</span>145<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Schultebraucks2016_146-0" class="reference"><a href="#cite_note-Schultebraucks2016-146"><span class="cite-bracket">[</span>146<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid10367986_147-0" class="reference"><a href="#cite_note-pmid10367986-147"><span class="cite-bracket">[</span>147<span class="cite-bracket">]</span></a></sup> In any case, it is possible that spironolactone might have the capacity to increase the risk of <a href="/wiki/Depression_(mood)" title="Depression (mood)">depressive</a> symptoms.<sup id="cite_ref-pmid25459896_145-1" class="reference"><a href="#cite_note-pmid25459896-145"><span class="cite-bracket">[</span>145<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Schultebraucks2016_146-1" class="reference"><a href="#cite_note-Schultebraucks2016-146"><span class="cite-bracket">[</span>146<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid10367986_147-1" class="reference"><a href="#cite_note-pmid10367986-147"><span class="cite-bracket">[</span>147<span class="cite-bracket">]</span></a></sup> However, a 2017 hybrid systematic review found that the incidence of depression in women treated with spironolactone for acne was less than 1%.<sup id="cite_ref-pmid28155090_63-18" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup> Likewise, a 10-year observational study found that the incidence of depression in 196 transgender women taking high-dose spironolactone in combination with an estrogen was less than 1%.<sup id="cite_ref-BassonPrior1997_148-0" class="reference"><a href="#cite_note-BassonPrior1997-148"><span class="cite-bracket">[</span>148<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Lipid_changes">Lipid changes</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=15" title="Edit section: Lipid changes"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone has been found to increase <a href="/wiki/LDL_cholesterol" class="mw-redirect" title="LDL cholesterol">LDL ("bad") cholesterol</a> and decrease <a href="/wiki/HDL_cholesterol" class="mw-redirect" title="HDL cholesterol">HDL ("good") cholesterol</a> levels at the relatively high doses used in women with <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a> (PCOS).<sup id="cite_ref-pmid28944709_149-0" class="reference"><a href="#cite_note-pmid28944709-149"><span class="cite-bracket">[</span>149<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19843067_150-0" class="reference"><a href="#cite_note-pmid19843067-150"><span class="cite-bracket">[</span>150<span class="cite-bracket">]</span></a></sup> As such, it may have unfavorable effects on the <a href="/wiki/Blood_lipids" title="Blood lipids">blood</a> <a href="/wiki/Lipid_profile" title="Lipid profile">lipid profile</a> in this context.<sup id="cite_ref-pmid28944709_149-1" class="reference"><a href="#cite_note-pmid28944709-149"><span class="cite-bracket">[</span>149<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19843067_150-1" class="reference"><a href="#cite_note-pmid19843067-150"><span class="cite-bracket">[</span>150<span class="cite-bracket">]</span></a></sup> Heightened LDL cholesterol levels are a potential <a href="/wiki/Risk_factor" title="Risk factor">risk factor</a> for <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> such as <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a> or <a href="/wiki/Coronary_heart_disease" class="mw-redirect" title="Coronary heart disease">coronary heart disease</a>.<sup id="cite_ref-pmid30586774_151-0" class="reference"><a href="#cite_note-pmid30586774-151"><span class="cite-bracket">[</span>151<span class="cite-bracket">]</span></a></sup> Consequently, it has been said that spironolactone should not be given to women with <a href="/wiki/Dyslipidemia" title="Dyslipidemia">dyslipidemia</a> (e.g., <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">high cholesterol</a>).<sup id="cite_ref-pmid28944709_149-2" class="reference"><a href="#cite_note-pmid28944709-149"><span class="cite-bracket">[</span>149<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19843067_150-2" class="reference"><a href="#cite_note-pmid19843067-150"><span class="cite-bracket">[</span>150<span class="cite-bracket">]</span></a></sup> Unfavorable lipid changes have also been seen with other antiandrogens, like <a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">cyproterone acetate</a><sup id="cite_ref-WPATH-SOC8_152-0" class="reference"><a href="#cite_note-WPATH-SOC8-152"><span class="cite-bracket">[</span>152<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid3318361_153-0" class="reference"><a href="#cite_note-pmid3318361-153"><span class="cite-bracket">[</span>153<span class="cite-bracket">]</span></a></sup> and <a href="/wiki/Bicalutamide" title="Bicalutamide">bicalutamide</a>.<sup id="cite_ref-pmid33334002_154-0" class="reference"><a href="#cite_note-pmid33334002-154"><span class="cite-bracket">[</span>154<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid29211888_84-1" class="reference"><a href="#cite_note-pmid29211888-84"><span class="cite-bracket">[</span>84<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Rare_reactions">Rare reactions</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=16" title="Edit section: Rare reactions"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Aside from hyperkalemia, spironolactone may rarely cause adverse reactions such as <a href="/wiki/Anaphylaxis" title="Anaphylaxis">anaphylaxis</a>, <a href="/wiki/Kidney_failure" title="Kidney failure">kidney failure</a>,<sup id="cite_ref-pmid19006114_155-0" class="reference"><a href="#cite_note-pmid19006114-155"><span class="cite-bracket">[</span>155<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Hepatitis" title="Hepatitis">hepatitis</a> (two reported cases, neither serious),<sup id="cite_ref-ThaiSinclair2001_156-0" class="reference"><a href="#cite_note-ThaiSinclair2001-156"><span class="cite-bracket">[</span>156<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Agranulocytosis" title="Agranulocytosis">agranulocytosis</a>, <a href="/wiki/DRESS_syndrome" class="mw-redirect" title="DRESS syndrome">DRESS syndrome</a>, <a href="/wiki/Stevens%E2%80%93Johnson_syndrome" title="Stevens–Johnson syndrome">Stevens–Johnson syndrome</a> or <a href="/wiki/Toxic_epidermal_necrolysis" title="Toxic epidermal necrolysis">toxic epidermal necrolysis</a>.<sup id="cite_ref-157" class="reference"><a href="#cite_note-157"><span class="cite-bracket">[</span>157<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-158" class="reference"><a href="#cite_note-158"><span class="cite-bracket">[</span>158<span class="cite-bracket">]</span></a></sup> Five cases of <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a> in patients who took spironolactone for prolonged periods of time have been reported.<sup id="cite_ref-Aronson2009_111-10" class="reference"><a href="#cite_note-Aronson2009-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-McInnes2008_132-2" class="reference"><a href="#cite_note-McInnes2008-132"><span class="cite-bracket">[</span>132<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Spironolactone_bodies">Spironolactone bodies</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=17" title="Edit section: Spironolactone bodies"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <figure typeof="mw:File/Thumb"><a href="/wiki/File:Spironolactone_bodies.png" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/8/8b/Spironolactone_bodies.png/175px-Spironolactone_bodies.png" decoding="async" width="175" height="131" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/8b/Spironolactone_bodies.png/263px-Spironolactone_bodies.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/8b/Spironolactone_bodies.png/350px-Spironolactone_bodies.png 2x" data-file-width="862" data-file-height="643" /></a><figcaption><a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> (<a href="/wiki/H%26E_stain" title="H&E stain">H&E stain</a>) of an <a href="/wiki/Adrenal_gland" title="Adrenal gland">adrenal gland</a> showing spironolactone bodies.</figcaption></figure> <p>Long-term administration of spironolactone gives the <a href="/wiki/Histologic" class="mw-redirect" title="Histologic">histologic</a> characteristic of "spironolactone bodies" in the <a href="/wiki/Adrenal_cortex" title="Adrenal cortex">adrenal cortex</a>. Spironolactone bodies are <a href="/wiki/Eosinophilic" title="Eosinophilic">eosinophilic</a>, round, concentrically laminated <a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasmic</a> inclusions surrounded by clear halos in preparations stained with <a href="/wiki/Hematoxylin" class="mw-redirect" title="Hematoxylin">hematoxylin</a> and <a href="/wiki/Eosin" title="Eosin">eosin</a>.<sup id="cite_ref-pmid7195152_159-0" class="reference"><a href="#cite_note-pmid7195152-159"><span class="cite-bracket">[</span>159<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Pregnancy_and_breastfeeding">Pregnancy and breastfeeding</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=18" title="Edit section: Pregnancy and breastfeeding"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone is able to cross the <a href="/wiki/Placenta" title="Placenta">placenta</a>.<sup id="cite_ref-Becker2001_128-2" class="reference"><a href="#cite_note-Becker2001-128"><span class="cite-bracket">[</span>128<span class="cite-bracket">]</span></a></sup> It has been found to be present in the breast milk of lactating mothers.<sup id="cite_ref-Aldactone_label_8-7" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> However, only very small amounts of spironolactone and its metabolite canrenone enter <a href="/wiki/Breast_milk" title="Breast milk">breast milk</a>, and the amount received by an infant during breastfeeding (<0.5% of the mother's dose) is considered to be insignificant.<sup id="cite_ref-Ainsworth2014_160-0" class="reference"><a href="#cite_note-Ainsworth2014-160"><span class="cite-bracket">[</span>160<span class="cite-bracket">]</span></a></sup> </p><p>A study found that spironolactone was not associated with <a href="/wiki/Teratogen" class="mw-redirect" title="Teratogen">teratogenicity</a> in the offspring of rats.<sup id="cite_ref-Little2006_161-0" class="reference"><a href="#cite_note-Little2006-161"><span class="cite-bracket">[</span>161<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-RubinRamsey2008_162-0" class="reference"><a href="#cite_note-RubinRamsey2008-162"><span class="cite-bracket">[</span>162<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BriggsFreeman2011_163-0" class="reference"><a href="#cite_note-BriggsFreeman2011-163"><span class="cite-bracket">[</span>163<span class="cite-bracket">]</span></a></sup> Because it is an antiandrogen, however, spironolactone could theoretically have the potential to cause feminization of male fetuses at sufficient doses.<sup id="cite_ref-Little2006_161-1" class="reference"><a href="#cite_note-Little2006-161"><span class="cite-bracket">[</span>161<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-RubinRamsey2008_162-1" class="reference"><a href="#cite_note-RubinRamsey2008-162"><span class="cite-bracket">[</span>162<span class="cite-bracket">]</span></a></sup> In accordance, a subsequent study found that partial feminization of the genitalia occurred in the male offspring of rats that received doses of spironolactone that were five times higher than those normally used in humans (200 mg/kg per day).<sup id="cite_ref-Little2006_161-2" class="reference"><a href="#cite_note-Little2006-161"><span class="cite-bracket">[</span>161<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BriggsFreeman2011_163-1" class="reference"><a href="#cite_note-BriggsFreeman2011-163"><span class="cite-bracket">[</span>163<span class="cite-bracket">]</span></a></sup> Another study found permanent, dose-related reproductive tract abnormalities rat offspring of both sexes at lower doses (50 to 100 mg/kg per day).<sup id="cite_ref-BriggsFreeman2011_163-2" class="reference"><a href="#cite_note-BriggsFreeman2011-163"><span class="cite-bracket">[</span>163<span class="cite-bracket">]</span></a></sup> </p><p>In practice however, although experience is limited, spironolactone has never been reported to cause observable feminization or any other congenital defects in humans.<sup id="cite_ref-Little2006_161-3" class="reference"><a href="#cite_note-Little2006-161"><span class="cite-bracket">[</span>161<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-RubinRamsey2008_162-2" class="reference"><a href="#cite_note-RubinRamsey2008-162"><span class="cite-bracket">[</span>162<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-ElkayamGleicher1998_164-0" class="reference"><a href="#cite_note-ElkayamGleicher1998-164"><span class="cite-bracket">[</span>164<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Schaefer2001_165-0" class="reference"><a href="#cite_note-Schaefer2001-165"><span class="cite-bracket">[</span>165<span class="cite-bracket">]</span></a></sup> Among 31 human newborns exposed to spironolactone in the first trimester, there were no signs of any specific <a href="/wiki/Birth_defect" title="Birth defect">birth defects</a>.<sup id="cite_ref-Schaefer2001_165-1" class="reference"><a href="#cite_note-Schaefer2001-165"><span class="cite-bracket">[</span>165<span class="cite-bracket">]</span></a></sup> A case report described a woman who was prescribed spironolactone during pregnancy with triplets and delivered all three (one boy and two girls) healthy; there was no feminization in the boy.<sup id="cite_ref-Schaefer2001_165-2" class="reference"><a href="#cite_note-Schaefer2001-165"><span class="cite-bracket">[</span>165<span class="cite-bracket">]</span></a></sup> In addition, spironolactone has been used at high doses to treat pregnant women with <a href="/wiki/Bartter%27s_syndrome" class="mw-redirect" title="Bartter's syndrome">Bartter's syndrome</a>, and none of the infants (three boys, two girls) showed toxicity, including feminization in the male infants.<sup id="cite_ref-Ainsworth2014_160-1" class="reference"><a href="#cite_note-Ainsworth2014-160"><span class="cite-bracket">[</span>160<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Little2006_161-4" class="reference"><a href="#cite_note-Little2006-161"><span class="cite-bracket">[</span>161<span class="cite-bracket">]</span></a></sup> There are similar findings, albeit also limited, for another antiandrogen, cyproterone acetate (prominent genital defects in male rats, but no human abnormalities (including feminization of male fetuses) at both a low dose of 2 mg/day or high doses of 50 to 100 mg/day).<sup id="cite_ref-Schaefer2001_165-3" class="reference"><a href="#cite_note-Schaefer2001-165"><span class="cite-bracket">[</span>165<span class="cite-bracket">]</span></a></sup> In any case, spironolactone is nonetheless not recommended during pregnancy due to theoretical concerns relating to feminization of males and also to potential alteration of fetal potassium levels.<sup id="cite_ref-Little2006_161-5" class="reference"><a href="#cite_note-Little2006-161"><span class="cite-bracket">[</span>161<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Upfal2006_166-0" class="reference"><a href="#cite_note-Upfal2006-166"><span class="cite-bracket">[</span>166<span class="cite-bracket">]</span></a></sup> </p><p>A 2019 systematic review found insufficient evidence that spironolactone causes birth defects in humans.<sup id="cite_ref-pmid30352280_167-0" class="reference"><a href="#cite_note-pmid30352280-167"><span class="cite-bracket">[</span>167<span class="cite-bracket">]</span></a></sup> However, there was also insufficient evidence to be certain that it does not.<sup id="cite_ref-pmid30352280_167-1" class="reference"><a href="#cite_note-pmid30352280-167"><span class="cite-bracket">[</span>167<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Overdose">Overdose</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=19" title="Edit section: Overdose"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone is relatively safe in acute <a href="/wiki/Overdose" class="mw-redirect" title="Overdose">overdose</a>.<sup id="cite_ref-Aldactone_label_8-8" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Symptom" class="mw-redirect" title="Symptom">Symptoms</a> following an acute overdose of spironolactone may include <a href="/wiki/Drowsiness" class="mw-redirect" title="Drowsiness">drowsiness</a>, <a href="/wiki/Mental_confusion" class="mw-redirect" title="Mental confusion">confusion</a>, <a href="/wiki/Maculopapular_rash" title="Maculopapular rash">maculopapular</a> or <a href="/wiki/Erythematous_rash" class="mw-redirect" title="Erythematous rash">erythematous rash</a>, <a href="/wiki/Nausea" title="Nausea">nausea</a>, <a href="/wiki/Vomiting" title="Vomiting">vomiting</a>, <a href="/wiki/Dizziness" title="Dizziness">dizziness</a>, and <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>.<sup id="cite_ref-Aldactone_label_8-9" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> In rare cases, <a href="/wiki/Hyponatremia" title="Hyponatremia">hyponatremia</a>, <a href="/wiki/Hyperkalemia" title="Hyperkalemia">hyperkalemia</a>, or <a href="/wiki/Hepatic_coma" class="mw-redirect" title="Hepatic coma">hepatic coma</a> may occur in individuals with <a href="/wiki/Severe_liver_disease" class="mw-redirect" title="Severe liver disease">severe liver disease</a>.<sup id="cite_ref-Aldactone_label_8-10" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> However, these <a href="/wiki/Adverse_reaction" class="mw-redirect" title="Adverse reaction">adverse reactions</a> are unlikely in the event of an acute overdose.<sup id="cite_ref-Aldactone_label_8-11" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> Hyperkalemia can occur following an overdose of spironolactone, and this is especially so in people with <a href="/wiki/Chronic_kidney_disease" title="Chronic kidney disease">decreased kidney function</a>.<sup id="cite_ref-Aldactone_label_8-12" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> Spironolactone has been studied at extremely high oral doses of up to 2,400 mg per day in <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trials</a>.<sup id="cite_ref-pmid28634268_107-1" class="reference"><a href="#cite_note-pmid28634268-107"><span class="cite-bracket">[</span>107<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid15134797_168-0" class="reference"><a href="#cite_note-pmid15134797-168"><span class="cite-bracket">[</span>168<span class="cite-bracket">]</span></a></sup> Its oral <a href="/wiki/Median_lethal_dose" title="Median lethal dose">median lethal dose</a> (LD<sub>50</sub>) is more than 1,000 mg/kg in mice, rats, and rabbits.<sup id="cite_ref-Aldactone_label_8-13" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> </p><p>There is no specific <a href="/wiki/Antidote" title="Antidote">antidote</a> for overdose of spironolactone.<sup id="cite_ref-Aldactone_label_8-14" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> Treatment may consist of induction of <a href="/wiki/Vomiting" title="Vomiting">vomiting</a> or <a href="/wiki/Stomach" title="Stomach">stomach</a> evacuation by <a href="/wiki/Gastric_lavage" title="Gastric lavage">gastric lavage</a>.<sup id="cite_ref-Aldactone_label_8-15" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> The treatment of spironolactone overdose is supportive, with the purpose of maintaining <a href="/wiki/Tissue_hydration" title="Tissue hydration">hydration</a>, <a href="/wiki/Electrolyte_balance" class="mw-redirect" title="Electrolyte balance">electrolyte balance</a>, and <a href="/wiki/Vital_function" class="mw-redirect" title="Vital function">vital functions</a>.<sup id="cite_ref-Aldactone_label_8-16" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> Spironolactone should be discontinued in people with impaired kidney function or hyperkalemia.<sup id="cite_ref-Aldactone_label_8-17" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Interactions">Interactions</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=20" title="Edit section: Interactions"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone often increases serum <a href="/wiki/Potassium" title="Potassium">potassium</a> levels and can cause <a href="/wiki/Hyperkalemia" title="Hyperkalemia">hyperkalemia</a>, a very serious condition. Therefore, it is recommended that people using this medication avoid potassium supplements and salt substitutes containing potassium.<sup id="cite_ref-169" class="reference"><a href="#cite_note-169"><span class="cite-bracket">[</span>169<span class="cite-bracket">]</span></a></sup> Physicians must be careful to monitor potassium levels in both males and females who are taking spironolactone as a diuretic, especially during the first twelve months of use and whenever the dosage is increased. Doctors may also recommend that some patients may be advised to limit dietary consumption of potassium-rich foods. However, recent data suggests that both potassium monitoring and dietary restriction of potassium intake is unnecessary in healthy young women taking spironolactone for acne<sup id="cite_ref-pmid25796182_125-2" class="reference"><a href="#cite_note-pmid25796182-125"><span class="cite-bracket">[</span>125<span class="cite-bracket">]</span></a></sup> and in healthy young gender-diverse individuals taking spironolactone for hormone therapy.<sup id="cite_ref-pmid36267595_127-1" class="reference"><a href="#cite_note-pmid36267595-127"><span class="cite-bracket">[</span>127<span class="cite-bracket">]</span></a></sup> Spironolactone together with <a href="/wiki/Trimethoprim/sulfamethoxazole" title="Trimethoprim/sulfamethoxazole">trimethoprim/sulfamethoxazole</a> increases the likelihood of hyperkalemia, especially in the elderly. The trimethoprim portion acts to prevent potassium excretion in the distal tubule of the nephron.<sup id="cite_ref-170" class="reference"><a href="#cite_note-170"><span class="cite-bracket">[</span>170<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone has been reported to induce the <a href="/wiki/Enzyme" title="Enzyme">enzymes</a> <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a> and certain <a href="/wiki/UDP-glucuronosyltransferase" class="mw-redirect" title="UDP-glucuronosyltransferase">UDP-glucuronosyltransferases</a> (UGTs), which can result in <a href="/wiki/Drug_interaction" title="Drug interaction">interactions</a> with various medications.<sup id="cite_ref-Parkinson2001_17-1" class="reference"><a href="#cite_note-Parkinson2001-17"><span class="cite-bracket">[</span>17<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Davis2009_171-0" class="reference"><a href="#cite_note-Davis2009-171"><span class="cite-bracket">[</span>171<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid1826112_172-0" class="reference"><a href="#cite_note-pmid1826112-172"><span class="cite-bracket">[</span>172<span class="cite-bracket">]</span></a></sup> However, it has also been reported that metabolites of spironolactone <a href="/wiki/Irreversible_inhibition" class="mw-redirect" title="Irreversible inhibition">irreversibly inhibit</a> CYP3A4.<sup id="cite_ref-Wolverton2007_173-0" class="reference"><a href="#cite_note-Wolverton2007-173"><span class="cite-bracket">[</span>173<span class="cite-bracket">]</span></a></sup> In any case, spironolactone has been found to reduce the <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a> of oral <a href="/wiki/Estradiol_(medication)" title="Estradiol (medication)">estradiol</a>, which could be due to induction of estradiol metabolism via CYP3A4.<sup id="cite_ref-pmid29756046_174-0" class="reference"><a href="#cite_note-pmid29756046-174"><span class="cite-bracket">[</span>174<span class="cite-bracket">]</span></a></sup> Spironolactone has also been found to <a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">inhibit</a> <a href="/wiki/UGT2B7" title="UGT2B7">UGT2B7</a>.<sup id="cite_ref-JhajraRamesh_Varkhede2012_175-0" class="reference"><a href="#cite_note-JhajraRamesh_Varkhede2012-175"><span class="cite-bracket">[</span>175<span class="cite-bracket">]</span></a></sup> Spironolactone can also have numerous other interactions, most commonly with other <a href="/wiki/Cardiac" class="mw-redirect" title="Cardiac">cardiac</a> and blood pressure medications, for instance <a href="/wiki/Digoxin" title="Digoxin">digoxin</a>.<sup id="cite_ref-Aldactone_label_8-18" class="reference"><a href="#cite_note-Aldactone_label-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup> </p><p><a href="/wiki/Licorice" class="mw-redirect" title="Licorice">Licorice</a>, which has indirect mineralocorticoid activity by inhibiting mineralocorticoid metabolism, has been found to inhibit the antimineralocorticoid effects of spironolactone.<sup id="cite_ref-pmid27450358_176-0" class="reference"><a href="#cite_note-pmid27450358-176"><span class="cite-bracket">[</span>176<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17113210_177-0" class="reference"><a href="#cite_note-pmid17113210-177"><span class="cite-bracket">[</span>177<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid13991036_178-0" class="reference"><a href="#cite_note-pmid13991036-178"><span class="cite-bracket">[</span>178<span class="cite-bracket">]</span></a></sup> Moreover, the addition of licorice to spironolactone has been found to reduce the antimineralocorticoid side effects of spironolactone in women treated with it for hyperandrogenism, and licorice hence may be used to reduce these side effects in women treated with spironolactone as an antiandrogen who are bothered by them.<sup id="cite_ref-pmid27450358_176-1" class="reference"><a href="#cite_note-pmid27450358-176"><span class="cite-bracket">[</span>176<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17113210_177-1" class="reference"><a href="#cite_note-pmid17113210-177"><span class="cite-bracket">[</span>177<span class="cite-bracket">]</span></a></sup> On the opposite end of the spectrum, spironolactone is useful in reversing licorice-induced <a href="/wiki/Hypokalemia" title="Hypokalemia">hypokalemia</a>.<sup id="cite_ref-pmid23185686_179-0" class="reference"><a href="#cite_note-pmid23185686-179"><span class="cite-bracket">[</span>179<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid12640291_180-0" class="reference"><a href="#cite_note-pmid12640291-180"><span class="cite-bracket">[</span>180<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Aspirin" title="Aspirin">Aspirin</a> and other <a href="/wiki/Nonsteroidal_anti-inflammatory_drug" title="Nonsteroidal anti-inflammatory drug">nonsteroidal anti-inflammatory drugs</a> (NSAIDs) have been found to attenuate the <a href="/wiki/Diuresis" title="Diuresis">diuresis</a> and <a href="/wiki/Natriuresis" title="Natriuresis">natriuresis</a> induced by spironolactone, but, not to affect its antihypertensive effect.<sup id="cite_ref-EndouHosoyamada1995_37-1" class="reference"><a href="#cite_note-EndouHosoyamada1995-37"><span class="cite-bracket">[</span>37<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17362671_181-0" class="reference"><a href="#cite_note-pmid17362671-181"><span class="cite-bracket">[</span>181<span class="cite-bracket">]</span></a></sup> </p><p>Some research has suggested that spironolactone might be able to interfere with the effectiveness of <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a> treatment. As the medication acts as an antimineralocorticoid, it is thought that it might be able to reduce the effectiveness of certain antidepressants by interfering with normalization of the <a href="/wiki/Hypothalamic%E2%80%93pituitary%E2%80%93adrenal_axis" title="Hypothalamic–pituitary–adrenal axis">hypothalamic–pituitary–adrenal axis</a> and by increasing levels of <a href="/wiki/Glucocorticoid" title="Glucocorticoid">glucocorticoids</a> such as <a href="/wiki/Cortisol" title="Cortisol">cortisol</a>.<sup id="cite_ref-182" class="reference"><a href="#cite_note-182"><span class="cite-bracket">[</span>182<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19909979_183-0" class="reference"><a href="#cite_note-pmid19909979-183"><span class="cite-bracket">[</span>183<span class="cite-bracket">]</span></a></sup> However, other research contradicts this hypothesis and has suggested that spironolactone might actually produce antidepressant effects, for instance studies showing antidepressant-like effects of spironolactone in animals.<sup id="cite_ref-pmid21515309_184-0" class="reference"><a href="#cite_note-pmid21515309-184"><span class="cite-bracket">[</span>184<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Pharmacology">Pharmacology</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=21" title="Edit section: Pharmacology"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <div class="mw-heading mw-heading3"><h3 id="Pharmacodynamics">Pharmacodynamics</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=22" title="Edit section: Pharmacodynamics"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Pharmacodynamics_of_spironolactone" title="Pharmacodynamics of spironolactone">Pharmacodynamics of spironolactone</a></div> <figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:7%CE%B1-Thiomethylspironolactone.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e8/7%CE%B1-Thiomethylspironolactone.svg/220px-7%CE%B1-Thiomethylspironolactone.svg.png" decoding="async" width="220" height="151" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e8/7%CE%B1-Thiomethylspironolactone.svg/330px-7%CE%B1-Thiomethylspironolactone.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e8/7%CE%B1-Thiomethylspironolactone.svg/440px-7%CE%B1-Thiomethylspironolactone.svg.png 2x" data-file-width="1290" data-file-height="885" /></a><figcaption><a href="/wiki/7%CE%B1-Thiomethylspironolactone" title="7α-Thiomethylspironolactone">7α-Thiomethylspironolactone</a>, the major <a href="/wiki/Active_metabolite" title="Active metabolite">active form</a> of spironolactone. It accounts for about 80% of the potassium-sparing effect of spironolactone.<sup id="cite_ref-pmid15947888_11-8" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-AgustiBourgeois2013_185-0" class="reference"><a href="#cite_note-AgustiBourgeois2013-185"><span class="cite-bracket">[</span>185<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-CancerOrganization2001_186-0" class="reference"><a href="#cite_note-CancerOrganization2001-186"><span class="cite-bracket">[</span>186<span class="cite-bracket">]</span></a></sup></figcaption></figure> <figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Canrenone.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/d/db/Canrenone.svg/220px-Canrenone.svg.png" decoding="async" width="220" height="154" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/db/Canrenone.svg/330px-Canrenone.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/db/Canrenone.svg/440px-Canrenone.svg.png 2x" data-file-width="512" data-file-height="359" /></a><figcaption><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a>, the second major <a href="/wiki/Active_metabolite" title="Active metabolite">active form</a> of spironolactone. It accounts for around 10 to 25% of the potassium-sparing effect of spironolactone.<sup id="cite_ref-GinésArroyo2008_187-0" class="reference"><a href="#cite_note-GinésArroyo2008-187"><span class="cite-bracket">[</span>187<span class="cite-bracket">]</span></a></sup></figcaption></figure> <p>The <a href="/wiki/Pharmacodynamics" title="Pharmacodynamics">pharmacodynamics</a> of spironolactone are characterized by high <a href="/wiki/Antimineralocorticoid" class="mw-redirect" title="Antimineralocorticoid">antimineralocorticoid</a> activity, moderate <a href="/wiki/Antiandrogen" title="Antiandrogen">antiandrogenic</a> activity, and weak <a href="/wiki/Steroidogenesis_inhibitor" title="Steroidogenesis inhibitor">steroidogenesis inhibition</a>, among other more minor activities.<sup id="cite_ref-pmid28634268_107-2" class="reference"><a href="#cite_note-pmid28634268-107"><span class="cite-bracket">[</span>107<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid984618_109-1" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8094898_134-1" class="reference"><a href="#cite_note-pmid8094898-134"><span class="cite-bracket">[</span>134<span class="cite-bracket">]</span></a></sup> Spironolactone is a <a href="/wiki/Prodrug" title="Prodrug">prodrug</a>, so most of its actions are actually mediated by its various <a href="/wiki/Active_metabolite" title="Active metabolite">active metabolites</a>.<sup id="cite_ref-pmid28634268_107-3" class="reference"><a href="#cite_note-pmid28634268-107"><span class="cite-bracket">[</span>107<span class="cite-bracket">]</span></a></sup> The major active forms of spironolactone are <a href="/wiki/7%CE%B1-thiomethylspironolactone" class="mw-redirect" title="7α-thiomethylspironolactone">7α-thiomethylspironolactone</a> (7α-TMS) and <a href="/wiki/Canrenone" title="Canrenone">canrenone</a> (7α-desthioacetyl-δ<sup>6</sup>-spironolactone).<sup id="cite_ref-pmid15947888_11-9" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28634268_107-4" class="reference"><a href="#cite_note-pmid28634268-107"><span class="cite-bracket">[</span>107<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone is a <a href="/wiki/Potency_(pharmacology)" title="Potency (pharmacology)">potent</a> antimineralocorticoid.<sup id="cite_ref-pmid15947888_11-10" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup> That is, it is an <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">antagonist</a> of the <a href="/wiki/Mineralocorticoid_receptor" title="Mineralocorticoid receptor">mineralocorticoid receptor</a> (MR), the <a href="/wiki/Biological_target" title="Biological target">biological target</a> of <a href="/wiki/Mineralocorticoid" title="Mineralocorticoid">mineralocorticoids</a> like <a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a> and <a href="/wiki/11-deoxycorticosterone" class="mw-redirect" title="11-deoxycorticosterone">11-deoxycorticosterone</a>.<sup id="cite_ref-pmid15947888_11-11" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup> By blocking the MR, spironolactone inhibits the effects of mineralocorticoids in the body.<sup id="cite_ref-pmid15947888_11-12" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup> The antimineralocorticoid activity of spironolactone is responsible for its therapeutic efficacy in the treatment of <a href="/wiki/Edema" title="Edema">edema</a>, <a href="/wiki/High_blood_pressure" class="mw-redirect" title="High blood pressure">high blood pressure</a>, <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a>, <a href="/wiki/Hyperaldosteronism" title="Hyperaldosteronism">hyperaldosteronism</a>, and <a href="/wiki/Ascites" title="Ascites">ascites</a> due to <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a>.<sup id="cite_ref-Feldman2008_188-0" class="reference"><a href="#cite_note-Feldman2008-188"><span class="cite-bracket">[</span>188<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Health2015_189-0" class="reference"><a href="#cite_note-Health2015-189"><span class="cite-bracket">[</span>189<span class="cite-bracket">]</span></a></sup> It is also responsible for many of the side effects of spironolactone, such as <a href="/wiki/Urinary_frequency" class="mw-redirect" title="Urinary frequency">urinary frequency</a>, <a href="/wiki/Dehydration" title="Dehydration">dehydration</a>, <a href="/wiki/Hyponatremia" title="Hyponatremia">hyponatremia</a>, <a href="/wiki/Low_blood_pressure" class="mw-redirect" title="Low blood pressure">low blood pressure</a>, <a href="/wiki/Fatigue_(medical)" class="mw-redirect" title="Fatigue (medical)">fatigue</a>, <a href="/wiki/Dizziness" title="Dizziness">dizziness</a>, <a href="/wiki/Metabolic_acidosis" title="Metabolic acidosis">metabolic acidosis</a>, decreased <a href="/wiki/Kidney_function" class="mw-redirect" title="Kidney function">kidney function</a>, and its risk of <a href="/wiki/Hyperkalemia" title="Hyperkalemia">hyperkalemia</a>.<sup id="cite_ref-pmid24456327_190-0" class="reference"><a href="#cite_note-pmid24456327-190"><span class="cite-bracket">[</span>190<span class="cite-bracket">]</span></a></sup> Due to the antimineralocorticoid activity of spironolactone, levels of <a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a> are significantly increased by the medication, probably reflecting an attempt of the body to maintain <a href="/wiki/Homeostasis" title="Homeostasis">homeostasis</a>.<sup id="cite_ref-pmid9420861_60-5" class="reference"><a href="#cite_note-pmid9420861-60"><span class="cite-bracket">[</span>60<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid10495361_86-9" class="reference"><a href="#cite_note-pmid10495361-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone is a moderate antiandrogen.<sup id="cite_ref-pmid984618_109-2" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8144871_141-1" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid1826112_172-1" class="reference"><a href="#cite_note-pmid1826112-172"><span class="cite-bracket">[</span>172<span class="cite-bracket">]</span></a></sup> That is, it is an <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">antagonist</a> of the <a href="/wiki/Androgen_receptor" title="Androgen receptor">androgen receptor</a> (AR), the biological target of <a href="/wiki/Androgen" title="Androgen">androgens</a> like <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> and <a href="/wiki/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> (DHT).<sup id="cite_ref-pmid984618_109-3" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8144871_141-2" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid1826112_172-2" class="reference"><a href="#cite_note-pmid1826112-172"><span class="cite-bracket">[</span>172<span class="cite-bracket">]</span></a></sup> By blocking the AR, spironolactone inhibits the effects of androgens in the body.<sup id="cite_ref-pmid984618_109-4" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8144871_141-3" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid1826112_172-3" class="reference"><a href="#cite_note-pmid1826112-172"><span class="cite-bracket">[</span>172<span class="cite-bracket">]</span></a></sup> The antiandrogenic activity of spironolactone is mainly responsible for its therapeutic efficacy in the treatment of <a href="/wiki/Androgen-dependent_condition" title="Androgen-dependent condition">androgen-dependent</a> <a href="/wiki/Cutaneous_condition" class="mw-redirect" title="Cutaneous condition">skin and hair conditions</a> like <a href="/wiki/Acne" title="Acne">acne</a>, <a href="/wiki/Seborrhea" class="mw-redirect" title="Seborrhea">seborrhea</a>, <a href="/wiki/Hirsutism" title="Hirsutism">hirsutism</a>, and <a href="/wiki/Pattern_hair_loss" title="Pattern hair loss">pattern hair loss</a> and <a href="/wiki/Hyperandrogenism" title="Hyperandrogenism">hyperandrogenism</a> in women, <a href="/wiki/Precocious_puberty" title="Precocious puberty">precocious puberty</a> in boys with <a href="/wiki/Testotoxicosis" class="mw-redirect" title="Testotoxicosis">testotoxicosis</a>, and as a component of <a href="/wiki/Feminizing_hormone_therapy" title="Feminizing hormone therapy">feminizing hormone therapy</a> for <a href="/wiki/Transgender_women" class="mw-redirect" title="Transgender women">transgender women</a>.<sup id="cite_ref-pmid8144871_141-4" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid29756046_174-1" class="reference"><a href="#cite_note-pmid29756046-174"><span class="cite-bracket">[</span>174<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid11322868_191-0" class="reference"><a href="#cite_note-pmid11322868-191"><span class="cite-bracket">[</span>191<span class="cite-bracket">]</span></a></sup> It is also primarily responsible for some of its side effects, like <a href="/wiki/Breast_tenderness" class="mw-redirect" title="Breast tenderness">breast tenderness</a>, <a href="/wiki/Gynecomastia" title="Gynecomastia">gynecomastia</a>, <a href="/wiki/Feminization_(biology)" title="Feminization (biology)">feminization</a>, and <a href="/wiki/Demasculinization" class="mw-redirect" title="Demasculinization">demasculinization</a> in men.<sup id="cite_ref-SeldinGiebisch1997_110-7" class="reference"><a href="#cite_note-SeldinGiebisch1997-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid11322868_191-1" class="reference"><a href="#cite_note-pmid11322868-191"><span class="cite-bracket">[</span>191<span class="cite-bracket">]</span></a></sup> Blockade of androgen signaling in the <a href="/wiki/Breast" title="Breast">breast</a> disinhibits the actions of <a href="/wiki/Estrogen" title="Estrogen">estrogens</a> in this tissue.<sup id="cite_ref-StraussIII2013_192-0" class="reference"><a href="#cite_note-StraussIII2013-192"><span class="cite-bracket">[</span>192<span class="cite-bracket">]</span></a></sup> Although useful as an antiandrogen in women, who have low testosterone levels compared to men,<sup id="cite_ref-pmid2941190_193-0" class="reference"><a href="#cite_note-pmid2941190-193"><span class="cite-bracket">[</span>193<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-GregoryTravis2015_194-0" class="reference"><a href="#cite_note-GregoryTravis2015-194"><span class="cite-bracket">[</span>194<span class="cite-bracket">]</span></a></sup> spironolactone is described as having relatively weak antiandrogenic activity.<sup id="cite_ref-Wu2012_195-0" class="reference"><a href="#cite_note-Wu2012-195"><span class="cite-bracket">[</span>195<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid11322868_191-2" class="reference"><a href="#cite_note-pmid11322868-191"><span class="cite-bracket">[</span>191<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BenniVemer1990_196-0" class="reference"><a href="#cite_note-BenniVemer1990-196"><span class="cite-bracket">[</span>196<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8915726_197-0" class="reference"><a href="#cite_note-pmid8915726-197"><span class="cite-bracket">[</span>197<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone is a weak steroidogenesis inhibitor.<sup id="cite_ref-pmid984618_109-5" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8094898_134-2" class="reference"><a href="#cite_note-pmid8094898-134"><span class="cite-bracket">[</span>134<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8144871_141-5" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid6786868_198-0" class="reference"><a href="#cite_note-pmid6786868-198"><span class="cite-bracket">[</span>198<span class="cite-bracket">]</span></a></sup> That is, it inhibits <a href="/wiki/Steroidogenic_enzyme" title="Steroidogenic enzyme">steroidogenic enzymes</a>, or <a href="/wiki/Enzyme" title="Enzyme">enzymes</a> involved in the <a href="/wiki/Steroidogenesis" class="mw-redirect" title="Steroidogenesis">production of steroid hormones</a>.<sup id="cite_ref-pmid984618_109-6" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8094898_134-3" class="reference"><a href="#cite_note-pmid8094898-134"><span class="cite-bracket">[</span>134<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8144871_141-6" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid6786868_198-1" class="reference"><a href="#cite_note-pmid6786868-198"><span class="cite-bracket">[</span>198<span class="cite-bracket">]</span></a></sup> Spironolactone and/or its metabolites have been found <i><a href="/wiki/In_vitro" title="In vitro">in vitro</a></i> to weakly <a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">inhibit</a> a broad array of steroidogenic enzymes including <a href="/wiki/Cholesterol_side-chain_cleavage_enzyme" title="Cholesterol side-chain cleavage enzyme">cholesterol side-chain cleavage enzyme</a>, <a href="/wiki/17%CE%B1-hydroxylase" class="mw-redirect" title="17α-hydroxylase">17α-hydroxylase</a>, <a href="/wiki/17,20-lyase" class="mw-redirect" title="17,20-lyase">17,20-lyase</a>, <a href="/wiki/5%CE%B1-reductase" class="mw-redirect" title="5α-reductase">5α-reductase</a>, <a href="/wiki/3%CE%B2-hydroxysteroid_dehydrogenase" class="mw-redirect" title="3β-hydroxysteroid dehydrogenase">3β-hydroxysteroid dehydrogenase</a>, <a href="/wiki/11%CE%B2-hydroxylase" class="mw-redirect" title="11β-hydroxylase">11β-hydroxylase</a>, <a href="/wiki/21-hydroxylase" class="mw-redirect" title="21-hydroxylase">21-hydroxylase</a>, and <a href="/wiki/Aldosterone_synthase" title="Aldosterone synthase">aldosterone synthase</a> (18-hydroxylase).<sup id="cite_ref-pmid8144871_141-7" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid6786868_198-2" class="reference"><a href="#cite_note-pmid6786868-198"><span class="cite-bracket">[</span>198<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26001184_199-0" class="reference"><a href="#cite_note-pmid26001184-199"><span class="cite-bracket">[</span>199<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18819053_200-0" class="reference"><a href="#cite_note-pmid18819053-200"><span class="cite-bracket">[</span>200<span class="cite-bracket">]</span></a></sup> However, although very high doses of spironolactone can considerably decrease steroid hormone levels in animals, spironolactone has shown mixed and inconsistent effects on steroid hormone levels in clinical studies, even at high clinical doses.<sup id="cite_ref-pmid28155090_63-19" class="reference"><a href="#cite_note-pmid28155090-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid984618_109-7" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8094898_134-4" class="reference"><a href="#cite_note-pmid8094898-134"><span class="cite-bracket">[</span>134<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8144871_141-8" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid1826112_172-4" class="reference"><a href="#cite_note-pmid1826112-172"><span class="cite-bracket">[</span>172<span class="cite-bracket">]</span></a></sup> In any case, the levels of most steroid hormones, including testosterone and <a href="/wiki/Cortisol" title="Cortisol">cortisol</a>, are usually unchanged by spironolactone in humans, which may in part be related to compensatory upregulation of their synthesis.<sup id="cite_ref-pmid984618_109-8" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8094898_134-5" class="reference"><a href="#cite_note-pmid8094898-134"><span class="cite-bracket">[</span>134<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-WattsFaingold2009_201-0" class="reference"><a href="#cite_note-WattsFaingold2009-201"><span class="cite-bracket">[</span>201<span class="cite-bracket">]</span></a></sup> The weak steroidogenesis inhibition of spironolactone might contribute to its antiandrogenic efficacy to some degree and may explain its side effect of menstrual irregularities in women.<sup id="cite_ref-pmid984618_109-9" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-SeldinGiebisch1997_110-8" class="reference"><a href="#cite_note-SeldinGiebisch1997-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup> However, its androgen synthesis inhibition is probably clinically insignificant.<sup id="cite_ref-pmid9238337_66-3" class="reference"><a href="#cite_note-pmid9238337-66"><span class="cite-bracket">[</span>66<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone has been found in some studies to increase levels of <a href="/wiki/Estradiol" title="Estradiol">estradiol</a>, an <a href="/wiki/Estrogen" title="Estrogen">estrogen</a>, although many other studies have found no changes in estradiol levels.<sup id="cite_ref-pmid984618_109-10" class="reference"><a href="#cite_note-pmid984618-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid8094898_134-6" class="reference"><a href="#cite_note-pmid8094898-134"><span class="cite-bracket">[</span>134<span class="cite-bracket">]</span></a></sup> The mechanism of how spironolactone increases estradiol levels is unclear, but it may involve inhibition of the inactivation of estradiol into <a href="/wiki/Estrone" title="Estrone">estrone</a> and enhancement of the peripheral conversion of testosterone into estradiol.<sup id="cite_ref-pmid12477487_202-0" class="reference"><a href="#cite_note-pmid12477487-202"><span class="cite-bracket">[</span>202<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid907238_203-0" class="reference"><a href="#cite_note-pmid907238-203"><span class="cite-bracket">[</span>203<span class="cite-bracket">]</span></a></sup> It is notable that spironolactone has been found <i>in vitro</i> to act as a weak inhibitor of <a href="/wiki/17%CE%B2-hydroxysteroid_dehydrogenase_2" class="mw-redirect" title="17β-hydroxysteroid dehydrogenase 2">17β-hydroxysteroid dehydrogenase 2</a>, an enzyme that is involved in the conversion of estradiol into estrone.<sup id="cite_ref-pmid12570693_204-0" class="reference"><a href="#cite_note-pmid12570693-204"><span class="cite-bracket">[</span>204<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19601747_205-0" class="reference"><a href="#cite_note-pmid19601747-205"><span class="cite-bracket">[</span>205<span class="cite-bracket">]</span></a></sup> Increased levels of estradiol with spironolactone may be involved in its preservation of <a href="/wiki/Bone_density" title="Bone density">bone density</a> and in its side effects such as breast tenderness, breast enlargement, and gynecomastia in women and men.<sup id="cite_ref-pmid12477487_202-1" class="reference"><a href="#cite_note-pmid12477487-202"><span class="cite-bracket">[</span>202<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid24189467_206-0" class="reference"><a href="#cite_note-pmid24189467-206"><span class="cite-bracket">[</span>206<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26230882_207-0" class="reference"><a href="#cite_note-pmid26230882-207"><span class="cite-bracket">[</span>207<span class="cite-bracket">]</span></a></sup> </p><p>In response to the antimineralocorticoid activity spironolactone, and in an attempt to maintain <a href="/wiki/Homeostasis" title="Homeostasis">homeostasis</a>, the body increases aldosterone production in the <a href="/wiki/Adrenal_cortex" title="Adrenal cortex">adrenal cortex</a>.<sup id="cite_ref-Adams2014_208-0" class="reference"><a href="#cite_note-Adams2014-208"><span class="cite-bracket">[</span>208<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid22836869_209-0" class="reference"><a href="#cite_note-pmid22836869-209"><span class="cite-bracket">[</span>209<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17035932_210-0" class="reference"><a href="#cite_note-pmid17035932-210"><span class="cite-bracket">[</span>210<span class="cite-bracket">]</span></a></sup> Some studies have found that levels of <a href="/wiki/Cortisol" title="Cortisol">cortisol</a>, a <a href="/wiki/Glucocorticoid" title="Glucocorticoid">glucocorticoid</a> hormone that is also produced in the adrenal cortex, are increased as well.<sup id="cite_ref-pmid22836869_209-1" class="reference"><a href="#cite_note-pmid22836869-209"><span class="cite-bracket">[</span>209<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17035932_210-1" class="reference"><a href="#cite_note-pmid17035932-210"><span class="cite-bracket">[</span>210<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid27519144_211-0" class="reference"><a href="#cite_note-pmid27519144-211"><span class="cite-bracket">[</span>211<span class="cite-bracket">]</span></a></sup> Spironolactone “acts at the basolateral side of the upper-distal tubule as well as in the collecting tubule,” and does not have glucocorticoid-like effects at these specific sites; it can sometimes be prescribed as an alternative to glucocorticoids for patients with Glucocorticoid-Remediable Aldosteronism characterized by aldosterone excess,<sup id="cite_ref-pmid8144871_141-9" class="reference"><a href="#cite_note-pmid8144871-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-FalconeHurd2007_212-0" class="reference"><a href="#cite_note-FalconeHurd2007-212"><span class="cite-bracket">[</span>212<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Hammerstein1990_97-1" class="reference"><a href="#cite_note-Hammerstein1990-97"><span class="cite-bracket">[</span>97<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid628197_213-0" class="reference"><a href="#cite_note-pmid628197-213"><span class="cite-bracket">[</span>213<span class="cite-bracket">]</span></a></sup> In patients “receiving spironolactone, there was a significant positive correlation between the change in cortisol and the change in HbA1c (r = 0.489, P = .003).”<sup id="cite_ref-pmid21095280_214-0" class="reference"><a href="#cite_note-pmid21095280-214"><span class="cite-bracket">[</span>214<span class="cite-bracket">]</span></a></sup> Patients taking spironolactone must be monitored for side effects including dizziness, headache, fatigue, diarrhea, hypertriglyceridemia and elevated liver enzymes.<sup id="cite_ref-KuntzKuntz2009_215-0" class="reference"><a href="#cite_note-KuntzKuntz2009-215"><span class="cite-bracket">[</span>215<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-MelmedPolonsky2011_216-0" class="reference"><a href="#cite_note-MelmedPolonsky2011-216"><span class="cite-bracket">[</span>216<span class="cite-bracket">]</span></a></sup> </p><p>Other activities of spironolactone may include very weak interactions with the <a href="/wiki/Estrogen_receptor" title="Estrogen receptor">estrogen</a> and <a href="/wiki/Progesterone_receptor" title="Progesterone receptor">progesterone receptors</a> and <a href="/wiki/Agonist" title="Agonist">agonism</a> of the <a href="/wiki/Pregnane_X_receptor" title="Pregnane X receptor">pregnane X receptor</a>.<sup id="cite_ref-Hammerstein1990_97-2" class="reference"><a href="#cite_note-Hammerstein1990-97"><span class="cite-bracket">[</span>97<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid12372848_217-0" class="reference"><a href="#cite_note-pmid12372848-217"><span class="cite-bracket">[</span>217<span class="cite-bracket">]</span></a></sup> These activities could contribute to the <a href="/wiki/Menstrual_irregularity" class="mw-redirect" title="Menstrual irregularity">menstrual irregularities</a> and <a href="/wiki/Breast" title="Breast">breast</a> side effects of spironolactone and to its <a href="/wiki/Drug_interaction" title="Drug interaction">drug interactions</a>, respectively.<sup id="cite_ref-pmid27072668_218-0" class="reference"><a href="#cite_note-pmid27072668-218"><span class="cite-bracket">[</span>218<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Delyani2000_219-0" class="reference"><a href="#cite_note-Delyani2000-219"><span class="cite-bracket">[</span>219<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid9727070_220-0" class="reference"><a href="#cite_note-pmid9727070-220"><span class="cite-bracket">[</span>220<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Pharmacokinetics">Pharmacokinetics</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=23" title="Edit section: Pharmacokinetics"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The <a href="/wiki/Pharmacokinetics" title="Pharmacokinetics">pharmacokinetics</a> of spironolactone have not been studied well, which is in part because it is an old medication that was developed in the 1950s.<sup id="cite_ref-Wilcox2008_135-1" class="reference"><a href="#cite_note-Wilcox2008-135"><span class="cite-bracket">[</span>135<span class="cite-bracket">]</span></a></sup> Nonetheless, much has been elucidated about the pharmacokinetics of spironolactone over the decades.<sup id="cite_ref-pmid363379_221-0" class="reference"><a href="#cite_note-pmid363379-221"><span class="cite-bracket">[</span>221<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid6369882_222-0" class="reference"><a href="#cite_note-pmid6369882-222"><span class="cite-bracket">[</span>222<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid3333882_223-0" class="reference"><a href="#cite_note-pmid3333882-223"><span class="cite-bracket">[</span>223<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid15947888_11-13" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid22099505_224-0" class="reference"><a href="#cite_note-pmid22099505-224"><span class="cite-bracket">[</span>224<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid21771637_225-0" class="reference"><a href="#cite_note-pmid21771637-225"><span class="cite-bracket">[</span>225<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26939027_226-0" class="reference"><a href="#cite_note-pmid26939027-226"><span class="cite-bracket">[</span>226<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid27830348_227-0" class="reference"><a href="#cite_note-pmid27830348-227"><span class="cite-bracket">[</span>227<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading4"><h4 id="Absorption">Absorption</h4><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=24" title="Edit section: Absorption"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <figure class="mw-halign-right" typeof="mw:File/Thumb"><a href="/wiki/File:Spironolactone_and_metabolite_levels_after_a_single_oral_dose_of_100_mg_spironolactone.png" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/d/db/Spironolactone_and_metabolite_levels_after_a_single_oral_dose_of_100_mg_spironolactone.png/400px-Spironolactone_and_metabolite_levels_after_a_single_oral_dose_of_100_mg_spironolactone.png" decoding="async" width="400" height="275" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/db/Spironolactone_and_metabolite_levels_after_a_single_oral_dose_of_100_mg_spironolactone.png/600px-Spironolactone_and_metabolite_levels_after_a_single_oral_dose_of_100_mg_spironolactone.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/db/Spironolactone_and_metabolite_levels_after_a_single_oral_dose_of_100_mg_spironolactone.png/800px-Spironolactone_and_metabolite_levels_after_a_single_oral_dose_of_100_mg_spironolactone.png 2x" data-file-width="1676" data-file-height="1151" /></a><figcaption>Levels of spironolactone and its major active metabolites after a single oral dose of 100 mg spironolactone in humans.<sup id="cite_ref-pmid8818057_228-0" class="reference"><a href="#cite_note-pmid8818057-228"><span class="cite-bracket">[</span>228<span class="cite-bracket">]</span></a></sup></figcaption></figure> <p>The <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a> of spironolactone when taken <a href="/wiki/Oral_administration" title="Oral administration">by mouth</a> is 60 to 90%.<sup id="cite_ref-pmid15947888_11-14" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18729003_12-4" class="reference"><a href="#cite_note-pmid18729003-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-CaroneOxberry2017_13-1" class="reference"><a href="#cite_note-CaroneOxberry2017-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup> The bioavailability of spironolactone and its metabolites increases significantly (+22–95% increases in levels) when spironolactone is taken with food, although it is uncertain whether this further increases the therapeutic effects of the medication.<sup id="cite_ref-DeinumRiksen2015_229-0" class="reference"><a href="#cite_note-DeinumRiksen2015-229"><span class="cite-bracket">[</span>229<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid3769384_230-0" class="reference"><a href="#cite_note-pmid3769384-230"><span class="cite-bracket">[</span>230<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid872489_231-0" class="reference"><a href="#cite_note-pmid872489-231"><span class="cite-bracket">[</span>231<span class="cite-bracket">]</span></a></sup> The increase in bioavailability is thought to be due to promotion of the gastric dissolution and <a href="/wiki/Absorption_(pharmacokinetics)" class="mw-redirect" title="Absorption (pharmacokinetics)">absorption</a> of spironolactone, as well as due to a decrease of the <a href="/wiki/First-pass_metabolism" class="mw-redirect" title="First-pass metabolism">first-pass metabolism</a>.<sup id="cite_ref-DeinumRiksen2015_229-1" class="reference"><a href="#cite_note-DeinumRiksen2015-229"><span class="cite-bracket">[</span>229<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Saini-ChohanHatch2009_232-0" class="reference"><a href="#cite_note-Saini-ChohanHatch2009-232"><span class="cite-bracket">[</span>232<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Al-HadiyaBelal2002_233-0" class="reference"><a href="#cite_note-Al-HadiyaBelal2002-233"><span class="cite-bracket">[</span>233<span class="cite-bracket">]</span></a></sup> The relationship between a single dose of spironolactone and plasma levels of <a href="/wiki/Canrenone" title="Canrenone">canrenone</a>, a major <a href="/wiki/Active_metabolite" title="Active metabolite">active metabolite</a> of spironolactone, has been found to be linear across a dose range of 25 to 200 mg spironolactone.<sup id="cite_ref-Wu2012_195-1" class="reference"><a href="#cite_note-Wu2012-195"><span class="cite-bracket">[</span>195<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Elimination_(pharmacology)#Steady_state" title="Elimination (pharmacology)">Steady-state concentrations</a> of spironolactone are achieved within 8 to 10 days of treatment initiation.<sup id="cite_ref-CancerOrganization2001_186-1" class="reference"><a href="#cite_note-CancerOrganization2001-186"><span class="cite-bracket">[</span>186<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Elsevier2019_234-0" class="reference"><a href="#cite_note-Elsevier2019-234"><span class="cite-bracket">[</span>234<span class="cite-bracket">]</span></a></sup> </p><p>Little or no systemic <a href="/wiki/Absorption_(pharmacokinetics)" class="mw-redirect" title="Absorption (pharmacokinetics)">absorption</a> has been observed with topical spironolactone.<sup id="cite_ref-pmid3411088_235-0" class="reference"><a href="#cite_note-pmid3411088-235"><span class="cite-bracket">[</span>235<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading4"><h4 id="Distribution">Distribution</h4><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=25" title="Edit section: Distribution"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone and its metabolite canrenone are highly <a href="/wiki/Plasma_protein_bound" class="mw-redirect" title="Plasma protein bound">plasma protein bound</a>, with percentages of 88.0% and 99.2%, respectively.<sup id="cite_ref-pmid15947888_11-15" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-TakamuraMaruyama1997_14-2" class="reference"><a href="#cite_note-TakamuraMaruyama1997-14"><span class="cite-bracket">[</span>14<span class="cite-bracket">]</span></a></sup> Spironolactone is bound equivalently to <a href="/wiki/Human_serum_albumin" title="Human serum albumin">albumin</a> and <a href="/wiki/Orosomucoid" title="Orosomucoid">α<sub>1</sub>-acid glycoprotein</a>, while canrenone is bound only to albumin.<sup id="cite_ref-pmid15947888_11-16" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-TakamuraMaruyama1997_14-3" class="reference"><a href="#cite_note-TakamuraMaruyama1997-14"><span class="cite-bracket">[</span>14<span class="cite-bracket">]</span></a></sup> Spironolactone and its metabolite <a href="/wiki/7%CE%B1-thiospironolactone" class="mw-redirect" title="7α-thiospironolactone">7α-thiospironolactone</a> show very low or negligible affinity for <a href="/wiki/Sex_hormone-binding_globulin" title="Sex hormone-binding globulin">sex hormone-binding globulin</a> (SHBG).<sup id="cite_ref-pmid86546_236-0" class="reference"><a href="#cite_note-pmid86546-236"><span class="cite-bracket">[</span>236<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid7195405_237-0" class="reference"><a href="#cite_note-pmid7195405-237"><span class="cite-bracket">[</span>237<span class="cite-bracket">]</span></a></sup> In accordance, a study of high-dosage spironolactone treatment found no change in steroid binding capacity related to SHBG or to <a href="/wiki/Corticosteroid-binding_globulin" class="mw-redirect" title="Corticosteroid-binding globulin">corticosteroid-binding globulin</a> (CBG), suggesting that spironolactone does not displace <a href="/wiki/Steroid_hormone" title="Steroid hormone">steroid hormones</a> from their <a href="/wiki/Carrier_protein" class="mw-redirect" title="Carrier protein">carrier proteins</a>.<sup id="cite_ref-pmid7189544_238-0" class="reference"><a href="#cite_note-pmid7189544-238"><span class="cite-bracket">[</span>238<span class="cite-bracket">]</span></a></sup> This is in contradiction with widespread statements that spironolactone increases free estradiol levels by displacing estradiol from SHBG.<sup id="cite_ref-Hammerstein1990_97-3" class="reference"><a href="#cite_note-Hammerstein1990-97"><span class="cite-bracket">[</span>97<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BlandIII2009_239-0" class="reference"><a href="#cite_note-BlandIII2009-239"><span class="cite-bracket">[</span>239<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone appears to cross the <a href="/wiki/Blood%E2%80%93brain_barrier" title="Blood–brain barrier">blood–brain barrier</a>.<sup id="cite_ref-pmid25376974_240-0" class="reference"><a href="#cite_note-pmid25376974-240"><span class="cite-bracket">[</span>240<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid22351473_241-0" class="reference"><a href="#cite_note-pmid22351473-241"><span class="cite-bracket">[</span>241<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading4"><h4 id="Metabolism">Metabolism</h4><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=26" title="Edit section: Metabolism"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <figure class="mw-halign-right" typeof="mw:File/Thumb"><a href="/wiki/File:Spironolactone_metabolism.png" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4f/Spironolactone_metabolism.png/400px-Spironolactone_metabolism.png" decoding="async" width="400" height="327" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4f/Spironolactone_metabolism.png/600px-Spironolactone_metabolism.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4f/Spironolactone_metabolism.png/800px-Spironolactone_metabolism.png 2x" data-file-width="2570" data-file-height="2100" /></a><figcaption>Spironolactone <a href="/wiki/Metabolism" title="Metabolism">metabolism</a> in humans.<sup id="cite_ref-pmid1629288_242-0" class="reference"><a href="#cite_note-pmid1629288-242"><span class="cite-bracket">[</span>242<span class="cite-bracket">]</span></a></sup> <a href="/wiki/Canrenone" title="Canrenone">Canrenone</a> may be further <a href="/wiki/Redox" title="Redox">reduced</a> (into di-, tetra-, and hexahydrogenated metabolites), <a href="/wiki/Hydroxylation" title="Hydroxylation">hydroxylated</a>, and <a href="/wiki/Conjugation_(biochemistry)" class="mw-redirect" title="Conjugation (biochemistry)">conjugated</a> (e.g., <a href="/wiki/Glucuronidation" title="Glucuronidation">glucuronidated</a>).<sup id="cite_ref-pmid1629288_242-1" class="reference"><a href="#cite_note-pmid1629288-242"><span class="cite-bracket">[</span>242<span class="cite-bracket">]</span></a></sup></figcaption></figure> <p>Spironolactone is rapidly and extensively <a href="/wiki/Metabolism" title="Metabolism">metabolized</a> in the <a href="/wiki/Liver" title="Liver">liver</a> upon <a href="/wiki/Oral_administration" title="Oral administration">oral administration</a> and has a very short <a href="/wiki/Biological_half-life" title="Biological half-life">terminal half-life</a> of 1.4 hours.<sup id="cite_ref-pmid15947888_11-17" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18729003_12-5" class="reference"><a href="#cite_note-pmid18729003-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup> The major <a href="/wiki/Metabolite" title="Metabolite">metabolites</a> of spironolactone are <a href="/wiki/7%CE%B1-thiomethylspironolactone" class="mw-redirect" title="7α-thiomethylspironolactone">7α-thiomethylspironolactone</a> (7α-TMS), <a href="/wiki/6%CE%B2-hydroxy-7%CE%B1-thiomethylspironolactone" class="mw-redirect" title="6β-hydroxy-7α-thiomethylspironolactone">6β-hydroxy-7α-thiomethylspironolactone</a> (6β-OH-7α-TMS), and <a href="/wiki/Canrenone" title="Canrenone">canrenone</a> (7α-desthioacetyl-δ<sup>6</sup>-spironolactone).<sup id="cite_ref-pmid15947888_11-18" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18729003_12-6" class="reference"><a href="#cite_note-pmid18729003-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-AgustiBourgeois2013_185-1" class="reference"><a href="#cite_note-AgustiBourgeois2013-185"><span class="cite-bracket">[</span>185<span class="cite-bracket">]</span></a></sup> These metabolites have much longer elimination half-lives than spironolactone of 13.8 hours, 15.0 hours, and 16.5 hours, respectively, and are responsible for the therapeutic effects of the medication.<sup id="cite_ref-pmid15947888_11-19" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18729003_12-7" class="reference"><a href="#cite_note-pmid18729003-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup> As such, spironolactone is a <a href="/wiki/Prodrug" title="Prodrug">prodrug</a>.<sup id="cite_ref-Oxford2003_243-0" class="reference"><a href="#cite_note-Oxford2003-243"><span class="cite-bracket">[</span>243<span class="cite-bracket">]</span></a></sup> The 7α-thiomethylated metabolites of spironolactone were not known for many years and it was originally thought that canrenone was the major active metabolite of the medication, but subsequent research identified 7α-TMS as the major metabolite.<sup id="cite_ref-pmid15947888_11-20" class="reference"><a href="#cite_note-pmid15947888-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-AgustiBourgeois2013_185-2" class="reference"><a href="#cite_note-AgustiBourgeois2013-185"><span class="cite-bracket">[</span>185<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-CancerOrganization2001_186-2" class="reference"><a href="#cite_note-CancerOrganization2001-186"><span class="cite-bracket">[</span>186<span class="cite-bracket">]</span></a></sup> Other known but more minor metabolites of spironolactone include <a href="/wiki/7%CE%B1-thiospironolactone" class="mw-redirect" title="7α-thiospironolactone">7α-thiospironolactone</a> (7α-TS), which is an important <a href="/wiki/Metabolic_intermediate" title="Metabolic intermediate">intermediate</a> to the major metabolites of spironolactone,<sup id="cite_ref-Parkinson2001_17-2" class="reference"><a href="#cite_note-Parkinson2001-17"><span class="cite-bracket">[</span>17<span class="cite-bracket">]</span></a></sup> as well as the 7α-methyl ethyl ester of spironolactone and the 6β-hydroxy-7α-methyl ethyl ester of spironolactone.<sup id="cite_ref-SzaszBudvari-Barany1990_15-1" class="reference"><a href="#cite_note-SzaszBudvari-Barany1990-15"><span class="cite-bracket">[</span>15<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone is <a href="/wiki/Hydrolysis" title="Hydrolysis">hydrolyzed</a> or <a href="/wiki/Acetylation" title="Acetylation">deacetylated</a> at the <a href="/wiki/Thioester" title="Thioester">thioester</a> of the C7α position into 7α-TS by <a href="/wiki/Carboxylesterase" title="Carboxylesterase">carboxylesterases</a>.<sup id="cite_ref-Parkinson2001_17-3" class="reference"><a href="#cite_note-Parkinson2001-17"><span class="cite-bracket">[</span>17<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-AnzenbacherZanger2012_244-0" class="reference"><a href="#cite_note-AnzenbacherZanger2012-244"><span class="cite-bracket">[</span>244<span class="cite-bracket">]</span></a></sup> Following formation of 7α-TS, it is <i>S</i>-<a href="/wiki/Oxidation" class="mw-redirect" title="Oxidation">oxygenated</a> by <a href="/wiki/Flavin-containing_monooxygenase" title="Flavin-containing monooxygenase">flavin-containing monooxygenases</a> to form an <a href="/wiki/Electrophilic" class="mw-redirect" title="Electrophilic">electrophilic</a> <a href="/wiki/Sulfenic_acid" title="Sulfenic acid">sulfenic acid</a> <a href="/wiki/Metabolite" title="Metabolite">metabolite</a>.<sup id="cite_ref-Parkinson2001_17-4" class="reference"><a href="#cite_note-Parkinson2001-17"><span class="cite-bracket">[</span>17<span class="cite-bracket">]</span></a></sup> This metabolite is involved in the CYP450 inhibition of spironolactone, and also binds <a href="/wiki/Covalent_bond" title="Covalent bond">covalently</a> to other <a href="/wiki/Protein" title="Protein">proteins</a>.<sup id="cite_ref-Parkinson2001_17-5" class="reference"><a href="#cite_note-Parkinson2001-17"><span class="cite-bracket">[</span>17<span class="cite-bracket">]</span></a></sup> 7α-TS is also <i>S</i>-<a href="/wiki/Methylation" title="Methylation">methylated</a> into 7α-TMS, a transformation catalyzed by <a href="/wiki/Thiol_S-methyltransferase" title="Thiol S-methyltransferase">thiol <i>S</i>-methyltransferase</a>.<sup id="cite_ref-Parkinson2001_17-6" class="reference"><a href="#cite_note-Parkinson2001-17"><span class="cite-bracket">[</span>17<span class="cite-bracket">]</span></a></sup> Unlike the related medication <a href="/wiki/Eplerenone" title="Eplerenone">eplerenone</a>, spironolactone is said to not be metabolized by <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a>.<sup id="cite_ref-SmithPh.D.2014_245-0" class="reference"><a href="#cite_note-SmithPh.D.2014-245"><span class="cite-bracket">[</span>245<span class="cite-bracket">]</span></a></sup> However, hepatic CYP3A4 is likely responsible for the 6β-<a href="/wiki/Hydroxylation" title="Hydroxylation">hydroxylation</a> of 7α-TMS into 6β-OH-7α-TMS.<sup id="cite_ref-Klaassen2007_18-1" class="reference"><a href="#cite_note-Klaassen2007-18"><span class="cite-bracket">[</span>18<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Montellano2015_246-0" class="reference"><a href="#cite_note-Montellano2015-246"><span class="cite-bracket">[</span>246<span class="cite-bracket">]</span></a></sup> 7α-TMS may also be <a href="/wiki/Hydroxyl" class="mw-redirect" title="Hydroxyl">hydroxylated</a> at the C3α and C3β positions.<sup id="cite_ref-pmid7895608_19-1" class="reference"><a href="#cite_note-pmid7895608-19"><span class="cite-bracket">[</span>19<span class="cite-bracket">]</span></a></sup> Spironolactone is <a href="/wiki/Dethioacetylated" class="mw-redirect" title="Dethioacetylated">dethioacetylated</a> into canrenone.<sup id="cite_ref-BlackElliott2006_20-1" class="reference"><a href="#cite_note-BlackElliott2006-20"><span class="cite-bracket">[</span>20<span class="cite-bracket">]</span></a></sup> Finally, the C17 γ-<a href="/wiki/Lactone" title="Lactone">lactone</a> <a href="/wiki/Ring_(chemistry)" title="Ring (chemistry)">ring</a> of spironolactone is hydrolyzed by the <a href="/wiki/Paraoxonase" title="Paraoxonase">paraoxonase</a> <a href="/wiki/PON3" title="PON3">PON3</a>.<sup id="cite_ref-pmid14579013_21-1" class="reference"><a href="#cite_note-pmid14579013-21"><span class="cite-bracket">[</span>21<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-AcademicPress2012_247-0" class="reference"><a href="#cite_note-AcademicPress2012-247"><span class="cite-bracket">[</span>247<span class="cite-bracket">]</span></a></sup> It was originally thought to be hydrolyzed by PON1, but this was due to contamination with PON3.<sup id="cite_ref-pmid14579013_21-2" class="reference"><a href="#cite_note-pmid14579013-21"><span class="cite-bracket">[</span>21<span class="cite-bracket">]</span></a></sup> </p> <table class="wikitable sortable mw-collapsible mw-collapsed" style="margin-left: auto; margin-right: auto; border: none;"> <caption class="nowrap"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Pharmacokinetics_of_100_mg_per_day_spironolactone_and_its_metabolites" title="Template:Pharmacokinetics of 100 mg per day spironolactone and its metabolites"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Pharmacokinetics_of_100_mg_per_day_spironolactone_and_its_metabolites" title="Template talk:Pharmacokinetics of 100 mg per day spironolactone and its metabolites"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Pharmacokinetics_of_100_mg_per_day_spironolactone_and_its_metabolites" title="Special:EditPage/Template:Pharmacokinetics of 100 mg per day spironolactone and its metabolites"><abbr title="Edit this template">e</abbr></a></li></ul></div> Pharmacokinetics of 100 mg/day spironolactone and its metabolites </caption> <tbody><tr> <th>Compound</th> <th><a href="/wiki/Peak_concentrations" class="mw-redirect" title="Peak concentrations"><abbr title="Peak concentrations">C<sub>max</sub></abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Peak concentrations</span> <span style="font-size:85%;">(day 1)</span></th> <th><a href="/wiki/Peak_concentrations" class="mw-redirect" title="Peak concentrations"><abbr title="Peak concentrations">C<sub>max</sub></abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Peak concentrations</span> <span style="font-size:85%;">(day 15)</span></th> <th><a href="/wiki/Area-under-the-curve_concentrations" class="mw-redirect" title="Area-under-the-curve concentrations"><abbr title="Area-under-the-curve concentrations">AUC</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Area-under-the-curve concentrations</span> <span style="font-size:85%;">(day 15)</span></th> <th><a href="/wiki/Elimination_half-life" class="mw-redirect" title="Elimination half-life"><abbr title="Elimination half-life">t<sub>1/2</sub></abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Elimination half-life</span> </th></tr> <tr> <td>Spironolactone</td> <td>72 ng/mL (173 nmol/L)</td> <td>80 ng/mL (192 nmol/L)</td> <td>231 ng•hour/mL (555 nmol•hour/L)</td> <td>1.4 hours </td></tr> <tr> <td><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></td> <td>155 ng/mL (455 nmol/L)</td> <td>181 ng/mL (532 nmol/L)</td> <td>2,173 ng•hour/mL (6,382 nmol•hour/L)</td> <td>16.5 hours </td></tr> <tr> <td><a href="/wiki/7%CE%B1-Thiomethylspironolactone" title="7α-Thiomethylspironolactone"><abbr title="7α-Thiomethylspironolactone">7α-TMS</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip 7α-Thiomethylspironolactone</span></td> <td>359 ng/mL (924 nmol/L)</td> <td>391 ng/mL (1,006 nmol/L)</td> <td>2,804 ng•hour/mL (7,216 nmol•hour/L)</td> <td>13.8 hours </td></tr> <tr> <td><a href="/wiki/6%CE%B2-Hydroxy-7%CE%B1-thiomethylspironolactone" title="6β-Hydroxy-7α-thiomethylspironolactone"><abbr title="6β-Hydroxy-7α-thiomethylspironolactone">6β-OH-7α-TMS</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip 6β-Hydroxy-7α-thiomethylspironolactone</span></td> <td>101 ng/mL (250 nmol/L)</td> <td>125 ng/mL (309 nmol/L)</td> <td>1,727 ng•hour/mL (4,269 nmol•hour/L)</td> <td>15.0 hours </td></tr> <tr class="sortbottom"> <td colspan="5" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Sources:</b> See template. </td></tr></tbody></table> <div class="mw-heading mw-heading4"><h4 id="Elimination">Elimination</h4><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=27" title="Edit section: Elimination"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The majority of spironolactone is eliminated by the <a href="/wiki/Kidney" title="Kidney">kidneys</a>, while minimal amounts are handled by <a href="/wiki/Bile" title="Bile">biliary</a> excretion.<sup id="cite_ref-Brittain2002_248-0" class="reference"><a href="#cite_note-Brittain2002-248"><span class="cite-bracket">[</span>248<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Chemistry">Chemistry</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=28" title="Edit section: Chemistry"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951"><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Spirolactone" title="Spirolactone">Spirolactone</a> and <a href="/wiki/List_of_steroidal_antiandrogens#Spirolactone_derivatives" title="List of steroidal antiandrogens">List of steroidal antiandrogens § Spirolactone derivatives</a></div> <p>Spironolactone, also known as <i>7α-acetylthiospirolactone</i>, is a <a href="/wiki/Steroid" title="Steroid">steroidal</a> <a href="/wiki/17%CE%B1-spirolactone" class="mw-redirect" title="17α-spirolactone">17α-spirolactone</a>, or more simply a spirolactone.<sup id="cite_ref-pmid28634268_107-5" class="reference"><a href="#cite_note-pmid28634268-107"><span class="cite-bracket">[</span>107<span class="cite-bracket">]</span></a></sup> It can most appropriately be conceptualized as a <a href="/wiki/Chemical_derivative" class="mw-redirect" title="Chemical derivative">derivative</a> of <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a>,<sup id="cite_ref-pmid15134800_133-3" class="reference"><a href="#cite_note-pmid15134800-133"><span class="cite-bracket">[</span>133<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-JamesonGroot2010_249-0" class="reference"><a href="#cite_note-JamesonGroot2010-249"><span class="cite-bracket">[</span>249<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Elsevier2019_234-1" class="reference"><a href="#cite_note-Elsevier2019-234"><span class="cite-bracket">[</span>234<span class="cite-bracket">]</span></a></sup> itself also a potent antimineralocorticoid, in which a <a href="/wiki/Hydroxyl_group" class="mw-redirect" title="Hydroxyl group">hydroxyl group</a> has been <a href="/wiki/Substituent" title="Substituent">substituted</a> at the C17α position (as in <a href="/wiki/17%CE%B1-hydroxyprogesterone" class="mw-redirect" title="17α-hydroxyprogesterone">17α-hydroxyprogesterone</a>), the <a href="/wiki/Acetyl_group" title="Acetyl group">acetyl group</a> at the C17β position has been <a href="/wiki/Cyclic_compound" title="Cyclic compound">cyclized</a> with the C17α hydroxyl group to form a <a href="/wiki/Spiro_compound" title="Spiro compound">spiro</a> 21-<a href="/wiki/Carboxylic_acid" title="Carboxylic acid">carboxylic acid</a> γ-<a href="/wiki/Lactone" title="Lactone">lactone</a> <a href="/wiki/Ring_(chemistry)" title="Ring (chemistry)">ring</a>, and an acetyl<a href="/wiki/Thio-" title="Thio-">thio</a> group has been substituted in at the C7α position.<sup id="cite_ref-Elks2014_250-0" class="reference"><a href="#cite_note-Elks2014-250"><span class="cite-bracket">[</span>250<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-PubChem_251-0" class="reference"><a href="#cite_note-PubChem-251"><span class="cite-bracket">[</span>251<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-ChemSpider_252-0" class="reference"><a href="#cite_note-ChemSpider-252"><span class="cite-bracket">[</span>252<span class="cite-bracket">]</span></a></sup> These <a href="/wiki/Structural_modification" class="mw-redirect" title="Structural modification">structural modifications</a> of progesterone confer increased <a href="/wiki/Oral_administration" title="Oral administration">oral</a> <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a> and <a href="/wiki/Potency_(pharmacology)" title="Potency (pharmacology)">potency</a>,<sup id="cite_ref-pmid8616985_253-0" class="reference"><a href="#cite_note-pmid8616985-253"><span class="cite-bracket">[</span>253<span class="cite-bracket">]</span></a></sup> potent antiandrogenic activity, and strongly reduced progestogenic activity.<sup id="cite_ref-pmid16101407_254-0" class="reference"><a href="#cite_note-pmid16101407-254"><span class="cite-bracket">[</span>254<span class="cite-bracket">]</span></a></sup> The C7α substitution is likely responsible for or involved in the antiandrogenic activity of spironolactone, as <a href="/wiki/7%CE%B1-thioprogesterone" class="mw-redirect" title="7α-thioprogesterone">7α-thioprogesterone</a> (SC-8365), unlike progesterone,<sup id="cite_ref-pmid16112947_255-0" class="reference"><a href="#cite_note-pmid16112947-255"><span class="cite-bracket">[</span>255<span class="cite-bracket">]</span></a></sup> is an antiandrogen with similar affinity to the AR as that of spironolactone.<sup id="cite_ref-pmid263288_256-0" class="reference"><a href="#cite_note-pmid263288-256"><span class="cite-bracket">[</span>256<span class="cite-bracket">]</span></a></sup> In addition, the C7α substitution appears to be responsible for the loss of progestogenic activity and good oral bioavailability of spironolactone, as <a href="/wiki/SC-5233" title="SC-5233">SC-5233</a>, the analogue of spironolactone without a C7α substitution, has potent progestogenic activity but very poor oral bioavailability similarly to progesterone.<sup id="cite_ref-pmid16112947_255-1" class="reference"><a href="#cite_note-pmid16112947-255"><span class="cite-bracket">[</span>255<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid13601900_257-0" class="reference"><a href="#cite_note-pmid13601900-257"><span class="cite-bracket">[</span>257<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Butterworth1961_258-0" class="reference"><a href="#cite_note-Butterworth1961-258"><span class="cite-bracket">[</span>258<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Names">Names</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=29" title="Edit section: Names"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone is also known by the following equivalent chemical names:<sup id="cite_ref-Elks2014_250-1" class="reference"><a href="#cite_note-Elks2014-250"><span class="cite-bracket">[</span>250<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-PubChem_251-1" class="reference"><a href="#cite_note-PubChem-251"><span class="cite-bracket">[</span>251<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-ChemSpider_252-1" class="reference"><a href="#cite_note-ChemSpider-252"><span class="cite-bracket">[</span>252<span class="cite-bracket">]</span></a></sup> </p> <ul><li>7α-Acetylthio-17α-hydroxy-3-oxopregn-4-ene-21-carboxylic acid γ-lactone</li> <li>7α-Acetylthio-3-oxo-17α-pregn-4-ene-21,17β-carbolactone</li> <li>3-(3-Oxo-7α-acetylthio-17β-hydroxyandrost-4-en-17α-yl)propionic acid lactone</li> <li>7α-Acetylthio-17α-(2-carboxyethyl)androst-4-en-17β-ol-3-one γ-lactone</li> <li>7α-Acetylthio-17α-(2-carboxyethyl)testosterone γ-lactone</li></ul> <div class="mw-heading mw-heading3"><h3 id="Analogues">Analogues</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=30" title="Edit section: Analogues"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <table role="presentation" cellpadding="0" style="border-spacing:0; clear:right; float:right;"> <tbody><tr> <td><div class="thumb tright"> <div class="thumbinner" style="width:552px;"> <div style="clear: both; font-weight: bold; font-size: 106.4%; text-align: center; background-color: aliceblue;margin-bottom:3px;"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Spirolactone_structures" title="Template:Spirolactone structures"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Spirolactone_structures" title="Template talk:Spirolactone structures"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Spirolactone_structures" title="Special:EditPage/Template:Spirolactone structures"><abbr title="Edit this template">e</abbr></a></li></ul></div> Chemical structures of <a href="/wiki/Spirolactone" title="Spirolactone">spirolactones</a></div> <div style="position:relative; width:550px; height:351px; overflow:hidden; border:solid #ccc 1px; background-color:white;"> <div style="left:0px; top:0px; width:550px; position:absolute"> <span typeof="mw:File"><span><img alt="Spirolactone structures" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Spirolactone_structures.png/550px-Spirolactone_structures.png" decoding="async" width="550" height="347" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Spirolactone_structures.png/825px-Spirolactone_structures.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4a/Spirolactone_structures.png/1100px-Spirolactone_structures.png 2x" data-file-width="2600" data-file-height="1640" /></span></span> </div> <div style="text-align:center; font-size:14px; line-height:110%"> <div style="background-color:transparent; color:black"><div id="annotation_53x134" style="position:absolute; left:53px; top:134px; line-height:110%;"><span style="background-color:transparent; color:inherit;"><a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">Progesterone</a></span></div> <div id="annotation_235x134" style="position:absolute; left:235px; top:134px; line-height:110%;"><span style="background-color:transparent; color:inherit;"><a href="/wiki/SC-5233" title="SC-5233">Spirolactone</a></span></div> <div id="annotation_420x134" style="position:absolute; left:420px; top:134px; line-height:110%;"><span style="background-color:transparent; color:inherit;"><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></span></div> <div id="annotation_53x322" style="position:absolute; left:53px; top:322px; line-height:110%;"><span style="background-color:transparent; color:inherit;">Spironolactone</span></div> <div id="annotation_235x322" style="position:absolute; left:235px; top:322px; line-height:110%;"><span style="background-color:transparent; color:inherit;"><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></span></div> <div id="annotation_420x322" style="position:absolute; left:420px; top:322px; line-height:110%;"><span style="background-color:transparent; color:inherit;"><a href="/wiki/Spirorenone" title="Spirorenone">Spirorenone</a></span></div></div> </div> </div> <div class="thumbcaption" style="clear:left"><div style="float:left;margin-right:0.5em"><span typeof="mw:File"><span title="The image above contains clickable links"><img alt="The image above contains clickable links" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e6/Interactive_icon.svg/18px-Interactive_icon.svg.png" decoding="async" width="18" height="27" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e6/Interactive_icon.svg/27px-Interactive_icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e6/Interactive_icon.svg/36px-Interactive_icon.svg.png 2x" data-file-width="133" data-file-height="200" /></span></span></div><a href="/wiki/Chemical_structure" title="Chemical structure">Chemical structures</a> of <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a> and <a href="/wiki/Spirolactone" title="Spirolactone">spirolactones</a> (steroid-17α-spirolactones).</div> </div> </div> </td></tr></tbody></table> <p>Spironolactone is closely related structurally to other clinically used spirolactones such as <a href="/wiki/Canrenone" title="Canrenone">canrenone</a>, <a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">potassium canrenoate</a>, <a href="/wiki/Drospirenone" title="Drospirenone">drospirenone</a>, and <a href="/wiki/Eplerenone" title="Eplerenone">eplerenone</a>, as well as to the never-marketed spirolactones <a href="/wiki/SC-5233" title="SC-5233">SC-5233</a> (6,7-dihydrocanrenone; 7α-desthioacetylspironolactone), <a href="/wiki/SC-8109" title="SC-8109">SC-8109</a> (19-nor-6,7-dihydrocanrenone), <a href="/wiki/Spiroxasone" title="Spiroxasone">spiroxasone</a>, <a href="/wiki/Prorenone" title="Prorenone">prorenone</a> (SC-23133), <a href="/wiki/Mexrenone" title="Mexrenone">mexrenone</a> (SC-25152, ZK-32055), <a href="/wiki/Dicirenone" title="Dicirenone">dicirenone</a> (SC-26304), <a href="/wiki/Spirorenone" title="Spirorenone">spirorenone</a> (ZK-35973), and <a href="/wiki/Mespirenone" title="Mespirenone">mespirenone</a> (ZK-94679).<sup id="cite_ref-pmid28634268_107-6" class="reference"><a href="#cite_note-pmid28634268-107"><span class="cite-bracket">[</span>107<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Synthesis">Synthesis</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=31" title="Edit section: Synthesis"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p><a href="/wiki/Chemical_synthesis" title="Chemical synthesis">Chemical syntheses</a> of spironolactone and its <a href="/wiki/Structural_analog" title="Structural analog">analogues</a> and <a href="/wiki/Chemical_derivative" class="mw-redirect" title="Chemical derivative">derivatives</a> have been described and reviewed.<sup id="cite_ref-pmid28041953_259-0" class="reference"><a href="#cite_note-pmid28041953-259"><span class="cite-bracket">[</span>259<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="History">History</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=32" title="Edit section: History"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The <a href="/wiki/Natriuretic" class="mw-redirect" title="Natriuretic">natriuretic</a> effects of <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a> were demonstrated in 1955, and the development of spironolactone as a <a href="/wiki/Synthetic_compound" class="mw-redirect" title="Synthetic compound">synthetic</a> antimineralocorticoid <a href="/wiki/Structural_analog" title="Structural analog">analogue</a> of progesterone shortly followed this.<sup id="cite_ref-pmid15134800_133-4" class="reference"><a href="#cite_note-pmid15134800-133"><span class="cite-bracket">[</span>133<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-JamesonGroot2010_249-1" class="reference"><a href="#cite_note-JamesonGroot2010-249"><span class="cite-bracket">[</span>249<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid13486053_260-0" class="reference"><a href="#cite_note-pmid13486053-260"><span class="cite-bracket">[</span>260<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid13486054_261-0" class="reference"><a href="#cite_note-pmid13486054-261"><span class="cite-bracket">[</span>261<span class="cite-bracket">]</span></a></sup> Spironolactone was first <a href="/wiki/Chemical_synthesis" title="Chemical synthesis">synthesized</a> in 1957,<sup id="cite_ref-OttowWeinmann2008_28-1" class="reference"><a href="#cite_note-OttowWeinmann2008-28"><span class="cite-bracket">[</span>28<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid13486053_260-1" class="reference"><a href="#cite_note-pmid13486053-260"><span class="cite-bracket">[</span>260<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid13486054_261-1" class="reference"><a href="#cite_note-pmid13486054-261"><span class="cite-bracket">[</span>261<span class="cite-bracket">]</span></a></sup> was <a href="/wiki/Patent" title="Patent">patented</a> between 1958 and 1961,<sup id="cite_ref-EngelKleemann2014_262-0" class="reference"><a href="#cite_note-EngelKleemann2014-262"><span class="cite-bracket">[</span>262<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-LandauAchilladelis1999_263-0" class="reference"><a href="#cite_note-LandauAchilladelis1999-263"><span class="cite-bracket">[</span>263<span class="cite-bracket">]</span></a></sup> and was first marketed, as an antimineralocorticoid, in 1959.<sup id="cite_ref-Jugdutt2014_264-0" class="reference"><a href="#cite_note-Jugdutt2014-264"><span class="cite-bracket">[</span>264<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Wermuth2011_265-0" class="reference"><a href="#cite_note-Wermuth2011-265"><span class="cite-bracket">[</span>265<span class="cite-bracket">]</span></a></sup> Gynecomastia was first reported with spironolactone in 1962,<sup id="cite_ref-pmid28634268_107-7" class="reference"><a href="#cite_note-pmid28634268-107"><span class="cite-bracket">[</span>107<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Smith1962_266-0" class="reference"><a href="#cite_note-Smith1962-266"><span class="cite-bracket">[</span>266<span class="cite-bracket">]</span></a></sup> and the antiandrogenic activity of the medication was first described in 1969.<sup id="cite_ref-pmid5344274_267-0" class="reference"><a href="#cite_note-pmid5344274-267"><span class="cite-bracket">[</span>267<span class="cite-bracket">]</span></a></sup> This shortly followed the discovery in 1967 that gynecomastia is an important and major side effect of AR antagonists.<sup id="cite_ref-pmid148431_268-0" class="reference"><a href="#cite_note-pmid148431-268"><span class="cite-bracket">[</span>268<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-NeillJohansson1968_269-0" class="reference"><a href="#cite_note-NeillJohansson1968-269"><span class="cite-bracket">[</span>269<span class="cite-bracket">]</span></a></sup> Spironolactone was first studied in the treatment of hirsutism in women in 1978.<sup id="cite_ref-pmid6205409_270-0" class="reference"><a href="#cite_note-pmid6205409-270"><span class="cite-bracket">[</span>270<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid27450358_176-2" class="reference"><a href="#cite_note-pmid27450358-176"><span class="cite-bracket">[</span>176<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid717935_271-0" class="reference"><a href="#cite_note-pmid717935-271"><span class="cite-bracket">[</span>271<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid488407_272-0" class="reference"><a href="#cite_note-pmid488407-272"><span class="cite-bracket">[</span>272<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid7410528_273-0" class="reference"><a href="#cite_note-pmid7410528-273"><span class="cite-bracket">[</span>273<span class="cite-bracket">]</span></a></sup> It has since become the most widely used antiandrogen for dermatological indications in women in the United States.<sup id="cite_ref-WakelinMaibach2002_103-1" class="reference"><a href="#cite_note-WakelinMaibach2002-103"><span class="cite-bracket">[</span>103<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Curtis2014_274-0" class="reference"><a href="#cite_note-Curtis2014-274"><span class="cite-bracket">[</span>274<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-ShahBhathena2004_275-0" class="reference"><a href="#cite_note-ShahBhathena2004-275"><span class="cite-bracket">[</span>275<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Hillard2013_276-0" class="reference"><a href="#cite_note-Hillard2013-276"><span class="cite-bracket">[</span>276<span class="cite-bracket">]</span></a></sup> Spironolactone was first studied as an antiandrogen in transgender women in 1986, and has since become widely adopted for this purpose as well, particularly in the United States where cyproterone acetate is not available.<sup id="cite_ref-DahlFeldman2006_277-0" class="reference"><a href="#cite_note-DahlFeldman2006-277"><span class="cite-bracket">[</span>277<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-PriorVigna1986_278-0" class="reference"><a href="#cite_note-PriorVigna1986-278"><span class="cite-bracket">[</span>278<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-FisherMaggi2015_279-0" class="reference"><a href="#cite_note-FisherMaggi2015-279"><span class="cite-bracket">[</span>279<span class="cite-bracket">]</span></a></sup> </p><p>Early oral spironolactone tablets showed poor absorption.<sup id="cite_ref-Dorfman2016_280-0" class="reference"><a href="#cite_note-Dorfman2016-280"><span class="cite-bracket">[</span>280<span class="cite-bracket">]</span></a></sup> The formulation was eventually changed to a <a href="/wiki/Micronization" title="Micronization">micronized</a> formulation with <a href="/wiki/Particle_size" title="Particle size">particle sizes</a> of less than 50 μg, which resulted in approximately 4-fold increased potency.<sup id="cite_ref-Dorfman2016_280-1" class="reference"><a href="#cite_note-Dorfman2016-280"><span class="cite-bracket">[</span>280<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-GlázVecsei2017_281-0" class="reference"><a href="#cite_note-GlázVecsei2017-281"><span class="cite-bracket">[</span>281<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Society_and_culture">Society and culture</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=33" title="Edit section: Society and culture"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <div class="mw-heading mw-heading3"><h3 id="Generic_names">Generic names</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=34" title="Edit section: Generic names"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Spironolactone_for_veterinary_use.jpg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Spironolactone_for_veterinary_use.jpg/220px-Spironolactone_for_veterinary_use.jpg" decoding="async" width="220" height="196" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Spironolactone_for_veterinary_use.jpg/330px-Spironolactone_for_veterinary_use.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Spironolactone_for_veterinary_use.jpg/440px-Spironolactone_for_veterinary_use.jpg 2x" data-file-width="1946" data-file-height="1732" /></a><figcaption>Generic spironolactone for veterinary use</figcaption></figure> <p>The English, French, and <a href="/wiki/Generic_drug" title="Generic drug">generic name</a> of the medication is spironolactone and this is its <a href="/wiki/International_Nonproprietary_Name" class="mw-redirect" title="International Nonproprietary Name"><abbr title="International Nonproprietary Name">INN</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip International Nonproprietary Name</span>, <a href="/wiki/United_States_Adopted_Name" title="United States Adopted Name"><abbr title="United States Adopted Name">USAN</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip United States Adopted Name</span>, <a href="/wiki/United_States_Pharmacopeia" title="United States Pharmacopeia"><abbr title="United States Pharmacopeia">USP</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip United States Pharmacopeia</span>, <a href="/wiki/British_Approved_Name" title="British Approved Name"><abbr title="British Approved Name">BAN</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip British Approved Name</span>, <a href="/wiki/D%C3%A9nomination_Commune_Fran%C3%A7aise" title="Dénomination Commune Française"><abbr title="Dénomination Commune Française">DCF</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Dénomination Commune Française</span>, and <a href="/wiki/Japanese_Accepted_Name" title="Japanese Accepted Name"><abbr title="Japanese Accepted Name">JAN</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Japanese Accepted Name</span>.<sup id="cite_ref-IndexNominum2000_105-1" class="reference"><a href="#cite_note-IndexNominum2000-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs.com_106-1" class="reference"><a href="#cite_note-Drugs.com-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Elks2014_250-2" class="reference"><a href="#cite_note-Elks2014-250"><span class="cite-bracket">[</span>250<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-MortonHall1999_282-0" class="reference"><a href="#cite_note-MortonHall1999-282"><span class="cite-bracket">[</span>282<span class="cite-bracket">]</span></a></sup> Its name is <span title="Latin-language text"><i lang="la">spironolactonum</i></span> in Latin, <span title="German-language text"><i lang="de">Spironolacton</i></span> in German, <span title="Spanish-language text"><i lang="es">espironolactona</i></span> in Spanish and Portuguese, and <span title="Italian-language text"><i lang="it">spironolattone</i></span> in Italian (which is also its <a href="/wiki/Denominazione_Comune_Italiana" title="Denominazione Comune Italiana"><abbr title="Denominazione Comune Italiana">DCIT</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Denominazione Comune Italiana</span>).<sup id="cite_ref-IndexNominum2000_105-2" class="reference"><a href="#cite_note-IndexNominum2000-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs.com_106-2" class="reference"><a href="#cite_note-Drugs.com-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-MortonHall1999_282-1" class="reference"><a href="#cite_note-MortonHall1999-282"><span class="cite-bracket">[</span>282<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone is also known by its developmental code names SC-9420 and NSC-150339.<sup id="cite_ref-IndexNominum2000_105-3" class="reference"><a href="#cite_note-IndexNominum2000-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs.com_106-3" class="reference"><a href="#cite_note-Drugs.com-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Elks2014_250-3" class="reference"><a href="#cite_note-Elks2014-250"><span class="cite-bracket">[</span>250<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Brand_names">Brand names</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=35" title="Edit section: Brand names"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone is marketed under a various brand names throughout the world.<sup id="cite_ref-IndexNominum2000_105-4" class="reference"><a href="#cite_note-IndexNominum2000-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs.com_106-4" class="reference"><a href="#cite_note-Drugs.com-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup> The original brand name of spironolactone is Aldactone.<sup id="cite_ref-IndexNominum2000_105-5" class="reference"><a href="#cite_note-IndexNominum2000-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs.com_106-5" class="reference"><a href="#cite_note-Drugs.com-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup> Other brand names include Aldactone-A, Berlactone, CaroSpir, Espironolactona, Espironolactona Genfar, Novo-Spiroton, Prilactone (<a href="/wiki/Veterinary_medicine" title="Veterinary medicine">veterinary</a>), Spiractin, Spiridon, Spirix, Spiroctan, Spiroderm (discontinued),<sup id="cite_ref-FARIDDiamanti-Kandarakis2009_5-2" class="reference"><a href="#cite_note-FARIDDiamanti-Kandarakis2009-5"><span class="cite-bracket">[</span>5<span class="cite-bracket">]</span></a></sup> Spirogamma, Spirohexal, Spirolon, Spirolone, Spiron, Spironolactone Actavis, Spironolactone Orion, Spironolactone Teva, Spirotone, Tempora (veterinary), Uractone, Uractonum, Verospiron, and Vivitar.<sup id="cite_ref-IndexNominum2000_105-6" class="reference"><a href="#cite_note-IndexNominum2000-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs.com_106-6" class="reference"><a href="#cite_note-Drugs.com-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone is also formulated in combination with a variety of other medications, including with <a href="/wiki/Hydrochlorothiazide" title="Hydrochlorothiazide">hydrochlorothiazide</a> as Aldactazide, with <a href="/wiki/Hydroflumethiazide" title="Hydroflumethiazide">hydroflumethiazide</a> as Aldactide, Lasilacton, Lasilactone, and Spiromide, with <a href="/wiki/Altizide" title="Altizide">altizide</a> as Aldactacine and Aldactazine, with <a href="/wiki/Furosemide" title="Furosemide">furosemide</a> as Fruselac, with <a href="/wiki/Benazepril" title="Benazepril">benazepril</a> as Cardalis (veterinary), with <a href="/wiki/Metolazone" title="Metolazone">metolazone</a> as Metolactone, with <a href="/wiki/Bendroflumethiazide" title="Bendroflumethiazide">bendroflumethiazide</a> as Sali-Aldopur, and with <a href="/wiki/Torasemide" title="Torasemide">torasemide</a> as Dytor Plus, Torlactone, and Zator Plus.<sup id="cite_ref-Drugs.com_106-7" class="reference"><a href="#cite_note-Drugs.com-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Availability">Availability</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=36" title="Edit section: Availability"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone is marketed throughout the world.<sup id="cite_ref-IndexNominum2000_105-7" class="reference"><a href="#cite_note-IndexNominum2000-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Drugs.com_106-8" class="reference"><a href="#cite_note-Drugs.com-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Research">Research</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=37" title="Edit section: Research"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <div class="mw-heading mw-heading3"><h3 id="Prostate_conditions">Prostate conditions</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=38" title="Edit section: Prostate conditions"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone has been studied at a high dosage in the treatment of <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">benign prostatic hyperplasia</a> (BPH; enlarged prostate).<sup id="cite_ref-Springer2012_283-0" class="reference"><a href="#cite_note-Springer2012-283"><span class="cite-bracket">[</span>283<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid1702565_284-0" class="reference"><a href="#cite_note-pmid1702565-284"><span class="cite-bracket">[</span>284<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid4104441_285-0" class="reference"><a href="#cite_note-pmid4104441-285"><span class="cite-bracket">[</span>285<span class="cite-bracket">]</span></a></sup> It was found to be better than placebo in terms of symptom relief following three months of treatment.<sup id="cite_ref-Springer2012_283-1" class="reference"><a href="#cite_note-Springer2012-283"><span class="cite-bracket">[</span>283<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid1702565_284-1" class="reference"><a href="#cite_note-pmid1702565-284"><span class="cite-bracket">[</span>284<span class="cite-bracket">]</span></a></sup> However, this was not maintained after six months of treatment, by which point the improvements had largely disappeared.<sup id="cite_ref-Springer2012_283-2" class="reference"><a href="#cite_note-Springer2012-283"><span class="cite-bracket">[</span>283<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid1702565_284-2" class="reference"><a href="#cite_note-pmid1702565-284"><span class="cite-bracket">[</span>284<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid4104441_285-1" class="reference"><a href="#cite_note-pmid4104441-285"><span class="cite-bracket">[</span>285<span class="cite-bracket">]</span></a></sup> Moreover, no difference was observed between spironolactone and placebo with regard to volume of residual urine or prostate size.<sup id="cite_ref-Springer2012_283-3" class="reference"><a href="#cite_note-Springer2012-283"><span class="cite-bracket">[</span>283<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid1702565_284-3" class="reference"><a href="#cite_note-pmid1702565-284"><span class="cite-bracket">[</span>284<span class="cite-bracket">]</span></a></sup> Gynecomastia was observed in about 5% of people.<sup id="cite_ref-pmid1702565_284-4" class="reference"><a href="#cite_note-pmid1702565-284"><span class="cite-bracket">[</span>284<span class="cite-bracket">]</span></a></sup> On the basis of these results, it has been said that spironolactone has no place in the treatment of BPH.<sup id="cite_ref-pmid1702565_284-5" class="reference"><a href="#cite_note-pmid1702565-284"><span class="cite-bracket">[</span>284<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone has been studied and used limitedly in the treatment of <a href="/wiki/Prostate_cancer" title="Prostate cancer">prostate cancer</a>.<sup id="cite_ref-pmid29603164_286-0" class="reference"><a href="#cite_note-pmid29603164-286"><span class="cite-bracket">[</span>286<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid3540320_287-0" class="reference"><a href="#cite_note-pmid3540320-287"><span class="cite-bracket">[</span>287<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-EndouHosoyamada1995_37-2" class="reference"><a href="#cite_note-EndouHosoyamada1995-37"><span class="cite-bracket">[</span>37<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Epstein–Barr_virus"><span id="Epstein.E2.80.93Barr_virus"></span>Epstein–Barr virus</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=39" title="Edit section: Epstein–Barr virus"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone has been found to block <a href="/wiki/Epstein%E2%80%93Barr_virus" title="Epstein–Barr virus">Epstein–Barr virus</a> (EBV) production and that of other <a href="/wiki/Human_herpesviruses" class="mw-redirect" title="Human herpesviruses">human herpesviruses</a> by inhibiting the function of an EBV protein SM, which is essential for infectious virus production.<sup id="cite_ref-Verma2016_288-0" class="reference"><a href="#cite_note-Verma2016-288"><span class="cite-bracket">[</span>288<span class="cite-bracket">]</span></a></sup> This effect of spironolactone was determined to be independent of its antimineralocorticoid actions.<sup id="cite_ref-Verma2016_288-1" class="reference"><a href="#cite_note-Verma2016-288"><span class="cite-bracket">[</span>288<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Other_conditions">Other conditions</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=40" title="Edit section: Other conditions"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Spironolactone has been studied in the treatment of <a href="/wiki/Rosacea" title="Rosacea">rosacea</a> in both males and females.<sup id="cite_ref-pmid15389184_289-0" class="reference"><a href="#cite_note-pmid15389184-289"><span class="cite-bracket">[</span>289<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-GiurcăneanuMarinescu2016_290-0" class="reference"><a href="#cite_note-GiurcăneanuMarinescu2016-290"><span class="cite-bracket">[</span>290<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Wollina2014_291-0" class="reference"><a href="#cite_note-Wollina2014-291"><span class="cite-bracket">[</span>291<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid9557251_74-1" class="reference"><a href="#cite_note-pmid9557251-74"><span class="cite-bracket">[</span>74<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid23594595_292-0" class="reference"><a href="#cite_note-pmid23594595-292"><span class="cite-bracket">[</span>292<span class="cite-bracket">]</span></a></sup> </p><p>Spironolactone has been studied in <a href="/wiki/Fibromyalgia" title="Fibromyalgia">fibromyalgia</a> in women.<sup id="cite_ref-WernzeHerdegen2014_293-0" class="reference"><a href="#cite_note-WernzeHerdegen2014-293"><span class="cite-bracket">[</span>293<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Kalso2014_294-0" class="reference"><a href="#cite_note-Kalso2014-294"><span class="cite-bracket">[</span>294<span class="cite-bracket">]</span></a></sup> It has also been studied in <a href="/wiki/Bulimia_nervosa" title="Bulimia nervosa">bulimia nervosa</a> in women, but was not found to be effective.<sup id="cite_ref-pmid22946772_295-0" class="reference"><a href="#cite_note-pmid22946772-295"><span class="cite-bracket">[</span>295<span class="cite-bracket">]</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="References">References</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Spironolactone&action=edit&section=41" title="Edit section: References"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <style data-mw-deduplicate="TemplateStyles:r1239543626">.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist"> <div class="mw-references-wrap mw-references-columns"><ol class="references"> <li id="cite_note-LoughlinGenerali2006-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-LoughlinGenerali2006_1-0">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1238218222">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}</style><cite id="CITEREFLoughlinGenerali2006" class="citation book cs1">Loughlin KR, Generali JA (2006). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=fhEFkBxEtH8C&pg=PA131"><i>The Guide to Off-label Prescription Drugs: New Uses for FDA-approved Prescription Drugs</i></a>. Simon and Schuster. pp. 131–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-7432-8667-1" title="Special:BookSources/978-0-7432-8667-1"><bdi>978-0-7432-8667-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007092256/https://books.google.com/books?id=fhEFkBxEtH8C&pg=PA131">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 November</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=The+Guide+to+Off-label+Prescription+Drugs%3A+New+Uses+for+FDA-approved+Prescription+Drugs&rft.pages=131-&rft.pub=Simon+and+Schuster&rft.date=2006&rft.isbn=978-0-7432-8667-1&rft.aulast=Loughlin&rft.aufirst=KR&rft.au=Generali%2C+JA&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DfhEFkBxEtH8C%26pg%3DPA131&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ClarkHarvey2011-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-ClarkHarvey2011_2-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFClarkHarveyFinkelRey2011" class="citation book cs1">Clark MA, Harvey RA, Finkel R, Rey JA, Whalen K (15 December 2011). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=Y558dgp_PjoC&pg=PA337"><i>Pharmacology</i></a>. Lippincott Williams & Wilkins. pp. 286, 337. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4511-1314-3" title="Special:BookSources/978-1-4511-1314-3"><bdi>978-1-4511-1314-3</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007092256/https://books.google.com/books?id=Y558dgp_PjoC&pg=PA337">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 November</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pharmacology&rft.pages=286%2C+337&rft.pub=Lippincott+Williams+%26+Wilkins&rft.date=2011-12-15&rft.isbn=978-1-4511-1314-3&rft.aulast=Clark&rft.aufirst=MA&rft.au=Harvey%2C+RA&rft.au=Finkel%2C+R&rft.au=Rey%2C+JA&rft.au=Whalen%2C+K&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DY558dgp_PjoC%26pg%3DPA337&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Drugs.com_pregnancy-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Drugs.com_pregnancy_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Drugs.com_pregnancy_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/pregnancy/spironolactone.html">"Spironolactone Pregnancy and Breastfeeding Warnings"</a>. The American Society of Health-System Pharmacists. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20151202081203/http://www.drugs.com/pregnancy/spironolactone.html">Archived</a> from the original on 2 December 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">29 November</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Spironolactone+Pregnancy+and+Breastfeeding+Warnings&rft.pub=The+American+Society+of+Health-System+Pharmacists&rft_id=https%3A%2F%2Fwww.drugs.com%2Fpregnancy%2Fspironolactone.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-AHFS2015-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-AHFS2015_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AHFS2015_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AHFS2015_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AHFS2015_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-AHFS2015_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-AHFS2015_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-AHFS2015_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-AHFS2015_4-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-AHFS2015_4-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/monograph/spironolactone.html">"Spironolactone"</a>. The American Society of Health-System Pharmacists. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20151116054857/http://www.drugs.com/monograph/spironolactone.html">Archived</a> from the original on 16 November 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Spironolactone&rft.pub=The+American+Society+of+Health-System+Pharmacists&rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fspironolactone.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-FARIDDiamanti-Kandarakis2009-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-FARIDDiamanti-Kandarakis2009_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FARIDDiamanti-Kandarakis2009_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FARIDDiamanti-Kandarakis2009_5-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFFaridDiamanti-Kandarakis2009" class="citation book cs1">Farid NR, Diamanti-Kandarakis E (27 February 2009). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=fgMYVxmPDnMC&pg=PA235"><i>Diagnosis and Management of Polycystic Ovary Syndrome</i></a>. Springer Science & Business Media. pp. 235–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-387-09718-3" title="Special:BookSources/978-0-387-09718-3"><bdi>978-0-387-09718-3</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093305/https://books.google.com/books?id=fgMYVxmPDnMC&pg=PA235">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 November</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Diagnosis+and+Management+of+Polycystic+Ovary+Syndrome&rft.pages=235-&rft.pub=Springer+Science+%26+Business+Media&rft.date=2009-02-27&rft.isbn=978-0-387-09718-3&rft.aulast=Farid&rft.aufirst=NR&rft.au=Diamanti-Kandarakis%2C+E&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DfgMYVxmPDnMC%26pg%3DPA235&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-FDA-AllBoxedWarnings-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA-AllBoxedWarnings_6-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802">"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)"</a>. <i>nctr-crs.fda.gov</i>. <a href="/wiki/FDA" class="mw-redirect" title="FDA">FDA</a><span class="reference-accessdate">. Retrieved <span class="nowrap">22 October</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=nctr-crs.fda.gov&rft.atitle=FDA-sourced+list+of+all+drugs+with+black+box+warnings+%28Use+Download+Full+Results+and+View+Query+links.%29&rft_id=https%3A%2F%2Fnctr-crs.fda.gov%2Ffdalabel%2Fui%2Fspl-summaries%2Fcriteria%2F343802&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.medicines.org.uk/emc/product/1619/smpc">"Aldactone 25 mg Film-Coated TabletsSummary of Product Characteristics (SmPC)"</a>. <i>(emc)</i>. 3 February 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221006131733/https://www.medicines.org.uk/emc/product/1619/smpc">Archived</a> from the original on 6 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">2 August</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=%28emc%29&rft.atitle=Aldactone+25+mg+Film-Coated+TabletsSummary+of+Product+Characteristics+%28SmPC%29&rft.date=2022-02-03&rft_id=https%3A%2F%2Fwww.medicines.org.uk%2Femc%2Fproduct%2F1619%2Fsmpc&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Aldactone_label-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Aldactone_label_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Aldactone_label_8-18"><sup><i><b>s</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0fed2822-3a03-4b64-9857-c682fcd462bc">"Aldactone- spironolactone tablet, film coated"</a>. <i>DailyMed</i>. 29 November 2018. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150910033318/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0fed2822-3a03-4b64-9857-c682fcd462bc">Archived</a> from the original on 10 September 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">1 January</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=DailyMed&rft.atitle=Aldactone-+spironolactone+tablet%2C+film+coated&rft.date=2018-11-29&rft_id=https%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fsetid%3D0fed2822-3a03-4b64-9857-c682fcd462bc&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Qaialdo_EPAR-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-Qaialdo_EPAR_9-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ema.europa.eu/en/medicines/human/EPAR/qaialdo">"Qaialdo EPAR"</a>. <i><a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA)</i>. 25 July 2023. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230727164314/https://www.ema.europa.eu/en/medicines/human/EPAR/qaialdo">Archived</a> from the original on 27 July 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">2 August</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=European+Medicines+Agency+%28EMA%29&rft.atitle=Qaialdo+EPAR&rft.date=2023-07-25&rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fmedicines%2Fhuman%2FEPAR%2Fqaialdo&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://ec.europa.eu/health/documents/community-register/html/h1731.htm">"Qaialdo"</a>. <i>Union Register of medicinal products</i>. 31 May 2023. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230606224550/https://ec.europa.eu/health/documents/community-register/html/h1731.htm">Archived</a> from the original on 6 June 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">6 June</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Union+Register+of+medicinal+products&rft.atitle=Qaialdo&rft.date=2023-05-31&rft_id=https%3A%2F%2Fec.europa.eu%2Fhealth%2Fdocuments%2Fcommunity-register%2Fhtml%2Fh1731.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid15947888-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15947888_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-pmid15947888_11-20"><sup><i><b>u</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSica2005" class="citation journal cs1">Sica DA (January 2005). "Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis". <i>Heart Failure Reviews</i>. <b>10</b> (1): 23–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10741-005-2345-1">10.1007/s10741-005-2345-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15947888">15947888</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:21437788">21437788</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Heart+Failure+Reviews&rft.atitle=Pharmacokinetics+and+pharmacodynamics+of+mineralocorticoid+blocking+agents+and+their+effects+on+potassium+homeostasis&rft.volume=10&rft.issue=1&rft.pages=23-9&rft.date=2005-01&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21437788%23id-name%3DS2CID&rft_id=info%3Apmid%2F15947888&rft_id=info%3Adoi%2F10.1007%2Fs10741-005-2345-1&rft.aulast=Sica&rft.aufirst=DA&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid18729003-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18729003_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18729003_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18729003_12-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18729003_12-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid18729003_12-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid18729003_12-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid18729003_12-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid18729003_12-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMaronLeopold2008" class="citation journal cs1">Maron BA, Leopold JA (September 2008). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967484">"Mineralocorticoid receptor antagonists and endothelial function"</a>. <i>Current Opinion in Investigational Drugs</i>. <b>9</b> (9): 963–9. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967484">2967484</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18729003">18729003</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Current+Opinion+in+Investigational+Drugs&rft.atitle=Mineralocorticoid+receptor+antagonists+and+endothelial+function&rft.volume=9&rft.issue=9&rft.pages=963-9&rft.date=2008-09&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2967484%23id-name%3DPMC&rft_id=info%3Apmid%2F18729003&rft.aulast=Maron&rft.aufirst=BA&rft.au=Leopold%2C+JA&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2967484&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-CaroneOxberry2017-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-CaroneOxberry2017_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CaroneOxberry2017_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCaroneOxberryTwycrossCharlesworth2017" class="citation journal cs1">Carone L, Oxberry SG, Twycross R, Charlesworth S, Mihalyo M, Wilcock A (February 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jpainsymman.2016.12.320">"Spironolactone"</a>. <i>Journal of Pain and Symptom Management</i>. <b>53</b> (2): 288–292. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jpainsymman.2016.12.320">10.1016/j.jpainsymman.2016.12.320</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28024992">28024992</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Pain+and+Symptom+Management&rft.atitle=Spironolactone&rft.volume=53&rft.issue=2&rft.pages=288-292&rft.date=2017-02&rft_id=info%3Adoi%2F10.1016%2Fj.jpainsymman.2016.12.320&rft_id=info%3Apmid%2F28024992&rft.aulast=Carone&rft.aufirst=L&rft.au=Oxberry%2C+SG&rft.au=Twycross%2C+R&rft.au=Charlesworth%2C+S&rft.au=Mihalyo%2C+M&rft.au=Wilcock%2C+A&rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jpainsymman.2016.12.320&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-TakamuraMaruyama1997-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-TakamuraMaruyama1997_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-TakamuraMaruyama1997_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-TakamuraMaruyama1997_14-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-TakamuraMaruyama1997_14-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTakamuraMaruyamaAhmedSuenaga1997" class="citation journal cs1">Takamura N, Maruyama T, Ahmed S, Suenaga A, Otagiri M (April 1997). "Interactions of aldosterone antagonist diuretics with human serum proteins". <i>Pharmaceutical Research</i>. <b>14</b> (4): 522–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1023%2FA%3A1012168020545">10.1023/A:1012168020545</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9144743">9144743</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13227538">13227538</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Pharmaceutical+Research&rft.atitle=Interactions+of+aldosterone+antagonist+diuretics+with+human+serum+proteins&rft.volume=14&rft.issue=4&rft.pages=522-6&rft.date=1997-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13227538%23id-name%3DS2CID&rft_id=info%3Apmid%2F9144743&rft_id=info%3Adoi%2F10.1023%2FA%3A1012168020545&rft.aulast=Takamura&rft.aufirst=N&rft.au=Maruyama%2C+T&rft.au=Ahmed%2C+S&rft.au=Suenaga%2C+A&rft.au=Otagiri%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-SzaszBudvari-Barany1990-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-SzaszBudvari-Barany1990_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-SzaszBudvari-Barany1990_15-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSzaszBudvari-Barany1990" class="citation book cs1">Szasz G, Budvari-Barany Z (19 December 1990). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=LMl4Sd38q4kC&pg=PA91"><i>Pharmaceutical Chemistry of Antihypertensive Agents</i></a>. CRC Press. pp. 91–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-8493-4724-5" title="Special:BookSources/978-0-8493-4724-5"><bdi>978-0-8493-4724-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pharmaceutical+Chemistry+of+Antihypertensive+Agents&rft.pages=91-&rft.pub=CRC+Press&rft.date=1990-12-19&rft.isbn=978-0-8493-4724-5&rft.aulast=Szasz&rft.aufirst=G&rft.au=Budvari-Barany%2C+Z&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DLMl4Sd38q4kC%26pg%3DPA91&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-McDonaghGardner2011-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-McDonaghGardner2011_16-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMcDonaghGardnerClarkDargie2011" class="citation book cs1">McDonagh TA, Gardner RS, Clark AL, Dargie H (14 July 2011). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=KDDCiTQyGLsC&pg=PA403"><i>Oxford Textbook of Heart Failure</i></a>. OUP Oxford. pp. 403–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-19-957772-9" title="Special:BookSources/978-0-19-957772-9"><bdi>978-0-19-957772-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170327090209/https://books.google.com/books?id=KDDCiTQyGLsC&pg=PA403">Archived</a> from the original on 27 March 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Oxford+Textbook+of+Heart+Failure&rft.pages=403-&rft.pub=OUP+Oxford&rft.date=2011-07-14&rft.isbn=978-0-19-957772-9&rft.aulast=McDonagh&rft.aufirst=TA&rft.au=Gardner%2C+RS&rft.au=Clark%2C+AL&rft.au=Dargie%2C+H&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DKDDCiTQyGLsC%26pg%3DPA403&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Parkinson2001-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Parkinson2001_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Parkinson2001_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Parkinson2001_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Parkinson2001_17-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Parkinson2001_17-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Parkinson2001_17-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Parkinson2001_17-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFParkinson2001" class="citation book cs1">Parkinson A (2001). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=pAovcgAACAAJ"><i>Biotransformation of Xenobiotics</i></a>. McGraw-Hill. pp. 137–138, 169, 171, 180, 195, 208. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095315/https://books.google.com/books?id=pAovcgAACAAJ">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">12 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Biotransformation+of+Xenobiotics&rft.pages=137-138%2C+169%2C+171%2C+180%2C+195%2C+208&rft.pub=McGraw-Hill&rft.date=2001&rft.aulast=Parkinson&rft.aufirst=A&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DpAovcgAACAAJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Klaassen2007-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Klaassen2007_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Klaassen2007_18-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKlaassen2007" class="citation book cs1">Klaassen CD (11 December 2007). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=4yi7-j48uhIC"><i>Casarett & Doull's Toxicology: The Basic Science of Poisons, Seventh Edition</i></a>. McGraw Hill Professional. p. 173. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-07-159351-9" title="Special:BookSources/978-0-07-159351-9"><bdi>978-0-07-159351-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095316/https://books.google.com/books?id=4yi7-j48uhIC">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">12 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Casarett+%26+Doull%27s+Toxicology%3A+The+Basic+Science+of+Poisons%2C+Seventh+Edition&rft.pages=173&rft.pub=McGraw+Hill+Professional&rft.date=2007-12-11&rft.isbn=978-0-07-159351-9&rft.aulast=Klaassen&rft.aufirst=CD&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D4yi7-j48uhIC&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid7895608-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid7895608_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid7895608_19-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLosPitzenbergerRamjitCoddington1994" class="citation journal cs1">Los LE, Pitzenberger SM, Ramjit HG, Coddington AB, Colby HD (1994). "Hepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites". <i>Drug Metabolism and Disposition</i>. <b>22</b> (6): 903–8. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7895608">7895608</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Drug+Metabolism+and+Disposition&rft.atitle=Hepatic+metabolism+of+spironolactone.+Production+of+3-hydroxy-thiomethyl+metabolites&rft.volume=22&rft.issue=6&rft.pages=903-8&rft.date=1994&rft_id=info%3Apmid%2F7895608&rft.aulast=Los&rft.aufirst=LE&rft.au=Pitzenberger%2C+SM&rft.au=Ramjit%2C+HG&rft.au=Coddington%2C+AB&rft.au=Colby%2C+HD&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-BlackElliott2006-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-BlackElliott2006_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BlackElliott2006_20-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBlackElliott2006" class="citation book cs1">Black HR, Elliott W (28 December 2006). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=42Fcmne6_w8C&pg=PA295"><i>Hypertension: A Companion to Braunwald's Heart Disease</i></a>. Elsevier Health Sciences. pp. 295–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4377-1078-6" title="Special:BookSources/978-1-4377-1078-6"><bdi>978-1-4377-1078-6</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095317/https://books.google.com/books?id=42Fcmne6_w8C&pg=PA295">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">12 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Hypertension%3A+A+Companion+to+Braunwald%27s+Heart+Disease&rft.pages=295-&rft.pub=Elsevier+Health+Sciences&rft.date=2006-12-28&rft.isbn=978-1-4377-1078-6&rft.aulast=Black&rft.aufirst=HR&rft.au=Elliott%2C+W&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D42Fcmne6_w8C%26pg%3DPA295&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid14579013-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid14579013_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid14579013_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid14579013_21-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDraganovLa_Du2004" class="citation journal cs1">Draganov DI, La Du BN (January 2004). "Pharmacogenetics of paraoxonases: a brief review". <i>Naunyn-Schmiedeberg's Archives of Pharmacology</i>. <b>369</b> (1): 78–88. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00210-003-0833-1">10.1007/s00210-003-0833-1</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2027.42%2F46312">2027.42/46312</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14579013">14579013</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:15825605">15825605</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Naunyn-Schmiedeberg%27s+Archives+of+Pharmacology&rft.atitle=Pharmacogenetics+of+paraoxonases%3A+a+brief+review&rft.volume=369&rft.issue=1&rft.pages=78-88&rft.date=2004-01&rft_id=info%3Ahdl%2F2027.42%2F46312&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A15825605%23id-name%3DS2CID&rft_id=info%3Apmid%2F14579013&rft_id=info%3Adoi%2F10.1007%2Fs00210-003-0833-1&rft.aulast=Draganov&rft.aufirst=DI&rft.au=La+Du%2C+BN&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFFriedman2015" class="citation journal cs1">Friedman AJ (October 2015). "Spironolactone for Adult Female Acne". <i>Cutis</i>. <b>96</b> (4): 216–7. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27141564">27141564</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Cutis&rft.atitle=Spironolactone+for+Adult+Female+Acne&rft.volume=96&rft.issue=4&rft.pages=216-7&rft.date=2015-10&rft_id=info%3Apmid%2F27141564&rft.aulast=Friedman&rft.aufirst=AJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMaizes2015" class="citation book cs1">Maizes V (2015). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=uveJCgAAQBAJ&pg=PA746"><i>Integrative Women's Health</i></a> (2 ed.). Oxford University Press. p. 746. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-19-021480-7" title="Special:BookSources/978-0-19-021480-7"><bdi>978-0-19-021480-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Integrative+Women%27s+Health&rft.pages=746&rft.edition=2&rft.pub=Oxford+University+Press&rft.date=2015&rft.isbn=978-0-19-021480-7&rft.aulast=Maizes&rft.aufirst=V&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DuveJCgAAQBAJ%26pg%3DPA746&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Burinkul_2021-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-Burinkul_2021_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Burinkul_2021_24-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Burinkul_2021_24-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBurinkulPanyakhamlerdSuwanTuntiviriyapun2021" class="citation journal cs1">Burinkul S, Panyakhamlerd K, Suwan A, Tuntiviriyapun P, Wainipitapong S (July 2021). "Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial". <i>The Journal of Sexual Medicine</i>. <b>18</b> (7): 1299–1307. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jsxm.2021.05.003">10.1016/j.jsxm.2021.05.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34274044">34274044</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Sexual+Medicine&rft.atitle=Anti-Androgenic+Effects+Comparison+Between+Cyproterone+Acetate+and+Spironolactone+in+Transgender+Women%3A+A+Randomized+Controlled+Trial&rft.volume=18&rft.issue=7&rft.pages=1299-1307&rft.date=2021-07&rft_id=info%3Adoi%2F10.1016%2Fj.jsxm.2021.05.003&rft_id=info%3Apmid%2F34274044&rft.aulast=Burinkul&rft.aufirst=S&rft.au=Panyakhamlerd%2C+K&rft.au=Suwan%2C+A&rft.au=Tuntiviriyapun%2C+P&rft.au=Wainipitapong%2C+S&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Sehgal_2023-25"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sehgal_2023_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sehgal_2023_25-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sehgal_2023_25-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSehgal2023" class="citation journal cs1">Sehgal I (2023). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355117">"Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations"</a>. <i>Frontiers in Endocrinology</i>. <b>14</b>: 1184024. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffendo.2023.1184024">10.3389/fendo.2023.1184024</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355117">10355117</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/37476490">37476490</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Frontiers+in+Endocrinology&rft.atitle=Review+of+adult+gender+transition+medications%3A+mechanisms%2C+efficacy+measures%2C+and+pharmacogenomic+considerations&rft.volume=14&rft.pages=1184024&rft.date=2023&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10355117%23id-name%3DPMC&rft_id=info%3Apmid%2F37476490&rft_id=info%3Adoi%2F10.3389%2Ffendo.2023.1184024&rft.aulast=Sehgal&rft.aufirst=I&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10355117&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ineffectiveness_in_HRT-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-ineffectiveness_in_HRT_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ineffectiveness_in_HRT_26-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCosgrove2018" class="citation web cs1">Cosgrove B (January 2018). <a rel="nofollow" class="external text" href="https://moderntranshormones.com/2018/01/01/whats-wrong-with-spironolactone/">"The Case Against Spironolactone"</a>. <i>Modern Trans Hormones</i><span class="reference-accessdate">. Retrieved <span class="nowrap">8 July</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Modern+Trans+Hormones&rft.atitle=The+Case+Against+Spironolactone&rft.date=2018-01&rft.aulast=Cosgrove&rft.aufirst=B&rft_id=https%3A%2F%2Fmoderntranshormones.com%2F2018%2F01%2F01%2Fwhats-wrong-with-spironolactone%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Deedwania2014-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-Deedwania2014_27-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDeedwania2014" class="citation book cs1">Deedwania PC (30 January 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=k8bUAgAAQBAJ&pg=PA47"><i>Drug & Device Selection in Heart Failure</i></a>. JP Medical Ltd. pp. 47–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-93-5090-723-8" title="Special:BookSources/978-93-5090-723-8"><bdi>978-93-5090-723-8</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007092257/https://books.google.com/books?id=k8bUAgAAQBAJ&pg=PA47">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Drug+%26+Device+Selection+in+Heart+Failure&rft.pages=47-&rft.pub=JP+Medical+Ltd&rft.date=2014-01-30&rft.isbn=978-93-5090-723-8&rft.aulast=Deedwania&rft.aufirst=PC&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dk8bUAgAAQBAJ%26pg%3DPA47&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-OttowWeinmann2008-28"><span class="mw-cite-backlink">^ <a href="#cite_ref-OttowWeinmann2008_28-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-OttowWeinmann2008_28-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOttowWeinmann2008" class="citation book cs1">Ottow E, Weinmann H (9 July 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=iATfLbPgRugC&pg=PA410"><i>Nuclear Receptors As Drug Targets</i></a>. John Wiley & Sons. p. 410. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-527-62330-3" title="Special:BookSources/978-3-527-62330-3"><bdi>978-3-527-62330-3</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130621121614/http://books.google.com/books?id=iATfLbPgRugC&pg=PA410">Archived</a> from the original on 21 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">28 May</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Nuclear+Receptors+As+Drug+Targets&rft.pages=410&rft.pub=John+Wiley+%26+Sons&rft.date=2008-07-09&rft.isbn=978-3-527-62330-3&rft.aulast=Ottow&rft.aufirst=E&rft.au=Weinmann%2C+H&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DiATfLbPgRugC%26pg%3DPA410&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Wermuth2008-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wermuth2008_29-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWermuth2008" class="citation book cs1"><a href="/wiki/Camille_Georges_Wermuth" class="mw-redirect" title="Camille Georges Wermuth">Wermuth CG</a> (24 July 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=Qmt1_DQkCpEC&pg=PA34"><i>The Practice of Medicinal Chemistry</i></a>. Academic Press. p. 34. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-12-374194-3" title="Special:BookSources/978-0-12-374194-3"><bdi>978-0-12-374194-3</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130621115634/http://books.google.com/books?id=Qmt1_DQkCpEC&pg=PA34">Archived</a> from the original on 21 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">27 May</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=The+Practice+of+Medicinal+Chemistry&rft.pages=34&rft.pub=Academic+Press&rft.date=2008-07-24&rft.isbn=978-0-12-374194-3&rft.aulast=Wermuth&rft.aufirst=CG&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DQmt1_DQkCpEC%26pg%3DPA34&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Sittig1988-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-Sittig1988_30-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSittig1988" class="citation book cs1">Sittig M (1988). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=XCsJgUnclbcC&pg=PA1385"><i>Pharmaceutical Manufacturing Encyclopedia</i></a>. William Andrew. p. 1385. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-8155-1144-1" title="Special:BookSources/978-0-8155-1144-1"><bdi>978-0-8155-1144-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130620225714/http://books.google.com/books?id=XCsJgUnclbcC&pg=PA1385">Archived</a> from the original on 20 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">27 May</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pharmaceutical+Manufacturing+Encyclopedia&rft.pages=1385&rft.pub=William+Andrew&rft.date=1988&rft.isbn=978-0-8155-1144-1&rft.aulast=Sittig&rft.aufirst=M&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DXCsJgUnclbcC%26pg%3DPA1385&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-WHO23rd-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-WHO23rd_31-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWorld_Health_Organization2023" class="citation book cs1"><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (2023). <i>The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023)</i>. Geneva: World Health Organization. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/10665%2F371090">10665/371090</a></span>. WHO/MHP/HPS/EML/2023.02.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=The+selection+and+use+of+essential+medicines+2023%3A+web+annex+A%3A+World+Health+Organization+model+list+of+essential+medicines%3A+23rd+list+%282023%29&rft.place=Geneva&rft.pub=World+Health+Organization&rft.date=2023&rft_id=info%3Ahdl%2F10665%2F371090&rft.au=World+Health+Organization&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://clincalc.com/DrugStats/Top300Drugs.aspx">"The Top 300 of 2022"</a>. <i>ClinCalc</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240830202410/https://clincalc.com/DrugStats/Top300Drugs.aspx">Archived</a> from the original on 30 August 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">30 August</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=ClinCalc&rft.atitle=The+Top+300+of+2022&rft_id=https%3A%2F%2Fclincalc.com%2FDrugStats%2FTop300Drugs.aspx&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://clincalc.com/DrugStats/Drugs/Spironolactone">"Spironolactone Drug Usage Statistics, United States, 2013 - 2022"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">30 August</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=ClinCalc&rft.atitle=Spironolactone+Drug+Usage+Statistics%2C+United+States%2C+2013+-+2022&rft_id=https%3A%2F%2Fclincalc.com%2FDrugStats%2FDrugs%2FSpironolactone&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPriorVignaWatson1989" class="citation journal cs1">Prior JC, Vigna YM, Watson D (1989). "Spironolactone with Physiological Female Steroids for Presurgical Therapy of Male-To-Female Transsexualism". <i>Archives of Sexual Behavior</i>. <b>18</b> (1): 49–57. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2FBF01579291">10.1007/BF01579291</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2540730">2540730</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Archives+of+Sexual+Behavior&rft.atitle=Spironolactone+with+Physiological+Female+Steroids+for+Presurgical+Therapy+of+Male-To-Female+Transsexualism&rft.volume=18&rft.issue=1&rft.pages=49-57&rft.date=1989&rft_id=info%3Adoi%2F10.1007%2FBF01579291&rft_id=info%3Apmid%2F2540730&rft.aulast=Prior&rft.aufirst=JC&rft.au=Vigna%2C+YM&rft.au=Watson%2C+D&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-RoncoBellomo2017-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-RoncoBellomo2017_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RoncoBellomo2017_35-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-RoncoBellomo2017_35-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-RoncoBellomo2017_35-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRoncoBellomoKellumRicci2017" class="citation book cs1">Ronco C, Bellomo R, Kellum JA, Ricci Z (14 December 2017). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=HTdDDwAAQBAJ&pg=PA371"><i>Critical Care Nephrology E-Book</i></a>. Elsevier Health Sciences. pp. 371–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-323-51199-5" title="Special:BookSources/978-0-323-51199-5"><bdi>978-0-323-51199-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093807/https://books.google.com/books?id=HTdDDwAAQBAJ&pg=PA371">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">17 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Critical+Care+Nephrology+E-Book&rft.pages=371-&rft.pub=Elsevier+Health+Sciences&rft.date=2017-12-14&rft.isbn=978-0-323-51199-5&rft.aulast=Ronco&rft.aufirst=C&rft.au=Bellomo%2C+R&rft.au=Kellum%2C+JA&rft.au=Ricci%2C+Z&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DHTdDDwAAQBAJ%26pg%3DPA371&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid10760075-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10760075_36-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDelyani2000" class="citation journal cs1">Delyani JA (April 2000). <a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1523-1755.2000.00983.x">"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology"</a>. <i>Kidney International</i>. <b>57</b> (4): 1408–11. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1523-1755.2000.00983.x">10.1046/j.1523-1755.2000.00983.x</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10760075">10760075</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Kidney+International&rft.atitle=Mineralocorticoid+receptor+antagonists%3A+the+evolution+of+utility+and+pharmacology&rft.volume=57&rft.issue=4&rft.pages=1408-11&rft.date=2000-04&rft_id=info%3Adoi%2F10.1046%2Fj.1523-1755.2000.00983.x&rft_id=info%3Apmid%2F10760075&rft.aulast=Delyani&rft.aufirst=JA&rft_id=https%3A%2F%2Fdoi.org%2F10.1046%252Fj.1523-1755.2000.00983.x&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-EndouHosoyamada1995-37"><span class="mw-cite-backlink">^ <a href="#cite_ref-EndouHosoyamada1995_37-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-EndouHosoyamada1995_37-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-EndouHosoyamada1995_37-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFEndouHosoyamada1995" class="citation book cs1">Endou H, Hosoyamada M (1995). "Potassium-Retaining Diuretics: Aldosterone Antagonists". <i>Diuretics</i>. Handbook of Experimental Pharmacology. Vol. 117. Springer. pp. 335–361. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-3-642-79565-7_9">10.1007/978-3-642-79565-7_9</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-642-79567-1" title="Special:BookSources/978-3-642-79567-1"><bdi>978-3-642-79567-1</bdi></a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0171-2004">0171-2004</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Potassium-Retaining+Diuretics%3A+Aldosterone+Antagonists&rft.btitle=Diuretics&rft.series=Handbook+of+Experimental+Pharmacology&rft.pages=335-361&rft.pub=Springer&rft.date=1995&rft.issn=0171-2004&rft_id=info%3Adoi%2F10.1007%2F978-3-642-79565-7_9&rft.isbn=978-3-642-79567-1&rft.aulast=Endou&rft.aufirst=H&rft.au=Hosoyamada%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid2969259-38"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid2969259_38-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid2969259_38-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHughesCunliffe1988" class="citation journal cs1">Hughes BR, Cunliffe WJ (May 1988). "Tolerance of spironolactone". <i>The British Journal of Dermatology</i>. <b>118</b> (5): 687–91. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-2133.1988.tb02571.x">10.1111/j.1365-2133.1988.tb02571.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2969259">2969259</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:208286107">208286107</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+British+Journal+of+Dermatology&rft.atitle=Tolerance+of+spironolactone&rft.volume=118&rft.issue=5&rft.pages=687-91&rft.date=1988-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A208286107%23id-name%3DS2CID&rft_id=info%3Apmid%2F2969259&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2133.1988.tb02571.x&rft.aulast=Hughes&rft.aufirst=BR&rft.au=Cunliffe%2C+WJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Preedy2012-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-Preedy2012_39-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPreedy2012" class="citation book cs1">Preedy VR (1 January 2012). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=7N3nEX6eL_MC&pg=PA132"><i>Handbook of Hair in Health and Disease</i></a>. Springer Science & Business Media. pp. 132–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-90-8686-728-8" title="Special:BookSources/978-90-8686-728-8"><bdi>978-90-8686-728-8</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007092258/https://books.google.com/books?id=7N3nEX6eL_MC&pg=PA132">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Handbook+of+Hair+in+Health+and+Disease&rft.pages=132-&rft.pub=Springer+Science+%26+Business+Media&rft.date=2012-01-01&rft.isbn=978-90-8686-728-8&rft.aulast=Preedy&rft.aufirst=VR&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D7N3nEX6eL_MC%26pg%3DPA132&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid3143568-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3143568_40-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLoySeibel1988" class="citation journal cs1">Loy R, Seibel MM (December 1988). "Evaluation and therapy of polycystic ovarian syndrome". <i>Endocrinology and Metabolism Clinics of North America</i>. <b>17</b> (4): 785–813. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0889-8529%2818%2930410-9">10.1016/S0889-8529(18)30410-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/3143568">3143568</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Endocrinology+and+Metabolism+Clinics+of+North+America&rft.atitle=Evaluation+and+therapy+of+polycystic+ovarian+syndrome&rft.volume=17&rft.issue=4&rft.pages=785-813&rft.date=1988-12&rft_id=info%3Adoi%2F10.1016%2FS0889-8529%2818%2930410-9&rft_id=info%3Apmid%2F3143568&rft.aulast=Loy&rft.aufirst=R&rft.au=Seibel%2C+MM&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Yancy_e147-239-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-Yancy_e147-239_41-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYancyJessupBozkurtButler2013" class="citation journal cs1">Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. (October 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jacc.2013.05.019">"2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines"</a>. <i>Journal of the American College of Cardiology</i>. <b>62</b> (16): e147-239. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jacc.2013.05.019">10.1016/j.jacc.2013.05.019</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23747642">23747642</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.atitle=2013+ACCF%2FAHA+guideline+for+the+management+of+heart+failure%3A+a+report+of+the+American+College+of+Cardiology+Foundation%2FAmerican+Heart+Association+Task+Force+on+Practice+Guidelines&rft.volume=62&rft.issue=16&rft.pages=e147-239&rft.date=2013-10&rft_id=info%3Adoi%2F10.1016%2Fj.jacc.2013.05.019&rft_id=info%3Apmid%2F23747642&rft.aulast=Yancy&rft.aufirst=CW&rft.au=Jessup%2C+M&rft.au=Bozkurt%2C+B&rft.au=Butler%2C+J&rft.au=Casey%2C+DE&rft.au=Drazner%2C+MH&rft.au=Fonarow%2C+GC&rft.au=Geraci%2C+SA&rft.au=Horwich%2C+T&rft.au=Januzzi%2C+JL&rft.au=Johnson%2C+MR&rft.au=Kasper%2C+EK&rft.au=Levy%2C+WC&rft.au=Masoudi%2C+FA&rft.au=McBride%2C+PE&rft.au=McMurray%2C+JJ&rft.au=Mitchell%2C+JE&rft.au=Peterson%2C+PN&rft.au=Riegel%2C+B&rft.au=Sam%2C+F&rft.au=Stevenson%2C+LW&rft.au=Tang%2C+WH&rft.au=Tsai%2C+EJ&rft.au=Wilkoff%2C+BL&rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jacc.2013.05.019&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Li_2018-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-Li_2018_42-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLiZhangDongGong2018" class="citation journal cs1">Li S, Zhang X, Dong M, Gong S, Shang Z, Jia X, et al. (August 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392615">"Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials"</a>. <i>Medicine</i>. <b>97</b> (35): e11942. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMD.0000000000011942">10.1097/MD.0000000000011942</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392615">6392615</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30170387">30170387</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Medicine&rft.atitle=Effects+of+spironolactone+in+heart+failure+with+preserved+ejection+fraction%3A+A+meta-analysis+of+randomized+controlled+trials&rft.volume=97&rft.issue=35&rft.pages=e11942&rft.date=2018-08&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6392615%23id-name%3DPMC&rft_id=info%3Apmid%2F30170387&rft_id=info%3Adoi%2F10.1097%2FMD.0000000000011942&rft.aulast=Li&rft.aufirst=S&rft.au=Zhang%2C+X&rft.au=Dong%2C+M&rft.au=Gong%2C+S&rft.au=Shang%2C+Z&rft.au=Jia%2C+X&rft.au=Chen%2C+W&rft.au=Yang%2C+J&rft.au=Li%2C+J&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6392615&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Kosmas_2018-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kosmas_2018_43-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKosmasSilverioSourlasMontan2018" class="citation journal cs1">Kosmas CE, Silverio D, Sourlas A, Montan PD, Guzman E (December 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.21037%2Fatm.2018.11.16">"Role of spironolactone in the treatment of heart failure with preserved ejection fraction"</a>. <i>Annals of Translational Medicine</i>. <b>6</b> (23): 461. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.21037%2Fatm.2018.11.16">10.21037/atm.2018.11.16</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312809">6312809</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30603649">30603649</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annals+of+Translational+Medicine&rft.atitle=Role+of+spironolactone+in+the+treatment+of+heart+failure+with+preserved+ejection+fraction&rft.volume=6&rft.issue=23&rft.pages=461&rft.date=2018-12&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6312809%23id-name%3DPMC&rft_id=info%3Apmid%2F30603649&rft_id=info%3Adoi%2F10.21037%2Fatm.2018.11.16&rft.aulast=Kosmas&rft.aufirst=CE&rft.au=Silverio%2C+D&rft.au=Sourlas%2C+A&rft.au=Montan%2C+PD&rft.au=Guzman%2C+E&rft_id=https%3A%2F%2Fdoi.org%2F10.21037%252Fatm.2018.11.16&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid22840667-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22840667_44-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFChatterjeeMoellerShahBolorunduro2012" class="citation journal cs1">Chatterjee S, Moeller C, Shah N, Bolorunduro O, Lichstein E, Moskovits N, et al. (August 2012). "Eplerenone is not superior to older and less expensive aldosterone antagonists". <i>The American Journal of Medicine</i>. <b>125</b> (8): 817–25. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.amjmed.2011.12.018">10.1016/j.amjmed.2011.12.018</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22840667">22840667</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+American+Journal+of+Medicine&rft.atitle=Eplerenone+is+not+superior+to+older+and+less+expensive+aldosterone+antagonists&rft.volume=125&rft.issue=8&rft.pages=817-25&rft.date=2012-08&rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2011.12.018&rft_id=info%3Apmid%2F22840667&rft.aulast=Chatterjee&rft.aufirst=S&rft.au=Moeller%2C+C&rft.au=Shah%2C+N&rft.au=Bolorunduro%2C+O&rft.au=Lichstein%2C+E&rft.au=Moskovits%2C+N&rft.au=Mukherjee%2C+D&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Bat2010-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bat2010_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bat2010_45-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBatterinkStablerTejaniFowkes2010" class="citation journal cs1">Batterink J, Stabler SN, Tejani AM, Fowkes CT (August 2010). "Spironolactone for hypertension". <i>The Cochrane Database of Systematic Reviews</i> (8): CD008169. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD008169.pub2">10.1002/14651858.CD008169.pub2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20687095">20687095</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&rft.atitle=Spironolactone+for+hypertension&rft.issue=8&rft.pages=CD008169&rft.date=2010-08&rft_id=info%3Adoi%2F10.1002%2F14651858.CD008169.pub2&rft_id=info%3Apmid%2F20687095&rft.aulast=Batterink&rft.aufirst=J&rft.au=Stabler%2C+SN&rft.au=Tejani%2C+AM&rft.au=Fowkes%2C+CT&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid30854950-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid30854950_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid30854950_46-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid30854950_46-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid30854950_46-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFStavropoulosPapadopoulosKoutsampasopoulosLales2018" class="citation journal cs1">Stavropoulos K, Papadopoulos C, Koutsampasopoulos K, Lales G, Mitas C, Doumas M (2018). "Mineralocorticoid Receptor Antagonists in Primary Aldosteronism". <i>Curr Pharm Des</i>. <b>24</b> (46): 5508–5516. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F1381612825666190311130138">10.2174/1381612825666190311130138</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30854950">30854950</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:73727928">73727928</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Curr+Pharm+Des&rft.atitle=Mineralocorticoid+Receptor+Antagonists+in+Primary+Aldosteronism&rft.volume=24&rft.issue=46&rft.pages=5508-5516&rft.date=2018&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A73727928%23id-name%3DS2CID&rft_id=info%3Apmid%2F30854950&rft_id=info%3Adoi%2F10.2174%2F1381612825666190311130138&rft.aulast=Stavropoulos&rft.aufirst=K&rft.au=Papadopoulos%2C+C&rft.au=Koutsampasopoulos%2C+K&rft.au=Lales%2C+G&rft.au=Mitas%2C+C&rft.au=Doumas%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid35536535-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid35536535_47-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFForestieroSconfienzaMulateroMonticone2022" class="citation journal cs1">Forestiero V, Sconfienza E, Mulatero P, Monticone S (May 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884655">"Primary aldosteronism in pregnancy"</a>. <i>Rev Endocr Metab Disord</i>. <b>24</b> (1): 39–48. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs11154-022-09729-6">10.1007/s11154-022-09729-6</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884655">9884655</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35536535">35536535</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:248574316">248574316</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Rev+Endocr+Metab+Disord&rft.atitle=Primary+aldosteronism+in+pregnancy&rft.volume=24&rft.issue=1&rft.pages=39-48&rft.date=2022-05&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9884655%23id-name%3DPMC&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A248574316%23id-name%3DS2CID&rft_id=info%3Apmid%2F35536535&rft_id=info%3Adoi%2F10.1007%2Fs11154-022-09729-6&rft.aulast=Forestiero&rft.aufirst=V&rft.au=Sconfienza%2C+E&rft.au=Mulatero%2C+P&rft.au=Monticone%2C+S&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9884655&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid27156905-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27156905_48-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLandauAmar2016" class="citation journal cs1">Landau E, Amar L (June 2016). "Primary aldosteronism and pregnancy". <i>Ann Endocrinol (Paris)</i>. <b>77</b> (2): 148–60. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ando.2016.04.009">10.1016/j.ando.2016.04.009</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27156905">27156905</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Ann+Endocrinol+%28Paris%29&rft.atitle=Primary+aldosteronism+and+pregnancy&rft.volume=77&rft.issue=2&rft.pages=148-60&rft.date=2016-06&rft_id=info%3Adoi%2F10.1016%2Fj.ando.2016.04.009&rft_id=info%3Apmid%2F27156905&rft.aulast=Landau&rft.aufirst=E&rft.au=Amar%2C+L&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid25163723-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid25163723_49-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRiesterReincke2015" class="citation journal cs1">Riester A, Reincke M (January 2015). <a rel="nofollow" class="external text" href="https://doi.org/10.1530%2FEJE-14-0444">"Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy"</a>. <i>Eur J Endocrinol</i>. <b>172</b> (1): R23–30. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1530%2FEJE-14-0444">10.1530/EJE-14-0444</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25163723">25163723</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:43338556">43338556</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Eur+J+Endocrinol&rft.atitle=Progress+in+primary+aldosteronism%3A+mineralocorticoid+receptor+antagonists+and+management+of+primary+aldosteronism+in+pregnancy&rft.volume=172&rft.issue=1&rft.pages=R23-30&rft.date=2015-01&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43338556%23id-name%3DS2CID&rft_id=info%3Apmid%2F25163723&rft_id=info%3Adoi%2F10.1530%2FEJE-14-0444&rft.aulast=Riester&rft.aufirst=A&rft.au=Reincke%2C+M&rft_id=https%3A%2F%2Fdoi.org%2F10.1530%252FEJE-14-0444&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid32586668-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid32586668_50-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAraujo-Castro2020" class="citation journal cs1">Araujo-Castro M (October 2020). "Treatment of primary hyperaldosteronism". <i>Med Clin (Barc)</i>. <b>155</b> (7): 302–308. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.medcli.2020.04.029">10.1016/j.medcli.2020.04.029</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32586668">32586668</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:225657804">225657804</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Med+Clin+%28Barc%29&rft.atitle=Treatment+of+primary+hyperaldosteronism&rft.volume=155&rft.issue=7&rft.pages=302-308&rft.date=2020-10&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A225657804%23id-name%3DS2CID&rft_id=info%3Apmid%2F32586668&rft_id=info%3Adoi%2F10.1016%2Fj.medcli.2020.04.029&rft.aulast=Araujo-Castro&rft.aufirst=M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid15507105-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15507105_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15507105_51-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFZouboulisDegitz2004" class="citation journal cs1">Zouboulis CC, Degitz K (2004). "Androgen action on human skin -- from basic research to clinical significance". <i>Experimental Dermatology</i>. <b>13</b> (Suppl 4): 5–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1600-0625.2004.00255.x">10.1111/j.1600-0625.2004.00255.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15507105">15507105</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34863608">34863608</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Experimental+Dermatology&rft.atitle=Androgen+action+on+human+skin+--+from+basic+research+to+clinical+significance&rft.volume=13&rft.issue=Suppl+4&rft.pages=5-10&rft.date=2004&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34863608%23id-name%3DS2CID&rft_id=info%3Apmid%2F15507105&rft_id=info%3Adoi%2F10.1111%2Fj.1600-0625.2004.00255.x&rft.aulast=Zouboulis&rft.aufirst=CC&rft.au=Degitz%2C+K&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid28979664-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid28979664_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid28979664_52-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFEndlyMiller2017" class="citation journal cs1">Endly DC, Miller RA (August 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605215">"Oily Skin: A review of Treatment Options"</a>. <i>The Journal of Clinical and Aesthetic Dermatology</i>. <b>10</b> (8): 49–55. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605215">5605215</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28979664">28979664</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+and+Aesthetic+Dermatology&rft.atitle=Oily+Skin%3A+A+review+of+Treatment+Options&rft.volume=10&rft.issue=8&rft.pages=49-55&rft.date=2017-08&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5605215%23id-name%3DPMC&rft_id=info%3Apmid%2F28979664&rft.aulast=Endly&rft.aufirst=DC&rft.au=Miller%2C+RA&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5605215&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ShalitaRosso2011-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-ShalitaRosso2011_53-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFShalitaDel_RossoWebster2011" class="citation book cs1">Shalita AR, Del Rosso JQ, Webster G (21 March 2011). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=CIPOBQAAQBAJ&pg=PA33"><i>Acne Vulgaris</i></a>. CRC Press. pp. 33–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-61631-009-7" title="Special:BookSources/978-1-61631-009-7"><bdi>978-1-61631-009-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161209210819/https://books.google.com/books?id=CIPOBQAAQBAJ&pg=PA33">Archived</a> from the original on 9 December 2016.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Acne+Vulgaris&rft.pages=33-&rft.pub=CRC+Press&rft.date=2011-03-21&rft.isbn=978-1-61631-009-7&rft.aulast=Shalita&rft.aufirst=AR&rft.au=Del+Rosso%2C+JQ&rft.au=Webster%2C+G&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DCIPOBQAAQBAJ%26pg%3DPA33&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ZouboulisKatsambas2014-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-ZouboulisKatsambas2014_54-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFZouboulisKatsambasKligman2014" class="citation book cs1">Zouboulis CC, Katsambas AD, Kligman AM (28 July 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=vnQqBAAAQBAJ&pg=PA121"><i>Pathogenesis and Treatment of Acne and Rosacea</i></a>. Springer. pp. 121–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-540-69375-8" title="Special:BookSources/978-3-540-69375-8"><bdi>978-3-540-69375-8</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161210040108/https://books.google.com/books?id=vnQqBAAAQBAJ&pg=PA121">Archived</a> from the original on 10 December 2016.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pathogenesis+and+Treatment+of+Acne+and+Rosacea&rft.pages=121-&rft.pub=Springer&rft.date=2014-07-28&rft.isbn=978-3-540-69375-8&rft.aulast=Zouboulis&rft.aufirst=CC&rft.au=Katsambas%2C+AD&rft.au=Kligman%2C+AM&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DvnQqBAAAQBAJ%26pg%3DPA121&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid16985920-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16985920_55-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMarks2004" class="citation journal cs1">Marks LS (2004). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472916">"5alpha-reductase: history and clinical importance"</a>. <i>Reviews in Urology</i>. <b>6</b> (Suppl 9): S11-21. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472916">1472916</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16985920">16985920</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reviews+in+Urology&rft.atitle=5alpha-reductase%3A+history+and+clinical+importance&rft.volume=6&rft.issue=Suppl+9&rft.pages=S11-21&rft.date=2004&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1472916%23id-name%3DPMC&rft_id=info%3Apmid%2F16985920&rft.aulast=Marks&rft.aufirst=LS&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1472916&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Sloane2002-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-Sloane2002_56-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSloane2002" class="citation book cs1">Sloane E (2002). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=kqcYyk7zlHYC&pg=PA160"><i>Biology of Women</i></a>. Cengage Learning. pp. 160–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-7668-1142-3" title="Special:BookSources/978-0-7668-1142-3"><bdi>978-0-7668-1142-3</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007092759/https://books.google.com/books?id=kqcYyk7zlHYC&pg=PA160">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Biology+of+Women&rft.pages=160-&rft.pub=Cengage+Learning&rft.date=2002&rft.isbn=978-0-7668-1142-3&rft.aulast=Sloane&rft.aufirst=E&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DkqcYyk7zlHYC%26pg%3DPA160&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-HannoGuzzo2014-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-HannoGuzzo2014_57-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHannoGuzzoMalkowiczWein2014" class="citation book cs1">Hanno PM, Guzzo TJ, Malkowicz SB, Wein AJ (26 January 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=OQTbAgAAQBAJ&pg=PA782"><i>Penn Clinical Manual of Urology E-Book: Expert Consult - Online</i></a>. Elsevier Health Sciences. pp. 782–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-323-24466-4" title="Special:BookSources/978-0-323-24466-4"><bdi>978-0-323-24466-4</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007092759/https://books.google.com/books?id=OQTbAgAAQBAJ&pg=PA782">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Penn+Clinical+Manual+of+Urology+E-Book%3A+Expert+Consult+-+Online&rft.pages=782-&rft.pub=Elsevier+Health+Sciences&rft.date=2014-01-26&rft.isbn=978-0-323-24466-4&rft.aulast=Hanno&rft.aufirst=PM&rft.au=Guzzo%2C+TJ&rft.au=Malkowicz%2C+SB&rft.au=Wein%2C+AJ&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DOQTbAgAAQBAJ%26pg%3DPA782&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Harper2007-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-Harper2007_58-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHarper2007" class="citation book cs1">Harper C (1 August 2007). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=fM6vAwAAQBAJ&pg=PA123"><i>Intersex</i></a>. Berg. pp. 123–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-84788-339-1" title="Special:BookSources/978-1-84788-339-1"><bdi>978-1-84788-339-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007092759/https://books.google.com/books?id=fM6vAwAAQBAJ&pg=PA123">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Intersex&rft.pages=123-&rft.pub=Berg&rft.date=2007-08-01&rft.isbn=978-1-84788-339-1&rft.aulast=Harper&rft.aufirst=C&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DfM6vAwAAQBAJ%26pg%3DPA123&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Blume-PeytaviWhiting2008-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-Blume-PeytaviWhiting2008_59-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBlume-PeytaviWhitingTrüeb2008" class="citation book cs1">Blume-Peytavi U, Whiting DA, Trüeb RM (26 June 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=pHrX2-huQCoC&pg=PA161"><i>Hair Growth and Disorders</i></a>. Springer Science & Business Media. pp. 161–162. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-540-46911-7" title="Special:BookSources/978-3-540-46911-7"><bdi>978-3-540-46911-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007092814/https://books.google.com/books?id=pHrX2-huQCoC&pg=PA161">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">16 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Hair+Growth+and+Disorders&rft.pages=161-162&rft.pub=Springer+Science+%26+Business+Media&rft.date=2008-06-26&rft.isbn=978-3-540-46911-7&rft.aulast=Blume-Peytavi&rft.aufirst=U&rft.au=Whiting%2C+DA&rft.au=Tr%C3%BCeb%2C+RM&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DpHrX2-huQCoC%26pg%3DPA161&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid9420861-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid9420861_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9420861_60-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid9420861_60-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid9420861_60-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid9420861_60-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid9420861_60-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDiamanti-KandarakisTolisDuleba1995" class="citation journal cs1">Diamanti-Kandarakis E, Tolis G, Duleba AJ (1995). "Androgens and therapeutic aspects of antiandrogens in women". <i>Journal of the Society for Gynecologic Investigation</i>. <b>2</b> (4): 577–92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F107155769500200401">10.1177/107155769500200401</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9420861">9420861</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32242838">32242838</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+Society+for+Gynecologic+Investigation&rft.atitle=Androgens+and+therapeutic+aspects+of+antiandrogens+in+women&rft.volume=2&rft.issue=4&rft.pages=577-92&rft.date=1995&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32242838%23id-name%3DS2CID&rft_id=info%3Apmid%2F9420861&rft_id=info%3Adoi%2F10.1177%2F107155769500200401&rft.aulast=Diamanti-Kandarakis&rft.aufirst=E&rft.au=Tolis%2C+G&rft.au=Duleba%2C+AJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid20082945-61"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20082945_61-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20082945_61-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKatsambasDessinioti2010" class="citation journal cs1">Katsambas AD, Dessinioti C (2010). "Hormonal therapy for acne: why not as first line therapy? facts and controversies". <i>Clinics in Dermatology</i>. <b>28</b> (1): 17–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clindermatol.2009.03.006">10.1016/j.clindermatol.2009.03.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20082945">20082945</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinics+in+Dermatology&rft.atitle=Hormonal+therapy+for+acne%3A+why+not+as+first+line+therapy%3F+facts+and+controversies&rft.volume=28&rft.issue=1&rft.pages=17-23&rft.date=2010&rft_id=info%3Adoi%2F10.1016%2Fj.clindermatol.2009.03.006&rft_id=info%3Apmid%2F20082945&rft.aulast=Katsambas&rft.aufirst=AD&rft.au=Dessinioti%2C+C&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid22468178-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22468178_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22468178_62-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid22468178_62-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid22468178_62-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid22468178_62-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid22468178_62-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid22468178_62-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid22468178_62-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid22468178_62-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid22468178_62-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKimDel_Rosso2012" class="citation journal cs1">Kim GK, Del Rosso JQ (March 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315877">"Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience"</a>. <i>The Journal of Clinical and Aesthetic Dermatology</i>. <b>5</b> (3): 37–50. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315877">3315877</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22468178">22468178</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+and+Aesthetic+Dermatology&rft.atitle=Oral+Spironolactone+in+Post-teenage+Female+Patients+with+Acne+Vulgaris%3A+Practical+Considerations+for+the+Clinician+Based+on+Current+Data+and+Clinical+Experience&rft.volume=5&rft.issue=3&rft.pages=37-50&rft.date=2012-03&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3315877%23id-name%3DPMC&rft_id=info%3Apmid%2F22468178&rft.aulast=Kim&rft.aufirst=GK&rft.au=Del+Rosso%2C+JQ&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3315877&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid28155090-63"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid28155090_63-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-pmid28155090_63-19"><sup><i><b>t</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLaytonEadyWhitehouseDel_Rosso2017" class="citation journal cs1">Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ (April 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360829">"Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review"</a>. <i>American Journal of Clinical Dermatology</i>. <b>18</b> (2): 169–191. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40257-016-0245-x">10.1007/s40257-016-0245-x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360829">5360829</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28155090">28155090</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Journal+of+Clinical+Dermatology&rft.atitle=Oral+Spironolactone+for+Acne+Vulgaris+in+Adult+Females%3A+A+Hybrid+Systematic+Review&rft.volume=18&rft.issue=2&rft.pages=169-191&rft.date=2017-04&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5360829%23id-name%3DPMC&rft_id=info%3Apmid%2F28155090&rft_id=info%3Adoi%2F10.1007%2Fs40257-016-0245-x&rft.aulast=Layton&rft.aufirst=AM&rft.au=Eady%2C+EA&rft.au=Whitehouse%2C+H&rft.au=Del+Rosso%2C+JQ&rft.au=Fedorowicz%2C+Z&rft.au=van+Zuuren%2C+EJ&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5360829&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSanterLawrenceRenzEminton2023" class="citation journal cs1">Santer M, Lawrence M, Renz S, Eminton Z, Stuart B, Sach TH, et al. (May 2023). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543374">"Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial"</a>. <i>BMJ</i>. <b>381</b>: e074349. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj-2022-074349">10.1136/bmj-2022-074349</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543374">10543374</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/37192767">37192767</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:258717921">258717921</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMJ&rft.atitle=Effectiveness+of+spironolactone+for+women+with+acne+vulgaris+%28SAFA%29+in+England+and+Wales%3A+pragmatic%2C+multicentre%2C+phase+3%2C+double+blind%2C+randomised+controlled+trial&rft.volume=381&rft.pages=e074349&rft.date=2023-05&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10543374%23id-name%3DPMC&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A258717921%23id-name%3DS2CID&rft_id=info%3Apmid%2F37192767&rft_id=info%3Adoi%2F10.1136%2Fbmj-2022-074349&rft.aulast=Santer&rft.aufirst=M&rft.au=Lawrence%2C+M&rft.au=Renz%2C+S&rft.au=Eminton%2C+Z&rft.au=Stuart%2C+B&rft.au=Sach%2C+TH&rft.au=Pyne%2C+S&rft.au=Ridd%2C+MJ&rft.au=Francis%2C+N&rft.au=Soulsby%2C+I&rft.au=Thomas%2C+K&rft.au=Permyakova%2C+N&rft.au=Little%2C+P&rft.au=Muller%2C+I&rft.au=Nuttall%2C+J&rft.au=Griffiths%2C+G&rft.au=Thomas%2C+KS&rft.au=Layton%2C+AM&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10543374&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid26897386-65"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid26897386_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid26897386_65-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid26897386_65-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid26897386_65-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid26897386_65-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid26897386_65-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFZaengleinPathySchlosserAlikhan2016" class="citation journal cs1">Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. (May 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jaad.2015.12.037">"Guidelines of care for the management of acne vulgaris"</a>. <i>Journal of the American Academy of Dermatology</i>. <b>74</b> (5): 945–73.e33. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jaad.2015.12.037">10.1016/j.jaad.2015.12.037</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26897386">26897386</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&rft.atitle=Guidelines+of+care+for+the+management+of+acne+vulgaris&rft.volume=74&rft.issue=5&rft.pages=945-73.e33&rft.date=2016-05&rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2015.12.037&rft_id=info%3Apmid%2F26897386&rft.aulast=Zaenglein&rft.aufirst=AL&rft.au=Pathy%2C+AL&rft.au=Schlosser%2C+BJ&rft.au=Alikhan%2C+A&rft.au=Baldwin%2C+HE&rft.au=Berson%2C+DS&rft.au=Bowe%2C+WP&rft.au=Graber%2C+EM&rft.au=Harper%2C+JC&rft.au=Kang%2C+S&rft.au=Keri%2C+JE&rft.au=Leyden%2C+JJ&rft.au=Reynolds%2C+RV&rft.au=Silverberg%2C+NB&rft.au=Stein+Gold%2C+LF&rft.au=Tollefson%2C+MM&rft.au=Weiss%2C+JS&rft.au=Dolan%2C+NC&rft.au=Sagan%2C+AA&rft.au=Stern%2C+M&rft.au=Boyer%2C+KM&rft.au=Bhushan%2C+R&rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jaad.2015.12.037&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid9238337-66"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid9238337_66-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9238337_66-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid9238337_66-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid9238337_66-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFShaw1996" class="citation journal cs1">Shaw JC (October 1996). "Antiandrogen and hormonal treatment of acne". <i>Dermatologic Clinics</i>. <b>14</b> (4): 803–11. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0733-8635%2805%2970405-8">10.1016/S0733-8635(05)70405-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9238337">9238337</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Dermatologic+Clinics&rft.atitle=Antiandrogen+and+hormonal+treatment+of+acne&rft.volume=14&rft.issue=4&rft.pages=803-11&rft.date=1996-10&rft_id=info%3Adoi%2F10.1016%2FS0733-8635%2805%2970405-8&rft_id=info%3Apmid%2F9238337&rft.aulast=Shaw&rft.aufirst=JC&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid24889738-67"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid24889738_67-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid24889738_67-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid24889738_67-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid24889738_67-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid24889738_67-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid24889738_67-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSomaniTurvy2014" class="citation journal cs1">Somani N, Turvy D (July 2014). "Hirsutism: an evidence-based treatment update". <i>American Journal of Clinical Dermatology</i>. <b>15</b> (3): 247–66. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40257-014-0078-4">10.1007/s40257-014-0078-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24889738">24889738</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:45234892">45234892</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Journal+of+Clinical+Dermatology&rft.atitle=Hirsutism%3A+an+evidence-based+treatment+update&rft.volume=15&rft.issue=3&rft.pages=247-66&rft.date=2014-07&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A45234892%23id-name%3DS2CID&rft_id=info%3Apmid%2F24889738&rft_id=info%3Adoi%2F10.1007%2Fs40257-014-0078-4&rft.aulast=Somani&rft.aufirst=N&rft.au=Turvy%2C+D&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid21413648-68"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid21413648_68-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid21413648_68-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRathnayakeSinclair2010" class="citation journal cs1">Rathnayake D, Sinclair R (2010). "Use of spironolactone in dermatology". <i>Skinmed</i>. <b>8</b> (6): 328–32, quiz 333. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21413648">21413648</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Skinmed&rft.atitle=Use+of+spironolactone+in+dermatology&rft.volume=8&rft.issue=6&rft.pages=328-32%2C+quiz+333&rft.date=2010&rft_id=info%3Apmid%2F21413648&rft.aulast=Rathnayake&rft.aufirst=D&rft.au=Sinclair%2C+R&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHarfmannBechtel2015" class="citation journal cs1">Harfmann KL, Bechtel MA (March 2015). "Hair loss in women". <i>Clinical Obstetrics and Gynecology</i>. <b>58</b> (1): 185–99. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FGRF.0000000000000081">10.1097/GRF.0000000000000081</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25517757">25517757</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20364810">20364810</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Obstetrics+and+Gynecology&rft.atitle=Hair+loss+in+women&rft.volume=58&rft.issue=1&rft.pages=185-99&rft.date=2015-03&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20364810%23id-name%3DS2CID&rft_id=info%3Apmid%2F25517757&rft_id=info%3Adoi%2F10.1097%2FGRF.0000000000000081&rft.aulast=Harfmann&rft.aufirst=KL&rft.au=Bechtel%2C+MA&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid20128792-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20128792_70-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCousenMessenger2010" class="citation journal cs1">Cousen P, Messenger A (May 2010). "Female pattern hair loss in complete androgen insensitivity syndrome". <i>The British Journal of Dermatology</i>. <b>162</b> (5): 1135–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-2133.2010.09661.x">10.1111/j.1365-2133.2010.09661.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20128792">20128792</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205259907">205259907</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+British+Journal+of+Dermatology&rft.atitle=Female+pattern+hair+loss+in+complete+androgen+insensitivity+syndrome&rft.volume=162&rft.issue=5&rft.pages=1135-7&rft.date=2010-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205259907%23id-name%3DS2CID&rft_id=info%3Apmid%2F20128792&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2133.2010.09661.x&rft.aulast=Cousen&rft.aufirst=P&rft.au=Messenger%2C+A&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-IswaranImai1997-71"><span class="mw-cite-backlink">^ <a href="#cite_ref-IswaranImai1997_71-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IswaranImai1997_71-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFIswaranImaiBettonSiddall1997" class="citation journal cs1">Iswaran TJ, Imai M, Betton GR, Siddall RA (May 1997). <a rel="nofollow" class="external text" href="https://doi.org/10.2131%2Fjts.22.2_75">"An overview of animal toxicology studies with bicalutamide (ICI 176,334)"</a>. <i>The Journal of Toxicological Sciences</i>. <b>22</b> (2): 75–88. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2131%2Fjts.22.2_75">10.2131/jts.22.2_75</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9198005">9198005</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Toxicological+Sciences&rft.atitle=An+overview+of+animal+toxicology+studies+with+bicalutamide+%28ICI+176%2C334%29&rft.volume=22&rft.issue=2&rft.pages=75-88&rft.date=1997-05&rft_id=info%3Adoi%2F10.2131%2Fjts.22.2_75&rft_id=info%3Apmid%2F9198005&rft.aulast=Iswaran&rft.aufirst=TJ&rft.au=Imai%2C+M&rft.au=Betton%2C+GR&rft.au=Siddall%2C+RA&rft_id=https%3A%2F%2Fdoi.org%2F10.2131%252Fjts.22.2_75&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Smith2013-72"><span class="mw-cite-backlink">^ <a href="#cite_ref-Smith2013_72-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Smith2013_72-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSmith2013" class="citation book cs1">Smith RE (4 April 2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=RkDcAwAAQBAJ&pg=PA306"><i>Medicinal Chemistry – Fusion of Traditional and Western Medicine</i></a>. Bentham Science Publishers. pp. 306–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-60805-149-6" title="Special:BookSources/978-1-60805-149-6"><bdi>978-1-60805-149-6</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160529034219/https://books.google.com/books?id=RkDcAwAAQBAJ&pg=PA306">Archived</a> from the original on 29 May 2016.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Medicinal+Chemistry+%E2%80%93+Fusion+of+Traditional+and+Western+Medicine&rft.pages=306-&rft.pub=Bentham+Science+Publishers&rft.date=2013-04-04&rft.isbn=978-1-60805-149-6&rft.aulast=Smith&rft.aufirst=RE&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DRkDcAwAAQBAJ%26pg%3DPA306&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Ostrzenski2002-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ostrzenski2002_73-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOstrzenski2002" class="citation book cs1">Ostrzenski A (2002). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=TYlZsGdwqrQC&pg=PA86"><i>Gynecology: Integrating Conventional, Complementary, and Natural Alternative Therapy</i></a>. Lippincott Williams & Wilkins. pp. 86–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-7817-2761-7" title="Special:BookSources/978-0-7817-2761-7"><bdi>978-0-7817-2761-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221006095556/https://books.google.com/books?id=TYlZsGdwqrQC&pg=PA86">Archived</a> from the original on 6 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Gynecology%3A+Integrating+Conventional%2C+Complementary%2C+and+Natural+Alternative+Therapy&rft.pages=86-&rft.pub=Lippincott+Williams+%26+Wilkins&rft.date=2002&rft.isbn=978-0-7817-2761-7&rft.aulast=Ostrzenski&rft.aufirst=A&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DTYlZsGdwqrQC%26pg%3DPA86&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid9557251-74"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid9557251_74-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9557251_74-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSchmidt1998" class="citation journal cs1">Schmidt JB (1998). "Other antiandrogens". <i>Dermatology</i>. <b>196</b> (1): 153–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000017850">10.1159/000017850</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9557251">9557251</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22119267">22119267</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Dermatology&rft.atitle=Other+antiandrogens&rft.volume=196&rft.issue=1&rft.pages=153-7&rft.date=1998&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22119267%23id-name%3DS2CID&rft_id=info%3Apmid%2F9557251&rft_id=info%3Adoi%2F10.1159%2F000017850&rft.aulast=Schmidt&rft.aufirst=JB&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-WPATH2011-75"><span class="mw-cite-backlink">^ <a href="#cite_ref-WPATH2011_75-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WPATH2011_75-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFThe_World_Professional_Association_for_Transgender_Health_(WPATH)2011" class="citation web cs1">The World Professional Association for Transgender Health (WPATH) (2011). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120523064935/http://www.wpath.org/documents/Standards%20of%20Care_FullBook_1g-1.pdf">"Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="http://www.wpath.org/documents/Standards%20of%20Care_FullBook_1g-1.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 23 May 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">27 May</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Standards+of+Care+for+the+Health+of+Transsexual%2C+Transgender%2C+and+Gender+Nonconforming+People&rft.date=2011&rft.au=The+World+Professional+Association+for+Transgender+Health+%28WPATH%29&rft_id=http%3A%2F%2Fwww.wpath.org%2Fdocuments%2FStandards%2520of%2520Care_FullBook_1g-1.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid19509099-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19509099_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19509099_76-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHembreeCohen-KettenisDelemarre-van_de_WaalGooren2009" class="citation journal cs1">Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ, Spack NP, et al. (September 2009). <a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2009-0345">"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline"</a>. <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>94</b> (9): 3132–54. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2009-0345">10.1210/jc.2009-0345</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19509099">19509099</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=Endocrine+treatment+of+transsexual+persons%3A+an+Endocrine+Society+clinical+practice+guideline&rft.volume=94&rft.issue=9&rft.pages=3132-54&rft.date=2009-09&rft_id=info%3Adoi%2F10.1210%2Fjc.2009-0345&rft_id=info%3Apmid%2F19509099&rft.aulast=Hembree&rft.aufirst=WC&rft.au=Cohen-Kettenis%2C+P&rft.au=Delemarre-van+de+Waal%2C+HA&rft.au=Gooren%2C+LJ&rft.au=Meyer%2C+WJ&rft.au=Spack%2C+NP&rft.au=Tangpricha%2C+V&rft.au=Montori%2C+VM&rft_id=https%3A%2F%2Fdoi.org%2F10.1210%252Fjc.2009-0345&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid2540730-77"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid2540730_77-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid2540730_77-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid2540730_77-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPriorVignaWatson1989" class="citation journal cs1">Prior JC, Vigna YM, Watson D (February 1989). "Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism". <i>Archives of Sexual Behavior</i>. <b>18</b> (1): 49–57. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fbf01579291">10.1007/bf01579291</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2540730">2540730</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22802329">22802329</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Archives+of+Sexual+Behavior&rft.atitle=Spironolactone+with+physiological+female+steroids+for+presurgical+therapy+of+male-to-female+transsexualism&rft.volume=18&rft.issue=1&rft.pages=49-57&rft.date=1989-02&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22802329%23id-name%3DS2CID&rft_id=info%3Apmid%2F2540730&rft_id=info%3Adoi%2F10.1007%2Fbf01579291&rft.aulast=Prior&rft.aufirst=JC&rft.au=Vigna%2C+YM&rft.au=Watson%2C+D&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid1387779-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid1387779_78-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCunliffeBottomley1992" class="citation journal cs1">Cunliffe WJ, Bottomley WW (September 1992). "Antiandrogens and acne. A topical approach?". <i>Archives of Dermatology</i>. <b>128</b> (9): 1261–4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchderm.1992.01680190117017">10.1001/archderm.1992.01680190117017</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/1387779">1387779</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Archives+of+Dermatology&rft.atitle=Antiandrogens+and+acne.+A+topical+approach%3F&rft.volume=128&rft.issue=9&rft.pages=1261-4&rft.date=1992-09&rft_id=info%3Adoi%2F10.1001%2Farchderm.1992.01680190117017&rft_id=info%3Apmid%2F1387779&rft.aulast=Cunliffe&rft.aufirst=WJ&rft.au=Bottomley%2C+WW&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid8112074-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8112074_79-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFVincenziTrevisiFarinaStinchi1993" class="citation journal cs1">Vincenzi C, Trevisi P, Farina P, Stinchi C, Tosti A (November 1993). "Facial contact dermatitis due to spironolactone in an anti-acne cream". <i>Contact Dermatitis</i>. <b>29</b> (5): 277–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1600-0536.1993.tb03569.x">10.1111/j.1600-0536.1993.tb03569.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8112074">8112074</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19134415">19134415</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Contact+Dermatitis&rft.atitle=Facial+contact+dermatitis+due+to+spironolactone+in+an+anti-acne+cream&rft.volume=29&rft.issue=5&rft.pages=277-8&rft.date=1993-11&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19134415%23id-name%3DS2CID&rft_id=info%3Apmid%2F8112074&rft_id=info%3Adoi%2F10.1111%2Fj.1600-0536.1993.tb03569.x&rft.aulast=Vincenzi&rft.aufirst=C&rft.au=Trevisi%2C+P&rft.au=Farina%2C+P&rft.au=Stinchi%2C+C&rft.au=Tosti%2C+A&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Benvenga2009-80"><span class="mw-cite-backlink">^ <a href="#cite_ref-Benvenga2009_80-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Benvenga2009_80-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBenvenga2009" class="citation book cs1">Benvenga S (2009). "Therapy of Hirsutism". <i>Diagnosis and Management of Polycystic Ovary Syndrome</i>. Springer. pp. 233–242. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-0-387-09718-3_19">10.1007/978-0-387-09718-3_19</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-387-09717-6" title="Special:BookSources/978-0-387-09717-6"><bdi>978-0-387-09717-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Therapy+of+Hirsutism&rft.btitle=Diagnosis+and+Management+of+Polycystic+Ovary+Syndrome&rft.pages=233-242&rft.pub=Springer&rft.date=2009&rft_id=info%3Adoi%2F10.1007%2F978-0-387-09718-3_19&rft.isbn=978-0-387-09717-6&rft.aulast=Benvenga&rft.aufirst=S&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid25918921-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid25918921_81-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFvan_ZuurenFedorowiczCarterPandis2015" class="citation journal cs1">van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N (April 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481758">"Interventions for hirsutism (excluding laser and photoepilation therapy alone)"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2015</b> (4): CD010334. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD010334.pub2">10.1002/14651858.CD010334.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481758">6481758</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25918921">25918921</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&rft.atitle=Interventions+for+hirsutism+%28excluding+laser+and+photoepilation+therapy+alone%29&rft.volume=2015&rft.issue=4&rft.pages=CD010334&rft.date=2015-04&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6481758%23id-name%3DPMC&rft_id=info%3Apmid%2F25918921&rft_id=info%3Adoi%2F10.1002%2F14651858.CD010334.pub2&rft.aulast=van+Zuuren&rft.aufirst=EJ&rft.au=Fedorowicz%2C+Z&rft.au=Carter%2C+B&rft.au=Pandis%2C+N&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6481758&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid29522176-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid29522176_82-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBarrionuevoNabhanAltayarWang2018" class="citation journal cs1">Barrionuevo P, Nabhan M, Altayar O, Wang Z, Erwin PJ, Asi N, et al. (April 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2017-02052">"Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis"</a>. <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>103</b> (4): 1258–1264. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2017-02052">10.1210/jc.2017-02052</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29522176">29522176</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3783739">3783739</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=Treatment+Options+for+Hirsutism%3A+A+Systematic+Review+and+Network+Meta-Analysis&rft.volume=103&rft.issue=4&rft.pages=1258-1264&rft.date=2018-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3783739%23id-name%3DS2CID&rft_id=info%3Apmid%2F29522176&rft_id=info%3Adoi%2F10.1210%2Fjc.2017-02052&rft.aulast=Barrionuevo&rft.aufirst=P&rft.au=Nabhan%2C+M&rft.au=Altayar%2C+O&rft.au=Wang%2C+Z&rft.au=Erwin%2C+PJ&rft.au=Asi%2C+N&rft.au=Martin%2C+KA&rft.au=Murad%2C+MH&rft_id=https%3A%2F%2Fdoi.org%2F10.1210%252Fjc.2017-02052&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid24455796-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid24455796_83-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFErem2013" class="citation journal cs1">Erem C (2013). "Update on idiopathic hirsutism: diagnosis and treatment". <i>Acta Clinica Belgica</i>. <b>68</b> (4): 268–74. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2143%2FACB.3267">10.2143/ACB.3267</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24455796">24455796</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39120534">39120534</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Acta+Clinica+Belgica&rft.atitle=Update+on+idiopathic+hirsutism%3A+diagnosis+and+treatment&rft.volume=68&rft.issue=4&rft.pages=268-74&rft.date=2013&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39120534%23id-name%3DS2CID&rft_id=info%3Apmid%2F24455796&rft_id=info%3Adoi%2F10.2143%2FACB.3267&rft.aulast=Erem&rft.aufirst=C&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid29211888-84"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid29211888_84-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid29211888_84-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMorettiGuccioneDi_GiacintoSimonelli2018" class="citation journal cs1">Moretti C, Guccione L, Di Giacinto P, Simonelli I, Exacoustos C, Toscano V, et al. (March 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2017-01186">"Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial"</a>. <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>103</b> (3): 824–838. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjc.2017-01186">10.1210/jc.2017-01186</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29211888">29211888</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3784055">3784055</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=Combined+Oral+Contraception+and+Bicalutamide+in+Polycystic+Ovary+Syndrome+and+Severe+Hirsutism%3A+A+Double-Blind+Randomized+Controlled+Trial&rft.volume=103&rft.issue=3&rft.pages=824-838&rft.date=2018-03&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3784055%23id-name%3DS2CID&rft_id=info%3Apmid%2F29211888&rft_id=info%3Adoi%2F10.1210%2Fjc.2017-01186&rft.aulast=Moretti&rft.aufirst=C&rft.au=Guccione%2C+L&rft.au=Di+Giacinto%2C+P&rft.au=Simonelli%2C+I&rft.au=Exacoustos%2C+C&rft.au=Toscano%2C+V&rft.au=Motta%2C+C&rft.au=De+Leo%2C+V&rft.au=Petraglia%2C+F&rft.au=Lenzi%2C+A&rft_id=https%3A%2F%2Fdoi.org%2F10.1210%252Fjc.2017-01186&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid22994662-85"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22994662_85-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22994662_85-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid22994662_85-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKamangarShinkai2012" class="citation journal cs1">Kamangar F, Shinkai K (October 2012). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-4632.2012.05519.x">"Acne in the adult female patient: a practical approach"</a>. <i>International Journal of Dermatology</i>. <b>51</b> (10): 1162–74. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-4632.2012.05519.x">10.1111/j.1365-4632.2012.05519.x</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22994662">22994662</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5777817">5777817</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Dermatology&rft.atitle=Acne+in+the+adult+female+patient%3A+a+practical+approach&rft.volume=51&rft.issue=10&rft.pages=1162-74&rft.date=2012-10&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5777817%23id-name%3DS2CID&rft_id=info%3Apmid%2F22994662&rft_id=info%3Adoi%2F10.1111%2Fj.1365-4632.2012.05519.x&rft.aulast=Kamangar&rft.aufirst=F&rft.au=Shinkai%2C+K&rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fj.1365-4632.2012.05519.x&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid10495361-86"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid10495361_86-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid10495361_86-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid10495361_86-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid10495361_86-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid10495361_86-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid10495361_86-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid10495361_86-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid10495361_86-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid10495361_86-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid10495361_86-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDiamanti-Kandarakis1999" class="citation journal cs1">Diamanti-Kandarakis E (September 1999). "Current aspects of antiandrogen therapy in women". <i>Current Pharmaceutical Design</i>. <b>5</b> (9): 707–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F1381612805666230111201150">10.2174/1381612805666230111201150</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10495361">10495361</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Current+Pharmaceutical+Design&rft.atitle=Current+aspects+of+antiandrogen+therapy+in+women&rft.volume=5&rft.issue=9&rft.pages=707-23&rft.date=1999-09&rft_id=info%3Adoi%2F10.2174%2F1381612805666230111201150&rft_id=info%3Apmid%2F10495361&rft.aulast=Diamanti-Kandarakis&rft.aufirst=E&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ShelleyShelley2001-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-ShelleyShelley2001_87-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFShelleyShelley2001" class="citation book cs1">Shelley WB, Shelley ED (2001). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=vuJsAAAAMAAJ"><i>Advanced Dermatologic Therapy II</i></a>. W. B. Saunders. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-7216-8258-7" title="Special:BookSources/978-0-7216-8258-7"><bdi>978-0-7216-8258-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221006095557/https://books.google.com/books?id=vuJsAAAAMAAJ">Archived</a> from the original on 6 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">2 January</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Advanced+Dermatologic+Therapy+II&rft.pub=W.+B.+Saunders&rft.date=2001&rft.isbn=978-0-7216-8258-7&rft.aulast=Shelley&rft.aufirst=WB&rft.au=Shelley%2C+ED&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DvuJsAAAAMAAJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-BalenFranks2010-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-BalenFranks2010_88-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBalenFranksHomburgKehoe2010" class="citation book cs1">Balen A, Franks S, Homburg R, Kehoe S (October 2010). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=0rtUBAAAQBAJ&pg=PA132"><i>Current Management of Polycystic Ovary Syndrome</i></a>. Cambridge University Press. pp. 132–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-906985-41-7" title="Special:BookSources/978-1-906985-41-7"><bdi>978-1-906985-41-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221006095557/https://books.google.com/books?id=0rtUBAAAQBAJ&pg=PA132">Archived</a> from the original on 6 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">2 January</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Current+Management+of+Polycystic+Ovary+Syndrome&rft.pages=132-&rft.pub=Cambridge+University+Press&rft.date=2010-10&rft.isbn=978-1-906985-41-7&rft.aulast=Balen&rft.aufirst=A&rft.au=Franks%2C+S&rft.au=Homburg%2C+R&rft.au=Kehoe%2C+S&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D0rtUBAAAQBAJ%26pg%3DPA132&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid28379593-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid28379593_89-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGiorgettidi_MuzioGiorgettiGirolami2017" class="citation journal cs1">Giorgetti R, di Muzio M, Giorgetti A, Girolami D, Borgia L, Tagliabracci A (March 2017). "Flutamide-induced hepatotoxicity: ethical and scientific issues". <i>European Review for Medical and Pharmacological Sciences</i>. <b>21</b> (1 Suppl): 69–77. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28379593">28379593</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=European+Review+for+Medical+and+Pharmacological+Sciences&rft.atitle=Flutamide-induced+hepatotoxicity%3A+ethical+and+scientific+issues&rft.volume=21&rft.issue=1+Suppl&rft.pages=69-77&rft.date=2017-03&rft_id=info%3Apmid%2F28379593&rft.aulast=Giorgetti&rft.aufirst=R&rft.au=di+Muzio%2C+M&rft.au=Giorgetti%2C+A&rft.au=Girolami%2C+D&rft.au=Borgia%2C+L&rft.au=Tagliabracci%2C+A&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid28492054-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid28492054_90-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTrivediShinkaiMurase2017" class="citation journal cs1">Trivedi MK, Shinkai K, Murase JE (March 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419026">"A Review of hormone-based therapies to treat adult acne vulgaris in women"</a>. <i>International Journal of Women's Dermatology</i>. <b>3</b> (1): 44–52. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ijwd.2017.02.018">10.1016/j.ijwd.2017.02.018</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419026">5419026</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28492054">28492054</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Women%27s+Dermatology&rft.atitle=A+Review+of+hormone-based+therapies+to+treat+adult+acne+vulgaris+in+women&rft.volume=3&rft.issue=1&rft.pages=44-52&rft.date=2017-03&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5419026%23id-name%3DPMC&rft_id=info%3Apmid%2F28492054&rft_id=info%3Adoi%2F10.1016%2Fj.ijwd.2017.02.018&rft.aulast=Trivedi&rft.aufirst=MK&rft.au=Shinkai%2C+K&rft.au=Murase%2C+JE&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5419026&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-YasaDural2016-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-YasaDural2016_91-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYasaDuralBastuUğurlucan2016" class="citation journal cs1">Yasa C, Dural Ö, Bastu E, Uğurlucan FG (2016). <a rel="nofollow" class="external text" href="https://doi.org/10.21613%2FGORM.2016.613">"Hirsutism, Acne, and Hair Loss: Management of Hyperandrogenic Cutaneous Manifestations of Polycystic Ovary Syndrome"</a>. <i>Gynecology Obstetrics & Reproductive Medicine</i>. <b>23</b> (2): 110–119. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.21613%2FGORM.2016.613">10.21613/GORM.2016.613</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1300-4751">1300-4751</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Gynecology+Obstetrics+%26+Reproductive+Medicine&rft.atitle=Hirsutism%2C+Acne%2C+and+Hair+Loss%3A+Management+of+Hyperandrogenic+Cutaneous+Manifestations+of+Polycystic+Ovary+Syndrome&rft.volume=23&rft.issue=2&rft.pages=110-119&rft.date=2016&rft_id=info%3Adoi%2F10.21613%2FGORM.2016.613&rft.issn=1300-4751&rft.aulast=Yasa&rft.aufirst=C&rft.au=Dural%2C+%C3%96&rft.au=Bastu%2C+E&rft.au=U%C4%9Furlucan%2C+FG&rft_id=https%3A%2F%2Fdoi.org%2F10.21613%252FGORM.2016.613&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid28274354-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid28274354_92-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBarrosThiboutot2017" class="citation journal cs1">Barros B, Thiboutot D (2017). "Hormonal therapies for acne". <i>Clinics in Dermatology</i>. <b>35</b> (2): 168–172. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clindermatol.2016.10.009">10.1016/j.clindermatol.2016.10.009</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28274354">28274354</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinics+in+Dermatology&rft.atitle=Hormonal+therapies+for+acne&rft.volume=35&rft.issue=2&rft.pages=168-172&rft.date=2017&rft_id=info%3Adoi%2F10.1016%2Fj.clindermatol.2016.10.009&rft_id=info%3Apmid%2F28274354&rft.aulast=Barros&rft.aufirst=B&rft.au=Thiboutot%2C+D&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid27416311-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27416311_93-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHassounChahalSivamaniLarsen2016" class="citation journal cs1">Hassoun LA, Chahal DS, Sivamani RK, Larsen LN (June 2016). "The use of hormonal agents in the treatment of acne". <i>Seminars in Cutaneous Medicine and Surgery</i>. <b>35</b> (2): 68–73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.12788%2Fj.sder.2016.027">10.12788/j.sder.2016.027</a> (inactive 1 November 2024). <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27416311">27416311</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Seminars+in+Cutaneous+Medicine+and+Surgery&rft.atitle=The+use+of+hormonal+agents+in+the+treatment+of+acne&rft.volume=35&rft.issue=2&rft.pages=68-73&rft.date=2016-06&rft_id=info%3Adoi%2F10.12788%2Fj.sder.2016.027&rft_id=info%3Apmid%2F27416311&rft.aulast=Hassoun&rft.aufirst=LA&rft.au=Chahal%2C+DS&rft.au=Sivamani%2C+RK&rft.au=Larsen%2C+LN&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_journal" title="Template:Cite journal">cite journal</a>}}</code>: CS1 maint: DOI inactive as of November 2024 (<a href="/wiki/Category:CS1_maint:_DOI_inactive_as_of_November_2024" title="Category:CS1 maint: DOI inactive as of November 2024">link</a>)</span></span> </li> <li id="cite_note-pmid30312645-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid30312645_94-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAzarchiBienenfeldLo_SiccoMarchbein2019" class="citation journal cs1">Azarchi S, Bienenfeld A, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR (June 2019). "Androgens in women: Hormone-modulating therapies for skin disease". <i>Journal of the American Academy of Dermatology</i>. <b>80</b> (6): 1509–1521. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jaad.2018.08.061">10.1016/j.jaad.2018.08.061</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30312645">30312645</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52973096">52973096</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&rft.atitle=Androgens+in+women%3A+Hormone-modulating+therapies+for+skin+disease&rft.volume=80&rft.issue=6&rft.pages=1509-1521&rft.date=2019-06&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52973096%23id-name%3DS2CID&rft_id=info%3Apmid%2F30312645&rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2018.08.061&rft.aulast=Azarchi&rft.aufirst=S&rft.au=Bienenfeld%2C+A&rft.au=Lo+Sicco%2C+K&rft.au=Marchbein%2C+S&rft.au=Shapiro%2C+J&rft.au=Nagler%2C+AR&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid27225981-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27225981_95-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFvan_ZuurenFedorowiczSchoones2016" class="citation journal cs1">van Zuuren EJ, Fedorowicz Z, Schoones J (May 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457957">"Interventions for female pattern hair loss"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2016</b> (5): CD007628. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD007628.pub4">10.1002/14651858.CD007628.pub4</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457957">6457957</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27225981">27225981</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&rft.atitle=Interventions+for+female+pattern+hair+loss&rft.volume=2016&rft.issue=5&rft.pages=CD007628&rft.date=2016-05&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6457957%23id-name%3DPMC&rft_id=info%3Apmid%2F27225981&rft_id=info%3Adoi%2F10.1002%2F14651858.CD007628.pub4&rft.aulast=van+Zuuren&rft.aufirst=EJ&rft.au=Fedorowicz%2C+Z&rft.au=Schoones%2C+J&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6457957&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid19370553-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19370553_96-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBrownFarquharLeeToomath2009" class="citation journal cs1">Brown J, Farquhar C, Lee O, Toomath R, Jepson RG (April 2009). "Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne". <i>The Cochrane Database of Systematic Reviews</i> (2): CD000194. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD000194.pub2">10.1002/14651858.CD000194.pub2</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2292%2F9640">2292/9640</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19370553">19370553</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&rft.atitle=Spironolactone+versus+placebo+or+in+combination+with+steroids+for+hirsutism+and%2For+acne&rft.issue=2&rft.pages=CD000194&rft.date=2009-04&rft_id=info%3Ahdl%2F2292%2F9640&rft_id=info%3Apmid%2F19370553&rft_id=info%3Adoi%2F10.1002%2F14651858.CD000194.pub2&rft.aulast=Brown&rft.aufirst=J&rft.au=Farquhar%2C+C&rft.au=Lee%2C+O&rft.au=Toomath%2C+R&rft.au=Jepson%2C+RG&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Hammerstein1990-97"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hammerstein1990_97-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hammerstein1990_97-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Hammerstein1990_97-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Hammerstein1990_97-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHammerstein1990" class="citation book cs1">Hammerstein J (1990). "Antiandrogens: Clinical Aspects". <i>Hair and Hair Diseases</i>. Springer. pp. 827–886. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-3-642-74612-3_35">10.1007/978-3-642-74612-3_35</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-642-74614-7" title="Special:BookSources/978-3-642-74614-7"><bdi>978-3-642-74614-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Antiandrogens%3A+Clinical+Aspects&rft.btitle=Hair+and+Hair+Diseases&rft.pages=827-886&rft.pub=Springer&rft.date=1990&rft_id=info%3Adoi%2F10.1007%2F978-3-642-74612-3_35&rft.isbn=978-3-642-74614-7&rft.aulast=Hammerstein&rft.aufirst=J&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Paradoxical_reactions-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-Paradoxical_reactions_98-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSundarDickinson2012" class="citation journal cs1">Sundar S, Dickinson PD (February 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291010">"Spironolactone, a possible selective androgen receptor modulator, should be used with caution in patients with metastatic carcinoma of the prostate"</a>. <i>BMJ Case Reports</i>. <b>2012</b>: bcr1120115238. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbcr.11.2011.5238">10.1136/bcr.11.2011.5238</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291010">3291010</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22665559">22665559</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMJ+Case+Reports&rft.atitle=Spironolactone%2C+a+possible+selective+androgen+receptor+modulator%2C+should+be+used+with+caution+in+patients+with+metastatic+carcinoma+of+the+prostate&rft.volume=2012&rft.pages=bcr1120115238&rft.date=2012-02&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3291010%23id-name%3DPMC&rft_id=info%3Apmid%2F22665559&rft_id=info%3Adoi%2F10.1136%2Fbcr.11.2011.5238&rft.aulast=Sundar&rft.aufirst=S&rft.au=Dickinson%2C+PD&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3291010&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRandolph2018" class="citation journal cs1">Randolph JF (December 2018). "Gender-Affirming Hormone Therapy for Transgender Females". <i>Clinical Obstetrics and Gynecology</i>. <b>61</b> (4): 705–721. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FGRF.0000000000000396">10.1097/GRF.0000000000000396</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30256230">30256230</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Obstetrics+and+Gynecology&rft.atitle=Gender-Affirming+Hormone+Therapy+for+Transgender+Females&rft.volume=61&rft.issue=4&rft.pages=705-721&rft.date=2018-12&rft_id=info%3Adoi%2F10.1097%2FGRF.0000000000000396&rft_id=info%3Apmid%2F30256230&rft.aulast=Randolph&rft.aufirst=JF&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Muller1998-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-Muller1998_100-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMullerDessing1998" class="citation book cs1">Muller NF, Dessing RP (19 June 1998). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=2HBPHmclMWIC&pg=PA44"><i>European Drug Index: European Drug Registrations</i></a> (Fourth ed.). CRC Press. pp. 44–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-7692-2114-5" title="Special:BookSources/978-3-7692-2114-5"><bdi>978-3-7692-2114-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093304/https://books.google.com/books?id=2HBPHmclMWIC&pg=PA44">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">29 November</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=European+Drug+Index%3A+European+Drug+Registrations&rft.pages=44-&rft.edition=Fourth&rft.pub=CRC+Press&rft.date=1998-06-19&rft.isbn=978-3-7692-2114-5&rft.aulast=Muller&rft.aufirst=NF&rft.au=Dessing%2C+RP&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D2HBPHmclMWIC%26pg%3DPA44&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-LeeDesai2007-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-LeeDesai2007_101-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLeeDesai2007" class="citation book cs1">Lee M, Desai A (2007). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=v0rLyVSc8EYC&pg=PA312"><i>Gibaldi's Drug Delivery Systems in Pharmaceutical Care</i></a>. ASHP. pp. 312–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-58528-136-7" title="Special:BookSources/978-1-58528-136-7"><bdi>978-1-58528-136-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093304/https://books.google.com/books?id=v0rLyVSc8EYC&pg=PA312">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Gibaldi%27s+Drug+Delivery+Systems+in+Pharmaceutical+Care&rft.pages=312-&rft.pub=ASHP&rft.date=2007&rft.isbn=978-1-58528-136-7&rft.aulast=Lee&rft.aufirst=M&rft.au=Desai%2C+A&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dv0rLyVSc8EYC%26pg%3DPA312&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Niazi2016-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-Niazi2016_102-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFNiazi2016" class="citation book cs1">Niazi SK (19 April 2016). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=XprMBQAAQBAJ&pg=PA470"><i>Handbook of Pharmaceutical Manufacturing Formulations, Second Edition: Volume One, Compressed Solid Products</i></a>. CRC Press. pp. 470–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4200-8117-6" title="Special:BookSources/978-1-4200-8117-6"><bdi>978-1-4200-8117-6</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093305/https://books.google.com/books?id=XprMBQAAQBAJ&pg=PA470">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Handbook+of+Pharmaceutical+Manufacturing+Formulations%2C+Second+Edition%3A+Volume+One%2C+Compressed+Solid+Products&rft.pages=470-&rft.pub=CRC+Press&rft.date=2016-04-19&rft.isbn=978-1-4200-8117-6&rft.aulast=Niazi&rft.aufirst=SK&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DXprMBQAAQBAJ%26pg%3DPA470&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-WakelinMaibach2002-103"><span class="mw-cite-backlink">^ <a href="#cite_ref-WakelinMaibach2002_103-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WakelinMaibach2002_103-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWakelinMaibachArcher2002" class="citation book cs1">Wakelin SH, Maibach HI, Archer CB (1 June 2002). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=F1ZiAgAAQBAJ&pg=PA35"><i>Systemic Drug Treatment in Dermatology: A Handbook</i></a>. CRC Press. pp. 32, 35. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-84076-013-2" title="Special:BookSources/978-1-84076-013-2"><bdi>978-1-84076-013-2</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093305/https://books.google.com/books?id=F1ZiAgAAQBAJ&pg=PA35">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Systemic+Drug+Treatment+in+Dermatology%3A+A+Handbook&rft.pages=32%2C+35&rft.pub=CRC+Press&rft.date=2002-06-01&rft.isbn=978-1-84076-013-2&rft.aulast=Wakelin&rft.aufirst=SH&rft.au=Maibach%2C+HI&rft.au=Archer%2C+CB&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DF1ZiAgAAQBAJ%26pg%3DPA35&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Drugs@FDA-104"><span class="mw-cite-backlink">^ <a href="#cite_ref-Drugs@FDA_104-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Drugs@FDA_104-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/daf/">"Drugs@FDA: FDA Approved Drug Products"</a>. U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161116164727/http://www.accessdata.fda.gov/scripts/cder/daf/">Archived</a> from the original on 16 November 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">14 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Drugs%40FDA%3A+FDA+Approved+Drug+Products&rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fcder%2Fdaf%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-IndexNominum2000-105"><span class="mw-cite-backlink">^ <a href="#cite_ref-IndexNominum2000_105-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IndexNominum2000_105-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IndexNominum2000_105-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-IndexNominum2000_105-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-IndexNominum2000_105-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-IndexNominum2000_105-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-IndexNominum2000_105-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-IndexNominum2000_105-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation book cs1"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA960"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor & Francis. January 2000. pp. 960ff. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-88763-075-1" title="Special:BookSources/978-3-88763-075-1"><bdi>978-3-88763-075-1</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Index+Nominum+2000%3A+International+Drug+Directory&rft.pages=960ff&rft.pub=Taylor+%26+Francis&rft.date=2000-01&rft.isbn=978-3-88763-075-1&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D5GpcTQD_L2oC%26pg%3DPA960&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Drugs.com-106"><span class="mw-cite-backlink">^ <a href="#cite_ref-Drugs.com_106-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Drugs.com_106-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Drugs.com_106-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Drugs.com_106-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Drugs.com_106-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Drugs.com_106-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Drugs.com_106-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Drugs.com_106-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Drugs.com_106-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/international/spironolactone.html">"Spironolactone"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161202040938/https://www.drugs.com/international/spironolactone.html">Archived</a> from the original on 2 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">1 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Spironolactone&rft_id=https%3A%2F%2Fwww.drugs.com%2Finternational%2Fspironolactone.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid28634268-107"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid28634268_107-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid28634268_107-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid28634268_107-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid28634268_107-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid28634268_107-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid28634268_107-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid28634268_107-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid28634268_107-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKolkhofBärfacker2017" class="citation journal cs1">Kolkhof P, Bärfacker L (July 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488394">"30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development"</a>. <i>The Journal of Endocrinology</i>. <b>234</b> (1): T125–T140. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1530%2FJOE-16-0600">10.1530/JOE-16-0600</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488394">5488394</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28634268">28634268</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Endocrinology&rft.atitle=30+YEARS+OF+THE+MINERALOCORTICOID+RECEPTOR%3A+Mineralocorticoid+receptor+antagonists%3A+60+years+of+research+and+development&rft.volume=234&rft.issue=1&rft.pages=T125-T140&rft.date=2017-07&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5488394%23id-name%3DPMC&rft_id=info%3Apmid%2F28634268&rft_id=info%3Adoi%2F10.1530%2FJOE-16-0600&rft.aulast=Kolkhof&rft.aufirst=P&rft.au=B%C3%A4rfacker%2C+L&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5488394&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-GoldsmithCovic2014-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-GoldsmithCovic2014_108-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGoldsmithCovicSpaak2014" class="citation book cs1">Goldsmith D, Covic A, Spaak J (12 November 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=GvZWBQAAQBAJ&pg=PA167"><i>Cardio-Renal Clinical Challenges</i></a>. Springer. pp. 167–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-319-09162-4" title="Special:BookSources/978-3-319-09162-4"><bdi>978-3-319-09162-4</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093305/https://books.google.com/books?id=GvZWBQAAQBAJ&pg=PA167">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">17 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Cardio-Renal+Clinical+Challenges&rft.pages=167-&rft.pub=Springer&rft.date=2014-11-12&rft.isbn=978-3-319-09162-4&rft.aulast=Goldsmith&rft.aufirst=D&rft.au=Covic%2C+A&rft.au=Spaak%2C+J&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DGvZWBQAAQBAJ%26pg%3DPA167&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid984618-109"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid984618_109-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid984618_109-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid984618_109-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid984618_109-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid984618_109-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid984618_109-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid984618_109-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid984618_109-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid984618_109-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid984618_109-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid984618_109-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLoriaux1976" class="citation journal cs1">Loriaux DL (November 1976). "Spironolactone and endocrine dysfunction". <i>Annals of Internal Medicine</i>. <b>85</b> (5): 630–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.7326%2F0003-4819-85-5-630">10.7326/0003-4819-85-5-630</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/984618">984618</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annals+of+Internal+Medicine&rft.atitle=Spironolactone+and+endocrine+dysfunction&rft.volume=85&rft.issue=5&rft.pages=630-6&rft.date=1976-11&rft_id=info%3Adoi%2F10.7326%2F0003-4819-85-5-630&rft_id=info%3Apmid%2F984618&rft.aulast=Loriaux&rft.aufirst=DL&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-SeldinGiebisch1997-110"><span class="mw-cite-backlink">^ <a href="#cite_ref-SeldinGiebisch1997_110-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-SeldinGiebisch1997_110-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-SeldinGiebisch1997_110-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-SeldinGiebisch1997_110-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-SeldinGiebisch1997_110-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-SeldinGiebisch1997_110-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-SeldinGiebisch1997_110-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-SeldinGiebisch1997_110-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-SeldinGiebisch1997_110-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSeldinGiebisch1997" class="citation book cs1">Seldin DW, Giebisch GH (23 September 1997). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=VHcsrw6unuAC&pg=PA630"><i>Diuretic Agents: Clinical Physiology and Pharmacology</i></a>. Academic Press. pp. 630–632. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-08-053046-8" title="Special:BookSources/978-0-08-053046-8"><bdi>978-0-08-053046-8</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140704201956/http://books.google.com/books?id=VHcsrw6unuAC&pg=PA630">Archived</a> from the original on 4 July 2014.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Diuretic+Agents%3A+Clinical+Physiology+and+Pharmacology&rft.pages=630-632&rft.pub=Academic+Press&rft.date=1997-09-23&rft.isbn=978-0-08-053046-8&rft.aulast=Seldin&rft.aufirst=DW&rft.au=Giebisch%2C+GH&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DVHcsrw6unuAC%26pg%3DPA630&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Aronson2009-111"><span class="mw-cite-backlink">^ <a href="#cite_ref-Aronson2009_111-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Aronson2009_111-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAronson2009" class="citation book cs1">Aronson JK (2 March 2009). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=oeBgU3UwgZkC&pg=PA255"><i>Meyler's Side Effects of Cardiovascular Drugs</i></a>. Elsevier. pp. 253–258. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-08-093289-7" title="Special:BookSources/978-0-08-093289-7"><bdi>978-0-08-093289-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093806/https://books.google.com/books?id=oeBgU3UwgZkC&pg=PA255">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">16 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Meyler%27s+Side+Effects+of+Cardiovascular+Drugs&rft.pages=253-258&rft.pub=Elsevier&rft.date=2009-03-02&rft.isbn=978-0-08-093289-7&rft.aulast=Aronson&rft.aufirst=JK&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DoeBgU3UwgZkC%26pg%3DPA255&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-CarrellPeterson2010-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-CarrellPeterson2010_112-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCarrellPeterson2010" class="citation book cs1">Carrell DT, Peterson CM (23 March 2010). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=lcBEheiufVcC&pg=PA162"><i>Reproductive Endocrinology and Infertility: Integrating Modern Clinical and Laboratory Practice</i></a>. Springer Science & Business Media. pp. 162–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4419-1436-1" title="Special:BookSources/978-1-4419-1436-1"><bdi>978-1-4419-1436-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093304/https://books.google.com/books?id=lcBEheiufVcC&pg=PA162">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Reproductive+Endocrinology+and+Infertility%3A+Integrating+Modern+Clinical+and+Laboratory+Practice&rft.pages=162-&rft.pub=Springer+Science+%26+Business+Media&rft.date=2010-03-23&rft.isbn=978-1-4419-1436-1&rft.aulast=Carrell&rft.aufirst=DT&rft.au=Peterson%2C+CM&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DlcBEheiufVcC%26pg%3DPA162&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-PescovitzEugster2004-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-PescovitzEugster2004_113-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPescovitzEugster2004" class="citation book cs1">Pescovitz OH, Eugster EA (2004). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=9gvBlktAT6YC&pg=PA368"><i>Pediatric Endocrinology: Mechanisms, Manifestations, and Management</i></a>. Lippincott Williams & Wilkins. pp. 368–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-7817-4059-3" title="Special:BookSources/978-0-7817-4059-3"><bdi>978-0-7817-4059-3</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pediatric+Endocrinology%3A+Mechanisms%2C+Manifestations%2C+and+Management&rft.pages=368-&rft.pub=Lippincott+Williams+%26+Wilkins&rft.date=2004&rft.isbn=978-0-7817-4059-3&rft.aulast=Pescovitz&rft.aufirst=OH&rft.au=Eugster%2C+EA&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D9gvBlktAT6YC%26pg%3DPA368&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSecoraShinQiaoAlexander2020" class="citation journal cs1">Secora AM, Shin JI, Qiao Y, Alexander GC, Chang AR, Inker LA, et al. (November 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005315">"Hyperkalemia and Acute Kidney Injury with Spironolactone Use Among Patients with Heart Failure"</a>. <i>Mayo Clinic Proceedings</i>. <b>95</b> (11): 2408–2419. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mayocp.2020.03.035">10.1016/j.mayocp.2020.03.035</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005315">8005315</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33153631">33153631</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Mayo+Clinic+Proceedings&rft.atitle=Hyperkalemia+and+Acute+Kidney+Injury+with+Spironolactone+Use+Among+Patients+with+Heart+Failure&rft.volume=95&rft.issue=11&rft.pages=2408-2419&rft.date=2020-11&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8005315%23id-name%3DPMC&rft_id=info%3Apmid%2F33153631&rft_id=info%3Adoi%2F10.1016%2Fj.mayocp.2020.03.035&rft.aulast=Secora&rft.aufirst=AM&rft.au=Shin%2C+JI&rft.au=Qiao%2C+Y&rft.au=Alexander%2C+GC&rft.au=Chang%2C+AR&rft.au=Inker%2C+LA&rft.au=Coresh%2C+J&rft.au=Grams%2C+ME&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8005315&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://medlineplus.gov/druginfo/meds/a682627.html">"Spironolactone"</a>. <i>MedlinePlus</i>. U.S. National Library of Medicine. 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160705111532/https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682627.html">Archived</a> from the original on 5 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">31 October</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=MedlinePlus&rft.atitle=Spironolactone&rft.date=2019&rft_id=https%3A%2F%2Fmedlineplus.gov%2Fdruginfo%2Fmeds%2Fa682627.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFVerhammeMosisDielemanStricker2006" class="citation journal cs1">Verhamme K, Mosis G, Dieleman J, Stricker B, Sturkenboom M (August 2006). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539051">"Spironolactone and risk of upper gastrointestinal events: population based case-control study"</a>. <i>BMJ</i>. <b>333</b> (7563): 330. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.38883.479549.2F">10.1136/bmj.38883.479549.2F</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539051">1539051</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16840442">16840442</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMJ&rft.atitle=Spironolactone+and+risk+of+upper+gastrointestinal+events%3A+population+based+case-control+study&rft.volume=333&rft.issue=7563&rft.pages=330&rft.date=2006-08&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1539051%23id-name%3DPMC&rft_id=info%3Apmid%2F16840442&rft_id=info%3Adoi%2F10.1136%2Fbmj.38883.479549.2F&rft.aulast=Verhamme&rft.aufirst=K&rft.au=Mosis%2C+G&rft.au=Dieleman%2C+J&rft.au=Stricker%2C+B&rft.au=Sturkenboom%2C+M&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1539051&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid18507655-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18507655_117-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGulmezLassenAalykkeDall2008" class="citation journal cs1">Gulmez SE, Lassen AT, Aalykke C, Dall M, Andries A, Andersen BS, et al. (August 2008). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2492928">"Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case-control study"</a>. <i>Br J Clin Pharmacol</i>. <b>66</b> (2): 294–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-2125.2008.03205.x">10.1111/j.1365-2125.2008.03205.x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2492928">2492928</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18507655">18507655</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Br+J+Clin+Pharmacol&rft.atitle=Spironolactone+use+and+the+risk+of+upper+gastrointestinal+bleeding%3A+a+population-based+case-control+study&rft.volume=66&rft.issue=2&rft.pages=294-9&rft.date=2008-08&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2492928%23id-name%3DPMC&rft_id=info%3Apmid%2F18507655&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2125.2008.03205.x&rft.aulast=Gulmez&rft.aufirst=SE&rft.au=Lassen%2C+AT&rft.au=Aalykke%2C+C&rft.au=Dall%2C+M&rft.au=Andries%2C+A&rft.au=Andersen%2C+BS&rft.au=Hansen%2C+JM&rft.au=Andersen%2C+M&rft.au=Hallas%2C+J&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2492928&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWandelt-Freerksen1977" class="citation journal cs1">Wandelt-Freerksen E (July 1977). "[Aldactone in the treatment of sarcoidosis of the lungs (author's transl)]". <i>Zeitschrift für Erkrankungen der Atmungsorgane</i>. <b>149</b> (1): 156–9. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/607621">607621</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Zeitschrift+f%C3%BCr+Erkrankungen+der+Atmungsorgane&rft.atitle=%5BAldactone+in+the+treatment+of+sarcoidosis+of+the+lungs+%28author%27s+transl%29%5D&rft.volume=149&rft.issue=1&rft.pages=156-9&rft.date=1977-07&rft_id=info%3Apmid%2F607621&rft.aulast=Wandelt-Freerksen&rft.aufirst=E&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid26404748-119"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid26404748_119-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid26404748_119-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLainscakPellicciaRosanoVitale2015" class="citation journal cs1">Lainscak M, Pelliccia F, Rosano G, Vitale C, Schiariti M, Greco C, et al. (December 2015). "Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone". <i>International Journal of Cardiology</i>. <b>200</b>: 25–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ijcard.2015.05.127">10.1016/j.ijcard.2015.05.127</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26404748">26404748</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Cardiology&rft.atitle=Safety+profile+of+mineralocorticoid+receptor+antagonists%3A+Spironolactone+and+eplerenone&rft.volume=200&rft.pages=25-9&rft.date=2015-12&rft_id=info%3Adoi%2F10.1016%2Fj.ijcard.2015.05.127&rft_id=info%3Apmid%2F26404748&rft.aulast=Lainscak&rft.aufirst=M&rft.au=Pelliccia%2C+F&rft.au=Rosano%2C+G&rft.au=Vitale%2C+C&rft.au=Schiariti%2C+M&rft.au=Greco%2C+C&rft.au=Speziale%2C+G&rft.au=Gaudio%2C+C&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid15295047-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15295047_120-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFJuurlinkMamdaniLeeKopp2004" class="citation journal cs1">Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, et al. (August 2004). <a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa040135">"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study"</a>. <i>The New England Journal of Medicine</i>. <b>351</b> (6): 543–51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa040135">10.1056/NEJMoa040135</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15295047">15295047</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+England+Journal+of+Medicine&rft.atitle=Rates+of+hyperkalemia+after+publication+of+the+Randomized+Aldactone+Evaluation+Study&rft.volume=351&rft.issue=6&rft.pages=543-51&rft.date=2004-08&rft_id=info%3Adoi%2F10.1056%2FNEJMoa040135&rft_id=info%3Apmid%2F15295047&rft.aulast=Juurlink&rft.aufirst=DN&rft.au=Mamdani%2C+MM&rft.au=Lee%2C+DS&rft.au=Kopp%2C+A&rft.au=Austin%2C+PC&rft.au=Laupacis%2C+A&rft.au=Redelmeier%2C+DA&rft_id=https%3A%2F%2Fdoi.org%2F10.1056%252FNEJMoa040135&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid22942339-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22942339_121-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFZannadGattis_StoughRossignolBauersachs2012" class="citation journal cs1">Zannad F, Gattis Stough W, Rossignol P, Bauersachs J, McMurray JJ, Swedberg K, et al. (November 2012). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Feurheartj%2Fehs257">"Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice"</a>. <i>European Heart Journal</i>. <b>33</b> (22): 2782–95. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Feurheartj%2Fehs257">10.1093/eurheartj/ehs257</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22942339">22942339</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=European+Heart+Journal&rft.atitle=Mineralocorticoid+receptor+antagonists+for+heart+failure+with+reduced+ejection+fraction%3A+integrating+evidence+into+clinical+practice&rft.volume=33&rft.issue=22&rft.pages=2782-95&rft.date=2012-11&rft_id=info%3Adoi%2F10.1093%2Feurheartj%2Fehs257&rft_id=info%3Apmid%2F22942339&rft.aulast=Zannad&rft.aufirst=F&rft.au=Gattis+Stough%2C+W&rft.au=Rossignol%2C+P&rft.au=Bauersachs%2C+J&rft.au=McMurray%2C+JJ&rft.au=Swedberg%2C+K&rft.au=Struthers%2C+AD&rft.au=Voors%2C+AA&rft.au=Ruilope%2C+LM&rft.au=Bakris%2C+GL&rft.au=O%27Connor%2C+CM&rft.au=Gheorghiade%2C+M&rft.au=Mentz%2C+RJ&rft.au=Cohen-Solal%2C+A&rft.au=Maggioni%2C+AP&rft.au=Beygui%2C+F&rft.au=Filippatos%2C+GS&rft.au=Massy%2C+ZA&rft.au=Pathak%2C+A&rft.au=Pi%C3%B1a%2C+IL&rft.au=Sabbah%2C+HN&rft.au=Sica%2C+DA&rft.au=Tavazzi%2C+L&rft.au=Pitt%2C+B&rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Feurheartj%252Fehs257&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid20483947-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20483947_122-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWeiStruthersFaheyWatson2010" class="citation journal cs1">Wei L, Struthers AD, Fahey T, Watson AD, Macdonald TM (May 2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.c1768">"Spironolactone use and renal toxicity: population based longitudinal analysis"</a>. <i>BMJ</i>. <b>340</b>: c1768. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.c1768">10.1136/bmj.c1768</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20483947">20483947</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:14815504">14815504</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMJ&rft.atitle=Spironolactone+use+and+renal+toxicity%3A+population+based+longitudinal+analysis&rft.volume=340&rft.pages=c1768&rft.date=2010-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A14815504%23id-name%3DS2CID&rft_id=info%3Apmid%2F20483947&rft_id=info%3Adoi%2F10.1136%2Fbmj.c1768&rft.aulast=Wei&rft.aufirst=L&rft.au=Struthers%2C+AD&rft.au=Fahey%2C+T&rft.au=Watson%2C+AD&rft.au=Macdonald%2C+TM&rft_id=https%3A%2F%2Fdoi.org%2F10.1136%252Fbmj.c1768&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid21911446-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21911446_123-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAntoniouGomesMamdaniYao2011" class="citation journal cs1">Antoniou T, Gomes T, Mamdani MM, Yao Z, Hellings C, Garg AX, et al. (September 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171211">"Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study"</a>. <i>BMJ</i>. <b>343</b>: d5228. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.d5228">10.1136/bmj.d5228</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171211">3171211</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21911446">21911446</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMJ&rft.atitle=Trimethoprim-sulfamethoxazole+induced+hyperkalaemia+in+elderly+patients+receiving+spironolactone%3A+nested+case-control+study&rft.volume=343&rft.pages=d5228&rft.date=2011-09&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3171211%23id-name%3DPMC&rft_id=info%3Apmid%2F21911446&rft_id=info%3Adoi%2F10.1136%2Fbmj.d5228&rft.aulast=Antoniou&rft.aufirst=T&rft.au=Gomes%2C+T&rft.au=Mamdani%2C+MM&rft.au=Yao%2C+Z&rft.au=Hellings%2C+C&rft.au=Garg%2C+AX&rft.au=Weir%2C+MA&rft.au=Juurlink%2C+DN&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3171211&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid25646289-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid25646289_124-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAntoniouHollandsMacdonaldGomes2015" class="citation journal cs1">Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN (March 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347789">"Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone"</a>. <i>CMAJ</i>. <b>187</b> (4): E138–E143. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1503%2Fcmaj.140816">10.1503/cmaj.140816</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347789">4347789</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25646289">25646289</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=CMAJ&rft.atitle=Trimethoprim-sulfamethoxazole+and+risk+of+sudden+death+among+patients+taking+spironolactone&rft.volume=187&rft.issue=4&rft.pages=E138-E143&rft.date=2015-03&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4347789%23id-name%3DPMC&rft_id=info%3Apmid%2F25646289&rft_id=info%3Adoi%2F10.1503%2Fcmaj.140816&rft.aulast=Antoniou&rft.aufirst=T&rft.au=Hollands%2C+S&rft.au=Macdonald%2C+EM&rft.au=Gomes%2C+T&rft.au=Mamdani%2C+MM&rft.au=Juurlink%2C+DN&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4347789&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid25796182-125"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid25796182_125-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid25796182_125-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid25796182_125-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPlovanichWengMostaghimi2015" class="citation journal cs1">Plovanich M, Weng QY, Mostaghimi A (September 2015). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamadermatol.2015.34">"Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne"</a>. <i>JAMA Dermatology</i>. <b>151</b> (9): 941–4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamadermatol.2015.34">10.1001/jamadermatol.2015.34</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25796182">25796182</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=JAMA+Dermatology&rft.atitle=Low+Usefulness+of+Potassium+Monitoring+Among+Healthy+Young+Women+Taking+Spironolactone+for+Acne&rft.volume=151&rft.issue=9&rft.pages=941-4&rft.date=2015-09&rft_id=info%3Adoi%2F10.1001%2Fjamadermatol.2015.34&rft_id=info%3Apmid%2F25796182&rft.aulast=Plovanich&rft.aufirst=M&rft.au=Weng%2C+QY&rft.au=Mostaghimi%2C+A&rft_id=https%3A%2F%2Fdoi.org%2F10.1001%252Fjamadermatol.2015.34&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid31065620-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid31065620_126-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMillingtonLiuChan2019" class="citation journal cs1">Millington K, Liu E, Chan YM (May 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjs.2019-00030">"The Utility of Potassium Monitoring in Gender-Diverse Adolescents Taking Spironolactone"</a>. <i>Journal of the Endocrine Society</i>. <b>3</b> (5): 1031–1038. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjs.2019-00030">10.1210/js.2019-00030</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497918">6497918</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31065620">31065620</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+Endocrine+Society&rft.atitle=The+Utility+of+Potassium+Monitoring+in+Gender-Diverse+Adolescents+Taking+Spironolactone&rft.volume=3&rft.issue=5&rft.pages=1031-1038&rft.date=2019-05&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6497918%23id-name%3DPMC&rft_id=info%3Apmid%2F31065620&rft_id=info%3Adoi%2F10.1210%2Fjs.2019-00030&rft.aulast=Millington&rft.aufirst=K&rft.au=Liu%2C+E&rft.au=Chan%2C+YM&rft_id=https%3A%2F%2Fdoi.org%2F10.1210%252Fjs.2019-00030&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid36267595-127"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid36267595_127-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid36267595_127-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHayesRussellHaugenNagavally2022" class="citation journal cs1">Hayes H, Russell R, Haugen A, Nagavally S, Sarvaideo J (October 2022). <a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjendso%2Fbvac133">"The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone"</a>. <i>Journal of the Endocrine Society</i>. <b>6</b> (11): bvac133. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjendso%2Fbvac133">10.1210/jendso/bvac133</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562816">9562816</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/36267595">36267595</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+Endocrine+Society&rft.atitle=The+Utility+of+Monitoring+Potassium+in+Transgender%2C+Gender+Diverse%2C+and+Nonbinary+Individuals+on+Spironolactone&rft.volume=6&rft.issue=11&rft.pages=bvac133&rft.date=2022-10&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9562816%23id-name%3DPMC&rft_id=info%3Apmid%2F36267595&rft_id=info%3Adoi%2F10.1210%2Fjendso%2Fbvac133&rft.aulast=Hayes&rft.aufirst=H&rft.au=Russell%2C+R&rft.au=Haugen%2C+A&rft.au=Nagavally%2C+S&rft.au=Sarvaideo%2C+J&rft_id=https%3A%2F%2Fdoi.org%2F10.1210%252Fjendso%252Fbvac133&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Becker2001-128"><span class="mw-cite-backlink">^ <a href="#cite_ref-Becker2001_128-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Becker2001_128-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Becker2001_128-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBecker2001" class="citation book cs1">Becker KL (2001). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=FVfzRvaucq8C&pg=PA1196"><i>Principles and Practice of Endocrinology and Metabolism</i></a>. Lippincott Williams & Wilkins. pp. 708, 777, 1087, 1196. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-7817-1750-2" title="Special:BookSources/978-0-7817-1750-2"><bdi>978-0-7817-1750-2</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221006095556/https://books.google.com/books?id=FVfzRvaucq8C&pg=PA1196">Archived</a> from the original on 6 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 May</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Principles+and+Practice+of+Endocrinology+and+Metabolism&rft.pages=708%2C+777%2C+1087%2C+1196&rft.pub=Lippincott+Williams+%26+Wilkins&rft.date=2001&rft.isbn=978-0-7817-1750-2&rft.aulast=Becker&rft.aufirst=KL&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DFVfzRvaucq8C%26pg%3DPA1196&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-TsioufisSchmieder2016-129"><span class="mw-cite-backlink">^ <a href="#cite_ref-TsioufisSchmieder2016_129-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-TsioufisSchmieder2016_129-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-TsioufisSchmieder2016_129-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTsioufisSchmiederMancia2016" class="citation book cs1">Tsioufis C, Schmieder R, Mancia G (15 August 2016). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=MFfYDAAAQBAJ&pg=PA44"><i>Interventional Therapies for Secondary and Essential Hypertension</i></a>. Springer. p. 44. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-319-34141-5" title="Special:BookSources/978-3-319-34141-5"><bdi>978-3-319-34141-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093807/https://books.google.com/books?id=MFfYDAAAQBAJ&pg=PA44">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">16 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Interventional+Therapies+for+Secondary+and+Essential+Hypertension&rft.pages=44&rft.pub=Springer&rft.date=2016-08-15&rft.isbn=978-3-319-34141-5&rft.aulast=Tsioufis&rft.aufirst=C&rft.au=Schmieder%2C+R&rft.au=Mancia%2C+G&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DMFfYDAAAQBAJ%26pg%3DPA44&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ConnJacobs1998-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-ConnJacobs1998_130-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFConnJacobs1998" class="citation journal cs1">Conn JJ, Jacobs HS (July 1998). "Managing hirsutism in gynaecological practice". <i>British Journal of Obstetrics and Gynaecology</i>. <b>105</b> (7): 687–96. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1471-0528.1998.tb10197.x">10.1111/j.1471-0528.1998.tb10197.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9692407">9692407</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34751086">34751086</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=British+Journal+of+Obstetrics+and+Gynaecology&rft.atitle=Managing+hirsutism+in+gynaecological+practice&rft.volume=105&rft.issue=7&rft.pages=687-96&rft.date=1998-07&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34751086%23id-name%3DS2CID&rft_id=info%3Apmid%2F9692407&rft_id=info%3Adoi%2F10.1111%2Fj.1471-0528.1998.tb10197.x&rft.aulast=Conn&rft.aufirst=JJ&rft.au=Jacobs%2C+HS&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Elsevier2014-131"><span class="mw-cite-backlink">^ <a href="#cite_ref-Elsevier2014_131-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Elsevier2014_131-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation book cs1"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=NfqxAwAAQBAJ&pg=PA293"><i>Side Effects of Drugs Annual: A worldwide yearly survey of new data in adverse drug reactions</i></a>. Elsevier Science. 1 December 2014. p. 293. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-444-63391-0" title="Special:BookSources/978-0-444-63391-0"><bdi>978-0-444-63391-0</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Side+Effects+of+Drugs+Annual%3A+A+worldwide+yearly+survey+of+new+data+in+adverse+drug+reactions&rft.pages=293&rft.pub=Elsevier+Science&rft.date=2014-12-01&rft.isbn=978-0-444-63391-0&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DNfqxAwAAQBAJ%26pg%3DPA293&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-McInnes2008-132"><span class="mw-cite-backlink">^ <a href="#cite_ref-McInnes2008_132-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-McInnes2008_132-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-McInnes2008_132-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMcInnes2008" class="citation book cs1">McInnes GT (2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=9nqP9iz7NNAC&pg=PA125"><i>Clinical Pharmacology and Therapeutics of Hypertension</i></a>. Elsevier. p. 125. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-444-51757-9" title="Special:BookSources/978-0-444-51757-9"><bdi>978-0-444-51757-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093807/https://books.google.com/books?id=9nqP9iz7NNAC&pg=PA125">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Clinical+Pharmacology+and+Therapeutics+of+Hypertension&rft.pages=125&rft.pub=Elsevier&rft.date=2008&rft.isbn=978-0-444-51757-9&rft.aulast=McInnes&rft.aufirst=GT&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D9nqP9iz7NNAC%26pg%3DPA125&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid15134800-133"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15134800_133-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15134800_133-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15134800_133-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid15134800_133-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid15134800_133-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMénard2004" class="citation journal cs1">Ménard J (March 2004). "The 45-year story of the development of an anti-aldosterone more specific than spironolactone". <i>Molecular and Cellular Endocrinology</i>. <b>217</b> (1–2): 45–52. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mce.2003.10.008">10.1016/j.mce.2003.10.008</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15134800">15134800</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19701784">19701784</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Molecular+and+Cellular+Endocrinology&rft.atitle=The+45-year+story+of+the+development+of+an+anti-aldosterone+more+specific+than+spironolactone&rft.volume=217&rft.issue=1%E2%80%932&rft.pages=45-52&rft.date=2004-03&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19701784%23id-name%3DS2CID&rft_id=info%3Apmid%2F15134800&rft_id=info%3Adoi%2F10.1016%2Fj.mce.2003.10.008&rft.aulast=M%C3%A9nard&rft.aufirst=J&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid8094898-134"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid8094898_134-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8094898_134-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid8094898_134-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid8094898_134-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid8094898_134-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid8094898_134-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid8094898_134-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFThompsonCarter1993" class="citation journal cs1">Thompson DF, Carter JR (1993). "Drug-induced gynecomastia". <i>Pharmacotherapy</i>. <b>13</b> (1): 37–45. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fj.1875-9114.1993.tb02688.x">10.1002/j.1875-9114.1993.tb02688.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8094898">8094898</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:30322620">30322620</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Pharmacotherapy&rft.atitle=Drug-induced+gynecomastia&rft.volume=13&rft.issue=1&rft.pages=37-45&rft.date=1993&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A30322620%23id-name%3DS2CID&rft_id=info%3Apmid%2F8094898&rft_id=info%3Adoi%2F10.1002%2Fj.1875-9114.1993.tb02688.x&rft.aulast=Thompson&rft.aufirst=DF&rft.au=Carter%2C+JR&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Wilcox2008-135"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wilcox2008_135-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wilcox2008_135-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWilcox2008" class="citation book cs1">Wilcox CS (22 August 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=XcnpBdq84MEC&pg=PA607"><i>Therapy in Nephrology and Hypertension E-Book: A Companion to Brenner & Rector's The Kidney</i></a>. Elsevier Health Sciences. pp. 607–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4377-1124-0" title="Special:BookSources/978-1-4377-1124-0"><bdi>978-1-4377-1124-0</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093807/https://books.google.com/books?id=XcnpBdq84MEC&pg=PA607">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">17 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Therapy+in+Nephrology+and+Hypertension+E-Book%3A+A+Companion+to+Brenner+%26+Rector%27s+The+Kidney&rft.pages=607-&rft.pub=Elsevier+Health+Sciences&rft.date=2008-08-22&rft.isbn=978-1-4377-1124-0&rft.aulast=Wilcox&rft.aufirst=CS&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DXcnpBdq84MEC%26pg%3DPA607&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid18983216-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18983216_136-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFEckmanDobs2008" class="citation journal cs1">Eckman A, Dobs A (November 2008). "Drug-induced gynecomastia". <i>Expert Opinion on Drug Safety</i>. <b>7</b> (6): 691–702. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1517%2F14740330802442382">10.1517/14740330802442382</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18983216">18983216</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:72716346">72716346</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Expert+Opinion+on+Drug+Safety&rft.atitle=Drug-induced+gynecomastia&rft.volume=7&rft.issue=6&rft.pages=691-702&rft.date=2008-11&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A72716346%23id-name%3DS2CID&rft_id=info%3Apmid%2F18983216&rft_id=info%3Adoi%2F10.1517%2F14740330802442382&rft.aulast=Eckman&rft.aufirst=A&rft.au=Dobs%2C+A&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid11546925-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11546925_137-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMathurBraunstein1997" class="citation journal cs1">Mathur R, Braunstein GD (1997). "Gynecomastia: pathomechanisms and treatment strategies". <i>Hormone Research</i>. <b>48</b> (3): 95–102. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000185497">10.1159/000185497</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11546925">11546925</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Hormone+Research&rft.atitle=Gynecomastia%3A+pathomechanisms+and+treatment+strategies&rft.volume=48&rft.issue=3&rft.pages=95-102&rft.date=1997&rft_id=info%3Adoi%2F10.1159%2F000185497&rft_id=info%3Apmid%2F11546925&rft.aulast=Mathur&rft.aufirst=R&rft.au=Braunstein%2C+GD&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid16076921-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16076921_138-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFChristyFranksCross2005" class="citation journal cs1">Christy NA, Franks AS, Cross LB (September 2005). "Spironolactone for hirsutism in polycystic ovary syndrome". <i>The Annals of Pharmacotherapy</i>. <b>39</b> (9): 1517–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1345%2Faph.1G025">10.1345/aph.1G025</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16076921">16076921</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:45708497">45708497</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Annals+of+Pharmacotherapy&rft.atitle=Spironolactone+for+hirsutism+in+polycystic+ovary+syndrome&rft.volume=39&rft.issue=9&rft.pages=1517-21&rft.date=2005-09&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A45708497%23id-name%3DS2CID&rft_id=info%3Apmid%2F16076921&rft_id=info%3Adoi%2F10.1345%2Faph.1G025&rft.aulast=Christy&rft.aufirst=NA&rft.au=Franks%2C+AS&rft.au=Cross%2C+LB&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid10792338-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10792338_139-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSpritzerLisboaMattielloLhullier2000" class="citation journal cs1">Spritzer PM, Lisboa KO, Mattiello S, Lhullier F (May 2000). "Spironolactone as a single agent for long-term therapy of hirsute patients". <i>Clinical Endocrinology</i>. <b>52</b> (5): 587–94. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1365-2265.2000.00982.x">10.1046/j.1365-2265.2000.00982.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10792338">10792338</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:40606594">40606594</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Endocrinology&rft.atitle=Spironolactone+as+a+single+agent+for+long-term+therapy+of+hirsute+patients&rft.volume=52&rft.issue=5&rft.pages=587-94&rft.date=2000-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A40606594%23id-name%3DS2CID&rft_id=info%3Apmid%2F10792338&rft_id=info%3Adoi%2F10.1046%2Fj.1365-2265.2000.00982.x&rft.aulast=Spritzer&rft.aufirst=PM&rft.au=Lisboa%2C+KO&rft.au=Mattiello%2C+S&rft.au=Lhullier%2C+F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-RabeGrunwald2009-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-RabeGrunwald2009_140-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRabeGrunwaldFeldmannRunnebaum2009" class="citation journal cs1">Rabe T, Grunwald K, Feldmann K, Runnebaum B (2009). "Treatment of hyperandrogenism in women". <i>Gynecological Endocrinology</i>. <b>10</b> (sup3): 1–44. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F09513599609045658">10.3109/09513599609045658</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0951-3590">0951-3590</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Gynecological+Endocrinology&rft.atitle=Treatment+of+hyperandrogenism+in+women&rft.volume=10&rft.issue=sup3&rft.pages=1-44&rft.date=2009&rft_id=info%3Adoi%2F10.3109%2F09513599609045658&rft.issn=0951-3590&rft.aulast=Rabe&rft.aufirst=T&rft.au=Grunwald%2C+K&rft.au=Feldmann%2C+K&rft.au=Runnebaum%2C+B&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid8144871-141"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid8144871_141-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8144871_141-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid8144871_141-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid8144871_141-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid8144871_141-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid8144871_141-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid8144871_141-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid8144871_141-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid8144871_141-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid8144871_141-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMcMullenVan_Herle1993" class="citation journal cs1">McMullen GR, Van Herle AJ (December 1993). "Hirsutism and the effectiveness of spironolactone in its management". <i>Journal of Endocrinological Investigation</i>. <b>16</b> (11): 925–32. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2FBF03348960">10.1007/BF03348960</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8144871">8144871</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:42231952">42231952</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Endocrinological+Investigation&rft.atitle=Hirsutism+and+the+effectiveness+of+spironolactone+in+its+management&rft.volume=16&rft.issue=11&rft.pages=925-32&rft.date=1993-12&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A42231952%23id-name%3DS2CID&rft_id=info%3Apmid%2F8144871&rft_id=info%3Adoi%2F10.1007%2FBF03348960&rft.aulast=McMullen&rft.aufirst=GR&rft.au=Van+Herle%2C+AJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid2744183-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2744183_142-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFNakajimaBrumstedRiddickGibson1989" class="citation journal cs1">Nakajima ST, Brumsted JR, Riddick DH, Gibson M (July 1989). "Absence of progestational activity of oral spironolactone". <i>Fertility and Sterility</i>. <b>52</b> (1): 155–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0015-0282%2816%2960807-5">10.1016/s0015-0282(16)60807-5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2744183">2744183</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Fertility+and+Sterility&rft.atitle=Absence+of+progestational+activity+of+oral+spironolactone&rft.volume=52&rft.issue=1&rft.pages=155-8&rft.date=1989-07&rft_id=info%3Adoi%2F10.1016%2Fs0015-0282%2816%2960807-5&rft_id=info%3Apmid%2F2744183&rft.aulast=Nakajima&rft.aufirst=ST&rft.au=Brumsted%2C+JR&rft.au=Riddick%2C+DH&rft.au=Gibson%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid32038990-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid32038990_143-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOlssonOlsson2020" class="citation journal cs1">Olsson HL, Olsson ML (2020). <a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffonc.2020.00021">"The Menstrual Cycle and Risk of Breast Cancer: A Review"</a>. <i>Frontiers in Oncology</i>. <b>10</b>: 21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffonc.2020.00021">10.3389/fonc.2020.00021</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993118">6993118</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32038990">32038990</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Frontiers+in+Oncology&rft.atitle=The+Menstrual+Cycle+and+Risk+of+Breast+Cancer%3A+A+Review&rft.volume=10&rft.pages=21&rft.date=2020&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6993118%23id-name%3DPMC&rft_id=info%3Apmid%2F32038990&rft_id=info%3Adoi%2F10.3389%2Ffonc.2020.00021&rft.aulast=Olsson&rft.aufirst=HL&rft.au=Olsson%2C+ML&rft_id=https%3A%2F%2Fdoi.org%2F10.3389%252Ffonc.2020.00021&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-JemecRevuz2006-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-JemecRevuz2006_144-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFJemecRevuzLeyden2006" class="citation book cs1">Jemec G, Revuz J, Leyden JJ (24 November 2006). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=hpKFsXwcKlgC&pg=PA125"><i>Hidradenitis Suppurativa</i></a>. Springer Science & Business Media. pp. 125–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-540-33101-8" title="Special:BookSources/978-3-540-33101-8"><bdi>978-3-540-33101-8</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093808/https://books.google.com/books?id=hpKFsXwcKlgC&pg=PA125">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">15 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Hidradenitis+Suppurativa&rft.pages=125-&rft.pub=Springer+Science+%26+Business+Media&rft.date=2006-11-24&rft.isbn=978-3-540-33101-8&rft.aulast=Jemec&rft.aufirst=G&rft.au=Revuz%2C+J&rft.au=Leyden%2C+JJ&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DhpKFsXwcKlgC%26pg%3DPA125&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid25459896-145"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid25459896_145-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid25459896_145-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFter_HeegdeDe_RijkVinkers2015" class="citation journal cs1">ter Heegde F, De Rijk RH, Vinkers CH (February 2015). "The brain mineralocorticoid receptor and stress resilience". <i>Psychoneuroendocrinology</i>. <b>52</b>: 92–110. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.psyneuen.2014.10.022">10.1016/j.psyneuen.2014.10.022</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/1874%2F331554">1874/331554</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25459896">25459896</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:14297156">14297156</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Psychoneuroendocrinology&rft.atitle=The+brain+mineralocorticoid+receptor+and+stress+resilience&rft.volume=52&rft.pages=92-110&rft.date=2015-02&rft_id=info%3Ahdl%2F1874%2F331554&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A14297156%23id-name%3DS2CID&rft_id=info%3Apmid%2F25459896&rft_id=info%3Adoi%2F10.1016%2Fj.psyneuen.2014.10.022&rft.aulast=ter+Heegde&rft.aufirst=F&rft.au=De+Rijk%2C+RH&rft.au=Vinkers%2C+CH&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Schultebraucks2016-146"><span class="mw-cite-backlink">^ <a href="#cite_ref-Schultebraucks2016_146-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Schultebraucks2016_146-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSchultebraucks2016" class="citation thesis cs1">Schultebraucks K (2016). <a rel="nofollow" class="external text" href="https://refubium.fu-berlin.de/handle/fub188/2739"><i>The Role of the Mineralocorticoid Receptor for Cognitive Function, Mood and Social Cognition</i></a> <span class="cs1-format">(PDF)</span> (Dissertation). <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.17169%2Frefubium-6940">10.17169/refubium-6940</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20181228082908/https://refubium.fu-berlin.de/handle/fub188/2739">Archived</a> from the original on 28 December 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">27 December</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adissertation&rft.title=The+Role+of+the+Mineralocorticoid+Receptor+for+Cognitive+Function%2C+Mood+and+Social+Cognition&rft.date=2016&rft_id=info%3Adoi%2F10.17169%2Frefubium-6940&rft.aulast=Schultebraucks&rft.aufirst=K&rft_id=https%3A%2F%2Frefubium.fu-berlin.de%2Fhandle%2Ffub188%2F2739&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid10367986-147"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid10367986_147-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid10367986_147-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHolsboer1999" class="citation journal cs1">Holsboer F (1999). "The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety". <i>Journal of Psychiatric Research</i>. <b>33</b> (3): 181–214. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0022-3956%2898%2990056-5">10.1016/S0022-3956(98)90056-5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10367986">10367986</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Psychiatric+Research&rft.atitle=The+rationale+for+corticotropin-releasing+hormone+receptor+%28CRH-R%29+antagonists+to+treat+depression+and+anxiety&rft.volume=33&rft.issue=3&rft.pages=181-214&rft.date=1999&rft_id=info%3Adoi%2F10.1016%2FS0022-3956%2898%2990056-5&rft_id=info%3Apmid%2F10367986&rft.aulast=Holsboer&rft.aufirst=F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-BassonPrior1997-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-BassonPrior1997_148-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBassonPrior1998" class="citation book cs1">Basson R, Prior JC (1998). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=zJBvR-Zy7LgC&pg=PA286">"Hormonal Therapy of Gender Dysphoria: The Male-to-Female Transsexual"</a>. In Denny D (ed.). <i>Current Concepts in Transgender Identity</i>. Taylor & Francis. pp. 277–296. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4324%2F9780203775134">10.4324/9780203775134</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-134-82110-5" title="Special:BookSources/978-1-134-82110-5"><bdi>978-1-134-82110-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093807/https://books.google.com/books?id=zJBvR-Zy7LgC&pg=PA286">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">2 January</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Hormonal+Therapy+of+Gender+Dysphoria%3A+The+Male-to-Female+Transsexual&rft.btitle=Current+Concepts+in+Transgender+Identity&rft.pages=277-296&rft.pub=Taylor+%26+Francis&rft.date=1998&rft_id=info%3Adoi%2F10.4324%2F9780203775134&rft.isbn=978-1-134-82110-5&rft.aulast=Basson&rft.aufirst=R&rft.au=Prior%2C+JC&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DzJBvR-Zy7LgC%26pg%3DPA286&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid28944709-149"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid28944709_149-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid28944709_149-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid28944709_149-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBaldaniSkrgaticOugouagKasum2018" class="citation journal cs1">Baldani DP, Skrgatic L, Ougouag R, Kasum M (February 2018). "The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment". <i>Gynecol Endocrinol</i>. <b>34</b> (2): 87–91. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F09513590.2017.1381681">10.1080/09513590.2017.1381681</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28944709">28944709</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205631980">205631980</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Gynecol+Endocrinol&rft.atitle=The+cardiometabolic+effect+of+current+management+of+polycystic+ovary+syndrome%3A+strategies+of+prevention+and+treatment&rft.volume=34&rft.issue=2&rft.pages=87-91&rft.date=2018-02&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205631980%23id-name%3DS2CID&rft_id=info%3Apmid%2F28944709&rft_id=info%3Adoi%2F10.1080%2F09513590.2017.1381681&rft.aulast=Baldani&rft.aufirst=DP&rft.au=Skrgatic%2C+L&rft.au=Ougouag%2C+R&rft.au=Kasum%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid19843067-150"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19843067_150-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19843067_150-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid19843067_150-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFNakhjavaniHamidiEsteghamatiAbbasi2009" class="citation journal cs1">Nakhjavani M, Hamidi S, Esteghamati A, Abbasi M, Nosratian-Jahromi S, Pasalar P (October 2009). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780289">"Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism"</a>. <i>Br J Clin Pharmacol</i>. <b>68</b> (4): 634–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-2125.2009.03483.x">10.1111/j.1365-2125.2009.03483.x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780289">2780289</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19843067">19843067</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Br+J+Clin+Pharmacol&rft.atitle=Short+term+effects+of+spironolactone+on+blood+lipid+profile%3A+a+3-month+study+on+a+cohort+of+young+women+with+hirsutism&rft.volume=68&rft.issue=4&rft.pages=634-7&rft.date=2009-10&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2780289%23id-name%3DPMC&rft_id=info%3Apmid%2F19843067&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2125.2009.03483.x&rft.aulast=Nakhjavani&rft.aufirst=M&rft.au=Hamidi%2C+S&rft.au=Esteghamati%2C+A&rft.au=Abbasi%2C+M&rft.au=Nosratian-Jahromi%2C+S&rft.au=Pasalar%2C+P&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2780289&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid30586774-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid30586774_151-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGrundyStoneBaileyBeam2019" class="citation journal cs1">Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. (June 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403606">"2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines"</a>. <i>Circulation</i>. <b>139</b> (25): e1082–e1143. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIR.0000000000000625">10.1161/CIR.0000000000000625</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403606">7403606</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30586774">30586774</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Circulation&rft.atitle=2018+AHA%2FACC%2FAACVPR%2FAAPA%2FABC%2FACPM%2FADA%2FAGS%2FAPhA%2FASPC%2FNLA%2FPCNA+Guideline+on+the+Management+of+Blood+Cholesterol%3A+A+Report+of+the+American+College+of+Cardiology%2FAmerican+Heart+Association+Task+Force+on+Clinical+Practice+Guidelines&rft.volume=139&rft.issue=25&rft.pages=e1082-e1143&rft.date=2019-06&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7403606%23id-name%3DPMC&rft_id=info%3Apmid%2F30586774&rft_id=info%3Adoi%2F10.1161%2FCIR.0000000000000625&rft.aulast=Grundy&rft.aufirst=SM&rft.au=Stone%2C+NJ&rft.au=Bailey%2C+AL&rft.au=Beam%2C+C&rft.au=Birtcher%2C+KK&rft.au=Blumenthal%2C+RS&rft.au=Braun%2C+LT&rft.au=de+Ferranti%2C+S&rft.au=Faiella-Tommasino%2C+J&rft.au=Forman%2C+DE&rft.au=Goldberg%2C+R&rft.au=Heidenreich%2C+PA&rft.au=Hlatky%2C+MA&rft.au=Jones%2C+DW&rft.au=Lloyd-Jones%2C+D&rft.au=Lopez-Pajares%2C+N&rft.au=Ndumele%2C+CE&rft.au=Orringer%2C+CE&rft.au=Peralta%2C+CA&rft.au=Saseen%2C+JJ&rft.au=Smith%2C+SC&rft.au=Sperling%2C+L&rft.au=Virani%2C+SS&rft.au=Yeboah%2C+J&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7403606&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-WPATH-SOC8-152"><span class="mw-cite-backlink"><b><a href="#cite_ref-WPATH-SOC8_152-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFColemanRadixBoumanBrown2022" class="citation journal cs1">Coleman E, Radix AE, Bouman WP, Brown GR, de Vries AL, Deutsch MB, et al. (August 2022). <a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F26895269.2022.2100644">"Standards of Care for the Health of Transgender and Gender Diverse People, Version 8"</a>. <i><a href="/wiki/International_Journal_of_Transgender_Health" title="International Journal of Transgender Health">International Journal of Transgender Health</a></i>. <b>23</b> (Suppl 1): S1–S259. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F26895269.2022.2100644">10.1080/26895269.2022.2100644</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/2689-5269">2689-5269</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553112">9553112</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/36238954">36238954</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Transgender+Health&rft.atitle=Standards+of+Care+for+the+Health+of+Transgender+and+Gender+Diverse+People%2C+Version+8&rft.volume=23&rft.issue=Suppl+1&rft.pages=S1-S259&rft.date=2022-08&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9553112%23id-name%3DPMC&rft.issn=2689-5269&rft_id=info%3Apmid%2F36238954&rft_id=info%3Adoi%2F10.1080%2F26895269.2022.2100644&rft.aulast=Coleman&rft.aufirst=E&rft.au=Radix%2C+AE&rft.au=Bouman%2C+WP&rft.au=Brown%2C+GR&rft.au=de+Vries%2C+AL&rft.au=Deutsch%2C+MB&rft.au=Ettner%2C+R&rft.au=Fraser%2C+L&rft.au=Goodman%2C+M&rft.au=Green%2C+J&rft.au=Hancock%2C+AB&rft.au=Johnson%2C+TW&rft.au=Karasic%2C+DH&rft.au=Knudson%2C+GA&rft.au=Leibowitz%2C+SF&rft.au=Meyer-Bahlburg%2C+HF&rft.au=Monstrey%2C+SJ&rft.au=Motmans%2C+J&rft.au=Nahata%2C+L&rft.au=Nieder%2C+TO&rft.au=Reisner%2C+SL&rft.au=Richards%2C+C&rft.au=Schechter%2C+LS&rft.au=Tangpricha%2C+V&rft.au=Tishelman%2C+AC&rft.au=Van+Trotsenburg%2C+MA&rft.au=Winter%2C+S&rft.au=Ducheny%2C+K&rft.au=Adams%2C+NJ&rft.au=Adri%C3%A1n%2C+TM&rft.au=Allen%2C+LR&rft.au=Azul%2C+D&rft.au=Bagga%2C+H&rft.au=Ba%C5%9Far%2C+K&rft.au=Bathory%2C+DS&rft.au=Belinky%2C+JJ&rft.au=Berg%2C+DR&rft.au=Berli%2C+JU&rft.au=Bluebond-Langner%2C+RO&rft.au=Bouman%2C+M&rft.au=Bowers%2C+ML&rft.au=Brassard%2C+PJ&rft.au=Byrne%2C+J&rft.au=Capit%C3%A1n%2C+L&rft.au=Cargill%2C+CJ&rft.au=Carswell%2C+JM&rft.au=Chang%2C+SC&rft.au=Chelvakumar%2C+G&rft.au=Corneil%2C+T&rft.au=Dalke%2C+KB&rft.au=De+Cuypere%2C+G&rft.au=de+Vries%2C+E&rft.au=Den+Heijer%2C+M&rft.au=Devor%2C+AH&rft.au=Dhejne%2C+C&rft.au=D%27Marco%2C+A&rft.au=Edmiston%2C+EK&rft.au=Edwards-Leeper%2C+L&rft.au=Ehrbar%2C+R&rft.au=Ehrensaft%2C+D&rft.au=Eisfeld%2C+J&rft.au=Elaut%2C+E&rft.au=Erickson-Schroth%2C+L&rft.au=Feldman%2C+JL&rft.au=Fisher%2C+AD&rft.au=Garcia%2C+MM&rft.au=Gijs%2C+L&rft.au=Green%2C+SE&rft.au=Hall%2C+BP&rft.au=Hardy%2C+TL&rft.au=Irwig%2C+MS&rft.au=Jacobs%2C+LA&rft.au=Janssen%2C+AC&rft.au=Johnson%2C+K&rft.au=Klink%2C+DT&rft.au=Kreukels%2C+BP&rft.au=Kuper%2C+LE&rft.au=Kvach%2C+EJ&rft.au=Malouf%2C+MA&rft.au=Massey%2C+R&rft.au=Mazur%2C+T&rft.au=McLachlan%2C+C&rft.au=Morrison%2C+SD&rft.au=Mosser%2C+SW&rft.au=Neira%2C+PM&rft.au=Nygren%2C+U&rft.au=Oates%2C+JM&rft.au=Obedin-Maliver%2C+J&rft.au=Pagkalos%2C+G&rft.au=Patton%2C+J&rft.au=Phanuphak%2C+N&rft.au=Rachlin%2C+K&rft.au=Reed%2C+T&rft.au=Rider%2C+GN&rft.au=Ristori%2C+J&rft.au=Robbins-Cherry%2C+S&rft.au=Roberts%2C+SA&rft.au=Rodriguez-Wallberg%2C+KA&rft.au=Rosenthal%2C+SM&rft.au=Sabir%2C+K&rft.au=Safer%2C+JD&rft.au=Scheim%2C+AI&rft.au=Seal%2C+LJ&rft.au=Sehoole%2C+TJ&rft.au=Spencer%2C+K&rft.au=St+Amand%2C+C&rft.au=Steensma%2C+TD&rft.au=Strang%2C+JF&rft.au=Taylor%2C+GB&rft.au=Tilleman%2C+K&rft.au=T%27Sjoen%2C+GG&rft.au=Vala%2C+LN&rft.au=Van+Mello%2C+NM&rft.au=Veale%2C+JF&rft.au=Vencill%2C+JA&rft.au=Vincent%2C+B&rft.au=Wesp%2C+LM&rft.au=West%2C+MA&rft.au=Arcelus%2C+J&rft_id=https%3A%2F%2Fdoi.org%2F10.1080%252F26895269.2022.2100644&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid3318361-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3318361_153-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGodslandWynnCrookMiller1987" class="citation journal cs1">Godsland IF, Wynn V, Crook D, Miller NE (December 1987). "Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions". <i>American Heart Journal</i>. <b>114</b> (6): 1467–1503. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0002-8703%2887%2990552-7">10.1016/0002-8703(87)90552-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/3318361">3318361</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Heart+Journal&rft.atitle=Sex%2C+plasma+lipoproteins%2C+and+atherosclerosis%3A+prevailing+assumptions+and+outstanding+questions&rft.volume=114&rft.issue=6&rft.pages=1467-1503&rft.date=1987-12&rft_id=info%3Adoi%2F10.1016%2F0002-8703%2887%2990552-7&rft_id=info%3Apmid%2F3318361&rft.aulast=Godsland&rft.aufirst=IF&rft.au=Wynn%2C+V&rft.au=Crook%2C+D&rft.au=Miller%2C+NE&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid33334002-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid33334002_154-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCignarellaMioniSabbadinDassie2020" class="citation journal cs1">Cignarella A, Mioni R, Sabbadin C, Dassie F, Parolin M, Vettor R, et al. (December 2020). <a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fijms21249554">"Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS"</a>. <i>Int J Mol Sci</i>. <b>21</b> (24): 9554. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fijms21249554">10.3390/ijms21249554</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765466">7765466</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33334002">33334002</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Int+J+Mol+Sci&rft.atitle=Pharmacological+Approaches+to+Controlling+Cardiometabolic+Risk+in+Women+with+PCOS&rft.volume=21&rft.issue=24&rft.pages=9554&rft.date=2020-12&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7765466%23id-name%3DPMC&rft_id=info%3Apmid%2F33334002&rft_id=info%3Adoi%2F10.3390%2Fijms21249554&rft.aulast=Cignarella&rft.aufirst=A&rft.au=Mioni%2C+R&rft.au=Sabbadin%2C+C&rft.au=Dassie%2C+F&rft.au=Parolin%2C+M&rft.au=Vettor%2C+R&rft.au=Barbot%2C+M&rft.au=Scaroni%2C+C&rft_id=https%3A%2F%2Fdoi.org%2F10.3390%252Fijms21249554&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid19006114-155"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19006114_155-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLopesLourençoMascarenhasAzevedo2008" class="citation journal cs1">Lopes RJ, Lourenço AP, Mascarenhas J, Azevedo A, Bettencourt P (November 2008). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652974">"Safety of spironolactone use in ambulatory heart failure patients"</a>. <i>Clinical Cardiology</i>. <b>31</b> (11): 509–13. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fclc.20284">10.1002/clc.20284</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652974">6652974</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19006114">19006114</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Cardiology&rft.atitle=Safety+of+spironolactone+use+in+ambulatory+heart+failure+patients&rft.volume=31&rft.issue=11&rft.pages=509-13&rft.date=2008-11&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6652974%23id-name%3DPMC&rft_id=info%3Apmid%2F19006114&rft_id=info%3Adoi%2F10.1002%2Fclc.20284&rft.aulast=Lopes&rft.aufirst=RJ&rft.au=Louren%C3%A7o%2C+AP&rft.au=Mascarenhas%2C+J&rft.au=Azevedo%2C+A&rft.au=Bettencourt%2C+P&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6652974&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ThaiSinclair2001-156"><span class="mw-cite-backlink"><b><a href="#cite_ref-ThaiSinclair2001_156-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFThaiSinclair2001" class="citation journal cs1">Thai KE, Sinclair RD (August 2001). "Spironolactone-induced hepatitis". <i>The Australasian Journal of Dermatology</i>. <b>42</b> (3): 180–2. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1440-0960.2001.00510.x">10.1046/j.1440-0960.2001.00510.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11488711">11488711</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:12160891">12160891</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Australasian+Journal+of+Dermatology&rft.atitle=Spironolactone-induced+hepatitis&rft.volume=42&rft.issue=3&rft.pages=180-2&rft.date=2001-08&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A12160891%23id-name%3DS2CID&rft_id=info%3Apmid%2F11488711&rft_id=info%3Adoi%2F10.1046%2Fj.1440-0960.2001.00510.x&rft.aulast=Thai&rft.aufirst=KE&rft.au=Sinclair%2C+RD&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-157">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20150310163603/https://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm258786.htm">"Aldactazide (spironolactone/hydrochlorothiazide) Tablets"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm258786.htm">the original</a> on 10 March 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&rft.atitle=Aldactazide+%28spironolactone%2Fhydrochlorothiazide%29+Tablets&rft_id=https%3A%2F%2Fwww.fda.gov%2FSafety%2FMedWatch%2FSafetyInformation%2Fucm258786.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-158">^</a></b></span> <span class="reference-text">online.lexi.com/lco/action/doc/retrieve/docid/patch_f/7699#f_adverse-reactions</span> </li> <li id="cite_note-pmid7195152-159"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7195152_159-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAibaSuzukiKageyamaMurai1981" class="citation journal cs1">Aiba M, Suzuki H, Kageyama K, Murai M, Tazaki H, Abe O, et al. (June 1981). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1903848">"Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa"</a>. <i>The American Journal of Pathology</i>. <b>103</b> (3): 404–10. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1903848">1903848</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7195152">7195152</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+American+Journal+of+Pathology&rft.atitle=Spironolactone+bodies+in+aldosteronomas+and+in+the+attached+adrenals.+Enzyme+histochemical+study+of+19+cases+of+primary+aldosteronism+and+a+case+of+aldosteronism+due+to+bilateral+diffuse+hyperplasia+of+the+zona+glomerulosa&rft.volume=103&rft.issue=3&rft.pages=404-10&rft.date=1981-06&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1903848%23id-name%3DPMC&rft_id=info%3Apmid%2F7195152&rft.aulast=Aiba&rft.aufirst=M&rft.au=Suzuki%2C+H&rft.au=Kageyama%2C+K&rft.au=Murai%2C+M&rft.au=Tazaki%2C+H&rft.au=Abe%2C+O&rft.au=Saruta%2C+T&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1903848&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Ainsworth2014-160"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ainsworth2014_160-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ainsworth2014_160-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAinsworth2014" class="citation book cs1">Ainsworth SB (10 November 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=VOLhBQAAQBAJ&pg=PA486"><i>Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life</i></a>. John Wiley & Sons. pp. 486–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-118-81959-3" title="Special:BookSources/978-1-118-81959-3"><bdi>978-1-118-81959-3</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908165041/https://books.google.com/books?id=VOLhBQAAQBAJ&pg=PA486">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Neonatal+Formulary%3A+Drug+Use+in+Pregnancy+and+the+First+Year+of+Life&rft.pages=486-&rft.pub=John+Wiley+%26+Sons&rft.date=2014-11-10&rft.isbn=978-1-118-81959-3&rft.aulast=Ainsworth&rft.aufirst=SB&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DVOLhBQAAQBAJ%26pg%3DPA486&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Little2006-161"><span class="mw-cite-backlink">^ <a href="#cite_ref-Little2006_161-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Little2006_161-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Little2006_161-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Little2006_161-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Little2006_161-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Little2006_161-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLittle2006" class="citation book cs1">Little B (29 September 2006). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=lnySHcBjXsEC&pg=PA63"><i>Drugs and Pregnancy: A Handbook</i></a>. CRC Press. pp. 63–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-340-80917-4" title="Special:BookSources/978-0-340-80917-4"><bdi>978-0-340-80917-4</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908165041/https://books.google.com/books?id=lnySHcBjXsEC&pg=PA63">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Drugs+and+Pregnancy%3A+A+Handbook&rft.pages=63-&rft.pub=CRC+Press&rft.date=2006-09-29&rft.isbn=978-0-340-80917-4&rft.aulast=Little&rft.aufirst=B&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DlnySHcBjXsEC%26pg%3DPA63&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-RubinRamsey2008-162"><span class="mw-cite-backlink">^ <a href="#cite_ref-RubinRamsey2008_162-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RubinRamsey2008_162-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-RubinRamsey2008_162-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRubinRamsey2008" class="citation book cs1">Rubin PC, Ramsey M (30 April 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=2zHGHec53oMC&pg=PA83"><i>Prescribing in Pregnancy</i></a>. John Wiley & Sons. pp. 83–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-470-69555-5" title="Special:BookSources/978-0-470-69555-5"><bdi>978-0-470-69555-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908165041/https://books.google.com/books?id=2zHGHec53oMC&pg=PA83">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Prescribing+in+Pregnancy&rft.pages=83-&rft.pub=John+Wiley+%26+Sons&rft.date=2008-04-30&rft.isbn=978-0-470-69555-5&rft.aulast=Rubin&rft.aufirst=PC&rft.au=Ramsey%2C+M&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D2zHGHec53oMC%26pg%3DPA83&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-BriggsFreeman2011-163"><span class="mw-cite-backlink">^ <a href="#cite_ref-BriggsFreeman2011_163-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BriggsFreeman2011_163-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BriggsFreeman2011_163-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBriggsFreemanYaffe2011" class="citation book cs1">Briggs GG, Freeman RK, Yaffe SJ (2011). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=OIgTE4aynrMC&pg=PA1349"><i>Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk</i></a>. Lippincott Williams & Wilkins. pp. 1349–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-60831-708-0" title="Special:BookSources/978-1-60831-708-0"><bdi>978-1-60831-708-0</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908165041/https://books.google.com/books?id=OIgTE4aynrMC&pg=PA1349">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Drugs+in+Pregnancy+and+Lactation%3A+A+Reference+Guide+to+Fetal+and+Neonatal+Risk&rft.pages=1349-&rft.pub=Lippincott+Williams+%26+Wilkins&rft.date=2011&rft.isbn=978-1-60831-708-0&rft.aulast=Briggs&rft.aufirst=GG&rft.au=Freeman%2C+RK&rft.au=Yaffe%2C+SJ&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DOIgTE4aynrMC%26pg%3DPA1349&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ElkayamGleicher1998-164"><span class="mw-cite-backlink"><b><a href="#cite_ref-ElkayamGleicher1998_164-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGleicherElkayamGleicher1998" class="citation book cs1">Gleicher N, Elkayam U, Gleicher N (23 June 1998). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=z6E-Hgeu1nYC&pg=PA353"><i>Cardiac Problems in Pregnancy: Diagnosis and Management of Maternal and Fetal Heart Disease</i></a>. John Wiley & Sons. pp. 353–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-471-16358-9" title="Special:BookSources/978-0-471-16358-9"><bdi>978-0-471-16358-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908165041/https://books.google.com/books?id=z6E-Hgeu1nYC&pg=PA353">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Cardiac+Problems+in+Pregnancy%3A+Diagnosis+and+Management+of+Maternal+and+Fetal+Heart+Disease&rft.pages=353-&rft.pub=John+Wiley+%26+Sons&rft.date=1998-06-23&rft.isbn=978-0-471-16358-9&rft.aulast=Gleicher&rft.aufirst=N&rft.au=Elkayam%2C+U&rft.au=Gleicher%2C+N&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dz6E-Hgeu1nYC%26pg%3DPA353&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Schaefer2001-165"><span class="mw-cite-backlink">^ <a href="#cite_ref-Schaefer2001_165-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Schaefer2001_165-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Schaefer2001_165-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Schaefer2001_165-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSchaefer2001" class="citation book cs1">Schaefer C (2001). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=CE569saGK70C&pg=PA115"><i>Drugs During Pregnancy and Lactation: Handbook of Prescription Drugs and Comparative Risk Assessment</i></a>. Gulf Professional Publishing. pp. 115, 143. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-444-50763-1" title="Special:BookSources/978-0-444-50763-1"><bdi>978-0-444-50763-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908165041/https://books.google.com/books?id=CE569saGK70C&pg=PA115">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Drugs+During+Pregnancy+and+Lactation%3A+Handbook+of+Prescription+Drugs+and+Comparative+Risk+Assessment&rft.pages=115%2C+143&rft.pub=Gulf+Professional+Publishing&rft.date=2001&rft.isbn=978-0-444-50763-1&rft.aulast=Schaefer&rft.aufirst=C&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DCE569saGK70C%26pg%3DPA115&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Upfal2006-166"><span class="mw-cite-backlink"><b><a href="#cite_ref-Upfal2006_166-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFUpfal2006" class="citation book cs1">Upfal J (2006). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=7O9kiqN2q2YC&pg=PA671"><i>Australian Drug Guide</i></a>. Black Inc. pp. 671–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-86395-174-6" title="Special:BookSources/978-1-86395-174-6"><bdi>978-1-86395-174-6</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908165041/https://books.google.com/books?id=7O9kiqN2q2YC&pg=PA671">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Australian+Drug+Guide&rft.pages=671-&rft.pub=Black+Inc.&rft.date=2006&rft.isbn=978-1-86395-174-6&rft.aulast=Upfal&rft.aufirst=J&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D7O9kiqN2q2YC%26pg%3DPA671&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid30352280-167"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid30352280_167-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid30352280_167-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLiszewskiBoull2019" class="citation journal cs1">Liszewski W, Boull C (April 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jaad.2018.10.023">"Lack of evidence for feminization of males exposed to spironolactone in utero: A systematic review"</a>. <i>Journal of the American Academy of Dermatology</i>. <b>80</b> (4): 1147–1148. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jaad.2018.10.023">10.1016/j.jaad.2018.10.023</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30352280">30352280</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:53022388">53022388</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&rft.atitle=Lack+of+evidence+for+feminization+of+males+exposed+to+spironolactone+in+utero%3A+A+systematic+review&rft.volume=80&rft.issue=4&rft.pages=1147-1148&rft.date=2019-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A53022388%23id-name%3DS2CID&rft_id=info%3Apmid%2F30352280&rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2018.10.023&rft.aulast=Liszewski&rft.aufirst=W&rft.au=Boull%2C+C&rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jaad.2018.10.023&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid15134797-168"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15134797_168-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGarthwaiteMcMahon2004" class="citation journal cs1">Garthwaite SM, McMahon EG (March 2004). "The evolution of aldosterone antagonists". <i>Molecular and Cellular Endocrinology</i>. <b>217</b> (1–2): 27–31. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mce.2003.10.005">10.1016/j.mce.2003.10.005</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15134797">15134797</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8499861">8499861</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Molecular+and+Cellular+Endocrinology&rft.atitle=The+evolution+of+aldosterone+antagonists&rft.volume=217&rft.issue=1%E2%80%932&rft.pages=27-31&rft.date=2004-03&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8499861%23id-name%3DS2CID&rft_id=info%3Apmid%2F15134797&rft_id=info%3Adoi%2F10.1016%2Fj.mce.2003.10.005&rft.aulast=Garthwaite&rft.aufirst=SM&rft.au=McMahon%2C+EG&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-169"><span class="mw-cite-backlink"><b><a href="#cite_ref-169">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20061115185827/http://www.losalt.com/docs/lo_salt_web_advice.pdf">"Advisory Statement"</a> <span class="cs1-format">(PDF)</span>. Klinge Chemicals / LoSalt. Archived from <a rel="nofollow" class="external text" href="http://www.losalt.com/docs/lo_salt_web_advice.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 15 November 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">15 March</span> 2007</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Advisory+Statement&rft.pub=Klinge+Chemicals+%2F+LoSalt&rft_id=http%3A%2F%2Fwww.losalt.com%2Fdocs%2Flo_salt_web_advice.pdf&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-170"><span class="mw-cite-backlink"><b><a href="#cite_ref-170">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFJuvetGourineniRaviZarich2013" class="citation journal cs1">Juvet T, Gourineni VC, Ravi S, Zarich SW (September 2013). "Life-threatening hyperkalemia: a potentially lethal drug combination". <i>Connecticut Medicine</i>. <b>77</b> (8): 491–3. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24156179">24156179</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Connecticut+Medicine&rft.atitle=Life-threatening+hyperkalemia%3A+a+potentially+lethal+drug+combination&rft.volume=77&rft.issue=8&rft.pages=491-3&rft.date=2013-09&rft_id=info%3Apmid%2F24156179&rft.aulast=Juvet&rft.aufirst=T&rft.au=Gourineni%2C+VC&rft.au=Ravi%2C+S&rft.au=Zarich%2C+SW&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Davis2009-171"><span class="mw-cite-backlink"><b><a href="#cite_ref-Davis2009_171-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDavis2009" class="citation book cs1">Davis MP (28 May 2009). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=aEzg6i2nPMQC&pg=PA222"><i>Opioids in Cancer Pain</i></a>. OUP Oxford. pp. 222–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-19-923664-0" title="Special:BookSources/978-0-19-923664-0"><bdi>978-0-19-923664-0</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094310/https://books.google.com/books?id=aEzg6i2nPMQC&pg=PA222">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Opioids+in+Cancer+Pain&rft.pages=222-&rft.pub=OUP+Oxford&rft.date=2009-05-28&rft.isbn=978-0-19-923664-0&rft.aulast=Davis&rft.aufirst=MP&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DaEzg6i2nPMQC%26pg%3DPA222&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid1826112-172"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid1826112_172-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid1826112_172-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid1826112_172-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid1826112_172-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid1826112_172-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFShaw1991" class="citation journal cs1">Shaw JC (February 1991). "Spironolactone in dermatologic therapy". <i>Journal of the American Academy of Dermatology</i>. <b>24</b> (2 Pt 1): 236–43. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0190-9622%2891%2970034-Y">10.1016/0190-9622(91)70034-Y</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/1826112">1826112</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&rft.atitle=Spironolactone+in+dermatologic+therapy&rft.volume=24&rft.issue=2+Pt+1&rft.pages=236-43&rft.date=1991-02&rft_id=info%3Adoi%2F10.1016%2F0190-9622%2891%2970034-Y&rft_id=info%3Apmid%2F1826112&rft.aulast=Shaw&rft.aufirst=JC&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Wolverton2007-173"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wolverton2007_173-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWolverton2007" class="citation book cs1">Wolverton SE (8 March 2007). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=AaJwq_X6U6MC&pg=PT2677"><i>Comprehensive Dermatologic Drug Therapy</i></a>. Elsevier Health Sciences. pp. 2677–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4377-2070-9" title="Special:BookSources/978-1-4377-2070-9"><bdi>978-1-4377-2070-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094310/https://books.google.com/books?id=AaJwq_X6U6MC&pg=PT2677">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Comprehensive+Dermatologic+Drug+Therapy&rft.pages=2677-&rft.pub=Elsevier+Health+Sciences&rft.date=2007-03-08&rft.isbn=978-1-4377-2070-9&rft.aulast=Wolverton&rft.aufirst=SE&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DAaJwq_X6U6MC%26pg%3DPT2677&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid29756046-174"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid29756046_174-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid29756046_174-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLeinungFeustelJoseph2018" class="citation journal cs1">Leinung MC, Feustel PJ, Joseph J (2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944393">"Hormonal Treatment of Transgender Women with Oral Estradiol"</a>. <i>Transgender Health</i>. <b>3</b> (1): 74–81. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1089%2Ftrgh.2017.0035">10.1089/trgh.2017.0035</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944393">5944393</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29756046">29756046</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Transgender+Health&rft.atitle=Hormonal+Treatment+of+Transgender+Women+with+Oral+Estradiol&rft.volume=3&rft.issue=1&rft.pages=74-81&rft.date=2018&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5944393%23id-name%3DPMC&rft_id=info%3Apmid%2F29756046&rft_id=info%3Adoi%2F10.1089%2Ftrgh.2017.0035&rft.aulast=Leinung&rft.aufirst=MC&rft.au=Feustel%2C+PJ&rft.au=Joseph%2C+J&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5944393&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-JhajraRamesh_Varkhede2012-175"><span class="mw-cite-backlink"><b><a href="#cite_ref-JhajraRamesh_Varkhede2012_175-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFJhajraRamesh_VarkhedeSuresh_AhireVidyasagar_Naik2012" class="citation book cs1">Jhajra S, Ramesh Varkhede N, Suresh Ahire D, Vidyasagar Naik B, Prasad B, Paliwal J, et al. (2012). "Extrahepatic Drug-Metabolizing Enzymes and Their Significance". <i>Encyclopedia of Drug Metabolism and Interactions</i>. Wiley. pp. 1–99. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F9780470921920.edm028">10.1002/9780470921920.edm028</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-470-92192-0" title="Special:BookSources/978-0-470-92192-0"><bdi>978-0-470-92192-0</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Extrahepatic+Drug-Metabolizing+Enzymes+and+Their+Significance&rft.btitle=Encyclopedia+of+Drug+Metabolism+and+Interactions&rft.pages=1-99&rft.pub=Wiley&rft.date=2012&rft_id=info%3Adoi%2F10.1002%2F9780470921920.edm028&rft.isbn=978-0-470-92192-0&rft.aulast=Jhajra&rft.aufirst=S&rft.au=Ramesh+Varkhede%2C+N&rft.au=Suresh+Ahire%2C+D&rft.au=Vidyasagar+Naik%2C+B&rft.au=Prasad%2C+B&rft.au=Paliwal%2C+J&rft.au=Singh%2C+S&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid27450358-176"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid27450358_176-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid27450358_176-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid27450358_176-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFArmaniniAndrisaniBordinSabbadin2016" class="citation journal cs1">Armanini D, Andrisani A, Bordin L, Sabbadin C (September 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F14656566.2016.1215430">"Spironolactone in the treatment of polycystic ovary syndrome"</a>. <i>Expert Opinion on Pharmacotherapy</i>. <b>17</b> (13): 1713–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F14656566.2016.1215430">10.1080/14656566.2016.1215430</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27450358">27450358</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19345088">19345088</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Expert+Opinion+on+Pharmacotherapy&rft.atitle=Spironolactone+in+the+treatment+of+polycystic+ovary+syndrome&rft.volume=17&rft.issue=13&rft.pages=1713-5&rft.date=2016-09&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19345088%23id-name%3DS2CID&rft_id=info%3Apmid%2F27450358&rft_id=info%3Adoi%2F10.1080%2F14656566.2016.1215430&rft.aulast=Armanini&rft.aufirst=D&rft.au=Andrisani%2C+A&rft.au=Bordin%2C+L&rft.au=Sabbadin%2C+C&rft_id=https%3A%2F%2Fdoi.org%2F10.1080%252F14656566.2016.1215430&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid17113210-177"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17113210_177-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17113210_177-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFArmaniniCastelloScaroniBonanni2007" class="citation journal cs1">Armanini D, Castello R, Scaroni C, Bonanni G, Faccini G, Pellati D, et al. (March 2007). "Treatment of polycystic ovary syndrome with spironolactone plus licorice". <i>European Journal of Obstetrics, Gynecology, and Reproductive Biology</i>. <b>131</b> (1): 61–67. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejogrb.2006.10.013">10.1016/j.ejogrb.2006.10.013</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17113210">17113210</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=European+Journal+of+Obstetrics%2C+Gynecology%2C+and+Reproductive+Biology&rft.atitle=Treatment+of+polycystic+ovary+syndrome+with+spironolactone+plus+licorice&rft.volume=131&rft.issue=1&rft.pages=61-67&rft.date=2007-03&rft_id=info%3Adoi%2F10.1016%2Fj.ejogrb.2006.10.013&rft_id=info%3Apmid%2F17113210&rft.aulast=Armanini&rft.aufirst=D&rft.au=Castello%2C+R&rft.au=Scaroni%2C+C&rft.au=Bonanni%2C+G&rft.au=Faccini%2C+G&rft.au=Pellati%2C+D&rft.au=Bertoldo%2C+A&rft.au=Fiore%2C+C&rft.au=Moghetti%2C+P&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid13991036-178"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid13991036_178-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSalassaMattoxRosevear1962" class="citation journal cs1">Salassa RM, Mattox VR, Rosevear JW (November 1962). "Inhibition of the "mineralocorticoid" activity of licorice by spironolactone". <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>22</b> (11): 1156–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjcem-22-11-1156">10.1210/jcem-22-11-1156</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/13991036">13991036</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=Inhibition+of+the+%22mineralocorticoid%22+activity+of+licorice+by+spironolactone&rft.volume=22&rft.issue=11&rft.pages=1156-9&rft.date=1962-11&rft_id=info%3Adoi%2F10.1210%2Fjcem-22-11-1156&rft_id=info%3Apmid%2F13991036&rft.aulast=Salassa&rft.aufirst=RM&rft.au=Mattox%2C+VR&rft.au=Rosevear%2C+JW&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid23185686-179"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23185686_179-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOmarKomarovaEl-GhonemiFathy2012" class="citation journal cs1">Omar HR, Komarova I, El-Ghonemi M, Fathy A, Rashad R, Abdelmalak HD, et al. (August 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498851">"Licorice abuse: time to send a warning message"</a>. <i>Therapeutic Advances in Endocrinology and Metabolism</i>. <b>3</b> (4): 125–38. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F2042018812454322">10.1177/2042018812454322</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498851">3498851</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23185686">23185686</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Therapeutic+Advances+in+Endocrinology+and+Metabolism&rft.atitle=Licorice+abuse%3A+time+to+send+a+warning+message&rft.volume=3&rft.issue=4&rft.pages=125-38&rft.date=2012-08&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3498851%23id-name%3DPMC&rft_id=info%3Apmid%2F23185686&rft_id=info%3Adoi%2F10.1177%2F2042018812454322&rft.aulast=Omar&rft.aufirst=HR&rft.au=Komarova%2C+I&rft.au=El-Ghonemi%2C+M&rft.au=Fathy%2C+A&rft.au=Rashad%2C+R&rft.au=Abdelmalak%2C+HD&rft.au=Yerramadha%2C+MR&rft.au=Ali%2C+Y&rft.au=Helal%2C+E&rft.au=Camporesi%2C+EM&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3498851&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid12640291-180"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12640291_180-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLinYangChauHalperin2003" class="citation journal cs1">Lin SH, Yang SS, Chau T, Halperin ML (March 2003). "An unusual cause of hypokalemic paralysis: chronic licorice ingestion". <i>The American Journal of the Medical Sciences</i>. <b>325</b> (3): 153–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F00000441-200303000-00008">10.1097/00000441-200303000-00008</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12640291">12640291</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+American+Journal+of+the+Medical+Sciences&rft.atitle=An+unusual+cause+of+hypokalemic+paralysis%3A+chronic+licorice+ingestion&rft.volume=325&rft.issue=3&rft.pages=153-6&rft.date=2003-03&rft_id=info%3Adoi%2F10.1097%2F00000441-200303000-00008&rft_id=info%3Apmid%2F12640291&rft.aulast=Lin&rft.aufirst=SH&rft.au=Yang%2C+SS&rft.au=Chau%2C+T&rft.au=Halperin%2C+ML&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid17362671-181"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17362671_181-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFParthasarathyMacDonald2007" class="citation journal cs1">Parthasarathy HK, MacDonald TM (March 2007). "Mineralocorticoid receptor antagonists". <i>Current Hypertension Reports</i>. <b>9</b> (1): 45–52. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs11906-007-0009-3">10.1007/s11906-007-0009-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17362671">17362671</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:2090391">2090391</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Current+Hypertension+Reports&rft.atitle=Mineralocorticoid+receptor+antagonists&rft.volume=9&rft.issue=1&rft.pages=45-52&rft.date=2007-03&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2090391%23id-name%3DS2CID&rft_id=info%3Apmid%2F17362671&rft_id=info%3Adoi%2F10.1007%2Fs11906-007-0009-3&rft.aulast=Parthasarathy&rft.aufirst=HK&rft.au=MacDonald%2C+TM&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-182"><span class="mw-cite-backlink"><b><a href="#cite_ref-182">^</a></b></span> <span class="reference-text">Holsboer, F. The Rationale for Corticotropin-Releasing Hormone Receptor (CRH-R) Antagonists to Treat Depression and Anxiety. J. Psychiatr. Res. 33, 181–214 (1999).</span> </li> <li id="cite_note-pmid19909979-183"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19909979_183-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOtteHinkelmannMoritzYassouridis2010" class="citation journal cs1">Otte C, Hinkelmann K, Moritz S, Yassouridis A, Jahn H, Wiedemann K, et al. (April 2010). "Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study". <i>Journal of Psychiatric Research</i>. <b>44</b> (6): 339–46. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jpsychires.2009.10.006">10.1016/j.jpsychires.2009.10.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19909979">19909979</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Psychiatric+Research&rft.atitle=Modulation+of+the+mineralocorticoid+receptor+as+add-on+treatment+in+depression%3A+a+randomized%2C+double-blind%2C+placebo-controlled+proof-of-concept+study&rft.volume=44&rft.issue=6&rft.pages=339-46&rft.date=2010-04&rft_id=info%3Adoi%2F10.1016%2Fj.jpsychires.2009.10.006&rft_id=info%3Apmid%2F19909979&rft.aulast=Otte&rft.aufirst=C&rft.au=Hinkelmann%2C+K&rft.au=Moritz%2C+S&rft.au=Yassouridis%2C+A&rft.au=Jahn%2C+H&rft.au=Wiedemann%2C+K&rft.au=Kellner%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid21515309-184"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21515309_184-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMostalac-Preciadode_GortariLópez-Rubalcava2011" class="citation journal cs1">Mostalac-Preciado CR, de Gortari P, López-Rubalcava C (September 2011). "Antidepressant-like effects of mineralocorticoid but not glucocorticoid antagonists in the lateral septum: interactions with the serotonergic system". <i>Behavioural Brain Research</i>. <b>223</b> (1): 88–98. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.bbr.2011.04.008">10.1016/j.bbr.2011.04.008</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21515309">21515309</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:26986501">26986501</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Behavioural+Brain+Research&rft.atitle=Antidepressant-like+effects+of+mineralocorticoid+but+not+glucocorticoid+antagonists+in+the+lateral+septum%3A+interactions+with+the+serotonergic+system&rft.volume=223&rft.issue=1&rft.pages=88-98&rft.date=2011-09&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A26986501%23id-name%3DS2CID&rft_id=info%3Apmid%2F21515309&rft_id=info%3Adoi%2F10.1016%2Fj.bbr.2011.04.008&rft.aulast=Mostalac-Preciado&rft.aufirst=CR&rft.au=de+Gortari%2C+P&rft.au=L%C3%B3pez-Rubalcava%2C+C&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-AgustiBourgeois2013-185"><span class="mw-cite-backlink">^ <a href="#cite_ref-AgustiBourgeois2013_185-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AgustiBourgeois2013_185-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AgustiBourgeois2013_185-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAgustiBourgeoisCartiserFessi2013" class="citation journal cs1">Agusti G, Bourgeois S, Cartiser N, Fessi H, Le Borgne M, Lomberget T (January 2013). "A safe and practical method for the preparation of 7α-thioether and thioester derivatives of spironolactone". <i>Steroids</i>. <b>78</b> (1): 102–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.steroids.2012.09.005">10.1016/j.steroids.2012.09.005</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23063964">23063964</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8992318">8992318</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Steroids&rft.atitle=A+safe+and+practical+method+for+the+preparation+of+7%CE%B1-thioether+and+thioester+derivatives+of+spironolactone&rft.volume=78&rft.issue=1&rft.pages=102-7&rft.date=2013-01&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8992318%23id-name%3DS2CID&rft_id=info%3Apmid%2F23063964&rft_id=info%3Adoi%2F10.1016%2Fj.steroids.2012.09.005&rft.aulast=Agusti&rft.aufirst=G&rft.au=Bourgeois%2C+S&rft.au=Cartiser%2C+N&rft.au=Fessi%2C+H&rft.au=Le+Borgne%2C+M&rft.au=Lomberget%2C+T&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-CancerOrganization2001-186"><span class="mw-cite-backlink">^ <a href="#cite_ref-CancerOrganization2001_186-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CancerOrganization2001_186-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-CancerOrganization2001_186-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFInternational_Agency_for_Research_on_CancerWorld_Health_Organization2001" class="citation book cs1">International Agency for Research on Cancer, World Health Organization (2001). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=l965aqw_LSkC&pg=PA325"><i>Some Thyrotropic Agents</i></a>. World Health Organization. pp. 325–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-92-832-1279-9" title="Special:BookSources/978-92-832-1279-9"><bdi>978-92-832-1279-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094813/https://books.google.com/books?id=l965aqw_LSkC&pg=PA325">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Some+Thyrotropic+Agents&rft.pages=325-&rft.pub=World+Health+Organization&rft.date=2001&rft.isbn=978-92-832-1279-9&rft.au=International+Agency+for+Research+on+Cancer&rft.au=World+Health+Organization&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dl965aqw_LSkC%26pg%3DPA325&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-GinésArroyo2008-187"><span class="mw-cite-backlink"><b><a href="#cite_ref-GinésArroyo2008_187-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGinésArroyoRodésSchrier2008" class="citation book cs1">Ginés P, Arroyo V, Rodés J, Schrier RW (15 April 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=Z3PARx4oYDgC&pg=PA231"><i>Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment</i></a>. John Wiley & Sons. pp. 229, 231. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4051-4370-7" title="Special:BookSources/978-1-4051-4370-7"><bdi>978-1-4051-4370-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007092802/https://books.google.com/books?id=Z3PARx4oYDgC&pg=PA231">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 May</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Ascites+and+Renal+Dysfunction+in+Liver+Disease%3A+Pathogenesis%2C+Diagnosis%2C+and+Treatment&rft.pages=229%2C+231&rft.pub=John+Wiley+%26+Sons&rft.date=2008-04-15&rft.isbn=978-1-4051-4370-7&rft.aulast=Gin%C3%A9s&rft.aufirst=P&rft.au=Arroyo%2C+V&rft.au=Rod%C3%A9s%2C+J&rft.au=Schrier%2C+RW&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DZ3PARx4oYDgC%26pg%3DPA231&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Feldman2008-188"><span class="mw-cite-backlink"><b><a href="#cite_ref-Feldman2008_188-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFFeldman2008" class="citation book cs1">Feldman AM (15 April 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=6IfumyQQ35wC&pg=PA89"><i>Heart Failure: Pharmacologic Management</i></a>. John Wiley & Sons. pp. 89–103. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4051-7253-0" title="Special:BookSources/978-1-4051-7253-0"><bdi>978-1-4051-7253-0</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094310/https://books.google.com/books?id=6IfumyQQ35wC&pg=PA89">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">13 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Heart+Failure%3A+Pharmacologic+Management&rft.pages=89-103&rft.pub=John+Wiley+%26+Sons&rft.date=2008-04-15&rft.isbn=978-1-4051-7253-0&rft.aulast=Feldman&rft.aufirst=AM&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D6IfumyQQ35wC%26pg%3DPA89&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Health2015-189"><span class="mw-cite-backlink"><b><a href="#cite_ref-Health2015_189-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWalar2015" class="citation book cs1">Walar K (15 June 2015). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=AK1fDwAAQBAJ&pg=PA248"><i>Pharmacology</i></a> (6th ed.). Wolter Kluwer Health. pp. 248–249. GGKEY:N57K51AQ0UA.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pharmacology&rft.pages=248-249&rft.edition=6th&rft.pub=Wolter+Kluwer+Health&rft.date=2015-06-15&rft.aulast=Walar&rft.aufirst=K&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DAK1fDwAAQBAJ%26pg%3DPA248&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title=" Dead link tagged January 2023">permanent dead link</span></a></i><span style="visibility:hidden; color:transparent; padding-left:2px">‍</span>]</span></sup></span> </li> <li id="cite_note-pmid24456327-190"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid24456327_190-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTamargoSeguraRuilope2014" class="citation journal cs1">Tamargo J, Segura J, Ruilope LM (April 2014). "Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents". <i>Expert Opinion on Pharmacotherapy</i>. <b>15</b> (5): 605–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1517%2F14656566.2014.879117">10.1517/14656566.2014.879117</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24456327">24456327</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:2338377">2338377</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Expert+Opinion+on+Pharmacotherapy&rft.atitle=Diuretics+in+the+treatment+of+hypertension.+Part+2%3A+loop+diuretics+and+potassium-sparing+agents&rft.volume=15&rft.issue=5&rft.pages=605-21&rft.date=2014-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2338377%23id-name%3DS2CID&rft_id=info%3Apmid%2F24456327&rft_id=info%3Adoi%2F10.1517%2F14656566.2014.879117&rft.aulast=Tamargo&rft.aufirst=J&rft.au=Segura%2C+J&rft.au=Ruilope%2C+LM&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid11322868-191"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid11322868_191-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11322868_191-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid11322868_191-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDoggrellBrown2001" class="citation journal cs1">Doggrell SA, Brown L (May 2001). "The spironolactone renaissance". <i>Expert Opinion on Investigational Drugs</i>. <b>10</b> (5): 943–54. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1517%2F13543784.10.5.943">10.1517/13543784.10.5.943</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11322868">11322868</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39820875">39820875</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Expert+Opinion+on+Investigational+Drugs&rft.atitle=The+spironolactone+renaissance&rft.volume=10&rft.issue=5&rft.pages=943-54&rft.date=2001-05&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39820875%23id-name%3DS2CID&rft_id=info%3Apmid%2F11322868&rft_id=info%3Adoi%2F10.1517%2F13543784.10.5.943&rft.aulast=Doggrell&rft.aufirst=SA&rft.au=Brown%2C+L&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-StraussIII2013-192"><span class="mw-cite-backlink"><b><a href="#cite_ref-StraussIII2013_192-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFStrauss_IIIBarbieri2013" class="citation book cs1">Strauss III JF, Barbieri RL (13 September 2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=KZ95AAAAQBAJ&pg=PA237"><i>Yen and Jaffe's Reproductive Endocrinology</i></a>. Elsevier Health Sciences. pp. 237–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4557-2758-2" title="Special:BookSources/978-1-4557-2758-2"><bdi>978-1-4557-2758-2</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094311/https://books.google.com/books?id=KZ95AAAAQBAJ&pg=PA237">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">13 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Yen+and+Jaffe%27s+Reproductive+Endocrinology&rft.pages=237-&rft.pub=Elsevier+Health+Sciences&rft.date=2013-09-13&rft.isbn=978-1-4557-2758-2&rft.aulast=Strauss+III&rft.aufirst=JF&rft.au=Barbieri%2C+RL&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DKZ95AAAAQBAJ%26pg%3DPA237&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid2941190-193"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2941190_193-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTremblay1986" class="citation journal cs1">Tremblay RR (May 1986). "Treatment of hirsutism with spironolactone". <i>Clinics in Endocrinology and Metabolism</i>. <b>15</b> (2): 363–71. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0300-595X%2886%2980030-5">10.1016/S0300-595X(86)80030-5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2941190">2941190</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinics+in+Endocrinology+and+Metabolism&rft.atitle=Treatment+of+hirsutism+with+spironolactone&rft.volume=15&rft.issue=2&rft.pages=363-71&rft.date=1986-05&rft_id=info%3Adoi%2F10.1016%2FS0300-595X%2886%2980030-5&rft_id=info%3Apmid%2F2941190&rft.aulast=Tremblay&rft.aufirst=RR&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-GregoryTravis2015-194"><span class="mw-cite-backlink"><b><a href="#cite_ref-GregoryTravis2015_194-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHaffTriplett2015" class="citation book cs1">Haff GG, Triplett NT (23 September 2015). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=bfuXCgAAQBAJ&pg=PA76"><i>Essentials of Strength Training and Conditioning 4th Edition</i></a>. Human Kinetics. pp. 76–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4925-0162-6" title="Special:BookSources/978-1-4925-0162-6"><bdi>978-1-4925-0162-6</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094311/https://books.google.com/books?id=bfuXCgAAQBAJ&pg=PA76">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">14 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Essentials+of+Strength+Training+and+Conditioning+4th+Edition&rft.pages=76-&rft.pub=Human+Kinetics&rft.date=2015-09-23&rft.isbn=978-1-4925-0162-6&rft.aulast=Haff&rft.aufirst=GG&rft.au=Triplett%2C+NT&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DbfuXCgAAQBAJ%26pg%3DPA76&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Wu2012-195"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wu2012_195-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wu2012_195-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWu2012" class="citation book cs1">Wu JJ (18 October 2012). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=Tqpsm5WKKlcC&pg=PA364"><i>Comprehensive Dermatologic Drug Therapy E-Book</i></a>. Elsevier Health Sciences. pp. 364–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4557-3801-4" title="Special:BookSources/978-1-4557-3801-4"><bdi>978-1-4557-3801-4</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007093304/https://books.google.com/books?id=Tqpsm5WKKlcC&pg=PA364">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 May</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Comprehensive+Dermatologic+Drug+Therapy+E-Book&rft.pages=364-&rft.pub=Elsevier+Health+Sciences&rft.date=2012-10-18&rft.isbn=978-1-4557-3801-4&rft.aulast=Wu&rft.aufirst=JJ&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DTqpsm5WKKlcC%26pg%3DPA364&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-BenniVemer1990-196"><span class="mw-cite-backlink"><b><a href="#cite_ref-BenniVemer1990_196-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCoelingh_BenniVemer1990" class="citation book cs1">Coelingh Benni HJ, Vemer HM (15 December 1990). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=q6zqFrCLUoIC&pg=PA152"><i>Chronic Hyperandrogenic Anovulation</i></a>. CRC Press. pp. 152–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-85070-322-8" title="Special:BookSources/978-1-85070-322-8"><bdi>978-1-85070-322-8</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094812/https://books.google.com/books?id=q6zqFrCLUoIC&pg=PA152">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Chronic+Hyperandrogenic+Anovulation&rft.pages=152-&rft.pub=CRC+Press&rft.date=1990-12-15&rft.isbn=978-1-85070-322-8&rft.aulast=Coelingh+Benni&rft.aufirst=HJ&rft.au=Vemer%2C+HM&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dq6zqFrCLUoIC%26pg%3DPA152&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid8915726-197"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8915726_197-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFShaw1996" class="citation journal cs1">Shaw JC (November 1996). "Antiandrogen therapy in dermatology". <i>International Journal of Dermatology</i>. <b>35</b> (11): 770–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-4362.1996.tb02970.x">10.1111/j.1365-4362.1996.tb02970.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8915726">8915726</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39334280">39334280</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Dermatology&rft.atitle=Antiandrogen+therapy+in+dermatology&rft.volume=35&rft.issue=11&rft.pages=770-8&rft.date=1996-11&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39334280%23id-name%3DS2CID&rft_id=info%3Apmid%2F8915726&rft_id=info%3Adoi%2F10.1111%2Fj.1365-4362.1996.tb02970.x&rft.aulast=Shaw&rft.aufirst=JC&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid6786868-198"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid6786868_198-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid6786868_198-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid6786868_198-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFColby1981" class="citation journal cs1">Colby HD (April 1981). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1568425">"Chemical suppression of steroidogenesis"</a>. <i>Environmental Health Perspectives</i>. <b>38</b>: 119–27. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1981EnvHP..38..119C">1981EnvHP..38..119C</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1289%2Fehp.8138119">10.1289/ehp.8138119</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1568425">1568425</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6786868">6786868</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Environmental+Health+Perspectives&rft.atitle=Chemical+suppression+of+steroidogenesis&rft.volume=38&rft.pages=119-27&rft.date=1981-04&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1568425%23id-name%3DPMC&rft_id=info%3Apmid%2F6786868&rft_id=info%3Adoi%2F10.1289%2Fehp.8138119&rft_id=info%3Abibcode%2F1981EnvHP..38..119C&rft.aulast=Colby&rft.aufirst=HD&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1568425&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid26001184-199"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid26001184_199-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRoccaVenturellaMocciaroDi_Cello2015" class="citation journal cs1">Rocca ML, Venturella R, Mocciaro R, Di Cello A, Sacchinelli A, Russo V, et al. (June 2015). "Polycystic ovary syndrome: chemical pharmacotherapy". <i>Expert Opinion on Pharmacotherapy</i>. <b>16</b> (9): 1369–93. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1517%2F14656566.2015.1047344">10.1517/14656566.2015.1047344</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26001184">26001184</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:43770017">43770017</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Expert+Opinion+on+Pharmacotherapy&rft.atitle=Polycystic+ovary+syndrome%3A+chemical+pharmacotherapy&rft.volume=16&rft.issue=9&rft.pages=1369-93&rft.date=2015-06&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43770017%23id-name%3DS2CID&rft_id=info%3Apmid%2F26001184&rft_id=info%3Adoi%2F10.1517%2F14656566.2015.1047344&rft.aulast=Rocca&rft.aufirst=ML&rft.au=Venturella%2C+R&rft.au=Mocciaro%2C+R&rft.au=Di+Cello%2C+A&rft.au=Sacchinelli%2C+A&rft.au=Russo%2C+V&rft.au=Trapasso%2C+S&rft.au=Zullo%2C+F&rft.au=Morelli%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid18819053-200"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18819053_200-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYeYamashitaPollockSasano2009" class="citation journal cs1">Ye P, Yamashita T, Pollock DM, Sasano H, Rainey WE (January 2009). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277847">"Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis"</a>. <i>Hormone and Metabolic Research</i>. <b>41</b> (1): 35–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1055%2Fs-0028-1087188">10.1055/s-0028-1087188</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277847">4277847</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18819053">18819053</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Hormone+and+Metabolic+Research&rft.atitle=Contrasting+effects+of+eplerenone+and+spironolactone+on+adrenal+cell+steroidogenesis&rft.volume=41&rft.issue=1&rft.pages=35-9&rft.date=2009-01&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4277847%23id-name%3DPMC&rft_id=info%3Apmid%2F18819053&rft_id=info%3Adoi%2F10.1055%2Fs-0028-1087188&rft.aulast=Ye&rft.aufirst=P&rft.au=Yamashita%2C+T&rft.au=Pollock%2C+DM&rft.au=Sasano%2C+H&rft.au=Rainey%2C+WE&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4277847&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-WattsFaingold2009-201"><span class="mw-cite-backlink"><b><a href="#cite_ref-WattsFaingold2009_201-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWattsFaingoldDunawayCrespo2009" class="citation book cs1">Watts S, Faingold C, Dunaway G, Crespo L (1 April 2009). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=kfsrz_-OrMQC&pg=PA472"><i>Brody's Human Pharmacology - E-Book</i></a>. Elsevier Health Sciences. pp. 472–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-323-07575-6" title="Special:BookSources/978-0-323-07575-6"><bdi>978-0-323-07575-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Brody%27s+Human+Pharmacology+-+E-Book&rft.pages=472-&rft.pub=Elsevier+Health+Sciences&rft.date=2009-04-01&rft.isbn=978-0-323-07575-6&rft.aulast=Watts&rft.aufirst=S&rft.au=Faingold%2C+C&rft.au=Dunaway%2C+G&rft.au=Crespo%2C+L&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dkfsrz_-OrMQC%26pg%3DPA472&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid12477487-202"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid12477487_202-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12477487_202-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSatohItohSekiItoh2002" class="citation journal cs1">Satoh T, Itoh S, Seki T, Itoh S, Nomura N, Yoshizawa I (October 2002). "On the inhibitory action of 29 drugs having side effect gynecomastia on estrogen production". <i>The Journal of Steroid Biochemistry and Molecular Biology</i>. <b>82</b> (2–3): 209–16. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0960-0760%2802%2900154-1">10.1016/S0960-0760(02)00154-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12477487">12477487</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:9972497">9972497</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Steroid+Biochemistry+and+Molecular+Biology&rft.atitle=On+the+inhibitory+action+of+29+drugs+having+side+effect+gynecomastia+on+estrogen+production&rft.volume=82&rft.issue=2%E2%80%933&rft.pages=209-16&rft.date=2002-10&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A9972497%23id-name%3DS2CID&rft_id=info%3Apmid%2F12477487&rft_id=info%3Adoi%2F10.1016%2FS0960-0760%2802%2900154-1&rft.aulast=Satoh&rft.aufirst=T&rft.au=Itoh%2C+S&rft.au=Seki%2C+T&rft.au=Itoh%2C+S&rft.au=Nomura%2C+N&rft.au=Yoshizawa%2C+I&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid907238-203"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid907238_203-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRoseUnderwoodNewmarkKisch1977" class="citation journal cs1">Rose LI, Underwood RH, Newmark SR, Kisch ES, Williams GH (October 1977). "Pathophysiology of spironolactone-induced gynecomastia". <i>Annals of Internal Medicine</i>. <b>87</b> (4): 398–403. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.7326%2F0003-4819-87-4-398">10.7326/0003-4819-87-4-398</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/907238">907238</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annals+of+Internal+Medicine&rft.atitle=Pathophysiology+of+spironolactone-induced+gynecomastia&rft.volume=87&rft.issue=4&rft.pages=398-403&rft.date=1977-10&rft_id=info%3Adoi%2F10.7326%2F0003-4819-87-4-398&rft_id=info%3Apmid%2F907238&rft.aulast=Rose&rft.aufirst=LI&rft.au=Underwood%2C+RH&rft.au=Newmark%2C+SR&rft.au=Kisch%2C+ES&rft.au=Williams%2C+GH&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid12570693-204"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12570693_204-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPoirier2003" class="citation journal cs1">Poirier D (March 2003). "Inhibitors of 17 beta-hydroxysteroid dehydrogenases". <i>Current Medicinal Chemistry</i>. <b>10</b> (6): 453–77. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F0929867033368222">10.2174/0929867033368222</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12570693">12570693</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Current+Medicinal+Chemistry&rft.atitle=Inhibitors+of+17+beta-hydroxysteroid+dehydrogenases&rft.volume=10&rft.issue=6&rft.pages=453-77&rft.date=2003-03&rft_id=info%3Adoi%2F10.2174%2F0929867033368222&rft_id=info%3Apmid%2F12570693&rft.aulast=Poirier&rft.aufirst=D&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid19601747-205"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19601747_205-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPoirier2009" class="citation journal cs1">Poirier D (July 2009). "Advances in development of inhibitors of 17beta hydroxysteroid dehydrogenases". <i>Anti-Cancer Agents in Medicinal Chemistry</i>. <b>9</b> (6): 642–60. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F187152009788680000">10.2174/187152009788680000</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19601747">19601747</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Anti-Cancer+Agents+in+Medicinal+Chemistry&rft.atitle=Advances+in+development+of+inhibitors+of+17beta+hydroxysteroid+dehydrogenases&rft.volume=9&rft.issue=6&rft.pages=642-60&rft.date=2009-07&rft_id=info%3Adoi%2F10.2174%2F187152009788680000&rft_id=info%3Apmid%2F19601747&rft.aulast=Poirier&rft.aufirst=D&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid24189467-206"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid24189467_206-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBiggarAndersenWohlfahrtMelbye2013" class="citation journal cs1">Biggar RJ, Andersen EW, Wohlfahrt J, Melbye M (December 2013). "Spironolactone use and the risk of breast and gynecologic cancers". <i>Cancer Epidemiology</i>. <b>37</b> (6): 870–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.canep.2013.10.004">10.1016/j.canep.2013.10.004</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24189467">24189467</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Cancer+Epidemiology&rft.atitle=Spironolactone+use+and+the+risk+of+breast+and+gynecologic+cancers&rft.volume=37&rft.issue=6&rft.pages=870-5&rft.date=2013-12&rft_id=info%3Adoi%2F10.1016%2Fj.canep.2013.10.004&rft_id=info%3Apmid%2F24189467&rft.aulast=Biggar&rft.aufirst=RJ&rft.au=Andersen%2C+EW&rft.au=Wohlfahrt%2C+J&rft.au=Melbye%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid26230882-207"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid26230882_207-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSoubhyeAlardvan_AntwerpenDufrasne2015" class="citation journal cs1">Soubhye J, Alard IC, van Antwerpen P, Dufrasne F (2015). "Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis". <i>Future Medicinal Chemistry</i>. <b>7</b> (11): 1431–56. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4155%2Ffmc.15.74">10.4155/fmc.15.74</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26230882">26230882</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Future+Medicinal+Chemistry&rft.atitle=Type+2+17-%CE%B2+hydroxysteroid+dehydrogenase+as+a+novel+target+for+the+treatment+of+osteoporosis&rft.volume=7&rft.issue=11&rft.pages=1431-56&rft.date=2015&rft_id=info%3Adoi%2F10.4155%2Ffmc.15.74&rft_id=info%3Apmid%2F26230882&rft.aulast=Soubhye&rft.aufirst=J&rft.au=Alard%2C+IC&rft.au=van+Antwerpen%2C+P&rft.au=Dufrasne%2C+F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Adams2014-208"><span class="mw-cite-backlink"><b><a href="#cite_ref-Adams2014_208-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAdams2014" class="citation book cs1">Adams KF (28 October 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=KNWlBAAAQBAJ&pg=PA562"><i>Pharmacologic Approaches to Heart Failure, An Issue of Heart Failure Clinics, E-Book</i></a>. Elsevier Health Sciences. pp. 562–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-323-32612-4" title="Special:BookSources/978-0-323-32612-4"><bdi>978-0-323-32612-4</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094813/https://books.google.com/books?id=KNWlBAAAQBAJ&pg=PA562">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">13 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pharmacologic+Approaches+to+Heart+Failure%2C+An+Issue+of+Heart+Failure+Clinics%2C+E-Book&rft.pages=562-&rft.pub=Elsevier+Health+Sciences&rft.date=2014-10-28&rft.isbn=978-0-323-32612-4&rft.aulast=Adams&rft.aufirst=KF&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DKNWlBAAAQBAJ%26pg%3DPA562&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid22836869-209"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22836869_209-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22836869_209-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBerardelliKaramouzisD'AngeloZichi2013" class="citation journal cs1">Berardelli R, Karamouzis I, D'Angelo V, Zichi C, Fussotto B, Giordano R, et al. (February 2013). "Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans". <i>Endocrine</i>. <b>43</b> (1): 51–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs12020-012-9750-8">10.1007/s12020-012-9750-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22836869">22836869</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34916537">34916537</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Endocrine&rft.atitle=Role+of+mineralocorticoid+receptors+on+the+hypothalamus-pituitary-adrenal+axis+in+humans&rft.volume=43&rft.issue=1&rft.pages=51-8&rft.date=2013-02&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34916537%23id-name%3DS2CID&rft_id=info%3Apmid%2F22836869&rft_id=info%3Adoi%2F10.1007%2Fs12020-012-9750-8&rft.aulast=Berardelli&rft.aufirst=R&rft.au=Karamouzis%2C+I&rft.au=D%27Angelo%2C+V&rft.au=Zichi%2C+C&rft.au=Fussotto%2C+B&rft.au=Giordano%2C+R&rft.au=Ghigo%2C+E&rft.au=Arvat%2C+E&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid17035932-210"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17035932_210-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17035932_210-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOtteMoritzYassouridisKoop2007" class="citation journal cs1">Otte C, Moritz S, Yassouridis A, Koop M, Madrischewski AM, Wiedemann K, et al. (January 2007). <a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fsj.npp.1301217">"Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition"</a>. <i>Neuropsychopharmacology</i>. <b>32</b> (1): 232–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fsj.npp.1301217">10.1038/sj.npp.1301217</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17035932">17035932</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:10624783">10624783</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Neuropsychopharmacology&rft.atitle=Blockade+of+the+mineralocorticoid+receptor+in+healthy+men%3A+effects+on+experimentally+induced+panic+symptoms%2C+stress+hormones%2C+and+cognition&rft.volume=32&rft.issue=1&rft.pages=232-8&rft.date=2007-01&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A10624783%23id-name%3DS2CID&rft_id=info%3Apmid%2F17035932&rft_id=info%3Adoi%2F10.1038%2Fsj.npp.1301217&rft.aulast=Otte&rft.aufirst=C&rft.au=Moritz%2C+S&rft.au=Yassouridis%2C+A&rft.au=Koop%2C+M&rft.au=Madrischewski%2C+AM&rft.au=Wiedemann%2C+K&rft.au=Kellner%2C+M&rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fsj.npp.1301217&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid27519144-211"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27519144_211-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHinkelmannHellmann-RegenWingenfeldKuehl2016" class="citation journal cs1">Hinkelmann K, Hellmann-Regen J, Wingenfeld K, Kuehl LK, Mews M, Fleischer J, et al. (November 2016). "Mineralocorticoid receptor function in depressed patients and healthy individuals". <i>Progress in Neuro-Psychopharmacology & Biological Psychiatry</i>. <b>71</b>: 183–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.pnpbp.2016.08.003">10.1016/j.pnpbp.2016.08.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27519144">27519144</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4775178">4775178</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Progress+in+Neuro-Psychopharmacology+%26+Biological+Psychiatry&rft.atitle=Mineralocorticoid+receptor+function+in+depressed+patients+and+healthy+individuals&rft.volume=71&rft.pages=183-8&rft.date=2016-11&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4775178%23id-name%3DS2CID&rft_id=info%3Apmid%2F27519144&rft_id=info%3Adoi%2F10.1016%2Fj.pnpbp.2016.08.003&rft.aulast=Hinkelmann&rft.aufirst=K&rft.au=Hellmann-Regen%2C+J&rft.au=Wingenfeld%2C+K&rft.au=Kuehl%2C+LK&rft.au=Mews%2C+M&rft.au=Fleischer%2C+J&rft.au=Heuser%2C+I&rft.au=Otte%2C+C&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-FalconeHurd2007-212"><span class="mw-cite-backlink"><b><a href="#cite_ref-FalconeHurd2007_212-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFFalconeHurd2007" class="citation book cs1">Falcone T, Hurd WW (1 January 2007). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=fOPtaEIKvcIC&pg=PA271"><i>Clinical Reproductive Medicine and Surgery</i></a>. Elsevier Health Sciences. pp. 271–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-323-03309-1" title="Special:BookSources/978-0-323-03309-1"><bdi>978-0-323-03309-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094813/https://books.google.com/books?id=fOPtaEIKvcIC&pg=PA271">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">13 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Clinical+Reproductive+Medicine+and+Surgery&rft.pages=271-&rft.pub=Elsevier+Health+Sciences&rft.date=2007-01-01&rft.isbn=978-0-323-03309-1&rft.aulast=Falcone&rft.aufirst=T&rft.au=Hurd%2C+WW&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DfOPtaEIKvcIC%26pg%3DPA271&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid628197-213"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid628197_213-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAbshagenSpörlL'age1978" class="citation journal cs1">Abshagen U, Spörl S, L'age M (February 1978). "Non-interaction of spironolactone medication and cortisol metabolism in man". <i>Klinische Wochenschrift</i>. <b>56</b> (3): 135–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2FBF01478568">10.1007/BF01478568</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/628197">628197</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:30885047">30885047</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Klinische+Wochenschrift&rft.atitle=Non-interaction+of+spironolactone+medication+and+cortisol+metabolism+in+man&rft.volume=56&rft.issue=3&rft.pages=135-8&rft.date=1978-02&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A30885047%23id-name%3DS2CID&rft_id=info%3Apmid%2F628197&rft_id=info%3Adoi%2F10.1007%2FBF01478568&rft.aulast=Abshagen&rft.aufirst=U&rft.au=Sp%C3%B6rl%2C+S&rft.au=L%27age%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid21095280-214"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21095280_214-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYamajiTsutamotoKawaharaNishiyama2010" class="citation journal cs1">Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, et al. (November 2010). "Effect of eplerenone versus spironolactone on cortisol and hemoglobin A<sub>1</sub>(c) levels in patients with chronic heart failure". <i>American Heart Journal</i>. <b>160</b> (5): 915–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ahj.2010.04.024">10.1016/j.ahj.2010.04.024</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21095280">21095280</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Heart+Journal&rft.atitle=Effect+of+eplerenone+versus+spironolactone+on+cortisol+and+hemoglobin+A%3Csub%3E1%3C%2Fsub%3E%28c%29+levels+in+patients+with+chronic+heart+failure&rft.volume=160&rft.issue=5&rft.pages=915-21&rft.date=2010-11&rft_id=info%3Adoi%2F10.1016%2Fj.ahj.2010.04.024&rft_id=info%3Apmid%2F21095280&rft.aulast=Yamaji&rft.aufirst=M&rft.au=Tsutamoto%2C+T&rft.au=Kawahara%2C+C&rft.au=Nishiyama%2C+K&rft.au=Yamamoto%2C+T&rft.au=Fujii%2C+M&rft.au=Horie%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-KuntzKuntz2009-215"><span class="mw-cite-backlink"><b><a href="#cite_ref-KuntzKuntz2009_215-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKuntzKuntz2009" class="citation book cs1">Kuntz E, Kuntz HD (11 March 2009). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=oL6d9KuVqLQC&pg=PA312"><i>Hepatology: Textbook and Atlas</i></a>. Springer Science & Business Media. pp. 312–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-540-76839-5" title="Special:BookSources/978-3-540-76839-5"><bdi>978-3-540-76839-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094813/https://books.google.com/books?id=oL6d9KuVqLQC&pg=PA312">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">13 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Hepatology%3A+Textbook+and+Atlas&rft.pages=312-&rft.pub=Springer+Science+%26+Business+Media&rft.date=2009-03-11&rft.isbn=978-3-540-76839-5&rft.aulast=Kuntz&rft.aufirst=E&rft.au=Kuntz%2C+HD&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DoL6d9KuVqLQC%26pg%3DPA312&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-MelmedPolonsky2011-216"><span class="mw-cite-backlink"><b><a href="#cite_ref-MelmedPolonsky2011_216-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMelmedPolonskyLarsenKronenberg2011" class="citation book cs1">Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (12 May 2011). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=nbg1QOAObicC&pg=PA571"><i>Williams Textbook of Endocrinology E-Book</i></a>. Elsevier Health Sciences. pp. 571–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4377-3600-7" title="Special:BookSources/978-1-4377-3600-7"><bdi>978-1-4377-3600-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Williams+Textbook+of+Endocrinology+E-Book&rft.pages=571-&rft.pub=Elsevier+Health+Sciences&rft.date=2011-05-12&rft.isbn=978-1-4377-3600-7&rft.aulast=Melmed&rft.aufirst=S&rft.au=Polonsky%2C+KS&rft.au=Larsen%2C+PR&rft.au=Kronenberg%2C+HM&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dnbg1QOAObicC%26pg%3DPA571&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid12372848-217"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12372848_217-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKliewerGoodwinWillson2002" class="citation journal cs1">Kliewer SA, Goodwin B, Willson TM (October 2002). <a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fer.2001-0038">"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism"</a>. <i>Endocrine Reviews</i>. <b>23</b> (5): 687–702. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fer.2001-0038">10.1210/er.2001-0038</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12372848">12372848</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Endocrine+Reviews&rft.atitle=The+nuclear+pregnane+X+receptor%3A+a+key+regulator+of+xenobiotic+metabolism&rft.volume=23&rft.issue=5&rft.pages=687-702&rft.date=2002-10&rft_id=info%3Adoi%2F10.1210%2Fer.2001-0038&rft_id=info%3Apmid%2F12372848&rft.aulast=Kliewer&rft.aufirst=SA&rft.au=Goodwin%2C+B&rft.au=Willson%2C+TM&rft_id=https%3A%2F%2Fdoi.org%2F10.1210%252Fer.2001-0038&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid27072668-218"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27072668_218-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSabbadinAndrisaniZermianiDonà2016" class="citation journal cs1">Sabbadin C, Andrisani A, Zermiani M, Donà G, Bordin L, Ragazzi E, et al. (September 2016). "Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI". <i>Journal of Endocrinological Investigation</i>. <b>39</b> (9): 1015–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40618-016-0466-0">10.1007/s40618-016-0466-0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27072668">27072668</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34201900">34201900</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Endocrinological+Investigation&rft.atitle=Spironolactone+and+intermenstrual+bleeding+in+polycystic+ovary+syndrome+with+normal+BMI&rft.volume=39&rft.issue=9&rft.pages=1015-21&rft.date=2016-09&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34201900%23id-name%3DS2CID&rft_id=info%3Apmid%2F27072668&rft_id=info%3Adoi%2F10.1007%2Fs40618-016-0466-0&rft.aulast=Sabbadin&rft.aufirst=C&rft.au=Andrisani%2C+A&rft.au=Zermiani%2C+M&rft.au=Don%C3%A0%2C+G&rft.au=Bordin%2C+L&rft.au=Ragazzi%2C+E&rft.au=Boscaro%2C+M&rft.au=Ambrosini%2C+G&rft.au=Armanini%2C+D&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Delyani2000-219"><span class="mw-cite-backlink"><b><a href="#cite_ref-Delyani2000_219-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDelyani2000" class="citation journal cs1">Delyani JA (April 2000). <a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1523-1755.2000.00983.x">"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology"</a>. <i>Kidney International</i>. <b>57</b> (4): 1408–11. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1523-1755.2000.00983.x">10.1046/j.1523-1755.2000.00983.x</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10760075">10760075</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Kidney+International&rft.atitle=Mineralocorticoid+receptor+antagonists%3A+the+evolution+of+utility+and+pharmacology&rft.volume=57&rft.issue=4&rft.pages=1408-11&rft.date=2000-04&rft_id=info%3Adoi%2F10.1046%2Fj.1523-1755.2000.00983.x&rft_id=info%3Apmid%2F10760075&rft.aulast=Delyani&rft.aufirst=JA&rft_id=https%3A%2F%2Fdoi.org%2F10.1046%252Fj.1523-1755.2000.00983.x&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid9727070-220"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9727070_220-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLehmannMcKeeWatsonWillson1998" class="citation journal cs1">Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA (September 1998). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC508967">"The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions"</a>. <i>The Journal of Clinical Investigation</i>. <b>102</b> (5): 1016–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1172%2FJCI3703">10.1172/JCI3703</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC508967">508967</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9727070">9727070</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+Investigation&rft.atitle=The+human+orphan+nuclear+receptor+PXR+is+activated+by+compounds+that+regulate+CYP3A4+gene+expression+and+cause+drug+interactions&rft.volume=102&rft.issue=5&rft.pages=1016-23&rft.date=1998-09&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC508967%23id-name%3DPMC&rft_id=info%3Apmid%2F9727070&rft_id=info%3Adoi%2F10.1172%2FJCI3703&rft.aulast=Lehmann&rft.aufirst=JM&rft.au=McKee%2C+DD&rft.au=Watson%2C+MA&rft.au=Willson%2C+TM&rft.au=Moore%2C+JT&rft.au=Kliewer%2C+SA&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC508967&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid363379-221"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid363379_221-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKarim1978" class="citation journal cs1">Karim A (1978). "Spironolactone: disposition, metabolism, pharmacodynamics, and bioavailability". <i>Drug Metabolism Reviews</i>. <b>8</b> (1): 151–88. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F03602537808993782">10.3109/03602537808993782</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/363379">363379</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Drug+Metabolism+Reviews&rft.atitle=Spironolactone%3A+disposition%2C+metabolism%2C+pharmacodynamics%2C+and+bioavailability&rft.volume=8&rft.issue=1&rft.pages=151-88&rft.date=1978&rft_id=info%3Adoi%2F10.3109%2F03602537808993782&rft_id=info%3Apmid%2F363379&rft.aulast=Karim&rft.aufirst=A&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid6369882-222"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid6369882_222-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBeermann1984" class="citation journal cs1">Beermann B (1984). "Aspects on pharmacokinetics of some diuretics". <i>Acta Pharmacologica et Toxicologica</i>. <b>54</b> (Suppl 1): 17–29. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1600-0773.1984.tb03626.x">10.1111/j.1600-0773.1984.tb03626.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6369882">6369882</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Acta+Pharmacologica+et+Toxicologica&rft.atitle=Aspects+on+pharmacokinetics+of+some+diuretics&rft.volume=54&rft.issue=Suppl+1&rft.pages=17-29&rft.date=1984&rft_id=info%3Adoi%2F10.1111%2Fj.1600-0773.1984.tb03626.x&rft_id=info%3Apmid%2F6369882&rft.aulast=Beermann&rft.aufirst=B&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid3333882-223"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3333882_223-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOverdiekMerkus1987" class="citation journal cs1">Overdiek HW, Merkus FW (1987). "The metabolism and biopharmaceutics of spironolactone in man". <i>Reviews on Drug Metabolism and Drug Interactions</i>. <b>5</b> (4): 273–302. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1515%2FDMDI.1987.5.4.273">10.1515/DMDI.1987.5.4.273</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/3333882">3333882</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:29482256">29482256</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Reviews+on+Drug+Metabolism+and+Drug+Interactions&rft.atitle=The+metabolism+and+biopharmaceutics+of+spironolactone+in+man&rft.volume=5&rft.issue=4&rft.pages=273-302&rft.date=1987&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A29482256%23id-name%3DS2CID&rft_id=info%3Apmid%2F3333882&rft_id=info%3Adoi%2F10.1515%2FDMDI.1987.5.4.273&rft.aulast=Overdiek&rft.aufirst=HW&rft.au=Merkus%2C+FW&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid22099505-224"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22099505_224-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBrater2011" class="citation journal cs1">Brater DC (November 2011). "Update in diuretic therapy: clinical pharmacology". <i>Seminars in Nephrology</i>. <b>31</b> (6): 483–94. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.semnephrol.2011.09.003">10.1016/j.semnephrol.2011.09.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22099505">22099505</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Seminars+in+Nephrology&rft.atitle=Update+in+diuretic+therapy%3A+clinical+pharmacology&rft.volume=31&rft.issue=6&rft.pages=483-94&rft.date=2011-11&rft_id=info%3Adoi%2F10.1016%2Fj.semnephrol.2011.09.003&rft_id=info%3Apmid%2F22099505&rft.aulast=Brater&rft.aufirst=DC&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid21771637-225"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21771637_225-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKolkhofBorden2012" class="citation journal cs1">Kolkhof P, Borden SA (March 2012). "Molecular pharmacology of the mineralocorticoid receptor: prospects for novel therapeutics". <i>Molecular and Cellular Endocrinology</i>. <b>350</b> (2): 310–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mce.2011.06.025">10.1016/j.mce.2011.06.025</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21771637">21771637</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:36894459">36894459</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Molecular+and+Cellular+Endocrinology&rft.atitle=Molecular+pharmacology+of+the+mineralocorticoid+receptor%3A+prospects+for+novel+therapeutics&rft.volume=350&rft.issue=2&rft.pages=310-7&rft.date=2012-03&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A36894459%23id-name%3DS2CID&rft_id=info%3Apmid%2F21771637&rft_id=info%3Adoi%2F10.1016%2Fj.mce.2011.06.025&rft.aulast=Kolkhof&rft.aufirst=P&rft.au=Borden%2C+SA&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid26939027-226"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid26939027_226-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFYangYoung2016" class="citation journal cs1">Yang J, Young MJ (April 2016). "Mineralocorticoid receptor antagonists-pharmacodynamics and pharmacokinetic differences". <i>Current Opinion in Pharmacology</i>. <b>27</b>: 78–85. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.coph.2016.02.005">10.1016/j.coph.2016.02.005</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26939027">26939027</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Current+Opinion+in+Pharmacology&rft.atitle=Mineralocorticoid+receptor+antagonists-pharmacodynamics+and+pharmacokinetic+differences&rft.volume=27&rft.pages=78-85&rft.date=2016-04&rft_id=info%3Adoi%2F10.1016%2Fj.coph.2016.02.005&rft_id=info%3Apmid%2F26939027&rft.aulast=Yang&rft.aufirst=J&rft.au=Young%2C+MJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid27830348-227"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27830348_227-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKolkhofJaisserKimFilippatos2017" class="citation book cs1">Kolkhof P, Jaisser F, Kim SY, Filippatos G, Nowack C, Pitt B (2017). "Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside". <i>Heart Failure</i>. Handbook of Experimental Pharmacology. Vol. 243. Springer. pp. 271–305. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F164_2016_76">10.1007/164_2016_76</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-319-59658-7" title="Special:BookSources/978-3-319-59658-7"><bdi>978-3-319-59658-7</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27830348">27830348</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Steroidal+and+Novel+Non-steroidal+Mineralocorticoid+Receptor+Antagonists+in+Heart+Failure+and+Cardiorenal+Diseases%3A+Comparison+at+Bench+and+Bedside&rft.btitle=Heart+Failure&rft.series=Handbook+of+Experimental+Pharmacology&rft.pages=271-305&rft.pub=Springer&rft.date=2017&rft_id=info%3Apmid%2F27830348&rft_id=info%3Adoi%2F10.1007%2F164_2016_76&rft.isbn=978-3-319-59658-7&rft.aulast=Kolkhof&rft.aufirst=P&rft.au=Jaisser%2C+F&rft.au=Kim%2C+SY&rft.au=Filippatos%2C+G&rft.au=Nowack%2C+C&rft.au=Pitt%2C+B&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid8818057-228"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8818057_228-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFJankowskiSkorek-JankowskaLamparczyk1996" class="citation journal cs1">Jankowski A, Skorek-Jankowska A, Lamparczyk H (June 1996). "Simultaneous determination of spironolactone and its metabolites in human plasma". <i>Journal of Pharmaceutical and Biomedical Analysis</i>. <b>14</b> (8–10): 1359–65. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0731-7085%2896%2901767-0">10.1016/S0731-7085(96)01767-0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8818057">8818057</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Pharmaceutical+and+Biomedical+Analysis&rft.atitle=Simultaneous+determination+of+spironolactone+and+its+metabolites+in+human+plasma&rft.volume=14&rft.issue=8%E2%80%9310&rft.pages=1359-65&rft.date=1996-06&rft_id=info%3Adoi%2F10.1016%2FS0731-7085%2896%2901767-0&rft_id=info%3Apmid%2F8818057&rft.aulast=Jankowski&rft.aufirst=A&rft.au=Skorek-Jankowska%2C+A&rft.au=Lamparczyk%2C+H&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-DeinumRiksen2015-229"><span class="mw-cite-backlink">^ <a href="#cite_ref-DeinumRiksen2015_229-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DeinumRiksen2015_229-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDeinumRiksenLenders2015" class="citation journal cs1">Deinum J, Riksen NP, Lenders JW (October 2015). "Pharmacological treatment of aldosterone excess". <i>Pharmacology & Therapeutics</i>. <b>154</b>: 120–33. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.pharmthera.2015.07.006">10.1016/j.pharmthera.2015.07.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26213109">26213109</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Pharmacology+%26+Therapeutics&rft.atitle=Pharmacological+treatment+of+aldosterone+excess&rft.volume=154&rft.pages=120-33&rft.date=2015-10&rft_id=info%3Adoi%2F10.1016%2Fj.pharmthera.2015.07.006&rft_id=info%3Apmid%2F26213109&rft.aulast=Deinum&rft.aufirst=J&rft.au=Riksen%2C+NP&rft.au=Lenders%2C+JW&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid3769384-230"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3769384_230-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOverdiekMerkus1986" class="citation journal cs1">Overdiek HW, Merkus FW (November 1986). "Influence of food on the bioavailability of spironolactone". <i>Clinical Pharmacology and Therapeutics</i>. <b>40</b> (5): 531–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fclpt.1986.219">10.1038/clpt.1986.219</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/3769384">3769384</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32313529">32313529</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Pharmacology+and+Therapeutics&rft.atitle=Influence+of+food+on+the+bioavailability+of+spironolactone&rft.volume=40&rft.issue=5&rft.pages=531-6&rft.date=1986-11&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32313529%23id-name%3DS2CID&rft_id=info%3Apmid%2F3769384&rft_id=info%3Adoi%2F10.1038%2Fclpt.1986.219&rft.aulast=Overdiek&rft.aufirst=HW&rft.au=Merkus%2C+FW&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid872489-231"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid872489_231-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMelanderDanielsonSchersténThulin1977" class="citation journal cs1">Melander A, Danielson K, Scherstén B, Thulin T, Wåhlin E (July 1977). "Enhancement by food of canrenone bioavailability from spironolactone". <i>Clinical Pharmacology and Therapeutics</i>. <b>22</b> (1): 100–3. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fcpt1977221100">10.1002/cpt1977221100</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/872489">872489</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:12827850">12827850</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Pharmacology+and+Therapeutics&rft.atitle=Enhancement+by+food+of+canrenone+bioavailability+from+spironolactone&rft.volume=22&rft.issue=1&rft.pages=100-3&rft.date=1977-07&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A12827850%23id-name%3DS2CID&rft_id=info%3Apmid%2F872489&rft_id=info%3Adoi%2F10.1002%2Fcpt1977221100&rft.aulast=Melander&rft.aufirst=A&rft.au=Danielson%2C+K&rft.au=Scherst%C3%A9n%2C+B&rft.au=Thulin%2C+T&rft.au=W%C3%A5hlin%2C+E&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Saini-ChohanHatch2009-232"><span class="mw-cite-backlink"><b><a href="#cite_ref-Saini-ChohanHatch2009_232-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSaini-ChohanHatch2009" class="citation journal cs1">Saini-Chohan HK, Hatch GM (March 2009). "Biological actions and metabolism of currently used pharmacological agents for the treatment of congestive heart failure". <i>Current Drug Metabolism</i>. <b>10</b> (3): 206–19. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F138920009787846314">10.2174/138920009787846314</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19442083">19442083</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Current+Drug+Metabolism&rft.atitle=Biological+actions+and+metabolism+of+currently+used+pharmacological+agents+for+the+treatment+of+congestive+heart+failure&rft.volume=10&rft.issue=3&rft.pages=206-19&rft.date=2009-03&rft_id=info%3Adoi%2F10.2174%2F138920009787846314&rft_id=info%3Apmid%2F19442083&rft.aulast=Saini-Chohan&rft.aufirst=HK&rft.au=Hatch%2C+GM&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Al-HadiyaBelal2002-233"><span class="mw-cite-backlink"><b><a href="#cite_ref-Al-HadiyaBelal2002_233-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAl-HadiyaBelalAsiriGubara2002" class="citation journal cs1">Al-Hadiya BM, Belal F, Asiri YA, Gubara OA (2002). "Spironolactone". <i>Analytical Profiles of Drug Substances and Excipients</i>. <b>29</b>: 261–320. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1075-6280%2802%2929009-6">10.1016/S1075-6280(02)29009-6</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-12-260829-2" title="Special:BookSources/978-0-12-260829-2"><bdi>978-0-12-260829-2</bdi></a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1075-6280">1075-6280</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Analytical+Profiles+of+Drug+Substances+and+Excipients&rft.atitle=Spironolactone&rft.volume=29&rft.pages=261-320&rft.date=2002&rft.issn=1075-6280&rft_id=info%3Adoi%2F10.1016%2FS1075-6280%2802%2929009-6&rft.isbn=978-0-12-260829-2&rft.aulast=Al-Hadiya&rft.aufirst=BM&rft.au=Belal%2C+F&rft.au=Asiri%2C+YA&rft.au=Gubara%2C+OA&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Elsevier2019-234"><span class="mw-cite-backlink">^ <a href="#cite_ref-Elsevier2019_234-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Elsevier2019_234-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation book cs1"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=5daEDwAAQBAJ&pg=PA11"><i>Aldosterone</i></a>. Elsevier Science. 23 January 2019. pp. 11, 46. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-12-817783-9" title="Special:BookSources/978-0-12-817783-9"><bdi>978-0-12-817783-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094813/https://books.google.com/books?id=5daEDwAAQBAJ&pg=PA11">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 September</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Aldosterone&rft.pages=11%2C+46&rft.pub=Elsevier+Science&rft.date=2019-01-23&rft.isbn=978-0-12-817783-9&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D5daEDwAAQBAJ%26pg%3DPA11&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid3411088-235"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3411088_235-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFReyValterioLocatelliRamelet1988" class="citation journal cs1">Rey FO, Valterio C, Locatelli L, Ramelet AA, Felber JP (April 1988). "Lack of endocrine systemic side effects after topical application of spironolactone in man". <i>Journal of Endocrinological Investigation</i>. <b>11</b> (4): 273–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2FBF03350151">10.1007/BF03350151</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/3411088">3411088</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:30535049">30535049</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Endocrinological+Investigation&rft.atitle=Lack+of+endocrine+systemic+side+effects+after+topical+application+of+spironolactone+in+man&rft.volume=11&rft.issue=4&rft.pages=273-8&rft.date=1988-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A30535049%23id-name%3DS2CID&rft_id=info%3Apmid%2F3411088&rft_id=info%3Adoi%2F10.1007%2FBF03350151&rft.aulast=Rey&rft.aufirst=FO&rft.au=Valterio%2C+C&rft.au=Locatelli%2C+L&rft.au=Ramelet%2C+AA&rft.au=Felber%2C+JP&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid86546-236"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid86546_236-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRifkaPitaVigerskyWilson1978" class="citation journal cs1">Rifka SM, Pita JC, Vigersky RA, Wilson YA, Loriaux DL (February 1978). "Interaction of digitalis and spironolactone with human sex steroid receptors". <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>46</b> (2): 338–44. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjcem-46-2-338">10.1210/jcem-46-2-338</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/86546">86546</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=Interaction+of+digitalis+and+spironolactone+with+human+sex+steroid+receptors&rft.volume=46&rft.issue=2&rft.pages=338-44&rft.date=1978-02&rft_id=info%3Adoi%2F10.1210%2Fjcem-46-2-338&rft_id=info%3Apmid%2F86546&rft.aulast=Rifka&rft.aufirst=SM&rft.au=Pita%2C+JC&rft.au=Vigersky%2C+RA&rft.au=Wilson%2C+YA&rft.au=Loriaux%2C+DL&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid7195405-237"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7195405_237-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPugeatDunnNisula1981" class="citation journal cs1">Pugeat MM, Dunn JF, Nisula BC (July 1981). "Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma". <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>53</b> (1): 69–75. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjcem-53-1-69">10.1210/jcem-53-1-69</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7195405">7195405</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=Transport+of+steroid+hormones%3A+interaction+of+70+drugs+with+testosterone-binding+globulin+and+corticosteroid-binding+globulin+in+human+plasma&rft.volume=53&rft.issue=1&rft.pages=69-75&rft.date=1981-07&rft_id=info%3Adoi%2F10.1210%2Fjcem-53-1-69&rft_id=info%3Apmid%2F7195405&rft.aulast=Pugeat&rft.aufirst=MM&rft.au=Dunn%2C+JF&rft.au=Nisula%2C+BC&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid7189544-238"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7189544_238-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKaulhausenRohnerSiedekLafosse1980" class="citation journal cs1 cs1-prop-foreign-lang-source">Kaulhausen H, Rohner HG, Siedek M, Lafosse M, Breuer H (February 1980). "[Binding capacity of sex hormone binding globulin and corticosteroid binding globulin in serum of male patients with liver cirrhosis (author's transl)]". <i>Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie</i> (in German). <b>18</b> (2): 137–43. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7189544">7189544</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Clinical+Chemistry+and+Clinical+Biochemistry.+Zeitschrift+f%C3%BCr+klinische+Chemie+und+klinische+Biochemie&rft.atitle=%5BBinding+capacity+of+sex+hormone+binding+globulin+and+corticosteroid+binding+globulin+in+serum+of+male+patients+with+liver+cirrhosis+%28author%27s+transl%29%5D&rft.volume=18&rft.issue=2&rft.pages=137-43&rft.date=1980-02&rft_id=info%3Apmid%2F7189544&rft.aulast=Kaulhausen&rft.aufirst=H&rft.au=Rohner%2C+HG&rft.au=Siedek%2C+M&rft.au=Lafosse%2C+M&rft.au=Breuer%2C+H&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-BlandIII2009-239"><span class="mw-cite-backlink"><b><a href="#cite_ref-BlandIII2009_239-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBlandCopeland_III2009" class="citation book cs1">Bland KI, Copeland III EM (9 September 2009). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=1u4x_iGiHNEC&pg=PA161"><i>The Breast: Comprehensive Management of Benign and Malignant Diseases</i></a>. Elsevier Health Sciences. pp. 161–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4377-1121-9" title="Special:BookSources/978-1-4377-1121-9"><bdi>978-1-4377-1121-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094814/https://books.google.com/books?id=1u4x_iGiHNEC&pg=PA161">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">14 September</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=The+Breast%3A+Comprehensive+Management+of+Benign+and+Malignant+Diseases&rft.pages=161-&rft.pub=Elsevier+Health+Sciences&rft.date=2009-09-09&rft.isbn=978-1-4377-1121-9&rft.aulast=Bland&rft.aufirst=KI&rft.au=Copeland+III%2C+EM&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D1u4x_iGiHNEC%26pg%3DPA161&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid25376974-240"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid25376974_240-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMurckBüttnerKircherKonrad2014" class="citation journal cs1">Murck H, Büttner M, Kircher T, Konrad C (2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000368265">"Genetic, molecular and clinical determinants for the involvement of aldosterone and its receptors in major depression"</a>. <i>Nephron Physiology</i>. <b>128</b> (1–2): 17–25. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000368265">10.1159/000368265</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25376974">25376974</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19905165">19905165</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Nephron+Physiology&rft.atitle=Genetic%2C+molecular+and+clinical+determinants+for+the+involvement+of+aldosterone+and+its+receptors+in+major+depression&rft.volume=128&rft.issue=1%E2%80%932&rft.pages=17-25&rft.date=2014&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19905165%23id-name%3DS2CID&rft_id=info%3Apmid%2F25376974&rft_id=info%3Adoi%2F10.1159%2F000368265&rft.aulast=Murck&rft.aufirst=H&rft.au=B%C3%BCttner%2C+M&rft.au=Kircher%2C+T&rft.au=Konrad%2C+C&rft_id=https%3A%2F%2Fdoi.org%2F10.1159%252F000368265&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid22351473-241"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22351473_241-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKünzel2012" class="citation journal cs1">Künzel HE (March 2012). "Psychopathological symptoms in patients with primary hyperaldosteronism--possible pathways". <i>Hormone and Metabolic Research</i>. <b>44</b> (3): 202–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1055%2Fs-0032-1301921">10.1055/s-0032-1301921</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22351473">22351473</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23273751">23273751</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Hormone+and+Metabolic+Research&rft.atitle=Psychopathological+symptoms+in+patients+with+primary+hyperaldosteronism--possible+pathways&rft.volume=44&rft.issue=3&rft.pages=202-7&rft.date=2012-03&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23273751%23id-name%3DS2CID&rft_id=info%3Apmid%2F22351473&rft_id=info%3Adoi%2F10.1055%2Fs-0032-1301921&rft.aulast=K%C3%BCnzel&rft.aufirst=HE&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid1629288-242"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid1629288_242-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid1629288_242-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFVarinTuBenoîtVilleneuve1992" class="citation journal cs1">Varin F, Tu TM, Benoît F, Villeneuve JP, Théorêt Y (February 1992). "High-performance liquid chromatographic determination of spironolactone and its metabolites in human biological fluids after solid-phase extraction". <i>Journal of Chromatography</i>. <b>574</b> (1): 57–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0378-4347%2892%2980097-A">10.1016/0378-4347(92)80097-A</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/1629288">1629288</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Chromatography&rft.atitle=High-performance+liquid+chromatographic+determination+of+spironolactone+and+its+metabolites+in+human+biological+fluids+after+solid-phase+extraction&rft.volume=574&rft.issue=1&rft.pages=57-64&rft.date=1992-02&rft_id=info%3Adoi%2F10.1016%2F0378-4347%2892%2980097-A&rft_id=info%3Apmid%2F1629288&rft.aulast=Varin&rft.aufirst=F&rft.au=Tu%2C+TM&rft.au=Beno%C3%AEt%2C+F&rft.au=Villeneuve%2C+JP&rft.au=Th%C3%A9or%C3%AAt%2C+Y&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Oxford2003-243"><span class="mw-cite-backlink"><b><a href="#cite_ref-Oxford2003_243-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation book cs1"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=_s65U1n9Lf8C&pg=RA1-PA962"><i>Oxford Textbook of Medicine: Vol. 1</i></a>. Oxford University Press. 2003. pp. 1–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-19-262922-7" title="Special:BookSources/978-0-19-262922-7"><bdi>978-0-19-262922-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007094814/https://books.google.com/books?id=_s65U1n9Lf8C&pg=RA1-PA962">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Oxford+Textbook+of+Medicine%3A+Vol.+1&rft.pages=1-&rft.pub=Oxford+University+Press&rft.date=2003&rft.isbn=978-0-19-262922-7&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D_s65U1n9Lf8C%26pg%3DRA1-PA962&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-AnzenbacherZanger2012-244"><span class="mw-cite-backlink"><b><a href="#cite_ref-AnzenbacherZanger2012_244-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAnzenbacherZanger2012" class="citation book cs1">Anzenbacher P, Zanger UM (23 February 2012). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=f-XHh17NfwgC&pg=PA166"><i>Metabolism of Drugs and Other Xenobiotics</i></a>. John Wiley & Sons. pp. 166, 169. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-527-64632-6" title="Special:BookSources/978-3-527-64632-6"><bdi>978-3-527-64632-6</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095315/https://books.google.com/books?id=f-XHh17NfwgC&pg=PA166">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">12 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Metabolism+of+Drugs+and+Other+Xenobiotics&rft.pages=166%2C+169&rft.pub=John+Wiley+%26+Sons&rft.date=2012-02-23&rft.isbn=978-3-527-64632-6&rft.aulast=Anzenbacher&rft.aufirst=P&rft.au=Zanger%2C+UM&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Df-XHh17NfwgC%26pg%3DPA166&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-SmithPh.D.2014-245"><span class="mw-cite-backlink"><b><a href="#cite_ref-SmithPh.D.2014_245-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSmithSeawardSmith2014" class="citation book cs1">Smith BT, Seaward BL, Smith BT (1 November 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=7P-9BQAAQBAJ&pg=PA169"><i>Pharmacology for Nurses</i></a>. Jones & Bartlett Publishers. pp. 169–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4496-8940-7" title="Special:BookSources/978-1-4496-8940-7"><bdi>978-1-4496-8940-7</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095315/https://books.google.com/books?id=7P-9BQAAQBAJ&pg=PA169">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pharmacology+for+Nurses&rft.pages=169-&rft.pub=Jones+%26+Bartlett+Publishers&rft.date=2014-11-01&rft.isbn=978-1-4496-8940-7&rft.aulast=Smith&rft.aufirst=BT&rft.au=Seaward%2C+BL&rft.au=Smith%2C+BT&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D7P-9BQAAQBAJ%26pg%3DPA169&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Montellano2015-246"><span class="mw-cite-backlink"><b><a href="#cite_ref-Montellano2015_246-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOrtiz_de_Montellano2015" class="citation book cs1">Ortiz de Montellano PR (13 March 2015). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=abZnBwAAQBAJ&pg=PA867"><i>Cytochrome P450: Structure, Mechanism, and Biochemistry</i></a>. Springer. pp. 867–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-319-12108-6" title="Special:BookSources/978-3-319-12108-6"><bdi>978-3-319-12108-6</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095316/https://books.google.com/books?id=abZnBwAAQBAJ&pg=PA867">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">12 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Cytochrome+P450%3A+Structure%2C+Mechanism%2C+and+Biochemistry&rft.pages=867-&rft.pub=Springer&rft.date=2015-03-13&rft.isbn=978-3-319-12108-6&rft.aulast=Ortiz+de+Montellano&rft.aufirst=PR&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DabZnBwAAQBAJ%26pg%3DPA867&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-AcademicPress2012-247"><span class="mw-cite-backlink"><b><a href="#cite_ref-AcademicPress2012_247-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation book cs1"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=sC8h4KM0nmYC&pg=PA69"><i>Advances in Clinical Chemistry</i></a>. Academic Press. 31 December 2012. pp. 69–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-12-405852-1" title="Special:BookSources/978-0-12-405852-1"><bdi>978-0-12-405852-1</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Advances+in+Clinical+Chemistry&rft.pages=69-&rft.pub=Academic+Press&rft.date=2012-12-31&rft.isbn=978-0-12-405852-1&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DsC8h4KM0nmYC%26pg%3DPA69&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Brittain2002-248"><span class="mw-cite-backlink"><b><a href="#cite_ref-Brittain2002_248-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBrittain2002" class="citation book cs1">Brittain HG (26 November 2002). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=RMN5zMW64ZEC&pg=PA309"><i>Analytical Profiles of Drug Substances and Excipients</i></a>. Academic Press. p. 309. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-12-260829-2" title="Special:BookSources/978-0-12-260829-2"><bdi>978-0-12-260829-2</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130621104609/http://books.google.com/books?id=RMN5zMW64ZEC&pg=PA309">Archived</a> from the original on 21 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">27 May</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Analytical+Profiles+of+Drug+Substances+and+Excipients&rft.pages=309&rft.pub=Academic+Press&rft.date=2002-11-26&rft.isbn=978-0-12-260829-2&rft.aulast=Brittain&rft.aufirst=HG&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DRMN5zMW64ZEC%26pg%3DPA309&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-JamesonGroot2010-249"><span class="mw-cite-backlink">^ <a href="#cite_ref-JamesonGroot2010_249-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-JamesonGroot2010_249-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFJamesonDe_Groot2010" class="citation book cs1">Jameson JL, De Groot LJ (18 May 2010). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=W4dZ-URK8ZoC&pg=PA2401"><i>Endocrinology - E-Book: Adult and Pediatric</i></a>. Elsevier Health Sciences. pp. 2401–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4557-1126-0" title="Special:BookSources/978-1-4557-1126-0"><bdi>978-1-4557-1126-0</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Endocrinology+-+E-Book%3A+Adult+and+Pediatric&rft.pages=2401-&rft.pub=Elsevier+Health+Sciences&rft.date=2010-05-18&rft.isbn=978-1-4557-1126-0&rft.aulast=Jameson&rft.aufirst=JL&rft.au=De+Groot%2C+LJ&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DW4dZ-URK8ZoC%26pg%3DPA2401&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Elks2014-250"><span class="mw-cite-backlink">^ <a href="#cite_ref-Elks2014_250-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Elks2014_250-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Elks2014_250-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Elks2014_250-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFElks2014" class="citation book cs1">Elks J (14 November 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA1111"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</i></a>. Springer. p. 1111. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4757-2085-3" title="Special:BookSources/978-1-4757-2085-3"><bdi>978-1-4757-2085-3</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170215024945/https://books.google.com/books?id=0vXTBwAAQBAJ">Archived</a> from the original on 15 February 2017.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=The+Dictionary+of+Drugs%3A+Chemical+Data%3A+Chemical+Data%2C+Structures+and+Bibliographies&rft.pages=1111&rft.pub=Springer&rft.date=2014-11-14&rft.isbn=978-1-4757-2085-3&rft.aulast=Elks&rft.aufirst=J&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D0vXTBwAAQBAJ%26pg%3DPA1111&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-PubChem-251"><span class="mw-cite-backlink">^ <a href="#cite_ref-PubChem_251-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PubChem_251-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://pubchem.ncbi.nlm.nih.gov/compound/5833">"Spironolactone"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160630101052/http://pubchem.ncbi.nlm.nih.gov/compound/5833/">Archived</a> from the original on 30 June 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">4 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Spironolactone&rft_id=https%3A%2F%2Fpubchem.ncbi.nlm.nih.gov%2Fcompound%2F5833&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ChemSpider-252"><span class="mw-cite-backlink">^ <a href="#cite_ref-ChemSpider_252-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ChemSpider_252-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.chemspider.com/Chemical-Structure.5628.html?rid=b578a389-d64b-4ec2-ae20-309e5f3abd11">"Spironolactone | C24H32O4S"</a>. <i>ChemSpider</i>. Royal Society of Chemistry. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170909005013/http://www.chemspider.com/Chemical-Structure.5628.html?rid=b578a389-d64b-4ec2-ae20-309e5f3abd11">Archived</a> from the original on 9 September 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">4 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=ChemSpider&rft.atitle=Spironolactone+%26%23124%3B+C24H32O4S&rft_id=http%3A%2F%2Fwww.chemspider.com%2FChemical-Structure.5628.html%3Frid%3Db578a389-d64b-4ec2-ae20-309e5f3abd11&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid8616985-253"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8616985_253-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSimon1995" class="citation journal cs1">Simon JA (December 1995). "Micronized progesterone: vaginal and oral uses". <i>Clinical Obstetrics and Gynecology</i>. <b>38</b> (4): 902–14. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F00003081-199538040-00024">10.1097/00003081-199538040-00024</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8616985">8616985</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Obstetrics+and+Gynecology&rft.atitle=Micronized+progesterone%3A+vaginal+and+oral+uses&rft.volume=38&rft.issue=4&rft.pages=902-14&rft.date=1995-12&rft_id=info%3Adoi%2F10.1097%2F00003081-199538040-00024&rft_id=info%3Apmid%2F8616985&rft.aulast=Simon&rft.aufirst=JA&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid16101407-254"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16101407_254-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHuLiMcMahonLala2005" class="citation journal cs1">Hu X, Li S, McMahon EG, Lala DS, Rudolph AE (August 2005). "Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone". <i>Mini Reviews in Medicinal Chemistry</i>. <b>5</b> (8): 709–18. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F1389557054553811">10.2174/1389557054553811</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16101407">16101407</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Mini+Reviews+in+Medicinal+Chemistry&rft.atitle=Molecular+mechanisms+of+mineralocorticoid+receptor+antagonism+by+eplerenone&rft.volume=5&rft.issue=8&rft.pages=709-18&rft.date=2005-08&rft_id=info%3Adoi%2F10.2174%2F1389557054553811&rft_id=info%3Apmid%2F16101407&rft.aulast=Hu&rft.aufirst=X&rft.au=Li%2C+S&rft.au=McMahon%2C+EG&rft.au=Lala%2C+DS&rft.au=Rudolph%2C+AE&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid16112947-255"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16112947_255-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16112947_255-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKuhl2005" class="citation journal cs1">Kuhl H (August 2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration". <i>Climacteric</i>. <b>8</b> (Suppl 1): 3–63. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13697130500148875">10.1080/13697130500148875</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16112947">16112947</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24616324">24616324</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Climacteric&rft.atitle=Pharmacology+of+estrogens+and+progestogens%3A+influence+of+different+routes+of+administration&rft.volume=8&rft.issue=Suppl+1&rft.pages=3-63&rft.date=2005-08&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24616324%23id-name%3DS2CID&rft_id=info%3Apmid%2F16112947&rft_id=info%3Adoi%2F10.1080%2F13697130500148875&rft.aulast=Kuhl&rft.aufirst=H&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid263288-256"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid263288_256-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCutlerPitaRifkaMenard1978" class="citation journal cs1">Cutler GB, Pita JC, Rifka SM, Menard RH, Sauer MA, Loriaux DL (July 1978). "SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate". <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>47</b> (1): 171–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjcem-47-1-171">10.1210/jcem-47-1-171</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/263288">263288</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=SC+25152%3A+A+potent+mineralocorticoid+antagonist+with+reduced+affinity+for+the+5+alpha-dihydrotestosterone+receptor+of+human+and+rat+prostate&rft.volume=47&rft.issue=1&rft.pages=171-5&rft.date=1978-07&rft_id=info%3Adoi%2F10.1210%2Fjcem-47-1-171&rft_id=info%3Apmid%2F263288&rft.aulast=Cutler&rft.aufirst=GB&rft.au=Pita%2C+JC&rft.au=Rifka%2C+SM&rft.au=Menard%2C+RH&rft.au=Sauer%2C+MA&rft.au=Loriaux%2C+DL&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid13601900-257"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid13601900_257-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHertzTullner1958" class="citation journal cs1">Hertz R, Tullner WW (November 1958). "Progestational activity of certain steroid-17-spirolactones". <i>Proceedings of the Society for Experimental Biology and Medicine</i>. <b>99</b> (2): 451–2. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3181%2F00379727-99-24380">10.3181/00379727-99-24380</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/13601900">13601900</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20150966">20150966</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Proceedings+of+the+Society+for+Experimental+Biology+and+Medicine&rft.atitle=Progestational+activity+of+certain+steroid-17-spirolactones&rft.volume=99&rft.issue=2&rft.pages=451-2&rft.date=1958-11&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20150966%23id-name%3DS2CID&rft_id=info%3Apmid%2F13601900&rft_id=info%3Adoi%2F10.3181%2F00379727-99-24380&rft.aulast=Hertz&rft.aufirst=R&rft.au=Tullner%2C+WW&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Butterworth1961-258"><span class="mw-cite-backlink"><b><a href="#cite_ref-Butterworth1961_258-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation book cs1"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=wvIfAQAAMAAJ"><i>The British Encyclopaedia of Medical Practice: Medical progress</i></a>. Butterworth & Company. 1961. p. 302. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095317/https://books.google.com/books?id=wvIfAQAAMAAJ">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">2 February</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=The+British+Encyclopaedia+of+Medical+Practice%3A+Medical+progress&rft.pages=302&rft.pub=Butterworth+%26+Company&rft.date=1961&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DwvIfAQAAMAAJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid28041953-259"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid28041953_259-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLarikSaeedShahzadFaisal2017" class="citation journal cs1">Larik FA, Saeed A, Shahzad D, Faisal M, El-Seedi H, Mehfooz H, et al. (February 2017). "Synthetic approaches towards the multi target drug spironolactone and its potent analogues/derivatives". <i>Steroids</i>. <b>118</b>: 76–92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.steroids.2016.12.010">10.1016/j.steroids.2016.12.010</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28041953">28041953</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7003499">7003499</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Steroids&rft.atitle=Synthetic+approaches+towards+the+multi+target+drug+spironolactone+and+its+potent+analogues%2Fderivatives&rft.volume=118&rft.pages=76-92&rft.date=2017-02&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7003499%23id-name%3DS2CID&rft_id=info%3Apmid%2F28041953&rft_id=info%3Adoi%2F10.1016%2Fj.steroids.2016.12.010&rft.aulast=Larik&rft.aufirst=FA&rft.au=Saeed%2C+A&rft.au=Shahzad%2C+D&rft.au=Faisal%2C+M&rft.au=El-Seedi%2C+H&rft.au=Mehfooz%2C+H&rft.au=Channar%2C+PA&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid13486053-260"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid13486053_260-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid13486053_260-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKagawaCellaVan_Arman1957" class="citation journal cs1">Kagawa CM, Cella JA, Van Arman CG (November 1957). "Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt". <i>Science</i>. <b>126</b> (3281): 1015–6. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1957Sci...126.1015K">1957Sci...126.1015K</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.126.3281.1015">10.1126/science.126.3281.1015</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/13486053">13486053</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Science&rft.atitle=Action+of+new+steroids+in+blocking+effects+of+aldosterone+and+desoxycorticosterone+on+salt&rft.volume=126&rft.issue=3281&rft.pages=1015-6&rft.date=1957-11&rft_id=info%3Apmid%2F13486053&rft_id=info%3Adoi%2F10.1126%2Fscience.126.3281.1015&rft_id=info%3Abibcode%2F1957Sci...126.1015K&rft.aulast=Kagawa&rft.aufirst=CM&rft.au=Cella%2C+JA&rft.au=Van+Arman%2C+CG&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid13486054-261"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid13486054_261-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid13486054_261-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLiddle1957" class="citation journal cs1">Liddle GW (November 1957). "Sodium diuresis induced by steroidal antagonists of aldosterone". <i>Science</i>. <b>126</b> (3281): 1016–8. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1957Sci...126.1016L">1957Sci...126.1016L</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.126.3281.1016">10.1126/science.126.3281.1016</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/13486054">13486054</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Science&rft.atitle=Sodium+diuresis+induced+by+steroidal+antagonists+of+aldosterone&rft.volume=126&rft.issue=3281&rft.pages=1016-8&rft.date=1957-11&rft_id=info%3Apmid%2F13486054&rft_id=info%3Adoi%2F10.1126%2Fscience.126.3281.1016&rft_id=info%3Abibcode%2F1957Sci...126.1016L&rft.aulast=Liddle&rft.aufirst=GW&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-EngelKleemann2014-262"><span class="mw-cite-backlink"><b><a href="#cite_ref-EngelKleemann2014_262-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFEngelKleemannKutscherReichert2014" class="citation book cs1">Engel J, Kleemann A, Kutscher B, Reichert D (14 May 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=4lCGAwAAQBAJ&pg=PA1279"><i>Pharmaceutical Substances, 5th Edition, 2009: Syntheses, Patents and Applications of the most relevant APIs</i></a>. Thieme. pp. 1279–1280. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-13-179275-4" title="Special:BookSources/978-3-13-179275-4"><bdi>978-3-13-179275-4</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095317/https://books.google.com/books?id=4lCGAwAAQBAJ&pg=PA1279">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">27 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pharmaceutical+Substances%2C+5th+Edition%2C+2009%3A+Syntheses%2C+Patents+and+Applications+of+the+most+relevant+APIs&rft.pages=1279-1280&rft.pub=Thieme&rft.date=2014-05-14&rft.isbn=978-3-13-179275-4&rft.aulast=Engel&rft.aufirst=J&rft.au=Kleemann%2C+A&rft.au=Kutscher%2C+B&rft.au=Reichert%2C+D&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D4lCGAwAAQBAJ%26pg%3DPA1279&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-LandauAchilladelis1999-263"><span class="mw-cite-backlink"><b><a href="#cite_ref-LandauAchilladelis1999_263-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFLandauAchilladelisScriabine1999" class="citation book cs1">Landau R, Achilladelis B, Scriabine A (1999). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=IH4lPs6S1bMC&pg=PA198"><i>Pharmaceutical Innovation: Revolutionizing Human Health</i></a>. Chemical Heritage Foundation. pp. 198–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-941901-21-5" title="Special:BookSources/978-0-941901-21-5"><bdi>978-0-941901-21-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095318/https://books.google.com/books?id=IH4lPs6S1bMC&pg=PA198">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">27 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Pharmaceutical+Innovation%3A+Revolutionizing+Human+Health&rft.pages=198-&rft.pub=Chemical+Heritage+Foundation&rft.date=1999&rft.isbn=978-0-941901-21-5&rft.aulast=Landau&rft.aufirst=R&rft.au=Achilladelis%2C+B&rft.au=Scriabine%2C+A&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DIH4lPs6S1bMC%26pg%3DPA198&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Jugdutt2014-264"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jugdutt2014_264-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFJugdutt2014" class="citation book cs1">Jugdutt BI (19 February 2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=0e23BAAAQBAJ&pg=PA175"><i>Aging and Heart Failure: Mechanisms and Management</i></a>. Springer Science & Business Media. pp. 175–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4939-0268-2" title="Special:BookSources/978-1-4939-0268-2"><bdi>978-1-4939-0268-2</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095841/https://books.google.com/books?id=0e23BAAAQBAJ&pg=PA175">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">27 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Aging+and+Heart+Failure%3A+Mechanisms+and+Management&rft.pages=175-&rft.pub=Springer+Science+%26+Business+Media&rft.date=2014-02-19&rft.isbn=978-1-4939-0268-2&rft.aulast=Jugdutt&rft.aufirst=BI&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D0e23BAAAQBAJ%26pg%3DPA175&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Wermuth2011-265"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wermuth2011_265-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWermuth2011" class="citation book cs1">Wermuth CG (2 May 2011). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=Qmt1_DQkCpEC&pg=PA34"><i>The Practice of Medicinal Chemistry</i></a>. Academic Press. pp. 34–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-08-056877-5" title="Special:BookSources/978-0-08-056877-5"><bdi>978-0-08-056877-5</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130621115634/http://books.google.com/books?id=Qmt1_DQkCpEC&pg=PA34">Archived</a> from the original on 21 June 2013.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=The+Practice+of+Medicinal+Chemistry&rft.pages=34-&rft.pub=Academic+Press&rft.date=2011-05-02&rft.isbn=978-0-08-056877-5&rft.aulast=Wermuth&rft.aufirst=CG&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DQmt1_DQkCpEC%26pg%3DPA34&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Smith1962-266"><span class="mw-cite-backlink"><b><a href="#cite_ref-Smith1962_266-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSmith1962" class="citation journal cs1">Smith WG (1962). "Spironolactone and gynaecomastia". <i>The Lancet</i>. <b>280</b> (7261): 886. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2862%2990668-2">10.1016/S0140-6736(62)90668-2</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0140-6736">0140-6736</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Lancet&rft.atitle=Spironolactone+and+gynaecomastia&rft.volume=280&rft.issue=7261&rft.pages=886&rft.date=1962&rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2862%2990668-2&rft.issn=0140-6736&rft.aulast=Smith&rft.aufirst=WG&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid5344274-267"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid5344274_267-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSteelmanBrooksMorganPatanelli1969" class="citation journal cs1">Steelman SL, Brooks JR, Morgan ER, Patanelli DJ (October 1969). "Anti-androgenic activity of spironolactone". <i>Steroids</i>. <b>14</b> (4): 449–50. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0039-128x%2869%2980007-3">10.1016/s0039-128x(69)80007-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/5344274">5344274</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Steroids&rft.atitle=Anti-androgenic+activity+of+spironolactone&rft.volume=14&rft.issue=4&rft.pages=449-50&rft.date=1969-10&rft_id=info%3Adoi%2F10.1016%2Fs0039-128x%2869%2980007-3&rft_id=info%3Apmid%2F5344274&rft.aulast=Steelman&rft.aufirst=SL&rft.au=Brooks%2C+JR&rft.au=Morgan%2C+ER&rft.au=Patanelli%2C+DJ&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid148431-268"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid148431_268-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFStewartPochi1978" class="citation journal cs1">Stewart ME, Pochi PE (April 1978). "Antiandrogens and the skin". <i>International Journal of Dermatology</i>. <b>17</b> (3): 167–79. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-4362.1978.tb06057.x">10.1111/j.1365-4362.1978.tb06057.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/148431">148431</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:43649686">43649686</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Dermatology&rft.atitle=Antiandrogens+and+the+skin&rft.volume=17&rft.issue=3&rft.pages=167-79&rft.date=1978-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43649686%23id-name%3DS2CID&rft_id=info%3Apmid%2F148431&rft_id=info%3Adoi%2F10.1111%2Fj.1365-4362.1978.tb06057.x&rft.aulast=Stewart&rft.aufirst=ME&rft.au=Pochi%2C+PE&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-NeillJohansson1968-269"><span class="mw-cite-backlink"><b><a href="#cite_ref-NeillJohansson1968_269-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFNeillJohanssonDattaKnobil1968" class="citation journal cs1">Neill JD, Johansson ED, Datta JK, Knobil, E (1968). "Endocrinology: Relationship Between the Plasma Levels of Luteinizing Hormone and Progesterone During the Normal Menstrual Cycle". <i>Obstetrical & Gynecological Survey</i>. <b>23</b> (3): 271–277. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F00006254-196803000-00006">10.1097/00006254-196803000-00006</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Obstetrical+%26+Gynecological+Survey&rft.atitle=Endocrinology%3A+Relationship+Between+the+Plasma+Levels+of+Luteinizing+Hormone+and+Progesterone+During+the+Normal+Menstrual+Cycle&rft.volume=23&rft.issue=3&rft.pages=271-277&rft.date=1968&rft_id=info%3Adoi%2F10.1097%2F00006254-196803000-00006&rft.aulast=Neill&rft.aufirst=JD&rft.au=Johansson%2C+ED&rft.au=Datta%2C+JK&rft.au=Knobil&rft.au=E&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid6205409-270"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid6205409_270-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTindallChangLoblCunningham1984" class="citation journal cs1">Tindall DJ, Chang CH, Lobl TJ, Cunningham GR (1984). "Androgen antagonists in androgen target tissues". <i>Pharmacology & Therapeutics</i>. <b>24</b> (3): 367–400. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0163-7258%2884%2990010-X">10.1016/0163-7258(84)90010-X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6205409">6205409</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Pharmacology+%26+Therapeutics&rft.atitle=Androgen+antagonists+in+androgen+target+tissues&rft.volume=24&rft.issue=3&rft.pages=367-400&rft.date=1984&rft_id=info%3Adoi%2F10.1016%2F0163-7258%2884%2990010-X&rft_id=info%3Apmid%2F6205409&rft.aulast=Tindall&rft.aufirst=DJ&rft.au=Chang%2C+CH&rft.au=Lobl%2C+TJ&rft.au=Cunningham%2C+GR&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid717935-271"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid717935_271-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFOberHennessy1978" class="citation journal cs1">Ober KP, Hennessy JF (November 1978). "Spironolactone therapy for hirsutism in a hyperandrogenic woman". <i>Annals of Internal Medicine</i>. <b>89</b> (5 Pt 1): 643–4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.7326%2F0003-4819-89-5-643">10.7326/0003-4819-89-5-643</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/717935">717935</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annals+of+Internal+Medicine&rft.atitle=Spironolactone+therapy+for+hirsutism+in+a+hyperandrogenic+woman&rft.volume=89&rft.issue=5+Pt+1&rft.pages=643-4&rft.date=1978-11&rft_id=info%3Adoi%2F10.7326%2F0003-4819-89-5-643&rft_id=info%3Apmid%2F717935&rft.aulast=Ober&rft.aufirst=KP&rft.au=Hennessy%2C+JF&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid488407-272"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid488407_272-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFBoisselleTremblay1979" class="citation journal cs1">Boisselle A, Tremblay RR (September 1979). "New therapeutic approach to the hirsute patient". <i>Fertility and Sterility</i>. <b>32</b> (3): 276–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0015-0282%2816%2944232-9">10.1016/s0015-0282(16)44232-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/488407">488407</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Fertility+and+Sterility&rft.atitle=New+therapeutic+approach+to+the+hirsute+patient&rft.volume=32&rft.issue=3&rft.pages=276-9&rft.date=1979-09&rft_id=info%3Adoi%2F10.1016%2Fs0015-0282%2816%2944232-9&rft_id=info%3Apmid%2F488407&rft.aulast=Boisselle&rft.aufirst=A&rft.au=Tremblay%2C+RR&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid7410528-273"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7410528_273-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFShapiroEvron1980" class="citation journal cs1">Shapiro G, Evron S (September 1980). "A novel use of spironolactone: treatment of hirsutism". <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>51</b> (3): 429–32. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fjcem-51-3-429">10.1210/jcem-51-3-429</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7410528">7410528</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&rft.atitle=A+novel+use+of+spironolactone%3A+treatment+of+hirsutism&rft.volume=51&rft.issue=3&rft.pages=429-32&rft.date=1980-09&rft_id=info%3Adoi%2F10.1210%2Fjcem-51-3-429&rft_id=info%3Apmid%2F7410528&rft.aulast=Shapiro&rft.aufirst=G&rft.au=Evron%2C+S&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Curtis2014-274"><span class="mw-cite-backlink"><b><a href="#cite_ref-Curtis2014_274-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCurtis2014" class="citation book cs1">Curtis M (2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=w2AGBAAAQBAJ&pg=PA47"><i>Glass' Office Gynecology</i></a>. Lippincott Williams & Wilkins. pp. 47–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-60831-820-9" title="Special:BookSources/978-1-60831-820-9"><bdi>978-1-60831-820-9</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Glass%27+Office+Gynecology&rft.pages=47-&rft.pub=Lippincott+Williams+%26+Wilkins&rft.date=2014&rft.isbn=978-1-60831-820-9&rft.aulast=Curtis&rft.aufirst=M&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dw2AGBAAAQBAJ%26pg%3DPA47&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-ShahBhathena2004-275"><span class="mw-cite-backlink"><b><a href="#cite_ref-ShahBhathena2004_275-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFShahBhathenaShroff2004" class="citation book cs1">Shah D, Bhathena RK, Shroff S (2004). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=Jxd03OBIn9wC&pg=PA78"><i>The Polycystic Ovary Syndrome</i></a>. Orient Blackswan. pp. 78–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-81-250-2633-4" title="Special:BookSources/978-81-250-2633-4"><bdi>978-81-250-2633-4</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095842/https://books.google.com/books?id=Jxd03OBIn9wC&pg=PA78">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">4 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=The+Polycystic+Ovary+Syndrome&rft.pages=78-&rft.pub=Orient+Blackswan&rft.date=2004&rft.isbn=978-81-250-2633-4&rft.aulast=Shah&rft.aufirst=D&rft.au=Bhathena%2C+RK&rft.au=Shroff%2C+S&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DJxd03OBIn9wC%26pg%3DPA78&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Hillard2013-276"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hillard2013_276-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFHillard2013" class="citation book cs1">Hillard PJ (29 March 2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=vAA5Z5aqlUQC&pg=PT371"><i>Practical Pediatric and Adolescent Gynecology</i></a>. John Wiley & Sons. pp. 371–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-118-53857-9" title="Special:BookSources/978-1-118-53857-9"><bdi>978-1-118-53857-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095842/https://books.google.com/books?id=vAA5Z5aqlUQC&pg=PT371">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">4 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Practical+Pediatric+and+Adolescent+Gynecology&rft.pages=371-&rft.pub=John+Wiley+%26+Sons&rft.date=2013-03-29&rft.isbn=978-1-118-53857-9&rft.aulast=Hillard&rft.aufirst=PJ&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DvAA5Z5aqlUQC%26pg%3DPT371&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-DahlFeldman2006-277"><span class="mw-cite-backlink"><b><a href="#cite_ref-DahlFeldman2006_277-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDahlFeldmanGoldbergJaberi2006" class="citation journal cs1">Dahl M, Feldman JL, Goldberg JM, Jaberi A (2006). "Physical Aspects of Transgender Endocrine Therapy". <i>International Journal of Transgenderism</i>. <b>9</b> (3–4): 111–134. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1300%2FJ485v09n03_06">10.1300/J485v09n03_06</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1553-2739">1553-2739</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:146232471">146232471</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Transgenderism&rft.atitle=Physical+Aspects+of+Transgender+Endocrine+Therapy&rft.volume=9&rft.issue=3%E2%80%934&rft.pages=111-134&rft.date=2006&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A146232471%23id-name%3DS2CID&rft.issn=1553-2739&rft_id=info%3Adoi%2F10.1300%2FJ485v09n03_06&rft.aulast=Dahl&rft.aufirst=M&rft.au=Feldman%2C+JL&rft.au=Goldberg%2C+JM&rft.au=Jaberi%2C+A&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-PriorVigna1986-278"><span class="mw-cite-backlink"><b><a href="#cite_ref-PriorVigna1986_278-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPriorVignaWatsonDiewold" class="citation journal cs1">Prior JC, Vigna YM, Watson D, Diewold P, Robinow O. "Spironolactone in the presurgical therapy of male to female transsexuals: Philosophy and experience of the Vancouver Gender Dysphoria Clinic". <i>Journal of Sex Information & Education Council of Canada</i> (1): 1–7.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Sex+Information+%26+Education+Council+of+Canada&rft.atitle=Spironolactone+in+the+presurgical+therapy+of+male+to+female+transsexuals%3A+Philosophy+and+experience+of+the+Vancouver+Gender+Dysphoria+Clinic&rft.issue=1&rft.pages=1-7&rft.aulast=Prior&rft.aufirst=JC&rft.au=Vigna%2C+YM&rft.au=Watson%2C+D&rft.au=Diewold%2C+P&rft.au=Robinow%2C+O&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-FisherMaggi2015-279"><span class="mw-cite-backlink"><b><a href="#cite_ref-FisherMaggi2015_279-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFFisherMaggi2015" class="citation book cs1">Fisher AD, Maggi M (2015). "Endocrine Treatment of Transsexual Male-to-Female Persons". <i>Management of Gender Dysphoria</i>. Springer. pp. 83–91. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-88-470-5696-1_10">10.1007/978-88-470-5696-1_10</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-88-470-5695-4" title="Special:BookSources/978-88-470-5695-4"><bdi>978-88-470-5695-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Endocrine+Treatment+of+Transsexual+Male-to-Female+Persons&rft.btitle=Management+of+Gender+Dysphoria&rft.pages=83-91&rft.pub=Springer&rft.date=2015&rft_id=info%3Adoi%2F10.1007%2F978-88-470-5696-1_10&rft.isbn=978-88-470-5695-4&rft.aulast=Fisher&rft.aufirst=AD&rft.au=Maggi%2C+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Dorfman2016-280"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dorfman2016_280-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dorfman2016_280-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFDorfman2016" class="citation book cs1">Dorfman RI (5 December 2016). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=BbLfBAAAQBAJ&pg=PA392"><i>Steroidal Activity in Experimental Animals and Man</i></a>. Elsevier Science. pp. 392–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4832-7299-3" title="Special:BookSources/978-1-4832-7299-3"><bdi>978-1-4832-7299-3</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Steroidal+Activity+in+Experimental+Animals+and+Man&rft.pages=392-&rft.pub=Elsevier+Science&rft.date=2016-12-05&rft.isbn=978-1-4832-7299-3&rft.aulast=Dorfman&rft.aufirst=RI&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DBbLfBAAAQBAJ%26pg%3DPA392&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-GlázVecsei2017-281"><span class="mw-cite-backlink"><b><a href="#cite_ref-GlázVecsei2017_281-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGlázVecsei2017" class="citation book cs1">Gláz E, Vecsei P (11 January 2017). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=ya3YBAAAQBAJ&pg=PA380"><i>Aldosterone: International Series of Monographs in Pure and Applied Biology</i></a>. Elsevier Science. p. 379. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4831-5997-3" title="Special:BookSources/978-1-4831-5997-3"><bdi>978-1-4831-5997-3</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221010052225/https://books.google.com/books?id=ya3YBAAAQBAJ&pg=PA380">Archived</a> from the original on 10 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">31 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Aldosterone%3A+International+Series+of+Monographs+in+Pure+and+Applied+Biology&rft.pages=379&rft.pub=Elsevier+Science&rft.date=2017-01-11&rft.isbn=978-1-4831-5997-3&rft.aulast=Gl%C3%A1z&rft.aufirst=E&rft.au=Vecsei%2C+P&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Dya3YBAAAQBAJ%26pg%3DPA380&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-MortonHall1999-282"><span class="mw-cite-backlink">^ <a href="#cite_ref-MortonHall1999_282-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MortonHall1999_282-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMortonHall1999" class="citation book cs1">Morton IK, Hall JM (31 October 1999). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=mqaOMOtk61IC&pg=PA261"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science & Business Media. pp. 261ff. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-0-7514-0499-9" title="Special:BookSources/978-0-7514-0499-9"><bdi>978-0-7514-0499-9</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095843/https://books.google.com/books?id=mqaOMOtk61IC&pg=PA261">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Concise+Dictionary+of+Pharmacological+Agents%3A+Properties+and+Synonyms&rft.pages=261ff&rft.pub=Springer+Science+%26+Business+Media&rft.date=1999-10-31&rft.isbn=978-0-7514-0499-9&rft.aulast=Morton&rft.aufirst=IK&rft.au=Hall%2C+JM&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DmqaOMOtk61IC%26pg%3DPA261&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Springer2012-283"><span class="mw-cite-backlink">^ <a href="#cite_ref-Springer2012_283-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Springer2012_283-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Springer2012_283-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Springer2012_283-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation book cs1"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=Z5K-BwAAQBAJ&pg=PA266"><i>Benign Prostatic Hypertrophy</i></a>. Springer Science & Business Media. 6 December 2012. pp. 266–. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-1-4612-5476-8" title="Special:BookSources/978-1-4612-5476-8"><bdi>978-1-4612-5476-8</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221007095843/https://books.google.com/books?id=Z5K-BwAAQBAJ&pg=PA266">Archived</a> from the original on 7 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">30 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Benign+Prostatic+Hypertrophy&rft.pages=266-&rft.pub=Springer+Science+%26+Business+Media&rft.date=2012-12-06&rft.isbn=978-1-4612-5476-8&rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DZ5K-BwAAQBAJ%26pg%3DPA266&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid1702565-284"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid1702565_284-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid1702565_284-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid1702565_284-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid1702565_284-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid1702565_284-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid1702565_284-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMatzkinBraf1991" class="citation journal cs1">Matzkin H, Braf Z (January 1991). "Endocrine treatment of benign prostatic hypertrophy: current concepts". <i>Urology</i>. <b>37</b> (1): 1–16. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0090-4295%2891%2980069-j">10.1016/0090-4295(91)80069-j</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/1702565">1702565</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Urology&rft.atitle=Endocrine+treatment+of+benign+prostatic+hypertrophy%3A+current+concepts&rft.volume=37&rft.issue=1&rft.pages=1-16&rft.date=1991-01&rft_id=info%3Adoi%2F10.1016%2F0090-4295%2891%2980069-j&rft_id=info%3Apmid%2F1702565&rft.aulast=Matzkin&rft.aufirst=H&rft.au=Braf%2C+Z&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid4104441-285"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid4104441_285-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid4104441_285-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCastroGriffithsEdwards1971" class="citation journal cs1">Castro JE, Griffiths HJ, Edwards DE (July 1971). "A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy". <i>The British Journal of Surgery</i>. <b>58</b> (7): 485–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fbjs.1800580703">10.1002/bjs.1800580703</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/4104441">4104441</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:27601630">27601630</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+British+Journal+of+Surgery&rft.atitle=A+double-blind%2C+controlled%2C+clinical+trial+of+spironolactone+for+benign+prostatic+hypertrophy&rft.volume=58&rft.issue=7&rft.pages=485-9&rft.date=1971-07&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A27601630%23id-name%3DS2CID&rft_id=info%3Apmid%2F4104441&rft_id=info%3Adoi%2F10.1002%2Fbjs.1800580703&rft.aulast=Castro&rft.aufirst=JE&rft.au=Griffiths%2C+HJ&rft.au=Edwards%2C+DE&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid29603164-286"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid29603164_286-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFScottMenonWalsh1980" class="citation journal cs1">Scott WW, Menon M, Walsh PC (April 1980). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fcncr.1980.45.s7.1929">"Hormonal Therapy of Prostatic Cancer"</a>. <i>Cancer</i>. <b>45</b> (Suppl 7): 1929–1936. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fcncr.1980.45.s7.1929">10.1002/cncr.1980.45.s7.1929</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29603164">29603164</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4492779">4492779</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Cancer&rft.atitle=Hormonal+Therapy+of+Prostatic+Cancer&rft.volume=45&rft.issue=Suppl+7&rft.pages=1929-1936&rft.date=1980-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4492779%23id-name%3DS2CID&rft_id=info%3Apmid%2F29603164&rft_id=info%3Adoi%2F10.1002%2Fcncr.1980.45.s7.1929&rft.aulast=Scott&rft.aufirst=WW&rft.au=Menon%2C+M&rft.au=Walsh%2C+PC&rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fcncr.1980.45.s7.1929&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid3540320-287"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3540320_287-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSmith1987" class="citation journal cs1">Smith JA (January 1987). "New methods of endocrine management of prostatic cancer". <i>The Journal of Urology</i>. <b>137</b> (1): 1–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0022-5347%2817%2943855-9">10.1016/S0022-5347(17)43855-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/3540320">3540320</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Urology&rft.atitle=New+methods+of+endocrine+management+of+prostatic+cancer&rft.volume=137&rft.issue=1&rft.pages=1-10&rft.date=1987-01&rft_id=info%3Adoi%2F10.1016%2FS0022-5347%2817%2943855-9&rft_id=info%3Apmid%2F3540320&rft.aulast=Smith&rft.aufirst=JA&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Verma2016-288"><span class="mw-cite-backlink">^ <a href="#cite_ref-Verma2016_288-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Verma2016_288-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFVermaThompsonSwaminathan2016" class="citation journal cs1">Verma D, Thompson J, Swaminathan S (March 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.1523686113">"Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>113</b> (13): 3609–14. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2016PNAS..113.3609V">2016PNAS..113.3609V</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.1523686113">10.1073/pnas.1523686113</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822607">4822607</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26976570">26976570</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&rft.atitle=Spironolactone+blocks+Epstein-Barr+virus+production+by+inhibiting+EBV+SM+protein+function&rft.volume=113&rft.issue=13&rft.pages=3609-14&rft.date=2016-03&rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4822607%23id-name%3DPMC&rft_id=info%3Apmid%2F26976570&rft_id=info%3Adoi%2F10.1073%2Fpnas.1523686113&rft_id=info%3Abibcode%2F2016PNAS..113.3609V&rft.aulast=Verma&rft.aufirst=D&rft.au=Thompson%2C+J&rft.au=Swaminathan%2C+S&rft_id=https%3A%2F%2Fdoi.org%2F10.1073%252Fpnas.1523686113&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid15389184-289"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15389184_289-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFPelleCrawfordJames2004" class="citation journal cs1">Pelle MT, Crawford GH, James WD (October 2004). "Rosacea: II. Therapy". <i>Journal of the American Academy of Dermatology</i>. <b>51</b> (4): 499–512, quiz 513–4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jaad.2004.03.033">10.1016/j.jaad.2004.03.033</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15389184">15389184</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&rft.atitle=Rosacea%3A+II.+Therapy&rft.volume=51&rft.issue=4&rft.pages=499-512%2C+quiz+513-4&rft.date=2004-10&rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2004.03.033&rft_id=info%3Apmid%2F15389184&rft.aulast=Pelle&rft.aufirst=MT&rft.au=Crawford%2C+GH&rft.au=James%2C+WD&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-GiurcăneanuMarinescu2016-290"><span class="mw-cite-backlink"><b><a href="#cite_ref-GiurcăneanuMarinescu2016_290-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMerticariuMarinescuGiurcăneanu2016" class="citation journal cs1">Merticariu A, Marinescu L, Giurcăneanu C (2016). "Rosacea and its comorbidities". <i>Journal of Translational Medicine and Research</i>. <b>21</b> (1): 17. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.21614%2Fjtmr-21-1-68">10.21614/jtmr-21-1-68</a></span> (inactive 9 November 2024). <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a> <a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/2393-4999">2393-4999</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Translational+Medicine+and+Research&rft.atitle=Rosacea+and+its+comorbidities&rft.volume=21&rft.issue=1&rft.pages=17&rft.date=2016&rft_id=info%3Adoi%2F10.21614%2Fjtmr-21-1-68&rft.issn=2393-4999&rft.aulast=Merticariu&rft.aufirst=A&rft.au=Marinescu%2C+L&rft.au=Giurc%C4%83neanu%2C+C&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_journal" title="Template:Cite journal">cite journal</a>}}</code>: CS1 maint: DOI inactive as of November 2024 (<a href="/wiki/Category:CS1_maint:_DOI_inactive_as_of_November_2024" title="Category:CS1 maint: DOI inactive as of November 2024">link</a>)</span></span> </li> <li id="cite_note-Wollina2014-291"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wollina2014_291-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWollina2014" class="citation book cs1">Wollina U (2014). "Nonclassical Treatments". <i>Pathogenesis and Treatment of Acne and Rosacea</i>. Springer. pp. 713–717. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-3-540-69375-8_95">10.1007/978-3-540-69375-8_95</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a> <a href="/wiki/Special:BookSources/978-3-540-69374-1" title="Special:BookSources/978-3-540-69374-1"><bdi>978-3-540-69374-1</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Nonclassical+Treatments&rft.btitle=Pathogenesis+and+Treatment+of+Acne+and+Rosacea&rft.pages=713-717&rft.pub=Springer&rft.date=2014&rft_id=info%3Adoi%2F10.1007%2F978-3-540-69375-8_95&rft.isbn=978-3-540-69374-1&rft.aulast=Wollina&rft.aufirst=U&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid23594595-292"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23594595_292-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSpoendlinVoegelJickMeier2013" class="citation journal cs1">Spoendlin J, Voegel JJ, Jick SS, Meier CR (October 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fjid.2013.186">"Spironolactone may reduce the risk of incident rosacea"</a>. <i>The Journal of Investigative Dermatology</i>. <b>133</b> (10): 2480–2483. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fjid.2013.186">10.1038/jid.2013.186</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23594595">23594595</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+Journal+of+Investigative+Dermatology&rft.atitle=Spironolactone+may+reduce+the+risk+of+incident+rosacea&rft.volume=133&rft.issue=10&rft.pages=2480-2483&rft.date=2013-10&rft_id=info%3Adoi%2F10.1038%2Fjid.2013.186&rft_id=info%3Apmid%2F23594595&rft.aulast=Spoendlin&rft.aufirst=J&rft.au=Voegel%2C+JJ&rft.au=Jick%2C+SS&rft.au=Meier%2C+CR&rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252Fjid.2013.186&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-WernzeHerdegen2014-293"><span class="mw-cite-backlink"><b><a href="#cite_ref-WernzeHerdegen2014_293-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWernzeHerdegen2014" class="citation journal cs1">Wernze H, Herdegen T (April 2014). "Long-term efficacy of spironolactone on pain, mood, and quality of life in women with fibromyalgia: An observational case series". <i>Scandinavian Journal of Pain</i>. <b>5</b> (2): 63–71. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.sjpain.2013.12.003">10.1016/j.sjpain.2013.12.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29913681">29913681</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:49305801">49305801</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Scandinavian+Journal+of+Pain&rft.atitle=Long-term+efficacy+of+spironolactone+on+pain%2C+mood%2C+and+quality+of+life+in+women+with+fibromyalgia%3A+An+observational+case+series&rft.volume=5&rft.issue=2&rft.pages=63-71&rft.date=2014-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A49305801%23id-name%3DS2CID&rft_id=info%3Apmid%2F29913681&rft_id=info%3Adoi%2F10.1016%2Fj.sjpain.2013.12.003&rft.aulast=Wernze&rft.aufirst=H&rft.au=Herdegen%2C+T&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-Kalso2014-294"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kalso2014_294-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKalso2014" class="citation journal cs1">Kalso E (April 2014). "From patient observation to potential new therapies-Is old spironolactone a new analgesic?". <i>Scandinavian Journal of Pain</i>. <b>5</b> (2): 61–62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.sjpain.2014.02.006">10.1016/j.sjpain.2014.02.006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29913669">29913669</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:49298333">49298333</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Scandinavian+Journal+of+Pain&rft.atitle=From+patient+observation+to+potential+new+therapies-Is+old+spironolactone+a+new+analgesic%3F&rft.volume=5&rft.issue=2&rft.pages=61-62&rft.date=2014-04&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A49298333%23id-name%3DS2CID&rft_id=info%3Apmid%2F29913669&rft_id=info%3Adoi%2F10.1016%2Fj.sjpain.2014.02.006&rft.aulast=Kalso&rft.aufirst=E&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> <li id="cite_note-pmid22946772-295"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22946772_295-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMcElroyGuerdjikovaMoriO'Melia2012" class="citation journal cs1">McElroy SL, Guerdjikova AI, Mori N, O'Melia AM (October 2012). "Current pharmacotherapy options for bulimia nervosa and binge eating disorder". <i>Expert Opinion on Pharmacotherapy</i>. <b>13</b> (14): 2015–26. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1517%2F14656566.2012.721781">10.1517/14656566.2012.721781</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22946772">22946772</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:1747393">1747393</a>.</cite><span title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Expert+Opinion+on+Pharmacotherapy&rft.atitle=Current+pharmacotherapy+options+for+bulimia+nervosa+and+binge+eating+disorder&rft.volume=13&rft.issue=14&rft.pages=2015-26&rft.date=2012-10&rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A1747393%23id-name%3DS2CID&rft_id=info%3Apmid%2F22946772&rft_id=info%3Adoi%2F10.1517%2F14656566.2012.721781&rft.aulast=McElroy&rft.aufirst=SL&rft.au=Guerdjikova%2C+AI&rft.au=Mori%2C+N&rft.au=O%27Melia%2C+AM&rfr_id=info%3Asid%2Fen.wikipedia.org%3ASpironolactone" class="Z3988"></span></span> </li> </ol></div></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><style data-mw-deduplicate="TemplateStyles:r1236075235">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}body.skin--responsive .mw-parser-output .navbox-image img{max-width:none!important}@media print{body.ns-0 .mw-parser-output .navbox{display:none!important}}</style></div><div role="navigation" class="navbox" aria-labelledby="Spironolactone" style="padding:3px"><table class="nowraplinks mw-collapsible expanded navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Spironolactone" title="Template:Spironolactone"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Spironolactone" title="Template talk:Spironolactone"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Spironolactone" title="Special:EditPage/Template:Spironolactone"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Spironolactone" style="font-size:114%;margin:0 4em"><a class="mw-selflink selflink">Spironolactone</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Topics</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Pharmacodynamics_of_spironolactone" title="Pharmacodynamics of spironolactone">Pharmacodynamics of spironolactone</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Metabolites</th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/7%CE%B1-Thiomethylspironolactone" title="7α-Thiomethylspironolactone">7α-Thiomethylspironolactone</a> (major)</li> <li><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a> (minor)</li> <li><a href="/wiki/6%CE%B2-Hydroxy-7%CE%B1-thiomethylspironolactone" title="6β-Hydroxy-7α-thiomethylspironolactone">6β-Hydroxy-7α-thiomethylspironolactone</a> (minor)</li> <li><a href="/wiki/7%CE%B1-Thiospironolactone" title="7α-Thiospironolactone">7α-Thiospironolactone</a> (minor)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Related drugs</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Spirolactone" title="Spirolactone">Spirolactone</a> <a href="/wiki/Antimineralocorticoid" class="mw-redirect" title="Antimineralocorticoid">antimineralocorticoids</a>: <a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></li> <li><a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">Potassium canrenoate</a></li> <li><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li> <li><a href="/wiki/Eplerenone" title="Eplerenone">Eplerenone</a></li></ul> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Medical_uses" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Medical_uses" style="font-size:114%;margin:0 4em"><a href="/wiki/Medicine" title="Medicine">Medical uses</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0;font-size:114%"><div style="padding:0px"> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-labelledby="Diuretics_(C03)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Diuretics" title="Template:Diuretics"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Diuretics" title="Template talk:Diuretics"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Diuretics" title="Special:EditPage/Template:Diuretics"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Diuretics_(C03)" style="font-size:114%;margin:0 4em"><a href="/wiki/Diuretic" title="Diuretic">Diuretics</a> (<a href="/wiki/ATC_code_C03" title="ATC code C03">C03</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sulfonamide_(medicine)" title="Sulfonamide (medicine)">Sulfonamides</a><br />(and <a href="/wiki/Etacrynic_acid" title="Etacrynic acid">etacrynic acid</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Carbonic_anhydrase_inhibitor" title="Carbonic anhydrase inhibitor">CA inhibitors</a> (at <a href="/wiki/Proximal_tubule" title="Proximal tubule">PT</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Acetazolamide" title="Acetazolamide">Acetazolamide</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Loop_diuretic" title="Loop diuretic">Loop</a> (<a href="/wiki/Na-K-Cl_cotransporter" class="mw-redirect" title="Na-K-Cl cotransporter">Na-K-Cl</a> at <a href="/wiki/Thick_ascending_limb_of_loop_of_Henle" class="mw-redirect" title="Thick ascending limb of loop of Henle">AL</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Furosemide" title="Furosemide">Furosemide</a><sup>#</sup></li> <li><a href="/wiki/Azosemide" title="Azosemide">Azosemide</a></li> <li><a href="/wiki/Bumetanide" title="Bumetanide">Bumetanide</a></li> <li><a href="/wiki/Etacrynic_acid" title="Etacrynic acid">Etacrynic acid</a></li> <li><a href="/wiki/Etozolin" title="Etozolin">Etozolin</a></li> <li><a href="/wiki/Indacrinone" title="Indacrinone">Indacrinone</a></li> <li><a href="/wiki/Muzolimine" title="Muzolimine">Muzolimine</a></li> <li><a href="/wiki/Ozolinone" title="Ozolinone">Ozolinone</a></li> <li><a href="/wiki/Piretanide" title="Piretanide">Piretanide</a></li> <li><a href="/wiki/Tienilic_acid" title="Tienilic acid">Tienilic acid</a><sup>‡</sup></li> <li><a href="/wiki/Torasemide" title="Torasemide">Torasemide</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Thiazide" title="Thiazide">Thiazides</a> (<a href="/wiki/Sodium-chloride_symporter" title="Sodium-chloride symporter">Na-Cl</a> at <a href="/wiki/Distal_convoluted_tubule" title="Distal convoluted tubule">DCT</a>,<br /><a href="/wiki/Diuretic#Calcium-sparing_diuretics" title="Diuretic">Calcium-sparing</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Altizide" title="Altizide">Altizide</a></li> <li><a href="/wiki/Bendroflumethiazide" title="Bendroflumethiazide">Bendroflumethiazide</a></li> <li><a href="/wiki/Butizide" title="Butizide">Butizide</a></li> <li><a href="/wiki/Chlorothiazide" title="Chlorothiazide">Chlorothiazide</a></li> <li><a href="/wiki/Cyclopenthiazide" title="Cyclopenthiazide">Cyclopenthiazide</a></li> <li><a href="/wiki/Cyclothiazide" title="Cyclothiazide">Cyclothiazide</a></li> <li><a href="/wiki/Epitizide" title="Epitizide">Epitizide</a></li> <li><a href="/wiki/Hydrochlorothiazide" title="Hydrochlorothiazide">Hydrochlorothiazide</a></li> <li><a href="/wiki/Hydroflumethiazide" title="Hydroflumethiazide">Hydroflumethiazide</a></li> <li><a href="/wiki/Mebutizide" title="Mebutizide">Mebutizide</a></li> <li><a href="/wiki/Methyclothiazide" title="Methyclothiazide">Methyclothiazide</a></li> <li><a href="/wiki/Polythiazide" title="Polythiazide">Polythiazide</a></li> <li><a href="/wiki/Trichlormethiazide" title="Trichlormethiazide">Trichlormethiazide</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Thiazide-like_diuretic" title="Thiazide-like diuretic">Thiazide-likes</a> (primarily <a href="/wiki/Distal_convoluted_tubule" title="Distal convoluted tubule">DCT</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Chlortalidone" title="Chlortalidone">Chlortalidone</a></li> <li><a href="/wiki/Clofenamide" title="Clofenamide">Clofenamide</a></li> <li><a href="/wiki/Clopamide" title="Clopamide">Clopamide</a></li> <li><a href="/wiki/Clorexolone" title="Clorexolone">Clorexolone</a></li> <li><a href="/wiki/Fenquizone" title="Fenquizone">Fenquizone</a></li> <li><a href="/wiki/Indapamide" title="Indapamide">Indapamide</a></li> <li><a href="/wiki/Mefruside" title="Mefruside">Mefruside</a></li> <li><a href="/wiki/Meticrane" title="Meticrane">Meticrane</a></li> <li><a href="/wiki/Metolazone" title="Metolazone">Metolazone</a></li> <li><a href="/wiki/Quinethazone" title="Quinethazone">Quinethazone</a></li> <li><a href="/wiki/Xipamide" title="Xipamide">Xipamide</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Potassium-sparing_diuretic" title="Potassium-sparing diuretic">Potassium-sparing</a> (at <a href="/wiki/Collecting_duct_system" title="Collecting duct system">CD</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Epithelial_sodium_channel_blocker" title="Epithelial sodium channel blocker">ESC blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Amiloride" title="Amiloride">Amiloride</a><sup>#</sup></li> <li><a href="/wiki/Benzamil" title="Benzamil">Benzamil</a></li> <li><a href="/wiki/Triamterene" title="Triamterene">Triamterene</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Antimineralocorticoid" class="mw-redirect" title="Antimineralocorticoid">Aldosterone antagonists</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/Spirolactone" title="Spirolactone">Spirolactones</a></i> <ul><li><a class="mw-selflink selflink">Spironolactone</a><sup>#</sup></li> <li><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></li> <li><a href="/wiki/Eplerenone" title="Eplerenone">Eplerenone</a></li> <li><a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">Potassium canrenoate</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Nonsteroidal" title="Nonsteroidal">Nonsteroidal</a></i> <ul><li><a href="/wiki/Finerenone" title="Finerenone">Finerenone</a></li></ul></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Osmotic_diuretic" title="Osmotic diuretic">Osmotic diuretics</a> (<a href="/wiki/Proximal_tubule" title="Proximal tubule">PT</a>, <a href="/wiki/Descending_limb_of_loop_of_Henle" title="Descending limb of loop of Henle">DL</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Mannitol" title="Mannitol">Mannitol</a><sup>#</sup></li> <li><a href="/wiki/Glycerol" title="Glycerol">Glycerol</a></li> <li><a href="/wiki/Urea" title="Urea">Urea</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Vasopressin_receptor_antagonist" title="Vasopressin receptor antagonist">Vasopressin receptor inhibitors</a><br />(<a href="/wiki/Distal_convoluted_tubule" title="Distal convoluted tubule">DCT</a> and <a href="/wiki/Collecting_duct" class="mw-redirect" title="Collecting duct">CD</a>)</th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/Vasopressin_receptor_antagonist#Vaptans" title="Vasopressin receptor antagonist">Vaptans</a></i> <ul><li><a href="/wiki/Conivaptan" title="Conivaptan">Conivaptan</a></li> <li><a href="/wiki/Mozavaptan" title="Mozavaptan">Mozavaptan</a></li> <li><a href="/wiki/Satavaptan" title="Satavaptan">Satavaptan</a></li> <li><a href="/wiki/Tolvaptan" title="Tolvaptan">Tolvaptan</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Vasopressin_receptor_antagonist#Demeclocycline_and_lithium" title="Vasopressin receptor antagonist">Others</a></i> <ul><li><a href="/wiki/Demeclocycline" title="Demeclocycline">Demeclocycline</a></li> <li><a href="/wiki/Lithium_carbonate" title="Lithium carbonate">Lithium carbonate</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Ethanol" title="Ethanol">Ethanol</a>, <a href="/wiki/Isopropanol" class="mw-redirect" title="Isopropanol">Isopropanol</a>, <a href="/wiki/Tert-Amyl_alcohol" title="Tert-Amyl alcohol">2M2B</a></li> <li><i><a href="/wiki/Mercurial_diuretic" title="Mercurial diuretic">mercurial diuretics</a></i> (<a href="/wiki/Chlormerodrin" title="Chlormerodrin">Chlormerodrin</a>, <a href="/wiki/Mersalyl" title="Mersalyl">Mersalyl</a>, <a href="/wiki/Meralluride" title="Meralluride">Meralluride</a>)</li> <li><a href="/wiki/Theobromine" title="Theobromine">Theobromine</a></li> <li><a href="/wiki/Cicletanine" title="Cicletanine">Cicletanine</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combination products</th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Hydrochlorothiazide/triamterene" title="Hydrochlorothiazide/triamterene">Hydrochlorothiazide/triamterene</a></li></ul> </div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist"> <ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li> <li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li> <li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>: <ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li> <li><sup>§</sup>Never to phase III</li></ul></li></ul> </div></div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-labelledby="Acne-treating_agents_(D10)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Acne-treating_agents" title="Template:Acne-treating agents"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Acne-treating_agents" title="Template talk:Acne-treating agents"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Acne-treating_agents" title="Special:EditPage/Template:Acne-treating agents"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Acne-treating_agents_(D10)" style="font-size:114%;margin:0 4em"><a href="/wiki/Acne_vulgaris" class="mw-redirect" title="Acne vulgaris">Acne</a>-treating agents (<a href="/wiki/ATC_code_D10" title="ATC code D10">D10</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Antiseptic" title="Antiseptic">Antibacterial</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Azelaic_acid" title="Azelaic acid">Azelaic acid</a></li> <li><a href="/wiki/Benzoyl_peroxide" title="Benzoyl peroxide">Benzoyl peroxide</a><sup>#</sup></li> <li><a href="/wiki/8-Hydroxyquinoline" title="8-Hydroxyquinoline">8-Hydroxyquinoline</a></li> <li><a href="/wiki/Light_therapy" title="Light therapy">Blue light therapy</a></li> <li><a href="/wiki/Tea_tree_oil" title="Tea tree oil">Tea tree oil</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Keratolytic" title="Keratolytic">Keratolytic</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Glycolic_acid" title="Glycolic acid">Glycolic acid</a></li> <li><a href="/wiki/Salicylic_acid" title="Salicylic acid">Salicylic acid</a><sup>#</sup></li> <li><a href="/wiki/Sulfur_(pharmacy)" class="mw-redirect" title="Sulfur (pharmacy)">Sulfur</a></li> <li><a href="/wiki/Benzoyl_peroxide" title="Benzoyl peroxide">Benzoyl peroxide</a><sup>#</sup></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Anti-inflammatory" title="Anti-inflammatory">Anti-inflammatory</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Niacinamide" class="mw-redirect" title="Niacinamide">Niacinamide</a></li> <li><a href="/wiki/Ibuprofen" title="Ibuprofen">Ibuprofen</a><sup>#</sup></li> <li><a href="/wiki/Aspirin" title="Aspirin">Aspirin</a><sup>#</sup></li> <li><a href="/wiki/Light_therapy" title="Light therapy">Red light therapy</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Antibiotics" class="mw-redirect" title="Antibiotics">Antibiotics</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Clindamycin" title="Clindamycin">Clindamycin</a></li> <li><a href="/wiki/Dapsone" title="Dapsone">Dapsone</a></li> <li><a href="/wiki/Erythromycin" title="Erythromycin">Erythromycin</a></li> <li><a href="/wiki/Sulfacetamide" title="Sulfacetamide">Sulfacetamide</a></li> <li><a href="/wiki/Tetracycline_antibiotics" title="Tetracycline antibiotics">Tetracyclines</a> (<a href="/wiki/Lymecycline" title="Lymecycline">Lymecycline</a></li> <li><a href="/wiki/Minocycline" title="Minocycline">Minocycline</a></li> <li><a href="/wiki/Doxycycline" title="Doxycycline">Doxycycline</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Hormone" title="Hormone">Hormonal</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a> <ul><li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a class="mw-selflink selflink">Spironolactone</a>)</li></ul></li> <li><a href="/wiki/Estrogen" title="Estrogen">Estrogens</a> <ul><li><a href="/wiki/Estradiol" title="Estradiol">Estradiol</a></li> <li><a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">Ethinylestradiol</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Retinoid" title="Retinoid">Retinoids</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Adapalene" title="Adapalene">Adapalene</a></li> <li><a href="/wiki/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li> <li><a href="/wiki/Motretinide" title="Motretinide">Motretinide</a></li> <li><a href="/wiki/Tazarotene" title="Tazarotene">Tazarotene</a></li> <li><a href="/wiki/Tretinoin" title="Tretinoin">Tretinoin</a></li> <li><a href="/wiki/Trifarotene" title="Trifarotene">Trifarotene</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Epristeride" title="Epristeride">Epristeride</a></li> <li><a href="/wiki/Mesulfen" title="Mesulfen">Mesulfen</a></li> <li><a href="/wiki/Pelretin" title="Pelretin">Pelretin</a></li> <li><a href="/wiki/Stridex" title="Stridex">Stridex</a></li> <li><a href="/wiki/Tioxolone" title="Tioxolone">Tioxolone</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combinations</th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Adapalene/benzoyl_peroxide" title="Adapalene/benzoyl peroxide">Adapalene/benzoyl peroxide</a></li> <li><a href="/wiki/Clindamycin/adapalene/benzoyl_peroxide" title="Clindamycin/adapalene/benzoyl peroxide">Clindamycin/adapalene/benzoyl peroxide</a></li> <li><a href="/wiki/Clindamycin/benzoyl_peroxide" title="Clindamycin/benzoyl peroxide">Clindamycin/benzoyl peroxide</a></li> <li><a href="/wiki/Clindamycin/tretinoin" title="Clindamycin/tretinoin">Clindamycin/tretinoin</a></li> <li><a href="/wiki/Erythromycin/benzoyl_peroxide" title="Erythromycin/benzoyl peroxide">Erythromycin/benzoyl peroxide</a></li> <li><a href="/wiki/Erythromycin/isotretinoin" title="Erythromycin/isotretinoin">Erythromycin/isotretinoin</a></li> <li><a href="/wiki/Sulfacetamide/sulfur" title="Sulfacetamide/sulfur">Sulfacetamide/sulfur</a></li> <li><a href="/wiki/Tretinoin/benzoyl_peroxide" title="Tretinoin/benzoyl peroxide">Tretinoin/benzoyl peroxide</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist"> <ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li> <li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li> <li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>: <ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li> <li><sup>§</sup>Never to phase III</li></ul></li></ul> </div></div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Other_dermatological_preparations_(D11)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Other_dermatological_preparations" title="Template:Other dermatological preparations"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Other_dermatological_preparations" title="Template talk:Other dermatological preparations"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Other_dermatological_preparations" title="Special:EditPage/Template:Other dermatological preparations"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Other_dermatological_preparations_(D11)" style="font-size:114%;margin:0 4em">Other <a href="/wiki/Dermatological" class="mw-redirect" title="Dermatological">dermatological</a> preparations (<a href="/wiki/ATC_code_D11" title="ATC code D11">D11</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Anti-seborrheic" title="Anti-seborrheic">Anti-seborrheics</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></i> <ul><li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li></ul></li> <li><i><a href="/wiki/Antifungal" title="Antifungal">Antifungals</a></i> <ul><li><a href="/wiki/Bifonazole" title="Bifonazole">Bifonazole</a></li> <li><a href="/wiki/Cetrimonium_bromide" title="Cetrimonium bromide">Cetrimonium bromide</a> (<a href="/wiki/Cetrimide" title="Cetrimide">cetrimide</a>)</li> <li><a href="/wiki/Ciclopirox_olamine" class="mw-redirect" title="Ciclopirox olamine">Ciclopirox olamine (ciclopirox)</a></li> <li><a href="/wiki/Climbazole" title="Climbazole">Climbazole</a></li> <li><a href="/wiki/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li> <li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li> <li><a href="/wiki/Miconazole" title="Miconazole">Miconazole</a></li> <li><a href="/wiki/Piroctone_olamine" title="Piroctone olamine">Piroctone olamine</a></li> <li><a href="/wiki/Selenium_disulfide" title="Selenium disulfide">Selenium disulfide (selenium sulfide)</a></li> <li><a href="/w/index.php?title=Xenysalate&action=edit&redlink=1" class="new" title="Xenysalate (page does not exist)">Xenysalate</a></li> <li><a href="/wiki/Zinc_pyrithione" title="Zinc pyrithione">Zinc pyrithione (pyrithione zinc)</a></li></ul></li> <li><i><a href="/wiki/Antihistamine" title="Antihistamine">Antihistamines</a></i></li> <li><i><a href="/wiki/Calcineurin_inhibitor" class="mw-redirect" title="Calcineurin inhibitor">Calcineurin inhibitors</a></i> <ul><li><a href="/wiki/Cyclosporin" class="mw-redirect" title="Cyclosporin">Cyclosporin</a></li> <li><a href="/wiki/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li> <li><a href="/wiki/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li></ul></li> <li><a href="/wiki/Isotretinoin" title="Isotretinoin">Isotretinoin</a></li> <li><i><a href="/wiki/Keratolytic" title="Keratolytic">Keratolytics</a></i> <ul><li><a href="/wiki/Coal_tar" title="Coal tar">Coal tar</a></li> <li><a href="/wiki/Resorcinol" title="Resorcinol">Resorcinol</a></li> <li><a href="/wiki/Salicylic_acid" title="Salicylic acid">Salicylic acid</a></li> <li><a href="/wiki/Sulfur" title="Sulfur">Sulfur</a></li> <li><a href="/wiki/Urea" title="Urea">Urea</a> (<a href="/wiki/Urea-containing_cream" title="Urea-containing cream">urea-containing cream</a>)</li></ul></li> <li><i><a href="/wiki/Lithium_(medication)" title="Lithium (medication)">Lithium salts</a></i> <ul><li><a href="/wiki/Lithium_gluconate" class="mw-redirect" title="Lithium gluconate">Lithium gluconate</a></li> <li><a href="/wiki/Lithium_succinate" title="Lithium succinate">Lithium succinate</a></li></ul></li> <li><i><a href="/wiki/Topical_steroid" title="Topical steroid">Topical corticosteroids</a></i> (e.g., <a href="/wiki/Hydrocortisone" title="Hydrocortisone">hydrocortisone</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Skin_whitening" title="Skin whitening">Skin lightening</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Hydroquinone" title="Hydroquinone">Hydroquinone</a></li> <li><a href="/wiki/Mequinol" title="Mequinol">Mequinol</a></li> <li><a href="/wiki/Monobenzone" title="Monobenzone">Monobenzone</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sun_tanning" title="Sun tanning">Skin darkening</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Afamelanotide" title="Afamelanotide">Afamelanotide</a></li> <li><a href="/wiki/Melanotan_II" title="Melanotan II">Melanotan II</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Anti-inflammatories" class="mw-redirect" title="Anti-inflammatories">Anti-inflammatories</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li> <li><a href="/wiki/Gamma-Linolenic_acid" class="mw-redirect" title="Gamma-Linolenic acid">Gamolenic acid</a></li> <li><a href="/wiki/Oxaceprol" title="Oxaceprol">Oxaceprol</a></li> <li><a href="/wiki/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li> <li><a href="/wiki/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li></ul> <ul><li><i><a href="/wiki/Topical_steroid" title="Topical steroid">Topical corticosteroids</a></i> (e.g., <a href="/wiki/Hydrocortisone" title="Hydrocortisone">hydrocortisone</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Management_of_hair_loss" title="Management of hair loss">Alopecia treatments</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/5%CE%B1-Reductase_inhibitor" title="5α-Reductase inhibitor">5α-Reductase inhibitors</a></i> <ul><li><a href="/wiki/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li> <li><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a></li> <li><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a></li> <li><a href="/wiki/Saw_palmetto_extract" title="Saw palmetto extract">Saw palmetto extract</a></li></ul></li> <li><i><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></i> <ul><li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li> <li><a href="/wiki/Topilutamide" title="Topilutamide">Topilutamide (fluridil)</a></li></ul></li> <li><i><a href="/wiki/Potassium_channel_opener" title="Potassium channel opener">Potassium channel openers</a></i> <ul><li><a href="/wiki/Minoxidil" title="Minoxidil">Minoxidil</a></li></ul></li> <li><i>Others</i> <ul><li><a href="/wiki/Nepidermin" title="Nepidermin">Nepidermin</a></li> <li><a href="/wiki/Ritlecitinib" title="Ritlecitinib">Ritlecitinib</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Hair_growth_inhibitor" class="mw-redirect" title="Hair growth inhibitor">Hair growth inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/5%CE%B1-Reductase_inhibitor" title="5α-Reductase inhibitor">5α-Reductase inhibitors</a></i> <ul><li><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a></li> <li><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a></li></ul></li> <li><i><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></i> <ul><li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li></ul></li> <li><a href="/wiki/Eflornithine" title="Eflornithine">Eflornithine</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Abrocitinib" title="Abrocitinib">Abrocitinib</a></li> <li><a href="/wiki/Aminobenzoate" class="mw-redirect" title="Aminobenzoate">Aminobenzoate potassium</a></li> <li><a href="/wiki/Androgen" title="Androgen">Androgens</a> (e.g., <a href="/wiki/Testosterone_(medication)" title="Testosterone (medication)">testosterone</a>)</li> <li><a href="/wiki/Benzoylperoxide" class="mw-redirect" title="Benzoylperoxide">Benzoylperoxide</a></li> <li><a href="/wiki/Brimonidine" title="Brimonidine">Brimonidine</a></li> <li><a href="/wiki/Caffeine" title="Caffeine">Caffeine</a></li> <li><a href="/wiki/Calcium_gluconate" title="Calcium gluconate">Calcium gluconate</a></li> <li><a href="/wiki/Collagen" title="Collagen">Collagen</a></li> <li><a href="/wiki/Crisaborole" title="Crisaborole">Crisaborole</a></li> <li><a href="/wiki/Cromoglicic_acid" title="Cromoglicic acid">Cromoglicic acid</a></li> <li><a href="/wiki/Delgocitinib" title="Delgocitinib">Delgocitinib</a></li> <li><a href="/wiki/Deoxycholic_acid" title="Deoxycholic acid">Deoxycholic acid</a></li> <li><a href="/wiki/Diclofenac" title="Diclofenac">Diclofenac</a></li> <li><a href="/wiki/Dupilumab" title="Dupilumab">Dupilumab</a></li> <li><a href="/wiki/Estrogen" title="Estrogen">Estrogens</a> (e.g., <a href="/wiki/Estradiol" title="Estradiol">estradiol</a>)</li> <li><a href="/wiki/Glycopyrronium_bromide" title="Glycopyrronium bromide">Glycopyrronium bromide</a></li> <li><a href="/wiki/Glycopyrronium_tosylate" title="Glycopyrronium tosylate">Glycopyrronium tosylate</a></li> <li><a href="/wiki/Hyaluronic_acid" title="Hyaluronic acid">Hyaluronic acid</a></li> <li><a href="/wiki/Hydrogen_peroxide" title="Hydrogen peroxide">Hydrogen peroxide</a></li> <li><a href="/wiki/Ivermectin" title="Ivermectin">Ivermectin</a></li> <li><a href="/wiki/Lebrikizumab" title="Lebrikizumab">Lebrikizumab</a></li> <li><a href="/wiki/Lokivetmab" title="Lokivetmab">Lokivetmab</a></li> <li><a href="/wiki/Magnesium_sulfate" title="Magnesium sulfate">Magnesium sulfate</a></li> <li><a href="/wiki/Metandienone" title="Metandienone">Metandienone</a></li> <li><a href="/wiki/Nemolizumab" title="Nemolizumab">Nemolizumab</a></li> <li><a href="/wiki/Oclacitinib" title="Oclacitinib">Oclacitinib</a></li> <li><a href="/wiki/Oxymetazoline" title="Oxymetazoline">Oxymetazoline</a></li> <li><a href="/wiki/Povidone-iodine" title="Povidone-iodine">Povidone-iodine</a></li> <li><a href="/wiki/Pregnenolone_acetate" title="Pregnenolone acetate">Pregnenolone acetate</a></li> <li><a href="/wiki/Progestogen" title="Progestogen">Progestogens</a> (e.g., <a href="/wiki/Progesterone_(medication)" title="Progesterone (medication)">progesterone</a>)</li> <li><a href="/wiki/Ruxolitinib" title="Ruxolitinib">Ruxolitinib</a></li> <li><a href="/wiki/Tiratricol" title="Tiratricol">Tiratricol</a></li> <li><a href="/wiki/Tralokinumab" title="Tralokinumab">Tralokinumab</a></li></ul> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-labelledby="Androgens_and_antiandrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Androgens_and_antiandrogens" title="Template:Androgens and antiandrogens"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Androgens_and_antiandrogens" title="Template talk:Androgens and antiandrogens"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Androgens_and_antiandrogens" title="Special:EditPage/Template:Androgens and antiandrogens"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Androgens_and_antiandrogens" style="font-size:114%;margin:0 4em"><a href="/wiki/Androgen" title="Androgen">Androgens</a> and <a href="/wiki/Antiandrogen" title="Antiandrogen">antiandrogens</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Androgen" title="Androgen">Androgens</a><br />(incl. <a href="/wiki/Anabolic%E2%80%93androgenic_steroid" class="mw-redirect" title="Anabolic–androgenic steroid"><abbr title="anabolic–androgenic steroid">AAS</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip anabolic–androgenic steroid</span>)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Androgen_receptor" title="Androgen receptor"><abbr title="Androgen receptor">AR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Androgen receptor</span> <a href="/wiki/Agonist" title="Agonist">agonists</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Testosterone derivatives:</i> <a href="/wiki/Androstenediol_dipropionate" title="Androstenediol dipropionate">Androstenediol dipropionate</a></li> <li><a href="/wiki/Boldenone_undecylenate" title="Boldenone undecylenate">Boldenone undecylenate</a></li> <li><a href="/wiki/Clostebol" title="Clostebol">Clostebol</a></li> <li><a href="/wiki/Clostebol_acetate" title="Clostebol acetate">Clostebol acetate</a></li> <li><a href="/wiki/Clostebol_caproate" title="Clostebol caproate">Clostebol caproate</a></li> <li><a href="/wiki/Clostebol_propionate" title="Clostebol propionate">Clostebol propionate</a></li> <li><a href="/wiki/Cloxotestosterone_acetate" title="Cloxotestosterone acetate">Cloxotestosterone acetate</a></li> <li><a href="/wiki/Prasterone" title="Prasterone">Prasterone (dehydroepiandrosterone, DHEA)</a></li> <li><a href="/wiki/Prasterone_enanthate" title="Prasterone enanthate">Prasterone enanthate (DHEA enanthate)</a></li> <li><a href="/wiki/Prasterone_sulfate" title="Prasterone sulfate">Prasterone sulfate (DHEA sulfate)</a></li> <li><a href="/wiki/Quinbolone" title="Quinbolone">Quinbolone</a></li> <li><a href="/wiki/Testosterone_(medication)" title="Testosterone (medication)">Testosterone</a><sup>#</sup></li> <li><a href="/wiki/List_of_androgen_esters#Testosterone_esters" title="List of androgen esters">Testosterone esters</a> (e.g., <a href="/wiki/Testosterone_cypionate" title="Testosterone cypionate">testosterone cypionate</a>, <a href="/wiki/Testosterone_enanthate" title="Testosterone enanthate">testosterone enanthate</a>, <a href="/wiki/Testosterone_propionate" title="Testosterone propionate">testosterone propionate</a>, <a href="/wiki/Testosterone_undecanoate" title="Testosterone undecanoate">testosterone undecanoate</a>, <a href="/wiki/Testosterone_ester_mixture" class="mw-redirect" title="Testosterone ester mixture">testosterone ester mixtures</a> (<a href="/wiki/Deposterona" class="mw-redirect" title="Deposterona">Deposterona</a>, <a href="/wiki/Omnadren" class="mw-redirect" title="Omnadren">Omnadren</a>, <a href="/wiki/Testosterone_propionate/testosterone_phenylpropionate/testosterone_isocaproate/testosterone_decanoate" title="Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate">Sustanon</a>, <a href="/wiki/Testoviron_depot" class="mw-redirect" title="Testoviron depot">Testoviron Depot</a>))</li></ul> <ul><li><i>Dihydrotestosterone derivatives:</i> <a href="/wiki/Androstanolone" title="Androstanolone">Androstanolone (stanolone, dihydrotestosterone, DHT)</a></li> <li><a href="/wiki/List_of_androgen_esters#Dihydrotestosterone_esters" title="List of androgen esters">Androstanolone esters</a></li> <li><a href="/wiki/Bolazine_capronate" title="Bolazine capronate">Bolazine capronate</a></li> <li><a href="/wiki/Drostanolone_propionate" title="Drostanolone propionate">Drostanolone propionate (dromostanolone propionate)</a></li> <li><a href="/wiki/Epitiostanol" title="Epitiostanol">Epitiostanol</a></li> <li><a href="/wiki/Mepitiostane" title="Mepitiostane">Mepitiostane</a></li> <li><a href="/wiki/Mesterolone" title="Mesterolone">Mesterolone</a></li> <li><a href="/wiki/Metenolone_acetate" title="Metenolone acetate">Metenolone acetate (methenolone acetate)</a></li> <li><a href="/wiki/Metenolone_enanthate" title="Metenolone enanthate">Metenolone enanthate (methenolone enanthate)</a></li> <li><a href="/wiki/Stenbolone_acetate" title="Stenbolone acetate">Stenbolone acetate</a></li></ul> <ul><li><i>19-Nortestosterone derivatives:</i> <a href="/wiki/Bolandiol_dipropionate" title="Bolandiol dipropionate">Bolandiol dipropionate</a></li> <li><a href="/wiki/List_of_androgen_esters#Nandrolone_esters" title="List of androgen esters">Nandrolone esters</a> (e.g., <a href="/wiki/Nandrolone_decanoate" title="Nandrolone decanoate">nandrolone decanoate</a>, <a href="/wiki/Nandrolone_phenylpropionate" title="Nandrolone phenylpropionate">nandrolone phenylpropionate</a>)</li> <li><a href="/wiki/Norclostebol" title="Norclostebol">Norclostebol</a></li> <li><a href="/wiki/Norclostebol_acetate" title="Norclostebol acetate">Norclostebol acetate</a></li> <li><a href="/wiki/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li> <li><a href="/wiki/Trenbolone_acetate" title="Trenbolone acetate">Trenbolone acetate</a></li> <li><a href="/wiki/Trenbolone_hexahydrobenzylcarbonate" title="Trenbolone hexahydrobenzylcarbonate">Trenbolone hexahydrobenzylcarbonate (trenbolone cyclohexylmethylcarbonate)</a></li></ul> <ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="/wiki/Bolasterone" title="Bolasterone">Bolasterone</a></li> <li><a href="/wiki/Calusterone" title="Calusterone">Calusterone</a></li> <li><a href="/wiki/Chlorodehydromethyltestosterone" title="Chlorodehydromethyltestosterone">Chlorodehydromethyltestosterone (CDMT)</a></li> <li><a href="/wiki/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li> <li><a href="/wiki/Formebolone" title="Formebolone">Formebolone</a></li> <li><a href="/wiki/Metandienone" title="Metandienone">Metandienone (methandienone, methandrostenolone)</a></li> <li><a href="/wiki/Methandriol" title="Methandriol">Methandriol (methylandrostenediol)</a></li> <li><a href="/wiki/Methandriol_bisenanthoyl_acetate" title="Methandriol bisenanthoyl acetate">Methandriol bisenanthoyl acetate</a></li> <li><a href="/wiki/Methandriol_dipropionate" title="Methandriol dipropionate">Methandriol dipropionate</a></li> <li><a href="/wiki/Methandriol_propionate" title="Methandriol propionate">Methandriol propionate</a></li> <li><a href="/wiki/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a></li> <li><a href="/wiki/Methyltestosterone_3-hexyl_ether" title="Methyltestosterone 3-hexyl ether">Methyltestosterone 3-hexyl ether</a></li> <li><a href="/wiki/Oxymesterone" title="Oxymesterone">Oxymesterone</a></li> <li><a href="/wiki/Penmesterol" title="Penmesterol">Penmesterol</a></li> <li><a href="/wiki/Tiomesterone" title="Tiomesterone">Tiomesterone (thiomesterone)</a></li></ul> <ul><li><i>17α-Alkylated dihydrotestosterone derivatives:</i> <a href="/wiki/Androisoxazole" title="Androisoxazole">Androisoxazole</a></li> <li><a href="/wiki/Furazabol" title="Furazabol">Furazabol</a></li> <li><a href="/wiki/Mebolazine" title="Mebolazine">Mebolazine (dimethazine)</a></li> <li><a href="/wiki/Mestanolone" title="Mestanolone">Mestanolone</a></li> <li><a href="/wiki/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li> <li><a href="/wiki/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li> <li><a href="/wiki/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul> <ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> <a href="/wiki/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li> <li><a href="/wiki/Mibolerone" title="Mibolerone">Mibolerone</a></li> <li><a href="/wiki/Norethandrolone" title="Norethandrolone">Norethandrolone</a></li> <li><a href="/wiki/Normethandrone" title="Normethandrone">Normethandrone (methylestrenolone, normethisterone)</a></li> <li><a href="/wiki/Propetandrol" title="Propetandrol">Propetandrol (propethandrol)</a></li></ul> <ul><li><i>17α-Vinyltestosterone derivatives:</i> <a href="/wiki/Norvinisterone" title="Norvinisterone">Norvinisterone (vinylnortestosterone)</a></li></ul> <ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="/wiki/Danazol" title="Danazol">Danazol</a></li> <li><a href="/wiki/Gestrinone" title="Gestrinone">Gestrinone</a></li> <li><a href="/wiki/Progestin" class="mw-redirect" title="Progestin">Progestins</a> (e.g., <a href="/wiki/Ethisterone" title="Ethisterone">ethisterone (ethynyltestosterone)</a>, <a href="/wiki/Levonorgestrel" title="Levonorgestrel">levonorgestrel</a>, <a href="/wiki/Norgestrel" title="Norgestrel">norgestrel</a>, <a href="/wiki/Norethisterone" title="Norethisterone">norethisterone (norethindrone)</a>, <a href="/wiki/Lynestrenol" title="Lynestrenol">lynestrenol</a>, <a href="/wiki/Norgestrienone" title="Norgestrienone">norgestrienone</a>)</li> <li><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a></li></ul> <ul><li><i>Progesterone derivatives:</i> <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Progonadotropin" title="Progonadotropin">Progonadotropins</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Antiestrogen" title="Antiestrogen">Antiestrogens</a> (e.g., <a href="/wiki/Tamoxifen" title="Tamoxifen">tamoxifen</a>, <a href="/wiki/Clomifene" title="Clomifene">clomifene</a>)</li> <li><a href="/wiki/GnRH_agonist" class="mw-redirect" title="GnRH agonist">GnRH agonists</a> (e.g., <a href="/wiki/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">GnRH (gonadorelin)</a>, <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li> <li><a href="/wiki/Gonadotropin" title="Gonadotropin">Gonadotropins</a> (e.g., <a href="/wiki/Luteinizing_hormone" title="Luteinizing hormone"><abbr title="luteinizing hormone">LH</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip luteinizing hormone</span>, <a href="/wiki/Human_chorionic_gonadotropin" title="Human chorionic gonadotropin"><abbr title="human chorionic gonadotropin">hCG</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip human chorionic gonadotropin</span>)</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Antiandrogen" title="Antiandrogen">Antiandrogens</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Androgen_receptor" title="Androgen receptor"><abbr title="Androgen receptor">AR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Androgen receptor</span> <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">antagonists</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Steroidal:</i> <a href="/wiki/Abiraterone_acetate" title="Abiraterone acetate">Abiraterone acetate</a> <a href="/wiki/Niraparib/abiraterone_acetate" title="Niraparib/abiraterone acetate">+niraparib</a></li> <li><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></li> <li><a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">Chlormadinone acetate</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Delmadinone_acetate" title="Delmadinone acetate">Delmadinone acetate</a></li> <li><a href="/wiki/Dienogest" title="Dienogest">Dienogest</a></li> <li><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li> <li><a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a></li> <li><a href="/wiki/Megestrol_acetate" title="Megestrol acetate">Megestrol acetate</a></li> <li><a href="/wiki/Nomegestrol_acetate" title="Nomegestrol acetate">Nomegestrol acetate</a></li> <li><a href="/wiki/Osaterone_acetate" title="Osaterone acetate">Osaterone acetate</a></li> <li><a href="/wiki/Oxendolone" title="Oxendolone">Oxendolone</a></li> <li><a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">Potassium canrenoate</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li></ul> <ul><li><i>Nonsteroidal:</i> <a href="/wiki/Apalutamide" title="Apalutamide">Apalutamide</a></li> <li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Cimetidine" title="Cimetidine">Cimetidine</a></li> <li><a href="/wiki/Darolutamide" title="Darolutamide">Darolutamide</a></li> <li><a href="/wiki/Enzalutamide" title="Enzalutamide">Enzalutamide</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li> <li><a href="/wiki/Nilutamide" title="Nilutamide">Nilutamide</a></li> <li><a href="/wiki/Seviteronel" title="Seviteronel">Seviteronel</a><sup>†</sup></li> <li><a href="/wiki/Topilutamide" title="Topilutamide">Topilutamide (fluridil)</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Steroidogenesis_inhibitor" title="Steroidogenesis inhibitor">Steroidogenesis<br />inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/5%CE%B1-Reductase_inhibitor" title="5α-Reductase inhibitor">5α-Reductase</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li> <li><a href="/wiki/Dutasteride" title="Dutasteride">Dutasteride</a></li> <li><a href="/wiki/Epristeride" title="Epristeride">Epristeride</a></li> <li><a href="/wiki/Finasteride" title="Finasteride">Finasteride</a></li> <li><a href="/wiki/Saw_palmetto_extract" title="Saw palmetto extract">Saw palmetto extract</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Abiraterone_acetate" title="Abiraterone acetate">Abiraterone acetate</a> <a href="/wiki/Niraparib/abiraterone_acetate" title="Niraparib/abiraterone acetate">+niraparib</a></li> <li><a href="/wiki/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li> <li><a href="/wiki/Bifluranol" title="Bifluranol">Bifluranol</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li> <li><a href="/wiki/Nilutamide" title="Nilutamide">Nilutamide</a></li> <li><a href="/wiki/Seviteronel" title="Seviteronel">Seviteronel</a><sup>†</sup></li> <li><a class="mw-selflink selflink">Spironolactone</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;"><a href="/wiki/Antigonadotropin" title="Antigonadotropin">Antigonadotropins</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/D2_receptor" class="mw-redirect" title="D2 receptor">D<sub>2</sub> receptor</a> <a href="/wiki/Dopamine_antagonist" title="Dopamine antagonist">antagonists</a> (<a href="/wiki/Prolactin_releaser" class="mw-redirect" title="Prolactin releaser">prolactin releasers</a>) (e.g., <a href="/wiki/Domperidone" title="Domperidone">domperidone</a>, <a href="/wiki/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>, <a href="/wiki/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="/wiki/Sulpiride" title="Sulpiride">sulpiride</a>)</li> <li><a href="/wiki/Estrogen" title="Estrogen">Estrogens</a> (e.g., <a href="/wiki/Bifluranol" title="Bifluranol">bifluranol</a>, <a href="/wiki/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>, <a href="/wiki/Estradiol" title="Estradiol">estradiol</a>, <a href="/wiki/List_of_estrogen_esters#Estradiol_esters" title="List of estrogen esters">estradiol esters</a>, <a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">ethinylestradiol</a>, <a href="/wiki/Ethinylestradiol_sulfonate" title="Ethinylestradiol sulfonate">ethinylestradiol sulfonate</a>, <a href="/wiki/Paroxypropione" title="Paroxypropione">paroxypropione</a>)</li> <li><a href="/wiki/GnRH_agonist" class="mw-redirect" title="GnRH agonist">GnRH agonists</a> (e.g., <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li> <li><a href="/wiki/GnRH_antagonist" class="mw-redirect" title="GnRH antagonist">GnRH antagonists</a> (e.g., <a href="/wiki/Cetrorelix" title="Cetrorelix">cetrorelix</a>)</li> <li><a href="/wiki/Progestogen" title="Progestogen">Progestogens</a> (incl., <a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">chlormadinone acetate</a>, <a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">cyproterone acetate</a>, <a href="/wiki/Hydroxyprogesterone_caproate" title="Hydroxyprogesterone caproate">hydroxyprogesterone caproate</a>, <a href="/wiki/Gestonorone_caproate" title="Gestonorone caproate">gestonorone caproate</a>, <a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, <a href="/wiki/Megestrol_acetate" title="Megestrol acetate">megestrol acetate</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Androstenedione immunogens:</i> <a href="/wiki/Androvax" title="Androvax">Androvax (androstenedione albumin)</a></li> <li><a href="/wiki/Ovandrotone_albumin" title="Ovandrotone albumin">Ovandrotone albumin (Fecundin)</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist"> <ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li> <li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li> <li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>: <ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li> <li><sup>§</sup>Never to phase III</li></ul></li></ul> </div> <dl><dt>See also</dt> <dd><a href="/wiki/Template:Androgen_receptor_modulators" title="Template:Androgen receptor modulators">Androgen receptor modulators</a></dd> <dd><a href="/wiki/Template:Estrogens_and_antiestrogens" title="Template:Estrogens and antiestrogens">Estrogens and antiestrogens</a></dd> <dd><a href="/wiki/Template:Progestogens_and_antiprogestogens" title="Template:Progestogens and antiprogestogens">Progestogens and antiprogestogens</a></dd> <dd><a href="/wiki/List_of_androgens/anabolic_steroids" class="mw-redirect" title="List of androgens/anabolic steroids">List of androgens/anabolic steroids</a></dd></dl></div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-labelledby="Mineralocorticoids_and_antimineralocorticoids_(H02)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Mineralocorticoids_and_antimineralocorticoids" title="Template:Mineralocorticoids and antimineralocorticoids"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Mineralocorticoids_and_antimineralocorticoids" title="Template talk:Mineralocorticoids and antimineralocorticoids"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Mineralocorticoids_and_antimineralocorticoids" title="Special:EditPage/Template:Mineralocorticoids and antimineralocorticoids"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Mineralocorticoids_and_antimineralocorticoids_(H02)" style="font-size:114%;margin:0 4em"><a href="/wiki/Mineralocorticoid" title="Mineralocorticoid">Mineralocorticoids</a> and <a href="/wiki/Antimineralocorticoid" class="mw-redirect" title="Antimineralocorticoid">antimineralocorticoids</a> (<a href="/wiki/ATC_code_H02" title="ATC code H02">H02</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Mineralocorticoid" title="Mineralocorticoid">Mineralocorticoids</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Deoxycortone" class="mw-redirect" title="Deoxycortone">Desoxycortone (desoxycorticosterone)</a> <ul><li><a href="/wiki/List_of_corticosteroid_esters#Desoxycortone_esters" title="List of corticosteroid esters">Desoxycortone esters</a></li></ul></li> <li><a href="/wiki/Hydrocortisone" title="Hydrocortisone">Hydrocortisone (cortisol)</a> <ul><li><a href="/wiki/List_of_corticosteroid_esters#Hydrocortisone_esters" title="List of corticosteroid esters">Hydrocortisone esters</a></li></ul></li> <li><a href="/wiki/Fludrocortisone" title="Fludrocortisone">Fludrocortisone</a> <ul><li><a href="/wiki/Fludrocortisone_acetate" class="mw-redirect" title="Fludrocortisone acetate">Fludrocortisone acetate</a></li></ul></li> <li><a href="/wiki/Methylprednisolone" title="Methylprednisolone">Methylprednisolone</a> <ul><li><a href="/wiki/List_of_corticosteroid_esters#Methylprednisolone_esters" title="List of corticosteroid esters">Methylprednisolone esters</a></li></ul></li> <li><a href="/wiki/Prednisolone" title="Prednisolone">Prednisolone</a> <ul><li><a href="/wiki/List_of_corticosteroid_esters#Prednisolone_esters" title="List of corticosteroid esters">Prednisolone esters</a></li></ul></li> <li><a href="/wiki/Prednisone" title="Prednisone">Prednisone</a> <ul><li><a href="/wiki/List_of_corticosteroid_esters#Prednisone_esters" title="List of corticosteroid esters">Prednisone esters</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Antimineralocorticoid" class="mw-redirect" title="Antimineralocorticoid">Antimineralocorticoids</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Steroidal:</i> <a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">Canrenoate potassium (potassium canrenoate)</a></li> <li><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></li> <li><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li> <li><a href="/wiki/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li> <li><a href="/wiki/Eplerenone" title="Eplerenone">Eplerenone</a></li> <li><a href="/wiki/Gestodene" title="Gestodene">Gestodene</a></li> <li><a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a></li> <li><a href="/wiki/Progesterone" title="Progesterone">Progesterone</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li> <li><a href="/wiki/Trimegestone" title="Trimegestone">Trimegestone</a></li></ul> <ul><li><i>Nonsteroidal:</i> <a href="/wiki/Amlodipine" title="Amlodipine">Amlodipine</a></li> <li><a href="/wiki/Apararenone" title="Apararenone">Apararenone</a><sup>§</sup></li> <li><a href="/wiki/Benidipine" title="Benidipine">Benidipine</a></li> <li><a href="/wiki/Esaxerenone" title="Esaxerenone">Esaxerenone</a><sup>†</sup></li> <li><a href="/wiki/Felodipine" title="Felodipine">Felodipine</a></li> <li><a href="/wiki/Finerenone" title="Finerenone">Finerenone</a></li> <li><a href="/wiki/Nifedipine" title="Nifedipine">Nifedipine</a></li> <li><a href="/wiki/Nimodipine" title="Nimodipine">Nimodipine</a></li> <li><a href="/wiki/Nitrendipine" title="Nitrendipine">Nitrendipine</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Steroidogenesis_inhibitor" title="Steroidogenesis inhibitor">Synthesis modifiers</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Acetoxolone" title="Acetoxolone">Acetoxolone</a></li> <li><a href="/wiki/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li> <li><a href="/wiki/Carbenoxolone" title="Carbenoxolone">Carbenoxolone</a></li> <li><a href="/wiki/Enoxolone" title="Enoxolone">Enoxolone</a></li> <li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li> <li><a href="/wiki/Metyrapone" title="Metyrapone">Metyrapone</a></li> <li><a href="/wiki/Mitotane" title="Mitotane">Mitotane</a></li> <li><a href="/wiki/Trilostane" title="Trilostane">Trilostane</a></li></ul> </div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist"> <ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li> <li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li> <li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>: <ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li> <li><sup>§</sup>Never to phase III</li></ul></li></ul> </div> <dl><dt>See also</dt> <dd><a href="/wiki/Template:Mineralocorticoid_receptor_modulators" title="Template:Mineralocorticoid receptor modulators">Mineralocorticoid receptor modulators</a></dd> <dd><a href="/wiki/Template:Glucocorticoids_and_antiglucocorticoids" title="Template:Glucocorticoids and antiglucocorticoids">Glucocorticoids and antiglucocorticoids</a></dd> <dd><a href="/wiki/List_of_corticosteroids" title="List of corticosteroids">List of corticosteroids</a></dd></dl></div></td></tr></tbody></table></div></div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Pharmacodynamics" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Pharmacodynamics" style="font-size:114%;margin:0 4em"><a href="/wiki/Pharmacodynamics" title="Pharmacodynamics">Pharmacodynamics</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0;font-size:114%"><div style="padding:0px"> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Androgen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Androgen_receptor_modulators" title="Template:Androgen receptor modulators"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Androgen_receptor_modulators" title="Template talk:Androgen receptor modulators"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Androgen_receptor_modulators" title="Special:EditPage/Template:Androgen receptor modulators"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Androgen_receptor_modulators" style="font-size:114%;margin:0 4em"><a href="/wiki/Androgen_receptor" title="Androgen receptor">Androgen receptor</a> <a href="/wiki/Receptor_modulator" title="Receptor modulator">modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Androgen_receptor" title="Androgen receptor"><abbr title="Androgen receptor">AR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Androgen receptor</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Testosterone derivatives:</i> <a href="/wiki/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li> <li><a href="/wiki/4-Dehydroepiandrosterone" title="4-Dehydroepiandrosterone">4-Dehydroepiandrosterone (4-DHEA)</a></li> <li><a href="/wiki/4-Hydroxytestosterone" title="4-Hydroxytestosterone">4-Hydroxytestosterone</a></li> <li><a href="/w/index.php?title=4,17%CE%B1-Dimethyltestosterone&action=edit&redlink=1" class="new" title="4,17α-Dimethyltestosterone (page does not exist)">4,17α-Dimethyltestosterone</a></li> <li><a href="/wiki/5-Androstenedione" title="5-Androstenedione">5-Androstenedione</a></li> <li><a href="/wiki/11-Ketotestosterone" title="11-Ketotestosterone">11-Ketotestosterone</a></li> <li><a href="/wiki/11%CE%B2-Hydroxyandrostenedione" title="11β-Hydroxyandrostenedione">11β-Hydroxyandrostenedione</a></li> <li><a href="/wiki/Adrenosterone" title="Adrenosterone">Adrenosterone (11-ketoandrostenedione, 11-oxoandrostenedione)</a></li> <li><a href="/wiki/5-Androstenediol" class="mw-redirect" title="5-Androstenediol">Androstenediol (5-androstenediol)</a> <ul><li><a href="/wiki/Androstenediol_3%CE%B2-acetate" title="Androstenediol 3β-acetate">Androstenediol 3β-acetate</a></li> <li><a href="/wiki/Androstenediol_17%CE%B2-acetate" title="Androstenediol 17β-acetate">Androstenediol 17β-acetate</a></li> <li><a href="/wiki/Androstenediol_diacetate" title="Androstenediol diacetate">Androstenediol diacetate</a></li> <li><a href="/wiki/Androstenediol_dipropionate" title="Androstenediol dipropionate">Androstenediol dipropionate</a></li></ul></li> <li><a href="/wiki/4-Androstenedione" class="mw-redirect" title="4-Androstenedione">Androstenedione (4-androstenedione)</a></li> <li><a href="/wiki/Atamestane" title="Atamestane">Atamestane</a></li> <li><a href="/wiki/Boldenone" title="Boldenone">Boldenone</a> <ul><li><a href="/wiki/Boldenone_undecylenate" title="Boldenone undecylenate">Boldenone undecylenate</a></li></ul></li> <li><a href="/wiki/Boldione" title="Boldione">Boldione (1,4-androstadienedione)</a></li> <li><a href="/wiki/Clostebol" title="Clostebol">Clostebol</a> <ul><li><a href="/wiki/Clostebol_acetate" title="Clostebol acetate">Clostebol acetate</a></li> <li><a href="/wiki/Clostebol_caproate" title="Clostebol caproate">Clostebol caproate</a></li> <li><a href="/wiki/Clostebol_propionate" title="Clostebol propionate">Clostebol propionate</a></li></ul></li> <li><a href="/wiki/Cloxotestosterone" title="Cloxotestosterone">Cloxotestosterone</a> <ul><li><a href="/wiki/Cloxotestosterone_acetate" title="Cloxotestosterone acetate">Cloxotestosterone acetate</a></li></ul></li> <li><a href="/wiki/Dehydroandrosterone" title="Dehydroandrosterone">Dehydroandrosterone</a></li> <li><a href="/wiki/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA (androstenolone, prasterone; 5-DHEA)</a> <ul><li><a href="/wiki/Prasterone_enanthate" title="Prasterone enanthate">DHEA enanthate (prasterone enanthate)</a></li> <li><a href="/wiki/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA sulfate</a></li></ul></li> <li><a href="/wiki/Exemestane" title="Exemestane">Exemestane</a></li> <li><a href="/wiki/Formestane" title="Formestane">Formestane</a></li> <li><a href="/wiki/Plomestane" title="Plomestane">Plomestane</a></li> <li><a href="/wiki/Quinbolone" title="Quinbolone">Quinbolone</a></li> <li><a href="/wiki/Silandrone" title="Silandrone">Silandrone</a></li> <li><a href="/wiki/Testosterone_(medication)" title="Testosterone (medication)">Testosterone</a><sup>#</sup> (<a href="/wiki/Testosterone/dutasteride" title="Testosterone/dutasteride">+dutasteride</a>) <ul><li><a href="/wiki/List_of_androgen_esters#Testosterone_esters" title="List of androgen esters">Testosterone esters</a></li> <li><a href="/wiki/Polytestosterone_phloretin_phosphate" title="Polytestosterone phloretin phosphate">Polytestosterone phloretin phosphate</a></li></ul></li></ul> <ul><li><i>5α-Dihydrotestosterone derivatives:</i> <a href="/wiki/1-Androstenediol" title="1-Androstenediol">1-Androstenediol</a></li> <li><a href="/wiki/1-Androstenedione" title="1-Androstenedione">1-Androstenedione</a></li> <li><a href="/wiki/1-Androsterone" title="1-Androsterone">1-Androsterone (1-andro, 1-DHEA)</a></li> <li><a href="/wiki/1-Testosterone" title="1-Testosterone">1-Testosterone</a></li> <li><a href="/wiki/3%CE%B1-Androstanediol" title="3α-Androstanediol">3α-Androstanediol</a></li> <li><a href="/wiki/5%CE%B1-Androst-2-en-17-one" class="mw-redirect" title="5α-Androst-2-en-17-one">5α-Androst-2-en-17-one</a></li> <li><a href="/wiki/7%CE%B2-Hydroxyepiandrosterone" title="7β-Hydroxyepiandrosterone">7β-Hydroxyepiandrosterone</a></li> <li><a href="/wiki/11-Ketodihydrotestosterone" title="11-Ketodihydrotestosterone">11-Ketodihydrotestosterone</a></li> <li><a href="/wiki/Androsterone" title="Androsterone">Androsterone</a></li> <li><a href="/wiki/Bolazine" title="Bolazine">Bolazine</a> <ul><li><a href="/wiki/Bolazine_capronate" title="Bolazine capronate">Bolazine capronate</a></li></ul></li> <li><a href="/w/index.php?title=Dihydroethyltestosterone&action=edit&redlink=1" class="new" title="Dihydroethyltestosterone (page does not exist)">Dihydroethyltestosterone</a></li> <li><a href="/wiki/Dihydrofluoxymesterone" title="Dihydrofluoxymesterone">Dihydrofluoxymesterone</a></li> <li><a href="/w/index.php?title=Dihydromethylandrostenediol&action=edit&redlink=1" class="new" title="Dihydromethylandrostenediol (page does not exist)">Dihydromethylandrostenediol</a></li> <li><a href="/wiki/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone (DHT)</a> (<a href="/wiki/Androstanolone" title="Androstanolone">androstanolone, stanolone</a>) <ul><li><a href="/wiki/List_of_androgen_esters#Dihydrotestosterone_esters" title="List of androgen esters">Dihydrotestosterone esters</a></li></ul></li> <li><a href="/wiki/Drostanolone" title="Drostanolone">Drostanolone</a> <ul><li><a href="/wiki/Drostanolone_propionate" title="Drostanolone propionate">Drostanolone propionate</a></li></ul></li> <li><a href="/wiki/Epiandrosterone" title="Epiandrosterone">Epiandrosterone</a></li> <li><a href="/wiki/Epitiostanol" title="Epitiostanol">Epitiostanol</a></li> <li><a href="/wiki/Mepitiostane" title="Mepitiostane">Mepitiostane</a></li> <li><a href="/wiki/Mesabolone" title="Mesabolone">Mesabolone</a></li> <li><a href="/wiki/Mesterolone" title="Mesterolone">Mesterolone</a> <ul><li><a href="/wiki/Mesterolone_cipionate" title="Mesterolone cipionate">Mesterolone cipionate</a></li></ul></li> <li><a href="/wiki/Methyldiazinol" title="Methyldiazinol">Methyldiazinol</a></li> <li><a href="/wiki/Nisterime" title="Nisterime">Nisterime</a> <ul><li><a href="/wiki/Nisterime_acetate" title="Nisterime acetate">Nisterime acetate</a></li></ul></li> <li><a href="/wiki/Prostanozol" title="Prostanozol">Prostanozol</a></li> <li><a href="/wiki/Stenbolone" title="Stenbolone">Stenbolone</a> <ul><li><a href="/wiki/Stenbolone_acetate" title="Stenbolone acetate">Stenbolone acetate</a></li></ul></li> <li><a href="/wiki/Testifenon" title="Testifenon">Testifenon (testiphenon, testiphenone)</a></li></ul> <ul><li><i>19-Nortestosterone derivatives:</i> <a href="/wiki/7%CE%B1-Methyl-19-norandrostenedione" title="7α-Methyl-19-norandrostenedione">7α-Methyl-19-norandrostenedione (MENT dione, trestione)</a></li> <li><a href="/wiki/11%CE%B2-Methyl-19-nortestosterone" title="11β-Methyl-19-nortestosterone">11β-Methyl-19-nortestosterone</a> <ul><li><a href="/wiki/11%CE%B2-Methyl-19-nortestosterone_dodecylcarbonate" title="11β-Methyl-19-nortestosterone dodecylcarbonate">11β-Methyl-19-nortestosterone dodecylcarbonate</a></li></ul></li> <li><a href="/wiki/19-Nor-5-androstenediol" title="19-Nor-5-androstenediol">19-Nor-5-androstenediol</a></li> <li><a href="/wiki/19-Nor-5-androstenedione" title="19-Nor-5-androstenedione">19-Nor-5-androstenedione</a></li> <li><a href="/wiki/19-Nordehydroepiandrosterone" title="19-Nordehydroepiandrosterone">19-Nordehydroepiandrosterone</a></li> <li><a href="/wiki/Bolandiol" title="Bolandiol">Bolandiol</a> <ul><li><a href="/wiki/Bolandiol_dipropionate" title="Bolandiol dipropionate">Bolandiol dipropionate</a></li></ul></li> <li><a href="/wiki/Bolandione" title="Bolandione">Bolandione (19-nor-4-androstenedione)</a></li> <li><a href="/wiki/Bolmantalate" title="Bolmantalate">Bolmantalate (nandrolone adamantoate)</a></li> <li><a href="/wiki/Dienedione" title="Dienedione">Dienedione</a></li> <li><a href="/wiki/Dienolone" title="Dienolone">Dienolone</a></li> <li><a href="/wiki/Dimethandrolone" title="Dimethandrolone">Dimethandrolone</a> <ul><li><a href="/wiki/Dimethandrolone_buciclate" title="Dimethandrolone buciclate">Dimethandrolone buciclate</a></li> <li><a href="/wiki/Dimethandrolone_dodecylcarbonate" title="Dimethandrolone dodecylcarbonate">Dimethandrolone dodecylcarbonate</a></li> <li><a href="/wiki/Dimethandrolone_undecanoate" title="Dimethandrolone undecanoate">Dimethandrolone undecanoate</a></li></ul></li> <li><a href="/wiki/LS-1727" title="LS-1727">LS-1727 (nandrolone 17β-<i>N</i>-(2-chloroethyl)-<i>N</i>-nitrosocarbamate)</a></li> <li><a href="/wiki/Methoxydienone" title="Methoxydienone">Methoxydienone (methoxygonadiene)</a></li> <li><a href="/wiki/Nandrolone" title="Nandrolone">Nandrolone</a> <ul><li><a href="/wiki/List_of_androgen_esters#Nandrolone_esters" title="List of androgen esters">Nandrolone esters</a></li></ul></li> <li><a href="/wiki/Norclostebol" title="Norclostebol">Norclostebol</a> <ul><li><a href="/wiki/Norclostebol_acetate" title="Norclostebol acetate">Norclostebol acetate</a></li></ul></li> <li><a href="/wiki/Normethandrone" title="Normethandrone">Normethandrone (methylestrenolone, normethisterone)</a></li> <li><a href="/wiki/Oxabolone" title="Oxabolone">Oxabolone</a> <ul><li><a href="/wiki/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li></ul></li> <li><a href="/wiki/Trenbolone" title="Trenbolone">Trenbolone</a> <ul><li><a href="/wiki/Trenbolone_acetate" title="Trenbolone acetate">Trenbolone acetate</a></li> <li><a href="/wiki/Trenbolone_enanthate" title="Trenbolone enanthate">Trenbolone enanthate</a></li> <li><a href="/wiki/Trenbolone_hexahydrobenzylcarbonate" title="Trenbolone hexahydrobenzylcarbonate">Trenbolone hexahydrobenzylcarbonate</a></li> <li><a href="/wiki/Trenbolone_undecanoate" title="Trenbolone undecanoate">Trenbolone undecanoate</a></li></ul></li> <li><a href="/wiki/Trendione" title="Trendione">Trendione</a></li> <li><a href="/wiki/Trestolone" title="Trestolone">Trestolone (MENT)</a> <ul><li><a href="/wiki/Trestolone_acetate" title="Trestolone acetate">Trestolone acetate</a></li> <li><a href="/wiki/Trestolone_enanthate" title="Trestolone enanthate">Trestolone enanthate</a></li></ul></li></ul> <ul><li><i>5α-Dihydro-19-nortestosterone derivatives:</i> <a href="/wiki/5%CE%B1-Dihydronandrolone" title="5α-Dihydronandrolone">5α-Dihydronandrolone</a></li> <li><a href="/w/index.php?title=5%CE%B1-Dihydrotrestolone&action=edit&redlink=1" class="new" title="5α-Dihydrotrestolone (page does not exist)">5α-Dihydrotrestolone</a></li> <li><a href="/wiki/19-Norandrosterone" title="19-Norandrosterone">19-Norandrosterone</a></li></ul> <ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="/wiki/Bolasterone" title="Bolasterone">Bolasterone</a></li> <li><a href="/wiki/Calusterone" title="Calusterone">Calusterone</a></li> <li><a href="/wiki/Chlorodehydromethylandrostenediol" title="Chlorodehydromethylandrostenediol">Chlorodehydromethylandrostenediol (CDMA)</a></li> <li><a href="/wiki/Chlorodehydromethyltestosterone" title="Chlorodehydromethyltestosterone">Chlorodehydromethyltestosterone (CDMT)</a></li> <li><a href="/wiki/Chloromethylandrostenediol" title="Chloromethylandrostenediol">Chloromethylandrostenediol (CMA)</a></li> <li><a href="/wiki/Enestebol" title="Enestebol">Enestebol</a></li> <li><a href="/wiki/Ethyltestosterone" title="Ethyltestosterone">Ethyltestosterone</a></li> <li><a href="/wiki/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li> <li><a href="/wiki/Formebolone" title="Formebolone">Formebolone</a></li> <li><a href="/wiki/Hydroxystenozole" title="Hydroxystenozole">Hydroxystenozole</a></li> <li><a href="/wiki/Metandienone" title="Metandienone">Metandienone (methandrostenolone)</a></li> <li><a href="/wiki/Methandriol" title="Methandriol">Methandriol (methylandrostenediol)</a> <ul><li><a href="/wiki/Methandriol_bisenanthoyl_acetate" title="Methandriol bisenanthoyl acetate">Methandriol bisenanthoyl acetate</a></li> <li><a href="/wiki/Methandriol_diacetate" title="Methandriol diacetate">Methandriol diacetate</a></li> <li><a href="/wiki/Methandriol_dipropionate" title="Methandriol dipropionate">Methandriol dipropionate</a></li> <li><a href="/wiki/Methandriol_propionate" title="Methandriol propionate">Methandriol propionate</a></li></ul></li> <li><a href="/wiki/Methylclostebol" title="Methylclostebol">Methylclostebol (chloromethyltestosterone)</a></li> <li><a href="/wiki/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a> (<a href="/wiki/Esterified_estrogens/methyltestosterone" title="Esterified estrogens/methyltestosterone">+esterified estrogens</a>) <ul><li><a href="/wiki/Methyltestosterone_3-hexyl_ether" title="Methyltestosterone 3-hexyl ether">Methyltestosterone 3-hexyl ether</a></li></ul></li> <li><a href="/wiki/Oxymesterone" title="Oxymesterone">Oxymesterone</a></li> <li><a href="/wiki/Penmesterol" title="Penmesterol">Penmesterol</a></li> <li><a href="/wiki/Tiomesterone" title="Tiomesterone">Tiomesterone</a></li></ul> <ul><li><i>17α-Alkylated 5α-dihydrotestosterone derivatives:</i> <a href="/wiki/Androisoxazole" title="Androisoxazole">Androisoxazole</a></li> <li><a href="/wiki/Desoxymethyltestosterone" title="Desoxymethyltestosterone">Desoxymethyltestosterone</a></li> <li><a href="/wiki/Furazabol" title="Furazabol">Furazabol</a></li> <li><a href="/wiki/Mebolazine" title="Mebolazine">Mebolazine (dimethazine)</a></li> <li><a href="/wiki/Mestanolone" title="Mestanolone">Mestanolone</a></li> <li><a href="/wiki/Metenolone" title="Metenolone">Metenolone</a> <ul><li><a href="/wiki/Metenolone_acetate" title="Metenolone acetate">Metenolone acetate</a></li> <li><a href="/wiki/Metenolone_enanthate" title="Metenolone enanthate">Metenolone enanthate</a></li></ul></li> <li><a href="/wiki/Methasterone" title="Methasterone">Methasterone</a></li> <li><a href="/wiki/Methyl-1-testosterone" title="Methyl-1-testosterone">Methyl-1-testosterone</a></li> <li><a href="/wiki/Methylepitiostanol" title="Methylepitiostanol">Methylepitiostanol</a></li> <li><a href="/wiki/Methylstenbolone" title="Methylstenbolone">Methylstenbolone</a></li> <li><a href="/wiki/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li> <li><a href="/wiki/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li> <li><a href="/wiki/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul> <ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> <a href="/wiki/Bolenol" title="Bolenol">Bolenol</a></li> <li><a href="/wiki/Dimethyldienolone" title="Dimethyldienolone">Dimethyldienolone</a></li> <li><a href="/wiki/Dimethyltrienolone" title="Dimethyltrienolone">Dimethyltrienolone</a></li> <li><a href="/wiki/Ethyldienolone" title="Ethyldienolone">Ethyldienolone</a></li> <li><a href="/wiki/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li> <li><a href="/wiki/Methyldienolone" title="Methyldienolone">Methyldienolone</a></li> <li><a href="/wiki/Methylhydroxynandrolone" title="Methylhydroxynandrolone">Methylhydroxynandrolone (MOHN, MHN)</a></li> <li><a href="/wiki/Metribolone" title="Metribolone">Metribolone</a></li> <li><a href="/wiki/Mibolerone" title="Mibolerone">Mibolerone</a></li> <li><a href="/wiki/Norboletone" title="Norboletone">Norboletone</a></li> <li><a href="/wiki/Norethandrolone" title="Norethandrolone">Norethandrolone</a></li> <li><a href="/wiki/Propetandrol" title="Propetandrol">Propetandrol</a></li> <li><a href="/wiki/RU-2309" title="RU-2309">RU-2309</a></li> <li><a href="/wiki/Tetrahydrogestrinone" title="Tetrahydrogestrinone">Tetrahydrogestrinone</a></li></ul> <ul><li><i>17α-Alkylated 5α-dihydro-19-nortestosterone derivatives:</i> <a href="/wiki/5%CE%B1-Dihydronorethandrolone" title="5α-Dihydronorethandrolone">5α-Dihydronorethandrolone</a></li> <li><a href="/wiki/5%CE%B1-Dihydronormethandrone" title="5α-Dihydronormethandrone">5α-Dihydronormethandrone</a></li></ul> <ul><li><i>17α-Vinyltestosterone derivatives:</i> <a href="/wiki/Norvinisterone" title="Norvinisterone">Norvinisterone (vinylnortestosterone)</a></li></ul> <ul><li><i>17α-Vinyl-19-nortestosterone derivatives:</i> <a href="/wiki/Vinyltestosterone" title="Vinyltestosterone">Vinyltestosterone</a></li></ul> <ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="/wiki/Danazol" title="Danazol">Danazol</a></li> <li><a href="/wiki/Ethinylandrostenediol" title="Ethinylandrostenediol">Ethinylandrostenediol</a> <ul><li><a href="/wiki/Ethandrostate" title="Ethandrostate">Ethandrostate</a></li></ul></li> <li><a href="/wiki/Ethisterone" title="Ethisterone">Ethisterone (ethynyltestosterone)</a></li></ul> <ul><li><i>5α-Dihydro-17α-ethynyltestosterone derivatives:</i> <a href="/wiki/17%CE%B1-Ethynyl-3%CE%B1-androstanediol" title="17α-Ethynyl-3α-androstanediol">17α-Ethynyl-3α-androstanediol</a></li> <li><a href="/wiki/17%CE%B1-Ethynyl-3%CE%B2-androstanediol" title="17α-Ethynyl-3β-androstanediol">17α-Ethynyl-3β-androstanediol</a></li> <li><a href="/wiki/Dihydroethisterone" class="mw-redirect" title="Dihydroethisterone">Dihydroethisterone</a></li></ul> <ul><li><i>17α-Ethynyl-19-nortestosterone derivatives:</i> <a href="/wiki/%CE%944-Tibolone" title="Δ4-Tibolone">Δ<sup>4</sup>-Tibolone</a></li> <li><a href="/wiki/Desogestrel" title="Desogestrel">Desogestrel</a></li> <li><a href="/wiki/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li> <li><a href="/wiki/Etynodiol" title="Etynodiol">Etynodiol</a> <ul><li><a href="/wiki/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li></ul></li> <li><a href="/wiki/Gestodene" title="Gestodene">Gestodene</a></li> <li><a href="/wiki/Gestrinone" title="Gestrinone">Gestrinone</a></li> <li><a href="/wiki/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a></li> <li><a href="/wiki/Levonorgestrel_ester" class="mw-redirect" title="Levonorgestrel ester">Levonorgestrel esters</a> (e.g., <a href="/wiki/Levonorgestrel_butanoate" title="Levonorgestrel butanoate">levonorgestrel butanoate</a>)</li> <li><a href="/wiki/Lynestrenol" title="Lynestrenol">Lynestrenol</a> <ul><li><a href="/wiki/Lynestrenol_phenylpropionate" title="Lynestrenol phenylpropionate">Lynestrenol phenylpropionate</a></li></ul></li> <li><a href="/wiki/Norethisterone" title="Norethisterone">Norethisterone</a></li> <li><a href="/wiki/Norethisterone_ester" class="mw-redirect" title="Norethisterone ester">Norethisterone esters</a> (e.g., <a href="/wiki/Norethisterone_acetate" title="Norethisterone acetate">norethisterone acetate</a>, <a href="/wiki/Norethisterone_enanthate" title="Norethisterone enanthate">norethisterone enanthate</a>)</li> <li><a href="/wiki/Norgestrel" title="Norgestrel">Norgestrel</a></li> <li><a href="/wiki/Norgestrienone" title="Norgestrienone">Norgestrienone</a></li> <li><a href="/wiki/Quingestanol" title="Quingestanol">Quingestanol</a> <ul><li><a href="/wiki/Quingestanol_acetate" title="Quingestanol acetate">Quingestanol acetate</a></li></ul></li> <li><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a></li></ul> <ul><li><i>5α-Dihydro-17α-ethynyl-19-nortestosterone derivatives:</i> <a href="/wiki/5%CE%B1-Dihydrolevonorgestrel" title="5α-Dihydrolevonorgestrel">5α-Dihydrolevonorgestrel</a></li> <li><a href="/wiki/5%CE%B1-Dihydronorethisterone" title="5α-Dihydronorethisterone">5α-Dihydronorethisterone</a></li></ul> <ul><li><i>Progesterone derivatives:</i> <a href="/wiki/6%CE%B1-Methylprogesterone" title="6α-Methylprogesterone">6α-Methylprogesterone</a></li> <li><a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li> <li><a href="/wiki/Megestrol_acetate" title="Megestrol acetate">Megestrol acetate</a></li></ul> <ul><li><i>Others/unsorted:</i> <a href="/wiki/3-Keto-5%CE%B1-abiraterone" title="3-Keto-5α-abiraterone">3-Keto-5α-abiraterone</a></li> <li><a href="/wiki/5%CE%B1-Androstane" class="mw-redirect" title="5α-Androstane">5α-Androstane</a></li> <li><a href="/wiki/Alternariol" title="Alternariol">Alternariol</a></li> <li><a href="/wiki/Cl-4AS-1" title="Cl-4AS-1">Cl-4AS-1</a></li> <li><a href="/wiki/Drupanol" title="Drupanol">Drupanol</a></li> <li><a href="/wiki/Trilostane" title="Trilostane">Trilostane</a></li> <li><a href="/wiki/ZM-182345" title="ZM-182345">ZM-182345</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center"><a href="/wiki/Selective_androgen_receptor_modulator" title="Selective androgen receptor modulator"><abbr title="Selective androgen receptor modulator">SARMs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Selective androgen receptor modulator</span></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Nonsteroidal:</i> <a href="/w/index.php?title=198RL26&action=edit&redlink=1" class="new" title="198RL26 (page does not exist)">198RL26</a></li> <li><a href="/wiki/ACP-105" title="ACP-105">ACP-105</a></li> <li><a href="/wiki/AC-262,536" title="AC-262,536">AC-262,536</a></li> <li><a href="/wiki/Acetothiolutamide" title="Acetothiolutamide">Acetothiolutamide</a></li> <li><a href="/wiki/Acetoxolutamide" title="Acetoxolutamide">Acetoxolutamide</a></li> <li><a href="/wiki/Andarine" title="Andarine">Andarine (acetamidoxolutamide, androxolutamide, GTx-007, S-4)</a></li> <li><a href="/wiki/BMS-564,929" title="BMS-564,929">BMS-564,929</a></li> <li><a href="/w/index.php?title=DTIB&action=edit&redlink=1" class="new" title="DTIB (page does not exist)">DTIB</a></li> <li><a href="/wiki/Enobosarm" title="Enobosarm">Enobosarm (ostarine, MK-2866, GTx-024, S-22)</a></li> <li><a href="/w/index.php?title=FTBU-1&action=edit&redlink=1" class="new" title="FTBU-1 (page does not exist)">FTBU-1</a></li> <li><a href="/wiki/GLPG-0492" title="GLPG-0492">GLPG-0492</a></li> <li><a href="/wiki/GSK2881078" title="GSK2881078">GSK2881078</a></li> <li><a href="/wiki/GSK-4336A" title="GSK-4336A">GSK-4336A</a></li> <li><a href="/w/index.php?title=GSK-8698&action=edit&redlink=1" class="new" title="GSK-8698 (page does not exist)">GSK-8698</a></li> <li><a href="/wiki/LG121071" title="LG121071">LG121071 (LGD-121071)</a></li> <li><a href="/wiki/LGD-2226" title="LGD-2226">LGD-2226</a></li> <li><a href="/wiki/LGD-2941" title="LGD-2941">LGD-2941 (LGD-122941)</a></li> <li><a href="/wiki/LGD-3303" title="LGD-3303">LGD-3303</a></li> <li><a href="/wiki/LGD-4033" class="mw-redirect" title="LGD-4033">LGD-4033</a></li> <li><a href="/wiki/LY305" title="LY305">LY305</a></li> <li><a href="/wiki/JNJ-26146900" title="JNJ-26146900">JNJ-26146900</a></li> <li><a href="/wiki/JNJ-28330835" title="JNJ-28330835">JNJ-28330835</a></li> <li><a href="/wiki/JNJ-37654032" title="JNJ-37654032">JNJ-37654032</a></li> <li><a href="/wiki/OPK-88004" title="OPK-88004">OPK-88004 (LY-2452473, TT-701)</a></li> <li><a href="/w/index.php?title=ORM-11984&action=edit&redlink=1" class="new" title="ORM-11984 (page does not exist)">ORM-11984</a></li> <li><a href="/wiki/PF-06260414" title="PF-06260414">PF-06260414</a></li> <li><a href="/w/index.php?title=R-1_(drug)&action=edit&redlink=1" class="new" title="R-1 (drug) (page does not exist)">R-1</a></li> <li><a href="/wiki/RU-59063" title="RU-59063">RU-59063</a></li> <li><a href="/w/index.php?title=S-1_(drug)&action=edit&redlink=1" class="new" title="S-1 (drug) (page does not exist)">S-1</a></li> <li><a href="/wiki/S-23_(drug)" title="S-23 (drug)">S-23</a></li> <li><a href="/wiki/S-40503" title="S-40503">S-40503</a></li> <li><a href="/w/index.php?title=S-101479&action=edit&redlink=1" class="new" title="S-101479 (page does not exist)">S-101479</a></li> <li><a href="/wiki/Vosilasarm" title="Vosilasarm">Vosilasarm</a></li></ul> <ul><li><i>Steroidal:</i> <a href="/w/index.php?title=EM-9017&action=edit&redlink=1" class="new" title="EM-9017 (page does not exist)">EM-9017</a></li> <li><a href="/wiki/MK-0773" title="MK-0773">MK-0773</a></li> <li><a href="/wiki/TFM-4AS-1" title="TFM-4AS-1">TFM-4AS-1</a></li> <li><a href="/wiki/YK-11" title="YK-11">YK-11</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Steroidal:</i> <a href="/wiki/7%CE%B1-Thioprogesterone" title="7α-Thioprogesterone">7α-Thioprogesterone</a></li> <li><a href="/wiki/7%CE%B1-Thiospironolactone" title="7α-Thiospironolactone">7α-Thiospironolactone</a></li> <li><a href="/wiki/7%CE%B1-Thiomethylspironolactone" title="7α-Thiomethylspironolactone">7α-Thiomethylspironolactone</a></li> <li><a href="/wiki/11%CE%B1-Hydroxyprogesterone" title="11α-Hydroxyprogesterone">11α-Hydroxyprogesterone</a></li> <li><a href="/wiki/15%CE%B2-Hydroxycyproterone_acetate" title="15β-Hydroxycyproterone acetate">15β-Hydroxycyproterone acetate</a></li> <li><a href="/wiki/Abiraterone" class="mw-redirect" title="Abiraterone">Abiraterone</a></li> <li><a href="/wiki/Abiraterone_acetate" title="Abiraterone acetate">Abiraterone acetate</a></li> <li><a href="/wiki/Allyltestosterone" title="Allyltestosterone">Allyltestosterone</a></li> <li><a href="/wiki/Benorterone" title="Benorterone">Benorterone</a></li> <li><a href="/wiki/BOMT" title="BOMT">BOMT</a></li> <li><a href="/wiki/Canrenoic_acid" title="Canrenoic acid">Canrenoic acid</a></li> <li><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></li> <li><a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">Chlormadinone acetate</a></li> <li><a href="/wiki/Clascoterone" title="Clascoterone">Clascoterone</a></li> <li><a href="/wiki/Clometerone" title="Clometerone">Clometerone</a></li> <li><a href="/wiki/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li> <li><a href="/wiki/Cyproterone" title="Cyproterone">Cyproterone</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Delanterone" title="Delanterone">Delanterone</a></li> <li><a href="/wiki/Delmadinone_acetate" title="Delmadinone acetate">Delmadinone acetate</a></li> <li><a href="/wiki/Dicirenone" title="Dicirenone">Dicirenone</a></li> <li><a href="/wiki/Dienogest" title="Dienogest">Dienogest</a></li> <li><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li> <li><a href="/wiki/DU-41165" title="DU-41165">DU-41165</a></li> <li><a href="/wiki/Edogestrone" title="Edogestrone">Edogestrone</a></li> <li><a href="/w/index.php?title=EM-4350&action=edit&redlink=1" class="new" title="EM-4350 (page does not exist)">EM-4350</a></li> <li><a href="/wiki/EM-5854" title="EM-5854">EM-5854</a></li> <li><a href="/w/index.php?title=EM-5855&action=edit&redlink=1" class="new" title="EM-5855 (page does not exist)">EM-5855</a></li> <li><a href="/w/index.php?title=EM-6537&action=edit&redlink=1" class="new" title="EM-6537 (page does not exist)">EM-6537</a></li> <li><a href="/wiki/Epitestosterone" title="Epitestosterone">Epitestosterone</a></li> <li><a href="/wiki/Galeterone" title="Galeterone">Galeterone</a></li> <li><a href="/wiki/Guggulsterone" title="Guggulsterone">Guggulsterone</a></li> <li><a href="/w/index.php?title=Ludaterone&action=edit&redlink=1" class="new" title="Ludaterone (page does not exist)">Ludaterone</a></li> <li><a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a></li> <li><a href="/wiki/Megestrol_acetate" title="Megestrol acetate">Megestrol acetate</a></li> <li><a href="/wiki/Mespirenone" title="Mespirenone">Mespirenone</a></li> <li><a href="/wiki/Metogest" title="Metogest">Metogest</a></li> <li><a href="/wiki/Mexrenone" title="Mexrenone">Mexrenone</a></li> <li><a href="/wiki/Mifepristone" title="Mifepristone">Mifepristone</a></li> <li><a href="/wiki/Nomegestrol_acetate" title="Nomegestrol acetate">Nomegestrol acetate</a></li> <li><a href="/wiki/Nordinone" title="Nordinone">Nordinone</a></li> <li><a href="/wiki/Osaterone" title="Osaterone">Osaterone</a></li> <li><a href="/wiki/Osaterone_acetate" title="Osaterone acetate">Osaterone acetate</a></li> <li><a href="/wiki/Oxendolone" title="Oxendolone">Oxendolone</a></li> <li><a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">Potassium canrenoate</a></li> <li><a href="/wiki/Promegestone" title="Promegestone">Promegestone</a></li> <li><a href="/wiki/Prorenone" title="Prorenone">Prorenone</a></li> <li><a href="/wiki/Rosterolone" title="Rosterolone">Rosterolone</a></li> <li><a href="/w/index.php?title=RU-15328&action=edit&redlink=1" class="new" title="RU-15328 (page does not exist)">RU-15328</a></li> <li><a href="/wiki/SC-5233" title="SC-5233">SC-5233 (spirolactone)</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li> <li><a href="/wiki/Spirorenone" title="Spirorenone">Spirorenone</a></li> <li><a href="/wiki/Spiroxasone" title="Spiroxasone">Spiroxasone</a></li> <li><a href="/wiki/Topterone" title="Topterone">Topterone</a></li> <li><a href="/wiki/Trimegestone" title="Trimegestone">Trimegestone</a></li> <li><a href="/wiki/Trimethyltrienolone" title="Trimethyltrienolone">Trimethyltrienolone (R-2956)</a></li> <li><a href="/wiki/Zanoterone" title="Zanoterone">Zanoterone</a></li></ul> <ul><li><i>Nonsteroidal:</i> <a href="/wiki/5N-Bicalutamide" title="5N-Bicalutamide">5<i>N</i>-Bicalutamide</a></li> <li><a href="/wiki/AA560" title="AA560">AA560</a></li> <li><a href="/w/index.php?title=Antarlide&action=edit&redlink=1" class="new" title="Antarlide (page does not exist)">Antarlides</a></li> <li><a href="/w/index.php?title=Arabilin&action=edit&redlink=1" class="new" title="Arabilin (page does not exist)">Arabilin</a></li> <li><a href="/wiki/Apalutamide" title="Apalutamide">Apalutamide</a></li> <li><a href="/wiki/Atraric_acid" title="Atraric acid">Atraric acid</a></li> <li><a href="/w/index.php?title=AZD-3514&action=edit&redlink=1" class="new" title="AZD-3514 (page does not exist)">AZD-3514</a></li> <li><a href="/wiki/Bakuchiol" title="Bakuchiol">Bakuchiol</a></li> <li><a href="/wiki/Bavdegalutamide" title="Bavdegalutamide">Bavdegalutamide</a></li> <li><a href="/w/index.php?title=BAY-1024767&action=edit&redlink=1" class="new" title="BAY-1024767 (page does not exist)">BAY-1024767</a></li> <li><a href="/wiki/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li> <li><a href="/wiki/Bisphenol" title="Bisphenol">Bisphenols</a> (e.g., <a href="/wiki/Bisphenol_A_diglycidyl_ether" title="Bisphenol A diglycidyl ether">BADGE</a>, <a href="/w/index.php?title=Bisphenol_F_diglycidyl_ether&action=edit&redlink=1" class="new" title="Bisphenol F diglycidyl ether (page does not exist)">BFDGE</a>, <a href="/wiki/Bisphenol_A" title="Bisphenol A">bisphenol A</a>, <a href="/wiki/Bisphenol_F" title="Bisphenol F">bisphenol F</a>, <a href="/wiki/Bisphenol_S" title="Bisphenol S">bisphenol S</a>)</li> <li><a href="/w/index.php?title=BMS-501949&action=edit&redlink=1" class="new" title="BMS-501949 (page does not exist)">BMS-501949</a></li> <li><a href="/w/index.php?title=BMS-570511&action=edit&redlink=1" class="new" title="BMS-570511 (page does not exist)">BMS-570511</a></li> <li><a href="/wiki/BMS-641988" title="BMS-641988">BMS-641988</a></li> <li><a href="/w/index.php?title=CH5137291&action=edit&redlink=1" class="new" title="CH5137291 (page does not exist)">CH5137291</a></li> <li><a href="/wiki/Cimetidine" title="Cimetidine">Cimetidine</a></li> <li><a href="/wiki/Cioteronel" title="Cioteronel">Cioteronel</a></li> <li><a href="/wiki/Cyanonilutamide" title="Cyanonilutamide">Cyanonilutamide</a></li> <li><a href="/wiki/Darolutamide" title="Darolutamide">Darolutamide</a></li> <li><a href="/wiki/DDT" title="DDT">DDT</a> (via metabolite <a href="/wiki/Dichlorodiphenyldichloroethylene" title="Dichlorodiphenyldichloroethylene">p,p’-DDE</a>)</li> <li><a href="/wiki/Dieldrin" title="Dieldrin">Dieldrin</a></li> <li><a href="/wiki/DIMP_(antiandrogen)" title="DIMP (antiandrogen)">DIMP</a></li> <li><a href="/wiki/Endosulfan" title="Endosulfan">Endosulfan</a></li> <li><a href="/wiki/Enzalutamide" title="Enzalutamide">Enzalutamide</a></li> <li><a href="/wiki/EPI-001" title="EPI-001">EPI-001</a></li> <li><a href="/wiki/Fenarimol" title="Fenarimol">Fenarimol</a></li> <li><a href="/wiki/Flutamide" title="Flutamide">Flutamide</a></li> <li><a href="/wiki/Hydroxyflutamide" title="Hydroxyflutamide">Hydroxyflutamide</a></li> <li><a href="/wiki/Inocoterone" title="Inocoterone">Inocoterone</a></li> <li><a href="/wiki/Inocoterone_acetate" title="Inocoterone acetate">Inocoterone acetate</a></li> <li><a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li> <li><a href="/wiki/Ketodarolutamide" title="Ketodarolutamide">Ketodarolutamide</a></li> <li><a href="/wiki/Lavender_oil" title="Lavender oil">Lavender oil</a></li> <li><a href="/w/index.php?title=LG-105&action=edit&redlink=1" class="new" title="LG-105 (page does not exist)">LG-105</a></li> <li><a href="/wiki/LG-120907" title="LG-120907">LG-120907</a></li> <li><a href="/w/index.php?title=LGD-1331&action=edit&redlink=1" class="new" title="LGD-1331 (page does not exist)">LGD-1331</a></li> <li><a href="/wiki/Linuron" title="Linuron">Linuron</a></li> <li><a href="/wiki/Masofaniten" title="Masofaniten">Masofaniten</a></li> <li><a href="/wiki/Methiocarb" title="Methiocarb">Methiocarb</a></li> <li><a href="/w/index.php?title=N-Butylbenzenesulfonamide&action=edit&redlink=1" class="new" title="N-Butylbenzenesulfonamide (page does not exist)"><i>N</i>-Butylbenzenesulfonamide</a></li> <li><a href="/wiki/N-Desmethylapalutamide" title="N-Desmethylapalutamide"><i>N</i>-Desmethylapalutamide</a></li> <li><a href="/wiki/N-Desmethylenzalutamide" title="N-Desmethylenzalutamide"><i>N</i>-Desmethylenzalutamide</a></li> <li><a href="/wiki/Nilutamide" title="Nilutamide">Nilutamide</a></li> <li><a href="/w/index.php?title=ONC1-13B&action=edit&redlink=1" class="new" title="ONC1-13B (page does not exist)">ONC1-13B</a></li> <li><a href="/wiki/Pentomone" title="Pentomone">Pentomone</a></li> <li><a href="/w/index.php?title=PF-998425&action=edit&redlink=1" class="new" title="PF-998425 (page does not exist)">PF-998425</a></li> <li><a href="/wiki/Phenothrin" title="Phenothrin">Phenothrin</a></li> <li><a href="/wiki/Prochloraz" title="Prochloraz">Prochloraz</a></li> <li><a href="/wiki/Procymidone" title="Procymidone">Procymidone</a></li> <li><a href="/wiki/Proxalutamide" title="Proxalutamide">Proxalutamide</a></li> <li><a href="/wiki/Pyrilutamide" title="Pyrilutamide">Pyrilutamide</a></li> <li><a href="/wiki/Ralaniten" title="Ralaniten">Ralaniten (EPI-002)</a></li> <li><a href="/wiki/Ralaniten_acetate" title="Ralaniten acetate">Ralaniten acetate (EPI-506)</a></li> <li><a href="/wiki/RD-162" title="RD-162">RD-162</a></li> <li><a href="/wiki/Rezvilutamide" title="Rezvilutamide">Rezvilutamide</a></li> <li><a href="/w/index.php?title=Ro_2-7239&action=edit&redlink=1" class="new" title="Ro 2-7239 (page does not exist)">Ro 2-7239</a></li> <li><a href="/w/index.php?title=Ro_5-2537&action=edit&redlink=1" class="new" title="Ro 5-2537 (page does not exist)">Ro 5-2537</a></li> <li><a href="/wiki/RU-22930" title="RU-22930">RU-22930</a></li> <li><a href="/wiki/RU-56187" title="RU-56187">RU-56187</a></li> <li><a href="/wiki/RU-57073" title="RU-57073">RU-57073</a></li> <li><a href="/wiki/RU-58642" title="RU-58642">RU-58642</a></li> <li><a href="/wiki/RU-58841" title="RU-58841">RU-58841</a></li> <li><a href="/wiki/Seviteronel" title="Seviteronel">Seviteronel</a></li> <li><a href="/wiki/Thalidomide" title="Thalidomide">Thalidomide</a></li> <li><a href="/wiki/Topilutamide" title="Topilutamide">Topilutamide (fluridil)</a></li> <li><a href="/wiki/Valproic_acid" class="mw-redirect" title="Valproic acid">Valproic acid</a></li> <li><a href="/wiki/Vinclozolin" title="Vinclozolin">Vinclozolin</a></li> <li><a href="/w/index.php?title=YM-580&action=edit&redlink=1" class="new" title="YM-580 (page does not exist)">YM-580</a></li> <li><a href="/w/index.php?title=YM-92088&action=edit&redlink=1" class="new" title="YM-92088 (page does not exist)">YM-92088</a></li> <li><a href="/w/index.php?title=YM-175735&action=edit&redlink=1" class="new" title="YM-175735 (page does not exist)">YM-175735</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/GPRC6A" title="GPRC6A">GPRC6A</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;">Agonists</th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Cation" class="mw-redirect" title="Cation">Cations</a> (incl. <a href="/wiki/Aluminium" title="Aluminium">aluminium</a>, <a href="/wiki/Calcium" title="Calcium">calcium</a>, <a href="/wiki/Gadolinium" title="Gadolinium">gadolinium</a>, <a href="/wiki/Magnesium" title="Magnesium">magnesium</a>, <a href="/wiki/Strontium" title="Strontium">strontium</a>, <a href="/wiki/Zinc" title="Zinc">zinc</a>)</li> <li><a href="/wiki/Dehydroandrosterone" title="Dehydroandrosterone">Dehydroandrosterone</a></li> <li><a href="/wiki/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone</a></li> <li><a href="/wiki/Estradiol" title="Estradiol">Estradiol</a></li> <li><a href="/wiki/Amino_acid" title="Amino acid"><small>L</small>-α-Amino acids</a> (incl. <a href="/wiki/Arginine" title="Arginine"><small>L</small>-arginine</a>, <a href="/wiki/Lysine" title="Lysine"><small>L</small>-lysine</a>, <a href="/wiki/Ornithine" title="Ornithine"><small>L</small>-ornithine</a>)</li> <li><a href="/wiki/Osteocalcin" title="Osteocalcin">Osteocalcin</a></li> <li><a href="/wiki/Sex_hormone-binding_globulin" title="Sex hormone-binding globulin"><abbr title="Sex hormone-binding globulin">SHBG</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Sex hormone-binding globulin</span></li> <li><a href="/wiki/Testosterone" title="Testosterone">Testosterone</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div> <dl><dt>See also</dt> <dd><a href="/wiki/Template:Receptor_modulators" title="Template:Receptor modulators">Receptor/signaling modulators</a></dd> <dd><a href="/wiki/Template:Androgens_and_antiandrogens" title="Template:Androgens and antiandrogens">Androgens and antiandrogens</a></dd> <dd><a href="/wiki/Template:Estrogen_receptor_modulators" title="Template:Estrogen receptor modulators">Estrogen receptor modulators</a></dd> <dd><a href="/wiki/Template:Progesterone_receptor_modulators" title="Template:Progesterone receptor modulators">Progesterone receptor modulators</a></dd> <dd><a href="/wiki/List_of_androgens_and_anabolic_steroids" title="List of androgens and anabolic steroids">List of androgens and anabolic steroids</a></dd></dl> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Estrogen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Estrogen_receptor_modulators" title="Template:Estrogen receptor modulators"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Estrogen_receptor_modulators" title="Template talk:Estrogen receptor modulators"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Estrogen_receptor_modulators" title="Special:EditPage/Template:Estrogen receptor modulators"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Estrogen_receptor_modulators" style="font-size:114%;margin:0 4em"><a href="/wiki/Estrogen_receptor" title="Estrogen receptor">Estrogen receptor</a> <a href="/wiki/Receptor_modulator" title="Receptor modulator">modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Estrogen_receptor" title="Estrogen receptor"><abbr title="Estrogen receptor">ER</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Estrogen receptor</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Steroidal:</i> <a href="/wiki/2-Hydroxyestradiol" title="2-Hydroxyestradiol">2-Hydroxyestradiol</a></li> <li><a href="/wiki/2-Hydroxyestrone" title="2-Hydroxyestrone">2-Hydroxyestrone</a></li> <li><a href="/wiki/3-Methyl-19-methyleneandrosta-3,5-dien-17%CE%B2-ol" title="3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol">3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol</a></li> <li><a href="/wiki/3%CE%B1-Androstanediol" title="3α-Androstanediol">3α-Androstanediol</a></li> <li><a href="/w/index.php?title=3%CE%B1,5%CE%B1-Dihydrolevonorgestrel&action=edit&redlink=1" class="new" title="3α,5α-Dihydrolevonorgestrel (page does not exist)">3α,5α-Dihydrolevonorgestrel</a></li> <li><a href="/w/index.php?title=3%CE%B2,5%CE%B1-Dihydrolevonorgestrel&action=edit&redlink=1" class="new" title="3β,5α-Dihydrolevonorgestrel (page does not exist)">3β,5α-Dihydrolevonorgestrel</a></li> <li><a href="/wiki/3%CE%B1-Hydroxytibolone" title="3α-Hydroxytibolone">3α-Hydroxytibolone</a></li> <li><a href="/wiki/3%CE%B2-Hydroxytibolone" title="3β-Hydroxytibolone">3β-Hydroxytibolone</a></li> <li><a href="/wiki/3%CE%B2-Androstanediol" title="3β-Androstanediol">3β-Androstanediol</a></li> <li><a href="/wiki/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li> <li><a href="/wiki/4-Androstenedione" class="mw-redirect" title="4-Androstenedione">4-Androstenedione</a></li> <li><a href="/wiki/4-Fluoroestradiol" title="4-Fluoroestradiol">4-Fluoroestradiol</a></li> <li><a href="/wiki/4-Hydroxyestradiol" title="4-Hydroxyestradiol">4-Hydroxyestradiol</a></li> <li><a href="/wiki/4-Hydroxyestrone" title="4-Hydroxyestrone">4-Hydroxyestrone</a></li> <li><a href="/wiki/4-Methoxyestradiol" title="4-Methoxyestradiol">4-Methoxyestradiol</a></li> <li><a href="/wiki/4-Methoxyestrone" title="4-Methoxyestrone">4-Methoxyestrone</a></li> <li><a href="/wiki/5-Androstenediol" class="mw-redirect" title="5-Androstenediol">5-Androstenediol</a></li> <li><a href="/wiki/7-Keto-DHEA" title="7-Keto-DHEA">7-Oxo-DHEA</a></li> <li><a href="/wiki/7%CE%B1-Hydroxy-DHEA" title="7α-Hydroxy-DHEA">7α-Hydroxy-DHEA</a></li> <li><a href="/wiki/7%CE%B1-Methylestradiol" title="7α-Methylestradiol">7α-Methylestradiol</a></li> <li><a href="/wiki/7%CE%B2-Hydroxyepiandrosterone" title="7β-Hydroxyepiandrosterone">7β-Hydroxyepiandrosterone</a></li> <li><a href="/wiki/8,9-Dehydroestradiol" title="8,9-Dehydroestradiol">8,9-Dehydroestradiol</a></li> <li><a href="/wiki/8,9-Dehydroestrone" title="8,9-Dehydroestrone">8,9-Dehydroestrone</a></li> <li><a href="/wiki/8%CE%B2-VE2" title="8β-VE2">8β-VE2</a></li> <li><a href="/wiki/10%CE%B2,17%CE%B2-Dihydroxyestra-1,4-dien-3-one" title="10β,17β-Dihydroxyestra-1,4-dien-3-one">10β,17β-Dihydroxyestra-1,4-dien-3-one (DHED)</a></li> <li><a href="/wiki/11%CE%B2-Chloromethylestradiol" title="11β-Chloromethylestradiol">11β-Chloromethylestradiol</a></li> <li><a href="/wiki/11%CE%B2-Methoxyestradiol" title="11β-Methoxyestradiol">11β-Methoxyestradiol</a></li> <li><a href="/wiki/15%CE%B1-Hydroxyestradiol" title="15α-Hydroxyestradiol">15α-Hydroxyestradiol</a></li> <li><a href="/wiki/16-Ketoestradiol" title="16-Ketoestradiol">16-Ketoestradiol</a></li> <li><a href="/wiki/16-Ketoestrone" title="16-Ketoestrone">16-Ketoestrone</a></li> <li><a href="/wiki/16%CE%B1-Fluoroestradiol" class="mw-redirect" title="16α-Fluoroestradiol">16α-Fluoroestradiol</a></li> <li><a href="/wiki/16%CE%B1-Hydroxy-DHEA" title="16α-Hydroxy-DHEA">16α-Hydroxy-DHEA</a></li> <li><a href="/wiki/16%CE%B1-Hydroxyestrone" title="16α-Hydroxyestrone">16α-Hydroxyestrone</a></li> <li><a href="/wiki/16%CE%B1-Iodoestradiol" class="mw-redirect" title="16α-Iodoestradiol">16α-Iodoestradiol</a></li> <li><a href="/wiki/16%CE%B1-LE2" title="16α-LE2">16α-LE2</a></li> <li><a href="/wiki/16%CE%B2-Hydroxyestrone" title="16β-Hydroxyestrone">16β-Hydroxyestrone</a></li> <li><a href="/wiki/16%CE%B2,17%CE%B1-Epiestriol" title="16β,17α-Epiestriol">16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)</a></li> <li><a href="/wiki/17%CE%B1-Estradiol" title="17α-Estradiol">17α-Estradiol</a> (<a href="/wiki/Alfatradiol" title="Alfatradiol">alfatradiol</a>)</li> <li><a href="/wiki/17%CE%B1-Dihydroequilenin" title="17α-Dihydroequilenin">17α-Dihydroequilenin</a></li> <li><a href="/wiki/17%CE%B1-Dihydroequilin" title="17α-Dihydroequilin">17α-Dihydroequilin</a></li> <li><a href="/wiki/17%CE%B1-Epiestriol" title="17α-Epiestriol">17α-Epiestriol (16α-hydroxy-17α-estradiol)</a></li> <li><a href="/wiki/17%CE%B1-Ethynyl-3%CE%B1-androstanediol" title="17α-Ethynyl-3α-androstanediol">17α-Ethynyl-3α-androstanediol</a></li> <li><a href="/wiki/17%CE%B1-Ethynyl-3%CE%B2-androstanediol" title="17α-Ethynyl-3β-androstanediol">17α-Ethynyl-3β-androstanediol</a></li> <li><a href="/wiki/17%CE%B2-Dihydroequilenin" title="17β-Dihydroequilenin">17β-Dihydroequilenin</a></li> <li><a href="/wiki/17%CE%B2-Dihydroequilin" title="17β-Dihydroequilin">17β-Dihydroequilin</a></li> <li><a href="/wiki/17%CE%B2-Methyl-17%CE%B1-dihydroequilenin" title="17β-Methyl-17α-dihydroequilenin">17β-Methyl-17α-dihydroequilenin</a></li> <li><a href="/wiki/Abiraterone" class="mw-redirect" title="Abiraterone">Abiraterone</a></li> <li><a href="/wiki/Abiraterone_acetate" title="Abiraterone acetate">Abiraterone acetate</a></li> <li><a href="/wiki/Alestramustine" title="Alestramustine">Alestramustine</a></li> <li><a href="/wiki/Almestrone" title="Almestrone">Almestrone</a></li> <li><a href="/wiki/Anabolic_steroid" title="Anabolic steroid">Anabolic steroids</a> (e.g., <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> and <a href="/wiki/List_of_androgen_esters#Testosterone_esters" title="List of androgen esters">esters</a>, <a href="/wiki/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, <a href="/wiki/Metandienone" title="Metandienone">metandienone (methandrostenolone)</a>, <a href="/wiki/Nandrolone" title="Nandrolone">nandrolone</a> and <a href="/wiki/List_of_androgen_esters#Nandrolone_esters" title="List of androgen esters">esters</a>, many others; via estrogenic metabolites)</li> <li><a href="/wiki/Atrimustine" title="Atrimustine">Atrimustine</a></li> <li><a href="/wiki/Bolandiol" title="Bolandiol">Bolandiol</a></li> <li><a href="/wiki/Bolandiol_dipropionate" title="Bolandiol dipropionate">Bolandiol dipropionate</a></li> <li><a href="/wiki/Butolame" title="Butolame">Butolame</a></li> <li><a href="/wiki/Clomestrone" title="Clomestrone">Clomestrone</a></li> <li><a href="/wiki/Cloxestradiol" title="Cloxestradiol">Cloxestradiol</a> <ul><li><a href="/wiki/Cloxestradiol_acetate" title="Cloxestradiol acetate">Cloxestradiol acetate</a></li></ul></li> <li><a href="/wiki/Conjugated_estriol" title="Conjugated estriol">Conjugated estriol</a></li> <li><a href="/wiki/Conjugated_estrogens" title="Conjugated estrogens">Conjugated estrogens</a></li> <li><a href="/wiki/Cyclodiol" title="Cyclodiol">Cyclodiol</a></li> <li><a href="/wiki/Cyclotriol" title="Cyclotriol">Cyclotriol</a></li> <li><a href="/wiki/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a></li> <li><a href="/wiki/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA-S</a></li> <li><a href="/wiki/Ent-Estradiol" title="Ent-Estradiol"><i>ent</i>-Estradiol</a></li> <li><a href="/wiki/Epiestriol" title="Epiestriol">Epiestriol (16β-epiestriol, 16β-hydroxy-17β-estradiol)</a></li> <li><a href="/wiki/Epimestrol" title="Epimestrol">Epimestrol</a></li> <li><a href="/wiki/Equilenin" title="Equilenin">Equilenin</a></li> <li><a href="/wiki/Equilin" title="Equilin">Equilin</a></li> <li><a href="/wiki/ERA-63" title="ERA-63">ERA-63 (ORG-37663)</a></li> <li><a href="/wiki/Esterified_estrogens" title="Esterified estrogens">Esterified estrogens</a></li> <li><a href="/wiki/Estetrol" title="Estetrol">Estetrol</a></li> <li><a href="/wiki/Estradiol" title="Estradiol">Estradiol</a> <ul><li><a href="/wiki/List_of_estrogen_esters#Estradiol_esters" title="List of estrogen esters">Estradiol esters</a></li> <li><a href="/wiki/Lipoidal_estradiol" title="Lipoidal estradiol">Lipoidal estradiol</a></li> <li><a href="/wiki/Polyestradiol_phosphate" title="Polyestradiol phosphate">Polyestradiol phosphate</a></li></ul></li> <li><a href="/wiki/Estramustine" title="Estramustine">Estramustine</a></li> <li><a href="/wiki/Estramustine_phosphate" title="Estramustine phosphate">Estramustine phosphate</a></li> <li><a href="/wiki/Estrapronicate" title="Estrapronicate">Estrapronicate</a></li> <li><a href="/wiki/Estrazinol" title="Estrazinol">Estrazinol</a></li> <li><a href="/wiki/Estriol" title="Estriol">Estriol</a> <ul><li><a href="/wiki/List_of_estrogen_esters#Estriol_esters" title="List of estrogen esters">Estriol esters</a></li> <li><a href="/wiki/Polyestriol_phosphate" title="Polyestriol phosphate">Polyestriol phosphate</a></li></ul></li> <li><a href="/wiki/Estrofurate" title="Estrofurate">Estrofurate</a></li> <li><a href="/wiki/Estrogenic_substances" title="Estrogenic substances">Estrogenic substances</a></li> <li><a href="/wiki/Estromustine" title="Estromustine">Estromustine</a></li> <li><a href="/wiki/Estrone" title="Estrone">Estrone</a> <ul><li><a href="/wiki/List_of_estrogen_esters#Estrone_esters" title="List of estrogen esters">Estrone esters</a></li> <li><a href="/wiki/Estrone_methyl_ether" title="Estrone methyl ether">Estrone methyl ether</a></li> <li><a href="/wiki/Estropipate" title="Estropipate">Estropipate</a></li></ul></li> <li><a href="/wiki/Etamestrol" title="Etamestrol">Etamestrol (eptamestrol)</a></li> <li><a href="/wiki/Ethinylandrostenediol" title="Ethinylandrostenediol">Ethinylandrostenediol</a> <ul><li><a href="/wiki/Ethandrostate" title="Ethandrostate">Ethandrostate</a></li></ul></li> <li><a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">Ethinylestradiol</a> <ul><li><a href="/wiki/Ethinylestradiol_3-benzoate" class="mw-redirect" title="Ethinylestradiol 3-benzoate">Ethinylestradiol 3-benzoate</a></li> <li><a href="/wiki/Ethinylestradiol_sulfonate" title="Ethinylestradiol sulfonate">Ethinylestradiol sulfonate</a></li></ul></li> <li><a href="/wiki/Ethinylestriol" title="Ethinylestriol">Ethinylestriol</a></li> <li><a href="/wiki/Ethylestradiol" title="Ethylestradiol">Ethylestradiol</a></li> <li><a href="/wiki/Etynodiol" title="Etynodiol">Etynodiol</a></li> <li><a href="/wiki/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li> <li><a href="/wiki/Hexolame" title="Hexolame">Hexolame</a></li> <li><a href="/wiki/Hippulin" title="Hippulin">Hippulin</a></li> <li><a href="/wiki/Hydroxyestrone_diacetate" title="Hydroxyestrone diacetate">Hydroxyestrone diacetate</a></li> <li><a href="/wiki/Lynestrenol" title="Lynestrenol">Lynestrenol</a></li> <li><a href="/wiki/Lynestrenol_phenylpropionate" title="Lynestrenol phenylpropionate">Lynestrenol phenylpropionate</a></li> <li><a href="/wiki/Mestranol" title="Mestranol">Mestranol</a></li> <li><a href="/wiki/Methylestradiol" title="Methylestradiol">Methylestradiol</a></li> <li><a href="/wiki/Moxestrol" title="Moxestrol">Moxestrol</a></li> <li><a href="/wiki/Mytatrienediol" title="Mytatrienediol">Mytatrienediol</a></li> <li><a href="/wiki/Nilestriol" title="Nilestriol">Nilestriol</a></li> <li><a href="/wiki/Norethisterone" title="Norethisterone">Norethisterone</a></li> <li><a href="/wiki/Noretynodrel" title="Noretynodrel">Noretynodrel</a></li> <li><a href="/wiki/Orestrate" title="Orestrate">Orestrate</a></li> <li><a href="/wiki/Pentolame" title="Pentolame">Pentolame</a></li> <li><a href="/wiki/Prodiame" title="Prodiame">Prodiame</a></li> <li><a href="/wiki/Prolame" title="Prolame">Prolame</a></li> <li><a href="/wiki/Promestriene" title="Promestriene">Promestriene</a></li> <li><a href="/wiki/RU-16117" title="RU-16117">RU-16117</a></li> <li><a href="/wiki/Quinestradol" title="Quinestradol">Quinestradol</a></li> <li><a href="/wiki/Quinestrol" title="Quinestrol">Quinestrol</a></li> <li><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a></li></ul> <ul><li><i>Nonsteroidal:</i> <a href="/wiki/(R,R)-Tetrahydrochrysene" title="(R,R)-Tetrahydrochrysene">(R,R)-THC</a></li> <li><a href="/wiki/(S,S)-Tetrahydrochrysene" title="(S,S)-Tetrahydrochrysene">(S,S)-THC</a></li> <li><a href="/wiki/2,8-Dihydroxyhexahydrochrysene" title="2,8-Dihydroxyhexahydrochrysene">2,8-DHHHC</a></li> <li><a href="/w/index.php?title=%CE%92-LGND1&action=edit&redlink=1" class="new" title="Β-LGND1 (page does not exist)">β-LGND1</a></li> <li><a href="/wiki/%CE%92-LGND2" title="Β-LGND2">β-LGND2 (GTx-878)</a></li> <li><a href="/w/index.php?title=AC-186&action=edit&redlink=1" class="new" title="AC-186 (page does not exist)">AC-186</a></li> <li><a href="/wiki/Allenestrol" title="Allenestrol">Allenestrol</a></li> <li><a href="/wiki/Allenolic_acid" title="Allenolic acid">Allenolic acid</a></li> <li><a href="/wiki/Benzestrol" title="Benzestrol">Benzestrol</a></li> <li><a href="/wiki/Bifluranol" title="Bifluranol">Bifluranol</a></li> <li><a href="/wiki/Bisdehydrodoisynolic_acid" title="Bisdehydrodoisynolic acid">Bisdehydrodoisynolic acid</a></li> <li><a href="/wiki/Butestrol" title="Butestrol">Butestrol</a></li> <li><a href="/wiki/Carbestrol" title="Carbestrol">Carbestrol</a></li> <li><a href="/wiki/D-15414" title="D-15414">D-15414</a></li> <li><a href="/wiki/DCW234" title="DCW234">DCW234</a></li> <li><a href="/wiki/Diarylpropionitrile" title="Diarylpropionitrile">Diarylpropionitrile</a></li> <li><a href="/wiki/Dienestrol" title="Dienestrol">Dienestrol</a> <ul><li><a href="/wiki/Dienestrol_diacetate" title="Dienestrol diacetate">Dienestrol diacetate</a></li></ul></li> <li><a href="/wiki/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a> <ul><li><a href="/wiki/List_of_estrogen_esters#Diethylstilbestrol_esters" title="List of estrogen esters">Diethylstilbestrol esters</a></li></ul></li> <li><a href="/wiki/Dimestrol" title="Dimestrol">Dimestrol (dianisylhexene)</a></li> <li><a href="/wiki/Dimethylstilbestrol" title="Dimethylstilbestrol">Dimethylstilbestrol</a></li> <li><a href="/wiki/Doisynoestrol" title="Doisynoestrol">Doisynoestrol (fenocycline)</a></li> <li><a href="/wiki/Doisynolic_acid" title="Doisynolic acid">Doisynolic acid</a></li> <li><a href="/wiki/Efavirenz" title="Efavirenz">Efavirenz</a></li> <li><a href="/wiki/Elacestrant" title="Elacestrant">Elacestrant</a></li> <li><a href="/wiki/ERB-196" title="ERB-196">ERB-196 (WAY-202196)</a></li> <li><a href="/wiki/Erteberel" title="Erteberel">Erteberel (SERBA-1, LY-500307)</a></li> <li><a href="/wiki/Estrobin" title="Estrobin">Estrobin (DBE)</a></li> <li><a href="/wiki/Fenestrel" title="Fenestrel">Fenestrel</a></li> <li><a href="/wiki/FERb_033" title="FERb 033">FERb 033</a></li> <li><a href="/wiki/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li> <li><a href="/wiki/Furostilbestrol" title="Furostilbestrol">Furostilbestrol (diethylstilbestrol difuroate)</a></li> <li><a href="/wiki/GTx-758" title="GTx-758">GTx-758</a></li> <li><a href="/wiki/Hexestrol" title="Hexestrol">Hexestrol</a> <ul><li><a href="/wiki/List_of_estrogen_esters#Hexestrol_esters" title="List of estrogen esters">Hexestrol esters</a></li></ul></li> <li><a href="/wiki/ICI-85966" title="ICI-85966">ICI-85966 (Stilbostat)</a></li> <li><a href="/wiki/M2613" title="M2613">M2613</a></li> <li><a href="/wiki/Meso-Butestrol" title="Meso-Butestrol"><i>meso</i>-Butestrol</a></li> <li><a href="/wiki/Meso-Hexestrol" class="mw-redirect" title="Meso-Hexestrol"><i>meso</i>-Hexestrol</a></li> <li><a href="/wiki/Mestilbol" title="Mestilbol">Mestilbol</a></li> <li><a href="/wiki/Methallenestril" title="Methallenestril">Methallenestril</a></li> <li><a href="/wiki/Methestrol" title="Methestrol">Methestrol</a></li> <li><a href="/wiki/Methestrol_dipropionate" title="Methestrol dipropionate">Methestrol dipropionate</a></li> <li><a href="/wiki/Paroxypropione" title="Paroxypropione">Paroxypropione</a></li> <li><a href="/wiki/Pentafluranol" title="Pentafluranol">Pentafluranol</a></li> <li><a href="/wiki/Phenestrol" title="Phenestrol">Phenestrol</a></li> <li><a href="/wiki/Prinaberel" title="Prinaberel">Prinaberel (ERB-041, WAY-202041)</a></li> <li><a href="/wiki/Propylpyrazoletriol" title="Propylpyrazoletriol">Propylpyrazoletriol</a></li> <li><a href="/wiki/Quadrosilan" title="Quadrosilan">Quadrosilan</a></li> <li><a href="/w/index.php?title=SC-3296&action=edit&redlink=1" class="new" title="SC-3296 (page does not exist)">SC-3296</a></li> <li><a href="/wiki/SC-4289" title="SC-4289">SC-4289</a></li> <li><a href="/wiki/SERBA-2" title="SERBA-2">SERBA-2</a></li> <li><a href="/wiki/SKF-82,958" title="SKF-82,958">SKF-82,958</a></li> <li><a href="/wiki/Terfluranol" title="Terfluranol">Terfluranol</a></li> <li><a href="/wiki/Triphenylbromoethylene" title="Triphenylbromoethylene">Triphenylbromoethylene</a></li> <li><a href="/wiki/Triphenylchloroethylene" title="Triphenylchloroethylene">Triphenylchloroethylene</a></li> <li><a href="/wiki/Triphenyliodoethylene" title="Triphenyliodoethylene">Triphenyliodoethylene</a></li> <li><a href="/wiki/Triphenylmethylethylene" title="Triphenylmethylethylene">Triphenylmethylethylene (triphenylpropene)</a></li> <li><a href="/wiki/WAY-166818" title="WAY-166818">WAY-166818</a></li> <li><a href="/w/index.php?title=WAY-169916&action=edit&redlink=1" class="new" title="WAY-169916 (page does not exist)">WAY-169916</a></li> <li><a href="/wiki/WAY-200070" title="WAY-200070">WAY-200070</a></li> <li><a href="/wiki/WAY-204688" title="WAY-204688">WAY-204688 (SIM-688)</a></li> <li><a href="/wiki/WAY-214156" title="WAY-214156">WAY-214156</a></li></ul> <ul><li><i>Unknown/unsorted:</i> <a href="/wiki/ERB-26" title="ERB-26">ERB-26</a></li> <li><a href="/wiki/ERA-45" title="ERA-45">ERA-45</a></li> <li><a href="/wiki/ERB-79" title="ERB-79">ERB-79</a></li> <li><a href="/wiki/ZK-283197" title="ZK-283197">ZK-283197</a></li></ul> <ul><li><i>Xenoestrogens:</i> <a href="/wiki/Anise" title="Anise">Anise</a>-related (e.g., <a href="/wiki/Anethole" title="Anethole">anethole</a>, <a href="/wiki/Anol" title="Anol">anol</a>, <a href="/wiki/Dianethole" title="Dianethole">dianethole</a>, <a href="/wiki/Dianol" title="Dianol">dianol</a>, <a href="/wiki/Photoanethole" title="Photoanethole">photoanethole</a>)</li> <li><a href="/wiki/Chalconoid" title="Chalconoid">Chalconoids</a> (e.g., <a href="/wiki/Isoliquiritigenin" title="Isoliquiritigenin">isoliquiritigenin</a>, <a href="/wiki/Phloretin" title="Phloretin">phloretin</a>, <a href="/wiki/Phlorizin" title="Phlorizin">phlorizin (phloridzin)</a>, <a href="/wiki/Wedelolactone" title="Wedelolactone">wedelolactone</a>)</li> <li><a href="/wiki/Coumestan" title="Coumestan">Coumestans</a> (e.g., <a href="/wiki/Coumestrol" title="Coumestrol">coumestrol</a>, <a href="/wiki/Psoralidin" title="Psoralidin">psoralidin</a>)</li> <li><a href="/wiki/Flavonoid" title="Flavonoid">Flavonoids</a> (incl. <a href="/wiki/7,8-Dihydroxyflavone" class="mw-redirect" title="7,8-Dihydroxyflavone">7,8-DHF</a>, <a href="/wiki/8-Prenylnaringenin" title="8-Prenylnaringenin">8-prenylnaringenin</a>, <a href="/wiki/Apigenin" title="Apigenin">apigenin</a>, <a href="/wiki/Baicalein" title="Baicalein">baicalein</a>, <a href="/wiki/Baicalin" title="Baicalin">baicalin</a>, <a href="/wiki/Biochanin_A" title="Biochanin A">biochanin A</a>, <a href="/wiki/Calycosin" title="Calycosin">calycosin</a>, <a href="/wiki/Catechin" title="Catechin">catechin</a>, <a href="/wiki/Daidzein" title="Daidzein">daidzein</a>, <a href="/wiki/Daidzin" title="Daidzin">daidzin</a>, <a href="/wiki/Epicatechin_gallate" title="Epicatechin gallate">ECG</a>, <a href="/wiki/Epigallocatechin_gallate" title="Epigallocatechin gallate">EGCG</a>, <a href="/wiki/Epicatechin" class="mw-redirect" title="Epicatechin">epicatechin</a>, <a href="/wiki/Equol" title="Equol">equol</a>, <a href="/wiki/Formononetin" title="Formononetin">formononetin</a>, <a href="/wiki/Glabrene" title="Glabrene">glabrene</a>, <a href="/wiki/Glabridin" title="Glabridin">glabridin</a>, <a href="/wiki/Genistein" title="Genistein">genistein</a>, <a href="/wiki/Genistin" title="Genistin">genistin</a>, <a href="/wiki/Glycitein" title="Glycitein">glycitein</a>, <a href="/wiki/Kaempferol" title="Kaempferol">kaempferol</a>, <a href="/wiki/Liquiritigenin" title="Liquiritigenin">liquiritigenin</a>, <a href="/wiki/Mirificin" title="Mirificin">mirificin</a>, <a href="/wiki/Myricetin" title="Myricetin">myricetin</a>, <a href="/wiki/Naringenin" title="Naringenin">naringenin</a>, <a href="/w/index.php?title=Penduletin&action=edit&redlink=1" class="new" title="Penduletin (page does not exist)">penduletin</a>, <a href="/wiki/Pinocembrin" title="Pinocembrin">pinocembrin</a>, <a href="/wiki/Prunetin" title="Prunetin">prunetin</a>, <a href="/wiki/Puerarin" title="Puerarin">puerarin</a>, <a href="/wiki/Quercetin" title="Quercetin">quercetin</a>, <a href="/wiki/Tectoridin" title="Tectoridin">tectoridin</a>, <a href="/wiki/Tectorigenin" title="Tectorigenin">tectorigenin</a>)</li> <li><a href="/wiki/Lavender_oil" title="Lavender oil">Lavender oil</a></li> <li><a href="/wiki/Lignan" title="Lignan">Lignans</a> (e.g., <a href="/wiki/Enterodiol" title="Enterodiol">enterodiol</a>, <a href="/wiki/Enterolactone" title="Enterolactone">enterolactone</a>, <a href="/wiki/Nyasol" title="Nyasol">nyasol (<i>cis</i>-hinokiresinol)</a>)</li> <li><a href="/wiki/Metalloestrogen" title="Metalloestrogen">Metalloestrogens</a> (e.g., <a href="/wiki/Cadmium" title="Cadmium">cadmium</a>)</li> <li><a href="/wiki/Pesticide" title="Pesticide">Pesticides</a> (e.g., <a href="/wiki/Alternariol" title="Alternariol">alternariol</a>, <a href="/wiki/Dieldrin" title="Dieldrin">dieldrin</a>, <a href="/wiki/Endosulfan" title="Endosulfan">endosulfan</a>, <a href="/wiki/Fenarimol" title="Fenarimol">fenarimol</a>, <a href="/wiki/HPTE" title="HPTE">HPTE</a>, <a href="/wiki/Methiocarb" title="Methiocarb">methiocarb</a>, <a href="/wiki/Methoxychlor" title="Methoxychlor">methoxychlor</a>, <a href="/wiki/Triclocarban" title="Triclocarban">triclocarban</a>, <a href="/wiki/Triclosan" title="Triclosan">triclosan</a>)</li> <li><a href="/wiki/Phytosteroid" title="Phytosteroid">Phytosteroids</a> (e.g., <a href="/wiki/Digitoxin" title="Digitoxin">digitoxin</a> (<a href="/wiki/Digitalis" title="Digitalis">digitalis</a>), <a href="/wiki/Diosgenin" title="Diosgenin">diosgenin</a>, <a href="/wiki/Guggulsterone" title="Guggulsterone">guggulsterone</a>)</li> <li><a href="/wiki/Phytosterol" title="Phytosterol">Phytosterols</a> (e.g., <a href="/wiki/%CE%92-sitosterol" class="mw-redirect" title="Β-sitosterol">β-sitosterol</a>, <a href="/wiki/Campesterol" title="Campesterol">campesterol</a>, <a href="/wiki/Stigmasterol" title="Stigmasterol">stigmasterol</a>)</li> <li><a href="/wiki/Resorcylic_acid_lactone" title="Resorcylic acid lactone">Resorcylic acid lactones</a> (e.g., <a href="/wiki/Zearalanone" title="Zearalanone">zearalanone</a>, <a href="/wiki/%CE%91-zearalenol" class="mw-redirect" title="Α-zearalenol">α-zearalenol</a>, <a href="/wiki/%CE%92-zearalenol" class="mw-redirect" title="Β-zearalenol">β-zearalenol</a>, <a href="/wiki/Zearalenone" title="Zearalenone">zearalenone</a>, <a href="/wiki/Zeranol" title="Zeranol">zeranol (α-zearalanol)</a>, <a href="/wiki/Taleranol" title="Taleranol">taleranol (teranol, β-zearalanol)</a>)</li> <li><a href="/wiki/Steroid" title="Steroid">Steroid</a>-like (e.g., <a href="/wiki/Deoxymiroestrol" class="mw-redirect" title="Deoxymiroestrol">deoxymiroestrol</a>, <a href="/wiki/Miroestrol" title="Miroestrol">miroestrol</a>)</li> <li><a href="/wiki/Stilbenoid" title="Stilbenoid">Stilbenoids</a> (e.g., <a href="/wiki/Resveratrol" title="Resveratrol">resveratrol</a>, <a href="/wiki/Rhaponticin" title="Rhaponticin">rhaponticin</a>)</li> <li><a href="/wiki/Synthetic_xenoestrogen" class="mw-redirect" title="Synthetic xenoestrogen">Synthetic xenoestrogens</a> (e.g., <a href="/wiki/Alkylphenol" title="Alkylphenol">alkylphenols</a>, <a href="/wiki/Bisphenol" title="Bisphenol">bisphenols</a> (e.g., <a href="/wiki/Bisphenol_A" title="Bisphenol A">BPA</a>, <a href="/wiki/Bisphenol_F" title="Bisphenol F">BPF</a>, <a href="/wiki/Bisphenol_S" title="Bisphenol S">BPS</a>), <a href="/wiki/Dichlorodiphenyltrichloroethane" class="mw-redirect" title="Dichlorodiphenyltrichloroethane">DDT</a>, <a href="/wiki/Paraben" title="Paraben">parabens</a>, <a href="/wiki/Polybrominated_biphenyl" title="Polybrominated biphenyl">PBBs</a>, <a href="/wiki/4-hydroxybenzoic_acid" class="mw-redirect" title="4-hydroxybenzoic acid">PHBA</a>, <a href="/wiki/Phthalate" class="mw-redirect" title="Phthalate">phthalates</a>, <a href="/wiki/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a>)</li> <li>Others (e.g., <a href="/wiki/Agnuside" title="Agnuside">agnuside</a>, <a href="/w/index.php?title=Rotundifuran&action=edit&redlink=1" class="new" title="Rotundifuran (page does not exist)">rotundifuran</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br />(<a href="/wiki/Selective_estrogen_receptor_modulators" class="mw-redirect" title="Selective estrogen receptor modulators"><abbr title="Selective estrogen receptor modulators">SERMs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Selective estrogen receptor modulators</span>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/2-Phenylbenzofuran" title="2-Phenylbenzofuran">2-Phenylbenzofuran</a></li> <li><a href="/w/index.php?title=2-Phenylbenzothiophene&action=edit&redlink=1" class="new" title="2-Phenylbenzothiophene (page does not exist)">2-Phenylbenzothiophene</a></li> <li><a href="/wiki/4%27-Hydroxynorendoxifen" title="4'-Hydroxynorendoxifen">4'-Hydroxynorendoxifen</a></li> <li><a href="/wiki/27-Hydroxycholesterol" title="27-Hydroxycholesterol">27-Hydroxycholesterol</a></li> <li><a href="/wiki/Acefluranol" title="Acefluranol">Acefluranol</a></li> <li><a href="/wiki/Acolbifene" title="Acolbifene">Acolbifene</a></li> <li><a href="/wiki/Afimoxifene" title="Afimoxifene">Afimoxifene</a></li> <li><a href="/wiki/Anordiol" title="Anordiol">Anordiol</a></li> <li><a href="/wiki/Anordrin" title="Anordrin">Anordrin</a></li> <li><a href="/wiki/Arzoxifene" title="Arzoxifene">Arzoxifene</a></li> <li><a href="/wiki/Bazedoxifene" title="Bazedoxifene">Bazedoxifene</a></li> <li><a href="/wiki/Brilanestrant" title="Brilanestrant">Brilanestrant</a></li> <li><a href="/wiki/Broparestrol" title="Broparestrol">Broparestrol</a></li> <li><a href="/wiki/Camizestrant" title="Camizestrant">Camizestrant</a></li> <li><a href="/wiki/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li> <li><a href="/wiki/Clomifene" title="Clomifene">Clomifene</a></li> <li><a href="/wiki/Clomifenoxide" title="Clomifenoxide">Clomifenoxide</a></li> <li><a href="/w/index.php?title=CN-55945-27&action=edit&redlink=1" class="new" title="CN-55945-27 (page does not exist)">CN-55945-27</a></li> <li><a href="/wiki/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li> <li><a href="/w/index.php?title=D-15413&action=edit&redlink=1" class="new" title="D-15413 (page does not exist)">D-15413</a></li> <li><a href="/wiki/Desmethylchlorotrianisene" title="Desmethylchlorotrianisene">Desmethylchlorotrianisene</a></li> <li><a href="/wiki/Droloxifene" title="Droloxifene">Droloxifene</a></li> <li><a href="/wiki/Enclomifene" title="Enclomifene">Enclomifene</a></li> <li><a href="/wiki/Endoxifen" title="Endoxifen">Endoxifen</a></li> <li><a href="/wiki/Etacstil" title="Etacstil">Etacstil (GW-5638, DPC-974)</a></li> <li><a href="/wiki/Ethamoxytriphetol" title="Ethamoxytriphetol">Ethamoxytriphetol (MER-25)</a></li> <li><a href="/wiki/Femarelle" title="Femarelle">Femarelle</a></li> <li><a href="/wiki/Fispemifene" title="Fispemifene">Fispemifene</a></li> <li><a href="/w/index.php?title=GW-7604&action=edit&redlink=1" class="new" title="GW-7604 (page does not exist)">GW-7604</a></li> <li><a href="/wiki/ICI-55548" class="mw-redirect" title="ICI-55548">ICI-55548</a></li> <li><a href="/wiki/Idoxifene" title="Idoxifene">Idoxifene</a></li> <li><a href="/wiki/Lasofoxifene" title="Lasofoxifene">Lasofoxifene</a></li> <li><a href="/wiki/Levormeloxifene" title="Levormeloxifene">Levormeloxifene</a></li> <li><a href="/wiki/LN-1643" class="mw-redirect" title="LN-1643">LN-1643</a></li> <li><a href="/wiki/LN-2299" class="mw-redirect" title="LN-2299">LN-2299</a></li> <li><a href="/w/index.php?title=LY-117018&action=edit&redlink=1" class="new" title="LY-117018 (page does not exist)">LY-117018</a></li> <li><a href="/wiki/Menerba" title="Menerba">Menerba</a></li> <li><a href="/wiki/Miproxifene" title="Miproxifene">Miproxifene</a></li> <li><a href="/wiki/Miproxifene_phosphate" title="Miproxifene phosphate">Miproxifene phosphate</a></li> <li><a href="/w/index.php?title=MRL-37&action=edit&redlink=1" class="new" title="MRL-37 (page does not exist)">MRL-37</a></li> <li><a href="/wiki/Nafoxidine" title="Nafoxidine">Nafoxidine</a></li> <li><a href="/wiki/Nitromifene" title="Nitromifene">Nitromifene</a></li> <li><a href="/wiki/NNC_45-0095" title="NNC 45-0095">NNC 45-0095</a></li> <li><a href="/w/index.php?title=NNC_45-0320&action=edit&redlink=1" class="new" title="NNC 45-0320 (page does not exist)">NNC 45-0320</a></li> <li><a href="/w/index.php?title=NNC_45-0781&action=edit&redlink=1" class="new" title="NNC 45-0781 (page does not exist)">NNC 45-0781</a></li> <li><a href="/w/index.php?title=NNC_45-1506&action=edit&redlink=1" class="new" title="NNC 45-1506 (page does not exist)">NNC 45-1506</a></li> <li><a href="/wiki/Ormeloxifene" title="Ormeloxifene">Ormeloxifene</a></li> <li><a href="/wiki/Ospemifene" title="Ospemifene">Ospemifene</a></li> <li><a href="/wiki/Panomifene" title="Panomifene">Panomifene</a></li> <li><a href="/wiki/Pipendoxifene" title="Pipendoxifene">Pipendoxifene</a></li> <li><a href="/w/index.php?title=Promensil&action=edit&redlink=1" class="new" title="Promensil (page does not exist)">Promensil</a></li> <li><a href="/wiki/Raloxifene" title="Raloxifene">Raloxifene</a></li> <li><a href="/wiki/Rimostil" title="Rimostil">Rimostil (P-081)</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li> <li><a href="/w/index.php?title=SS1010&action=edit&redlink=1" class="new" title="SS1010 (page does not exist)">SS1010</a></li> <li><a href="/wiki/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li> <li><a href="/wiki/TAS-108" title="TAS-108">TAS-108 (SR-16234)</a></li> <li><a href="/wiki/Toremifene" title="Toremifene">Toremifene</a></li> <li><a href="/wiki/Trioxifene" title="Trioxifene">Trioxifene</a></li> <li><a href="/w/index.php?title=TZE-5323&action=edit&redlink=1" class="new" title="TZE-5323 (page does not exist)">TZE-5323</a></li> <li><a href="/w/index.php?title=U-11555A&action=edit&redlink=1" class="new" title="U-11555A (page does not exist)">U-11555A</a></li> <li><a href="/w/index.php?title=U-11634&action=edit&redlink=1" class="new" title="U-11634 (page does not exist)">U-11634</a></li> <li><a href="/w/index.php?title=Y-134&action=edit&redlink=1" class="new" title="Y-134 (page does not exist)">Y-134</a></li> <li><a href="/wiki/Zindoxifene" title="Zindoxifene">Zindoxifene</a></li> <li><a href="/wiki/Zuclomifene" title="Zuclomifene">Zuclomifene</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/(R,R)-Tetrahydrochrysene" title="(R,R)-Tetrahydrochrysene">(R,R)-THC</a></li> <li><a href="/wiki/7%CE%B2-Hydroxy-DHEA" title="7β-Hydroxy-DHEA">7β-Hydroxy-DHEA</a></li> <li><a href="/w/index.php?title=Chloroindazole&action=edit&redlink=1" class="new" title="Chloroindazole (page does not exist)">Chloroindazole</a></li> <li><a href="/wiki/Cytestrol_acetate" title="Cytestrol acetate">Cytestrol acetate</a></li> <li><a href="/w/index.php?title=EM-800&action=edit&redlink=1" class="new" title="EM-800 (page does not exist)">EM-800 (SCH-57050)</a></li> <li><a href="/wiki/Epitiostanol" title="Epitiostanol">Epitiostanol</a></li> <li><a href="/w/index.php?title=ERA-90&action=edit&redlink=1" class="new" title="ERA-90 (page does not exist)">ERA-90</a></li> <li><a href="/w/index.php?title=ERB-88&action=edit&redlink=1" class="new" title="ERB-88 (page does not exist)">ERB-88</a></li> <li><a href="/wiki/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li> <li><a href="/wiki/Glyceollin" title="Glyceollin">Glyceollins</a> (<a href="/wiki/Glyceollin_I" title="Glyceollin I">I</a>, <a href="/w/index.php?title=Glyceollin_II&action=edit&redlink=1" class="new" title="Glyceollin II (page does not exist)">II</a>, <a href="/wiki/Glyceollin_III" title="Glyceollin III">III</a>, <a href="/w/index.php?title=Glyceollin_IV&action=edit&redlink=1" class="new" title="Glyceollin IV (page does not exist)">IV</a>)</li> <li><a href="/wiki/ICI-164384" title="ICI-164384">ICI-164384</a></li> <li><a href="/w/index.php?title=MDL-101906&action=edit&redlink=1" class="new" title="MDL-101906 (page does not exist)">MDL-101906</a></li> <li><a href="/wiki/Mepitiostane" title="Mepitiostane">Mepitiostane</a></li> <li><a href="/wiki/Methylepitiostanol" title="Methylepitiostanol">Methylepitiostanol</a></li> <li><a href="/wiki/Methylpiperidinopyrazole" title="Methylpiperidinopyrazole">Methylpiperidinopyrazole</a></li> <li><a href="/wiki/MIBE" title="MIBE">MIBE</a></li> <li><a href="/w/index.php?title=Oxabicycloheptene_sulfonate&action=edit&redlink=1" class="new" title="Oxabicycloheptene sulfonate (page does not exist)">Oxabicycloheptene sulfonate</a></li> <li><a href="/wiki/Phenytoin" title="Phenytoin">Phenytoin</a></li> <li><a href="/wiki/PHTPP" title="PHTPP">PHTPP</a></li> <li><a href="/wiki/Prochloraz" title="Prochloraz">Prochloraz</a></li> <li><a href="/w/index.php?title=RU-39411&action=edit&redlink=1" class="new" title="RU-39411 (page does not exist)">RU-39411</a></li> <li><a href="/w/index.php?title=RU-58668&action=edit&redlink=1" class="new" title="RU-58668 (page does not exist)">RU-58668</a></li> <li><a href="/w/index.php?title=SS1020&action=edit&redlink=1" class="new" title="SS1020 (page does not exist)">SS1020</a></li> <li><a href="/wiki/TAS-108" title="TAS-108">TAS-108 (SR-16234)</a></li> <li><a href="/wiki/ZB716" title="ZB716">ZB716</a></li> <li><a href="/w/index.php?title=ZK-164015&action=edit&redlink=1" class="new" title="ZK-164015 (page does not exist)">ZK-164015</a></li> <li><a href="/w/index.php?title=ZK-191703&action=edit&redlink=1" class="new" title="ZK-191703 (page does not exist)">ZK-191703</a></li></ul> <ul><li><i>Coregulator-binding modulators:</i> <a href="/wiki/ERX-11" title="ERX-11">ERX-11</a></li></ul> <ul><li><i>Noncompetitive inhibitors:</i> <a href="/wiki/Trilostane" title="Trilostane">Trilostane</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/G_protein-coupled_estrogen_receptor" class="mw-redirect" title="G protein-coupled estrogen receptor"><abbr title="G protein-coupled estrogen receptor">GPER</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip G protein-coupled estrogen receptor</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/2-Methoxyestradiol" title="2-Methoxyestradiol">2-Methoxyestradiol</a></li> <li><a href="/wiki/7%CE%B2-Hydroxyepiandrosterone" title="7β-Hydroxyepiandrosterone">7β-Hydroxyepiandrosterone</a></li> <li><a href="/wiki/Afimoxifene" title="Afimoxifene">Afimoxifene (4-hydroxytamoxifen)</a></li> <li><a href="/wiki/Aldosterone" title="Aldosterone">Aldosterone</a></li> <li><a href="/wiki/Atrazine" title="Atrazine">Atrazine</a></li> <li><a href="/wiki/Bisphenol_A" title="Bisphenol A">Bisphenol A</a></li> <li><a href="/wiki/Daidzein" title="Daidzein">Daidzein</a></li> <li><a href="/wiki/DDT" title="DDT">DDT</a> (<a href="/wiki/P,p%27-DDT" class="mw-redirect" title="P,p'-DDT">p,p'-DDT</a>, <a href="/w/index.php?title=O%27,p%27-DDE&action=edit&redlink=1" class="new" title="O',p'-DDE (page does not exist)">o',p'-DDE</a>)</li> <li><a href="/wiki/Diarylpropionitrile" title="Diarylpropionitrile">Diarylpropionitrile</a></li> <li><a href="/wiki/Equol" title="Equol">Equol</a></li> <li><a href="/wiki/Estradiol" title="Estradiol">Estradiol</a></li> <li><a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">Ethinylestradiol</a></li> <li><a href="/wiki/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li> <li><a href="/w/index.php?title=G-1_(drug)&action=edit&redlink=1" class="new" title="G-1 (drug) (page does not exist)">G-1</a></li> <li><a href="/wiki/Genistein" title="Genistein">Genistein</a></li> <li><a href="/w/index.php?title=GPER-L1&action=edit&redlink=1" class="new" title="GPER-L1 (page does not exist)">GPER-L1</a></li> <li><a href="/w/index.php?title=GPER-L2&action=edit&redlink=1" class="new" title="GPER-L2 (page does not exist)">GPER-L2</a></li> <li><a href="/wiki/Hydroxytyrosol" title="Hydroxytyrosol">Hydroxytyrosol</a></li> <li><a href="/wiki/Kepone" class="mw-redirect" title="Kepone">Kepone</a></li> <li><a href="/wiki/Niacin" title="Niacin">Niacin</a></li> <li><a href="/wiki/Niacinamide" class="mw-redirect" title="Niacinamide">Niacinamide</a></li> <li><a href="/wiki/Nonylphenol" title="Nonylphenol">Nonylphenol</a></li> <li><a href="/wiki/Oleuropein" title="Oleuropein">Oleuropein</a></li> <li><a href="/wiki/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a> (<a href="/w/index.php?title=2,2%27,5%27-PCB-4-OH&action=edit&redlink=1" class="new" title="2,2',5'-PCB-4-OH (page does not exist)">2,2',5'-PCB-4-OH</a>)</li> <li><a href="/wiki/Propylpyrazoletriol" title="Propylpyrazoletriol">Propylpyrazoletriol</a></li> <li><a href="/wiki/Quercetin" title="Quercetin">Quercetin</a></li> <li><a href="/wiki/Raloxifene" title="Raloxifene">Raloxifene</a></li> <li><a href="/wiki/Resveratrol" title="Resveratrol">Resveratrol</a></li> <li><a href="/w/index.php?title=STX_(drug)&action=edit&redlink=1" class="new" title="STX (drug) (page does not exist)">STX</a></li> <li><a href="/wiki/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li> <li><a href="/wiki/Tectoridin" title="Tectoridin">Tectoridin</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/CCL18" title="CCL18">CCL18</a></li> <li><a href="/wiki/Estriol" title="Estriol">Estriol</a></li> <li><a href="/w/index.php?title=G-15_(drug)&action=edit&redlink=1" class="new" title="G-15 (drug) (page does not exist)">G-15</a></li> <li><a href="/w/index.php?title=G-36_(drug)&action=edit&redlink=1" class="new" title="G-36 (drug) (page does not exist)">G-36</a></li> <li><a href="/wiki/MIBE" title="MIBE">MIBE</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Unknown</th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></li> <li><a href="/wiki/Zearalenone" title="Zearalenone">Zearalenone</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div> <dl><dt>See also</dt> <dd><a href="/wiki/Template:Receptor_modulators" title="Template:Receptor modulators">Receptor/signaling modulators</a></dd> <dd><a href="/wiki/Template:Estrogens_and_antiestrogens" title="Template:Estrogens and antiestrogens">Estrogens and antiestrogens</a></dd> <dd><a href="/wiki/Template:Androgen_receptor_modulators" title="Template:Androgen receptor modulators">Androgen receptor modulators</a></dd> <dd><a href="/wiki/Template:Progesterone_receptor_modulators" title="Template:Progesterone receptor modulators">Progesterone receptor modulators</a></dd> <dd><a href="/wiki/List_of_steroidal_estrogens" class="mw-redirect" title="List of steroidal estrogens">List of estrogens</a></dd></dl> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Mineralocorticoid_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Mineralocorticoid_receptor_modulators" title="Template:Mineralocorticoid receptor modulators"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Mineralocorticoid_receptor_modulators" title="Template talk:Mineralocorticoid receptor modulators"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Mineralocorticoid_receptor_modulators" title="Special:EditPage/Template:Mineralocorticoid receptor modulators"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Mineralocorticoid_receptor_modulators" style="font-size:114%;margin:0 4em"><a href="/wiki/Mineralocorticoid_receptor" title="Mineralocorticoid receptor">Mineralocorticoid receptor</a> <a href="/wiki/Receptor_modulator" title="Receptor modulator">modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Mineralocorticoid_receptor" title="Mineralocorticoid receptor"><abbr title="Mineralocorticoid receptor">MR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Mineralocorticoid receptor</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/11-Dehydrocorticosterone" title="11-Dehydrocorticosterone">11-Dehydrocorticosterone (11-oxocorticosterone, 17-deoxycortisone)</a> <ul><li><a href="/w/index.php?title=11-Dehydrocorticosterone_acetate&action=edit&redlink=1" class="new" title="11-Dehydrocorticosterone acetate (page does not exist)">11-Dehydrocorticosterone acetate</a></li></ul></li> <li><a href="/wiki/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycorticosterone (desoxycortone, deoxycortone, desoxycorticosterone)</a> <ul><li><a href="/wiki/List_of_corticosteroid_esters#Desoxycortone_esters" title="List of corticosteroid esters">Desoxycortone esters</a></li></ul></li> <li><a href="/wiki/11-Deoxycortisol" title="11-Deoxycortisol">11-Deoxycortisol (cortodoxone, cortexolone)</a> <ul><li><a href="/wiki/Cortifen" title="Cortifen">Cortifen (cortiphen, kortifen)</a></li> <li><a href="/w/index.php?title=Cortodoxone_acetate&action=edit&redlink=1" class="new" title="Cortodoxone acetate (page does not exist)">Cortodoxone acetate</a></li></ul></li> <li><a href="/wiki/11%CE%B2-Hydroxyprogesterone" title="11β-Hydroxyprogesterone">11β-Hydroxyprogesterone</a></li> <li><a href="/w/index.php?title=16%CE%B1,18-Dihydroxy-11-deoxycorticosterone&action=edit&redlink=1" class="new" title="16α,18-Dihydroxy-11-deoxycorticosterone (page does not exist)">16α,18-Dihydroxy-11-deoxycorticosterone</a></li> <li><a href="/w/index.php?title=17%CE%B1-Hydroxyaldosterone&action=edit&redlink=1" class="new" title="17α-Hydroxyaldosterone (page does not exist)">17α-Hydroxyaldosterone</a></li> <li><a href="/wiki/18-Hydroxy-11-deoxycorticosterone" title="18-Hydroxy-11-deoxycorticosterone">18-Hydroxy-11-deoxycorticosterone</a></li> <li><a href="/wiki/19-Norprogesterone" title="19-Norprogesterone">19-Norprogesterone</a></li> <li><a href="/wiki/Aldosterone" title="Aldosterone">Aldosterone</a></li> <li><a href="/wiki/Corticosterone" title="Corticosterone">Corticosterone</a> <ul><li><a href="/w/index.php?title=Corticosterone_acetate&action=edit&redlink=1" class="new" title="Corticosterone acetate (page does not exist)">Corticosterone acetate</a></li> <li><a href="/w/index.php?title=Corticosterone_benzoate&action=edit&redlink=1" class="new" title="Corticosterone benzoate (page does not exist)">Corticosterone benzoate</a></li></ul></li> <li><a href="/wiki/Cortisol" title="Cortisol">Cortisol</a> (<a href="/wiki/Hydrocortisone" title="Hydrocortisone">hydrocortisone</a>) <ul><li><a href="/wiki/Benzodrocortisone" title="Benzodrocortisone">Benzodrocortisone (hydrocortisone benzoate)</a></li> <li><a href="/wiki/Hydrocortamate" title="Hydrocortamate">Hydrocortamate (hydrocortisone diethylaminoacetate)</a></li> <li><a href="/wiki/List_of_corticosteroid_esters#Hydrocortisone_esters" title="List of corticosteroid esters">Hydrocortisone esters</a></li></ul></li> <li><a href="/wiki/Cortisone" title="Cortisone">Cortisone</a> <ul><li><a href="/wiki/Cortisone_acetate" title="Cortisone acetate">Cortisone acetate</a></li></ul></li> <li><a href="/wiki/Fludrocortisone" title="Fludrocortisone">Fludrocortisone (fludrocortone)</a> <ul><li><a href="/wiki/Fludrocortisone_acetate" class="mw-redirect" title="Fludrocortisone acetate">Fludrocortisone acetate</a></li></ul></li> <li><a href="/wiki/Mometasone" title="Mometasone">Mometasone</a> <ul><li><a href="/wiki/Mometasone_furoate" class="mw-redirect" title="Mometasone furoate">Mometasone furoate</a></li></ul></li> <li><a href="/wiki/Prednisolone" title="Prednisolone">Prednisolone</a> <ul><li><a href="/wiki/Prednazate" title="Prednazate">Prednazate</a></li> <li><a href="/wiki/Prednazoline" title="Prednazoline">Prednazoline</a></li> <li><a href="/wiki/Prednicarbate" title="Prednicarbate">Prednicarbate (prednisolone ethylcarbonate propionate)</a></li> <li><a href="/wiki/Prednimustine" title="Prednimustine">Prednimustine</a></li> <li><a href="/wiki/Prednisolamate" title="Prednisolamate">Prednisolamate (prednisolone diethylaminoacetate)</a></li> <li><a href="/wiki/List_of_corticosteroid_esters#Prednisolone_esters" title="List of corticosteroid esters">Prednisolone esters</a></li></ul></li> <li><a href="/wiki/Prednisone" title="Prednisone">Prednisone</a> <ul><li><a href="/wiki/List_of_corticosteroid_esters#Prednisone_esters" title="List of corticosteroid esters">Prednisone esters</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Steroidal:</i> <a href="/wiki/6%CE%B2-Hydroxy-7%CE%B1-thiomethylspironolactone" title="6β-Hydroxy-7α-thiomethylspironolactone">6β-Hydroxy-7α-thiomethylspironolactone</a></li> <li><a href="/w/index.php?title=7%CE%B1-Acetylthio-17%CE%B1-hydroxyprogesterone&action=edit&redlink=1" class="new" title="7α-Acetylthio-17α-hydroxyprogesterone (page does not exist)">7α-Acetylthio-17α-hydroxyprogesterone</a></li> <li><a href="/wiki/7%CE%B1-Thiomethylspironolactone" title="7α-Thiomethylspironolactone">7α-Thiomethylspironolactone (SC-26519)</a></li> <li><a href="/wiki/7%CE%B1-Thioprogesterone" title="7α-Thioprogesterone">7α-Thioprogesterone (SC-8365)</a></li> <li><a href="/wiki/7%CE%B1-Thiospironolactone" title="7α-Thiospironolactone">7α-Thiospironolactone (SC-24813)</a></li> <li><a href="/wiki/16%CE%B1-Hydroxyprogesterone" title="16α-Hydroxyprogesterone">16α-Hydroxyprogesterone</a></li> <li><a href="/wiki/17%CE%B1-Hydroxyprogesterone" title="17α-Hydroxyprogesterone">17α-Hydroxyprogesterone (hydroxyprogesterone)</a></li> <li><a href="/wiki/18-Deoxyaldosterone" title="18-Deoxyaldosterone">18-Deoxyaldosterone</a></li> <li><a href="/w/index.php?title=18,19-Dinorprogesterone&action=edit&redlink=1" class="new" title="18,19-Dinorprogesterone (page does not exist)">18,19-Dinorprogesterone</a></li> <li><a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">Canrenoate potassium (potassium canrenoate)</a></li> <li><a href="/wiki/Canrenoic_acid" title="Canrenoic acid">Canrenoic acid (canrenoate)</a></li> <li><a href="/wiki/Canrenone" title="Canrenone">Canrenone (canrenoate y-lactone)</a></li> <li><a href="/wiki/Dicirenone" title="Dicirenone">Dicirenone</a></li> <li><a href="/wiki/Dimethisterone" title="Dimethisterone">Dimethisterone</a></li> <li><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li> <li><a href="/wiki/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li> <li><a href="/wiki/Eplerenone" title="Eplerenone">Eplerenone</a></li> <li><a href="/wiki/Gestodene" title="Gestodene">Gestodene</a></li> <li><a href="/wiki/Guggulsterone" title="Guggulsterone">Guggulsterone</a></li> <li><a href="/wiki/Hydroxyprogesterone_caproate" title="Hydroxyprogesterone caproate">Hydroxyprogesterone caproate</a></li> <li><a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a></li> <li><a href="/wiki/Mespirenone" title="Mespirenone">Mespirenone</a></li> <li><a href="/wiki/Metribolone" title="Metribolone">Metribolone</a></li> <li><a href="/wiki/Mexrenoate_potassium" title="Mexrenoate potassium">Mexrenoate potassium</a></li> <li><a href="/wiki/Mexrenoic_acid" title="Mexrenoic acid">Mexrenoic acid (mexrenoate)</a></li> <li><a href="/wiki/Mexrenone" title="Mexrenone">Mexrenone</a></li> <li><a href="/wiki/Oxprenoic_acid" title="Oxprenoic acid">Oxprenoic acid (oxprenoate)</a></li> <li><a href="/wiki/Oxprenoate_potassium" title="Oxprenoate potassium">Oxprenoate potassium (RU-28318)</a></li> <li><a href="/wiki/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li> <li><a href="/wiki/Progesterone" title="Progesterone">Progesterone</a></li> <li><a href="/wiki/Prorenoate_potassium" title="Prorenoate potassium">Prorenoate potassium</a></li> <li><a href="/wiki/Prorenoic_acid" title="Prorenoic acid">Prorenoic acid (prorenoate)</a></li> <li><a href="/wiki/Prorenone" title="Prorenone">Prorenone</a></li> <li><a href="/w/index.php?title=RO-14-9012&action=edit&redlink=1" class="new" title="RO-14-9012 (page does not exist)">RO-14-9012</a></li> <li><a href="/w/index.php?title=RU-26752&action=edit&redlink=1" class="new" title="RU-26752 (page does not exist)">RU-26752</a></li> <li><a href="/wiki/SC-5233" title="SC-5233">SC-5233 (spirolactone)</a></li> <li><a href="/wiki/SC-8109" title="SC-8109">SC-8109</a></li> <li><a href="/w/index.php?title=SC-11927&action=edit&redlink=1" class="new" title="SC-11927 (page does not exist)">SC-11927 (CS-1)</a></li> <li><a href="/w/index.php?title=SC-19886&action=edit&redlink=1" class="new" title="SC-19886 (page does not exist)">SC-19886</a></li> <li><a href="/w/index.php?title=SC-27169&action=edit&redlink=1" class="new" title="SC-27169 (page does not exist)">SC-27169</a></li> <li><a href="/wiki/Spirorenone" title="Spirorenone">Spirorenone</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li> <li><a href="/wiki/Spiroxasone" title="Spiroxasone">Spiroxasone</a></li> <li><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a></li> <li><a href="/wiki/Trimegestone" title="Trimegestone">Trimegestone</a></li> <li><a href="/wiki/Vamorolone" title="Vamorolone">Vamorolone</a></li> <li><a href="/w/index.php?title=ZK-91587&action=edit&redlink=1" class="new" title="ZK-91587 (page does not exist)">ZK-91587</a></li> <li><a href="/w/index.php?title=ZK-97894&action=edit&redlink=1" class="new" title="ZK-97894 (page does not exist)">ZK-97894</a></li></ul> <ul><li><i>Nonsteroidal:</i> <a href="/wiki/Amlodipine" title="Amlodipine">Amlodipine</a></li> <li><a href="/wiki/Apararenone" title="Apararenone">Apararenone</a></li> <li><a href="/wiki/Benidipine" title="Benidipine">Benidipine</a></li> <li><a href="/w/index.php?title=BR-4628&action=edit&redlink=1" class="new" title="BR-4628 (page does not exist)">BR-4628</a></li> <li><a href="/wiki/Esaxerenone" title="Esaxerenone">Esaxerenone</a></li> <li><a href="/wiki/Felodipine" title="Felodipine">Felodipine</a></li> <li><a href="/wiki/Finerenone" title="Finerenone">Finerenone</a></li> <li><a href="/wiki/Miricorilant" title="Miricorilant">Miricorilant (CORT-118335)</a></li> <li><a href="/wiki/Nifedipine" title="Nifedipine">Nifedipine</a></li> <li><a href="/wiki/Nimodipine" title="Nimodipine">Nimodipine</a></li> <li><a href="/wiki/Nitrendipine" title="Nitrendipine">Nitrendipine</a></li> <li><a href="/wiki/Ocedurenone" title="Ocedurenone">Ocedurenone</a></li> <li><a href="/w/index.php?title=PF-03882845&action=edit&redlink=1" class="new" title="PF-03882845 (page does not exist)">PF-03882845</a></li> <li><a href="/w/index.php?title=SM-368229&action=edit&redlink=1" class="new" title="SM-368229 (page does not exist)">SM-368229</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div> <dl><dt>See also</dt> <dd><a href="/wiki/Template:Receptor_modulators" title="Template:Receptor modulators">Receptor/signaling modulators</a></dd> <dd><a href="/wiki/Template:Mineralocorticoids_and_antimineralocorticoids" title="Template:Mineralocorticoids and antimineralocorticoids">Mineralocorticoids and antimineralocorticoids</a></dd> <dd><a href="/wiki/Template:Glucocorticoid_receptor_modulators" title="Template:Glucocorticoid receptor modulators">Glucocorticoid receptor modulators</a></dd> <dd><a href="/wiki/List_of_corticosteroids" title="List of corticosteroids">List of corticosteroids</a></dd></dl> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Progesterone_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Progesterone_receptor_modulators" title="Template:Progesterone receptor modulators"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Progesterone_receptor_modulators" title="Template talk:Progesterone receptor modulators"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Progesterone_receptor_modulators" title="Special:EditPage/Template:Progesterone receptor modulators"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Progesterone_receptor_modulators" style="font-size:114%;margin:0 4em"><a href="/wiki/Progesterone_receptor" title="Progesterone receptor">Progesterone receptor</a> <a href="/wiki/Receptor_modulator" title="Receptor modulator">modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Progesterone_receptor" title="Progesterone receptor"><abbr title="Progesterone receptor">PR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Progesterone receptor</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Progesterone derivatives:</i> <a href="/wiki/3%CE%B2-Dihydroprogesterone" title="3β-Dihydroprogesterone">3β-Dihydroprogesterone</a></li> <li><a href="/wiki/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">5α-Dihydroprogesterone</a></li> <li><a href="/wiki/6%CE%B1-Methylprogesterone" title="6α-Methylprogesterone">6α-Methylprogesterone</a></li> <li><a href="/wiki/9%CE%B1-Bromo-11-ketoprogesterone" class="mw-redirect" title="9α-Bromo-11-ketoprogesterone">9α-Bromo-11-ketoprogesterone</a></li> <li><a href="/wiki/11-Dehydroprogesterone" title="11-Dehydroprogesterone">11-Dehydroprogesterone</a></li> <li><a href="/wiki/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycorticosterone</a></li> <li><a href="/wiki/16%CE%B1-Hydroxyprogesterone" title="16α-Hydroxyprogesterone">16α-Hydroxyprogesterone</a></li> <li><a href="/w/index.php?title=17%CE%B1-Methyl-11-deoxycorticosterone_acetate&action=edit&redlink=1" class="new" title="17α-Methyl-11-deoxycorticosterone acetate (page does not exist)">17α-Methyl-11-deoxycorticosterone acetate</a></li> <li><a href="/wiki/20%CE%B1-Dihydroprogesterone" title="20α-Dihydroprogesterone">20α-Dihydroprogesterone</a></li> <li><a href="/wiki/20%CE%B2-Dihydroprogesterone" title="20β-Dihydroprogesterone">20β-Dihydroprogesterone</a></li> <li><a href="/wiki/Dimepregnen" title="Dimepregnen">Dimepregnen</a></li> <li><a href="/wiki/Diosgenin" title="Diosgenin">Diosgenin</a></li> <li><a href="/wiki/P1-185" title="P1-185">P1-185</a></li> <li><a href="/wiki/Progesterone" title="Progesterone">Progesterone</a></li> <li><a href="/wiki/Progesterone_3-acetyl_enol_ether" title="Progesterone 3-acetyl enol ether">Progesterone 3-acetyl enol ether</a></li> <li><a href="/wiki/Quingestrone" title="Quingestrone">Quingestrone</a></li></ul> <ul><li><i>Retroprogesterone derivatives:</i> <a href="/wiki/20%CE%B1-Dihydrodydrogesterone" title="20α-Dihydrodydrogesterone">20α-Dihydrodydrogesterone</a></li> <li><a href="/wiki/20%CE%B1-Dihydrotrengestone" title="20α-Dihydrotrengestone">20α-Dihydrotrengestone</a></li> <li><a href="/wiki/DU-41164" title="DU-41164">DU-41164</a></li> <li><a href="/wiki/DU-41165" title="DU-41165">DU-41165</a></li> <li><a href="/wiki/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li> <li><a href="/wiki/Retroprogesterone" title="Retroprogesterone">Retroprogesterone</a></li> <li><a href="/wiki/Ro_6-3129" title="Ro 6-3129">Ro 6-3129</a></li> <li><a href="/wiki/Trengestone" title="Trengestone">Trengestone</a></li></ul> <ul><li><i>17α-Substituted progesterone derivatives:</i> <a href="/wiki/6%CE%B1-Methyl-17%CE%B1-bromoprogesterone" title="6α-Methyl-17α-bromoprogesterone">6α-Methyl-17α-bromoprogesterone</a></li> <li><a href="/wiki/15%CE%B2-Hydroxycyproterone_acetate" title="15β-Hydroxycyproterone acetate">15β-Hydroxycyproterone acetate</a></li> <li><a href="/wiki/16-Methylene-17%CE%B1-hydroxyprogesterone_acetate" title="16-Methylene-17α-hydroxyprogesterone acetate">16-Methylene-17α-hydroxyprogesterone acetate</a></li> <li><a href="/wiki/17%CE%B1-Bromoprogesterone" title="17α-Bromoprogesterone">17α-Bromoprogesterone</a></li> <li><a href="/wiki/17%CE%B1-Hydroxyprogesterone" title="17α-Hydroxyprogesterone">17α-Hydroxyprogesterone (hydroxyprogesterone)</a></li> <li><a href="/wiki/17%CE%B1-Methylprogesterone" title="17α-Methylprogesterone">17α-Methylprogesterone</a></li> <li><a href="/wiki/Acetomepregenol" title="Acetomepregenol">Acetomepregenol (mepregenol diacetate)</a></li> <li><a href="/wiki/Algestone" title="Algestone">Algestone</a></li> <li><a href="/wiki/Algestone_acetonide" title="Algestone acetonide">Algestone acetonide</a></li> <li><a href="/wiki/Algestone_acetophenide" title="Algestone acetophenide">Algestone acetophenide</a></li> <li><a href="/wiki/Anagestone" title="Anagestone">Anagestone</a></li> <li><a href="/wiki/Anagestone_acetate" title="Anagestone acetate">Anagestone acetate</a></li> <li><a href="/w/index.php?title=Bromethenmadinone&action=edit&redlink=1" class="new" title="Bromethenmadinone (page does not exist)">Bromethenmadinone</a></li> <li><a href="/wiki/Bromethenmadinone_acetate" title="Bromethenmadinone acetate">Bromethenmadinone acetate</a></li> <li><a href="/wiki/Butagest" title="Butagest">Butagest (buterol)</a></li> <li><a href="/wiki/Chlormadinone" title="Chlormadinone">Chlormadinone</a></li> <li><a href="/wiki/Chlormadinone_acetate" title="Chlormadinone acetate">Chlormadinone acetate</a></li> <li><a href="/wiki/Chlormadinone_caproate" title="Chlormadinone caproate">Chlormadinone caproate</a></li> <li><a href="/w/index.php?title=Chlormethenmadinone&action=edit&redlink=1" class="new" title="Chlormethenmadinone (page does not exist)">Chlormethenmadinone</a></li> <li><a href="/wiki/Chlormethenmadinone_acetate" title="Chlormethenmadinone acetate">Chlormethenmadinone acetate</a></li> <li><a href="/wiki/Cismadinone" title="Cismadinone">Cismadinone</a></li> <li><a href="/wiki/Cismadinone_acetate" title="Cismadinone acetate">Cismadinone acetate</a></li> <li><a href="/wiki/Clogestone" title="Clogestone">Clogestone</a></li> <li><a href="/wiki/Clogestone_acetate" title="Clogestone acetate">Clogestone acetate</a></li> <li><a href="/wiki/Clomegestone" title="Clomegestone">Clomegestone</a></li> <li><a href="/wiki/Clomegestone_acetate" title="Clomegestone acetate">Clomegestone acetate</a></li> <li><a href="/wiki/Cymegesolate" title="Cymegesolate">Cymegesolate</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Delmadinone" title="Delmadinone">Delmadinone</a></li> <li><a href="/wiki/Delmadinone_acetate" title="Delmadinone acetate">Delmadinone acetate</a></li> <li><a href="/wiki/Edogestrone" title="Edogestrone">Edogestrone</a></li> <li><a href="/wiki/Flugestone" title="Flugestone">Flugestone</a></li> <li><a href="/wiki/Flugestone_acetate" title="Flugestone acetate">Flugestone acetate</a></li> <li><a href="/wiki/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li> <li><a href="/wiki/Fluorometholone_acetate" title="Fluorometholone acetate">Fluorometholone acetate</a></li> <li><a href="/wiki/Flumedroxone" title="Flumedroxone">Flumedroxone</a></li> <li><a href="/wiki/Flumedroxone_acetate" title="Flumedroxone acetate">Flumedroxone acetate</a></li> <li><a href="/wiki/Fluoromedroxyprogesterone_acetate" title="Fluoromedroxyprogesterone acetate">Fluoromedroxyprogesterone acetate</a></li> <li><a href="/wiki/Gestaclone" title="Gestaclone">Gestaclone</a></li> <li><a href="/w/index.php?title=Gestobutanoyl&action=edit&redlink=1" class="new" title="Gestobutanoyl (page does not exist)">Gestobutanoyl</a></li> <li><a href="/wiki/Haloprogesterone" title="Haloprogesterone">Haloprogesterone</a></li> <li><a href="/wiki/Hydromadinone" title="Hydromadinone">Hydromadinone</a></li> <li><a href="/wiki/Hydromadinone_acetate" title="Hydromadinone acetate">Hydromadinone acetate</a></li> <li><a href="/wiki/Hydroxyprogesterone_acetate" title="Hydroxyprogesterone acetate">Hydroxyprogesterone acetate</a></li> <li><a href="/wiki/Hydroxyprogesterone_caproate" title="Hydroxyprogesterone caproate">Hydroxyprogesterone caproate (hydroxyprogesterone hexanoate)</a></li> <li><a href="/wiki/Hydroxyprogesterone_heptanoate" title="Hydroxyprogesterone heptanoate">Hydroxyprogesterone heptanoate (hydroxyprogesterone enanthate)</a></li> <li><a href="/wiki/Hydroxyprogesterone_heptanoate_benzilic_acid_hydrazone" title="Hydroxyprogesterone heptanoate benzilic acid hydrazone">Hydroxyprogesterone heptanoate benzilic acid hydrazone</a></li> <li><a href="/wiki/Mecigestone" title="Mecigestone">Mecigestone (pentarane B)</a></li> <li><a href="/wiki/Medrogestone" title="Medrogestone">Medrogestone</a></li> <li><a href="/wiki/Medroxyprogesterone" title="Medroxyprogesterone">Medroxyprogesterone</a></li> <li><a href="/wiki/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li> <li><a href="/wiki/Medroxyprogesterone_caproate" title="Medroxyprogesterone caproate">Medroxyprogesterone caproate</a></li> <li><a href="/wiki/Megestrol" title="Megestrol">Megestrol</a></li> <li><a href="/wiki/Megestrol_acetate" title="Megestrol acetate">Megestrol acetate</a></li> <li><a href="/wiki/Megestrol_caproate" title="Megestrol caproate">Megestrol caproate</a></li> <li><a href="/wiki/Melengestrol" title="Melengestrol">Melengestrol</a></li> <li><a href="/wiki/Melengestrol_acetate" title="Melengestrol acetate">Melengestrol acetate</a></li> <li><a href="/wiki/Methenmadinone" title="Methenmadinone">Methenmadinone</a></li> <li><a href="/wiki/Methenmadinone_acetate" title="Methenmadinone acetate">Methenmadinone acetate</a></li> <li><a href="/wiki/Methenmadinone_caproate" title="Methenmadinone caproate">Methenmadinone caproate</a></li> <li><a href="/wiki/Mometasone" title="Mometasone">Mometasone</a></li> <li><a href="/wiki/Mometasone_furoate" class="mw-redirect" title="Mometasone furoate">Mometasone furoate</a></li> <li><a href="/wiki/Osaterone" title="Osaterone">Osaterone</a></li> <li><a href="/wiki/Osaterone_acetate" title="Osaterone acetate">Osaterone acetate</a></li> <li><a href="/wiki/Pentagestrone" title="Pentagestrone">Pentagestrone</a></li> <li><a href="/wiki/Pentagestrone_acetate" title="Pentagestrone acetate">Pentagestrone acetate</a></li> <li><a href="/wiki/Pentarane_A" title="Pentarane A">Pentarane A</a></li> <li><a href="/wiki/Proligestone" title="Proligestone">Proligestone</a></li> <li><a href="/wiki/Triamcinolone_acetonide" title="Triamcinolone acetonide">Triamcinolone acetonide</a></li></ul> <ul><li><i>19-Norprogesterone derivatives:</i> <a href="/wiki/17%CE%B1-Methyl-19-norprogesterone" title="17α-Methyl-19-norprogesterone">17α-Methyl-19-norprogesterone</a></li> <li><a href="/wiki/18-Methylsegesterone_acetate" title="18-Methylsegesterone acetate">18-Methylsegesterone acetate</a></li> <li><a href="/wiki/19-Norprogesterone" title="19-Norprogesterone">19-Norprogesterone</a></li> <li><a href="/wiki/Amadinone" title="Amadinone">Amadinone</a></li> <li><a href="/wiki/Amadinone_acetate" title="Amadinone acetate">Amadinone acetate</a></li> <li><a href="/wiki/Demegestone" title="Demegestone">Demegestone</a></li> <li><a href="/w/index.php?title=Fluoro_ethyl_norprogesterone&action=edit&redlink=1" class="new" title="Fluoro ethyl norprogesterone (page does not exist)">Fluoro ethyl norprogesterone</a></li> <li><a href="/w/index.php?title=Fluoro_furanyl_norprogesterone&action=edit&redlink=1" class="new" title="Fluoro furanyl norprogesterone (page does not exist)">Fluoro furanyl norprogesterone</a></li> <li><a href="/wiki/Gestadienol" title="Gestadienol">Gestadienol</a></li> <li><a href="/wiki/Gestadienol_acetate" title="Gestadienol acetate">Gestadienol acetate</a></li> <li><a href="/wiki/Gestonorone_acetate" title="Gestonorone acetate">Gestonorone acetate (gestronol acetate)</a></li> <li><a href="/wiki/Gestonorone_caproate" title="Gestonorone caproate">Gestonorone caproate (gestronol hexanoate)</a></li> <li><a href="/wiki/Gestronol" title="Gestronol">Gestronol (gestonorone)</a></li> <li><a href="/wiki/Nomegestrol" title="Nomegestrol">Nomegestrol</a></li> <li><a href="/wiki/Nomegestrol_acetate" title="Nomegestrol acetate">Nomegestrol acetate</a></li> <li><a href="/wiki/Norgestomet" title="Norgestomet">Norgestomet</a></li> <li><a href="/wiki/ORG-2058" title="ORG-2058">ORG-2058</a></li> <li><a href="/wiki/Oxogestone" title="Oxogestone">Oxogestone</a></li> <li><a href="/wiki/Oxogestone_phenpropionate" title="Oxogestone phenpropionate">Oxogestone phenpropionate (xinogestone)</a></li> <li><a href="/wiki/Promegestone" title="Promegestone">Promegestone</a></li> <li><a href="/wiki/Segesterone" title="Segesterone">Segesterone</a></li> <li><a href="/wiki/Nestorone" class="mw-redirect" title="Nestorone">Segesterone acetate (nestorone)</a></li> <li><a href="/wiki/Trimegestone" title="Trimegestone">Trimegestone</a></li></ul> <ul><li><i>Testosterone derivatives:</i> Progestins: <a href="/wiki/6,6-Difluoronorethisterone" title="6,6-Difluoronorethisterone">6,6-Difluoronorethisterone</a></li> <li><a href="/wiki/6,6-Difluoronorethisterone_acetate" title="6,6-Difluoronorethisterone acetate">6,6-Difluoronorethisterone acetate</a></li> <li><a href="/wiki/17%CE%B1-Allyl-19-nortestosterone" title="17α-Allyl-19-nortestosterone">17α-Allyl-19-nortestosterone</a></li> <li><a href="/wiki/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li> <li><a href="/wiki/Altrenogest" title="Altrenogest">Altrenogest</a></li> <li><a href="/wiki/Chloroethynylnorgestrel" title="Chloroethynylnorgestrel">Chloroethynylnorgestrel</a></li> <li><a href="/wiki/Cingestol" title="Cingestol">Cingestol</a></li> <li><a href="/wiki/Danazol" title="Danazol">Danazol</a></li> <li><a href="/wiki/Desogestrel" title="Desogestrel">Desogestrel</a></li> <li><a href="/wiki/Dienogest" title="Dienogest">Dienogest</a></li> <li><a href="/wiki/Ethinylandrostenediol" title="Ethinylandrostenediol">Ethinylandrostenediol</a> <ul><li><a href="/wiki/Ethandrostate" title="Ethandrostate">Ethandrostate</a></li></ul></li> <li><a href="/wiki/Ethisterone" title="Ethisterone">Ethisterone</a></li> <li><a href="/wiki/Ethynerone" title="Ethynerone">Ethynerone</a></li> <li><a href="/wiki/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li> <li><a href="/wiki/Etynodiol" title="Etynodiol">Etynodiol</a></li> <li><a href="/wiki/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li> <li><a href="/wiki/Gestodene" title="Gestodene">Gestodene</a></li> <li><a href="/wiki/Gestrinone" title="Gestrinone">Gestrinone</a></li> <li><a href="/wiki/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a></li> <li><a href="/wiki/Levonorgestrel_ester" class="mw-redirect" title="Levonorgestrel ester">Levonorgestrel esters</a> (e.g., <a href="/wiki/Levonorgestrel_butanoate" title="Levonorgestrel butanoate">levonorgestrel butanoate</a>)</li> <li><a href="/wiki/Lynestrenol" title="Lynestrenol">Lynestrenol</a></li> <li><a href="/wiki/Lynestrenol_phenylpropionate" title="Lynestrenol phenylpropionate">Lynestrenol phenylpropionate</a></li> <li><a href="/wiki/Metynodiol" title="Metynodiol">Metynodiol</a></li> <li><a href="/wiki/Metynodiol_diacetate" title="Metynodiol diacetate">Metynodiol diacetate</a></li> <li><a href="/wiki/Norelgestromin" title="Norelgestromin">Norelgestromin</a></li> <li><a href="/wiki/Norethisterone" title="Norethisterone">Norethisterone (norethindrone)</a></li> <li><a href="/wiki/Norethisterone_ester" class="mw-redirect" title="Norethisterone ester">Norethisterone esters</a> (e.g., <a href="/wiki/Norethisterone_acetate" title="Norethisterone acetate">norethisterone acetate</a>, <a href="/wiki/Norethisterone_enanthate" title="Norethisterone enanthate">norethisterone enanthate</a>)</li> <li><a href="/wiki/Noretynodrel" title="Noretynodrel">Noretynodrel</a></li> <li><a href="/wiki/Norgesterone" title="Norgesterone">Norgesterone</a></li> <li><a href="/wiki/Norgestimate" title="Norgestimate">Norgestimate</a></li> <li><a href="/wiki/Norgestrel" title="Norgestrel">Norgestrel</a></li> <li><a href="/wiki/Norgestrienone" title="Norgestrienone">Norgestrienone</a></li> <li><a href="/wiki/Norvinisterone" title="Norvinisterone">Norvinisterone</a></li> <li><a href="/wiki/Oxendolone" title="Oxendolone">Oxendolone</a></li> <li><a href="/wiki/Quingestanol" title="Quingestanol">Quingestanol</a></li> <li><a href="/wiki/Quingestanol_acetate" title="Quingestanol acetate">Quingestanol acetate</a></li> <li><a href="/wiki/Tibolone" title="Tibolone">Tibolone</a></li> <li><a href="/wiki/Tigestol" title="Tigestol">Tigestol</a></li> <li><a href="/wiki/Tosagestin" title="Tosagestin">Tosagestin</a>; Anabolic–androgenic steroids: <a href="/wiki/11%CE%B2-Methyl-19-nortestosterone" title="11β-Methyl-19-nortestosterone">11β-Methyl-19-nortestosterone</a></li> <li><a href="/wiki/11%CE%B2-Methyl-19-nortestosterone_dodecylcarbonate" title="11β-Methyl-19-nortestosterone dodecylcarbonate">11β-Methyl-19-nortestosterone dodecylcarbonate</a></li> <li><a href="/wiki/19-Nor-5-androstenediol" title="19-Nor-5-androstenediol">19-Nor-5-androstenediol</a></li> <li><a href="/wiki/19-Nor-5-androstenedione" title="19-Nor-5-androstenedione">19-Nor-5-androstenedione</a></li> <li><a href="/wiki/19-Nordehydroepiandrosterone" title="19-Nordehydroepiandrosterone">19-Nordehydroepiandrosterone</a></li> <li><a href="/wiki/Bolandiol" title="Bolandiol">Bolandiol</a></li> <li><a href="/wiki/Bolandiol_dipropionate" title="Bolandiol dipropionate">Bolandiol dipropionate</a></li> <li><a href="/wiki/Bolandione" title="Bolandione">Bolandione</a></li> <li><a href="/wiki/Dimethisterone" title="Dimethisterone">Dimethisterone</a></li> <li><a href="/wiki/Dienedione" title="Dienedione">Dienedione</a></li> <li><a href="/wiki/Dienolone" title="Dienolone">Dienolone</a></li> <li><a href="/wiki/Dimethandrolone" title="Dimethandrolone">Dimethandrolone</a></li> <li><a href="/wiki/Dimethandrolone_buciclate" title="Dimethandrolone buciclate">Dimethandrolone buciclate</a></li> <li><a href="/wiki/Dimethandrolone_dodecylcarbonate" title="Dimethandrolone dodecylcarbonate">Dimethandrolone dodecylcarbonate</a></li> <li><a href="/wiki/Dimethandrolone_undecanoate" title="Dimethandrolone undecanoate">Dimethandrolone undecanoate</a></li> <li><a href="/wiki/Dimethyldienolone" title="Dimethyldienolone">Dimethyldienolone</a></li> <li><a href="/wiki/Dimethyltrienolone" title="Dimethyltrienolone">Dimethyltrienolone</a></li> <li><a href="/wiki/Ethyldienolone" title="Ethyldienolone">Ethyldienolone</a></li> <li><a href="/wiki/Ethylestrenol" title="Ethylestrenol">Ethylestrenol (ethylnandrol)</a></li> <li><a href="/wiki/Methyldienolone" title="Methyldienolone">Methyldienolone</a></li> <li><a href="/wiki/Metribolone" title="Metribolone">Metribolone (R-1881)</a></li> <li><a href="/wiki/Methoxydienone" title="Methoxydienone">Methoxydienone (methoxygonadiene)</a></li> <li><a href="/wiki/Mibolerone" title="Mibolerone">Mibolerone</a></li> <li><a href="/wiki/Nandrolone" title="Nandrolone">Nandrolone</a></li> <li><a href="/wiki/Nandrolone_ester" class="mw-redirect" title="Nandrolone ester">Nandrolone esters</a> (e.g., <a href="/wiki/Nandrolone_decanoate" title="Nandrolone decanoate">nandrolone decanoate</a>, <a href="/wiki/Nandrolone_phenylpropionate" title="Nandrolone phenylpropionate">nandrolone phenylpropionate</a>)</li> <li><a href="/wiki/Norethandrolone" title="Norethandrolone">Norethandrolone</a></li> <li><a href="/wiki/Normethandrone" title="Normethandrone">Normethandrone (methylestrenolone, normethandrolone, normethisterone)</a></li> <li><a href="/wiki/RU-2309" title="RU-2309">RU-2309</a></li> <li><a href="/wiki/Tetrahydrogestrinone" title="Tetrahydrogestrinone">Tetrahydrogestrinone</a></li> <li><a href="/wiki/Trenbolone" title="Trenbolone">Trenbolone (trienolone)</a></li> <li><a href="/wiki/Trenbolone_ester" class="mw-redirect" title="Trenbolone ester">Trenbolone esters</a> (e.g., <a href="/wiki/Trenbolone_acetate" title="Trenbolone acetate">trenbolone acetate</a>, <a href="/wiki/Trenbolone_enanthate" title="Trenbolone enanthate">trenbolone enanthate</a>)</li> <li><a href="/wiki/Trendione" title="Trendione">Trendione</a></li> <li><a href="/wiki/Trestolone" title="Trestolone">Trestolone</a></li> <li><a href="/wiki/Trestolone_acetate" title="Trestolone acetate">Trestolone acetate</a></li></ul> <ul><li><i>Spirolactone derivatives:</i> <a href="/wiki/Canrenoic_acid" title="Canrenoic acid">Canrenoic acid</a></li> <li><a href="/wiki/Canrenone" title="Canrenone">Canrenone</a></li> <li><a href="/wiki/Drospirenone" title="Drospirenone">Drospirenone</a></li> <li><a href="/wiki/Mespirenone" title="Mespirenone">Mespirenone</a></li> <li><a href="/wiki/Potassium_canrenoate" title="Potassium canrenoate">Potassium canrenoate</a></li> <li><a href="/wiki/Prorenone" title="Prorenone">Prorenone</a></li> <li><a href="/wiki/SC-5233" title="SC-5233">SC-5233 (spirolactone)</a></li> <li><a href="/wiki/SC-8109" title="SC-8109">SC-8109</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li> <li><a href="/wiki/Spirorenone" title="Spirorenone">Spirorenone</a></li></ul> <ul><li><i>Nonsteroidal:</i> <a href="/wiki/3,8-Dihydrodiligustilide" title="3,8-Dihydrodiligustilide">3,8-Dihydrodiligustilide</a></li> <li><a href="/wiki/LG-2527" title="LG-2527">LG-2527</a></li> <li><a href="/w/index.php?title=LG-100128&action=edit&redlink=1" class="new" title="LG-100128 (page does not exist)">LG-100128</a></li> <li><a href="/wiki/Riligustilide" title="Riligustilide">Riligustilide</a></li> <li><a href="/w/index.php?title=RWJ-26819&action=edit&redlink=1" class="new" title="RWJ-26819 (page does not exist)">RWJ-26819</a></li> <li><a href="/w/index.php?title=RWJ-49853&action=edit&redlink=1" class="new" title="RWJ-49853 (page does not exist)">RWJ-49853</a></li> <li><a href="/w/index.php?title=RWJ-60130&action=edit&redlink=1" class="new" title="RWJ-60130 (page does not exist)">RWJ-60130</a></li> <li><a href="/wiki/Tanaproget" title="Tanaproget">Tanaproget</a></li> <li><a href="/wiki/ZM-182345" title="ZM-182345">ZM-182345</a></li></ul> <ul><li><i>Unknown:</i> <a href="/wiki/ORG-47241" title="ORG-47241">ORG-47241</a></li> <li><a href="/wiki/ORG-201745" title="ORG-201745">ORG-201745</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br />(<a href="/wiki/Selective_progesterone_receptor_modulators" class="mw-redirect" title="Selective progesterone receptor modulators"><abbr title="Selective progesterone receptor modulators">SPRMs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Selective progesterone receptor modulators</span>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Steroidal:</i> <a href="/wiki/Dihydroethisterone" class="mw-redirect" title="Dihydroethisterone">Dihydroethisterone</a></li> <li><a href="/wiki/5%CE%B1-Dihydrolevonorgestrel" title="5α-Dihydrolevonorgestrel">5α-Dihydrolevonorgestrel</a></li> <li><a href="/wiki/5%CE%B1-Dihydronorethisterone" title="5α-Dihydronorethisterone">5α-Dihydronorethisterone</a></li> <li><a href="/wiki/Asoprisnil" title="Asoprisnil">Asoprisnil</a></li> <li><a href="/wiki/Asoprisnil_ecamate" title="Asoprisnil ecamate">Asoprisnil ecamate</a></li> <li><a href="/wiki/Guggulsterone" title="Guggulsterone">Guggulsterone</a></li> <li><a href="/w/index.php?title=J1042&action=edit&redlink=1" class="new" title="J1042 (page does not exist)">J1042</a></li> <li><a href="/w/index.php?title=LG-120838&action=edit&redlink=1" class="new" title="LG-120838 (page does not exist)">LG-120838</a></li> <li><a href="/wiki/Metapristone" title="Metapristone">Metapristone (RU-42633)</a></li> <li><a href="/wiki/Mifepristone" title="Mifepristone">Mifepristone (RU-486)</a></li> <li><a href="/w/index.php?title=ORF-9371&action=edit&redlink=1" class="new" title="ORF-9371 (page does not exist)">ORF-9371</a></li> <li><a href="/wiki/ORF-9326" class="mw-redirect" title="ORF-9326">ORF-9326</a></li> <li><a href="/w/index.php?title=ORG-31710&action=edit&redlink=1" class="new" title="ORG-31710 (page does not exist)">ORG-31710</a></li> <li><a href="/w/index.php?title=ORG-33628&action=edit&redlink=1" class="new" title="ORG-33628 (page does not exist)">ORG-33628</a></li> <li><a href="/w/index.php?title=RMI-12936&action=edit&redlink=1" class="new" title="RMI-12936 (page does not exist)">RMI-12936</a></li> <li><a href="/wiki/Telapristone" title="Telapristone">Telapristone</a></li> <li><a href="/wiki/Ulipristal_acetate" title="Ulipristal acetate">Ulipristal acetate</a></li> <li><a href="/wiki/Vilaprisan" title="Vilaprisan">Vilaprisan</a></li> <li><a href="/w/index.php?title=ZK-137316&action=edit&redlink=1" class="new" title="ZK-137316 (page does not exist)">ZK-137316</a></li></ul> <ul><li><i>Nonsteroidal:</i> <a href="/wiki/Apigenin" title="Apigenin">Apigenin</a></li> <li><a href="/wiki/Kaempferol" title="Kaempferol">Kaempferol</a></li> <li><a href="/w/index.php?title=LG-120920&action=edit&redlink=1" class="new" title="LG-120920 (page does not exist)">LG-120920</a></li> <li><a href="/wiki/Naringenin" title="Naringenin">Naringenin</a></li> <li><a href="/w/index.php?title=PRA-910&action=edit&redlink=1" class="new" title="PRA-910 (page does not exist)">PRA-910</a></li> <li><a href="/wiki/Syringic_acid" title="Syringic acid">Syringic acid</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><i>Steroidal:</i> <a href="/wiki/Aglepristone" title="Aglepristone">Aglepristone</a></li> <li><a href="/wiki/Lilopristone" title="Lilopristone">Lilopristone</a></li> <li><a href="/wiki/Lonaprisan" title="Lonaprisan">Lonaprisan</a></li> <li><a href="/wiki/Onapristone" title="Onapristone">Onapristone</a></li> <li><a href="/w/index.php?title=ORG-31710&action=edit&redlink=1" class="new" title="ORG-31710 (page does not exist)">ORG-31710</a></li> <li><a href="/w/index.php?title=ORG-31806&action=edit&redlink=1" class="new" title="ORG-31806 (page does not exist)">ORG-31806</a></li> <li><a href="/w/index.php?title=ORG-33628&action=edit&redlink=1" class="new" title="ORG-33628 (page does not exist)">ORG-33628</a></li> <li><a href="/w/index.php?title=RTI_3021%E2%80%93022&action=edit&redlink=1" class="new" title="RTI 3021–022 (page does not exist)">RTI 3021–022</a></li> <li><a href="/wiki/Toripristone" title="Toripristone">Toripristone</a></li> <li><a href="/wiki/Zanoterone" title="Zanoterone">Zanoterone</a></li></ul> <ul><li><i>Nonsteroidal:</i> <a href="/wiki/Darolutamide" title="Darolutamide">Darolutamide</a></li> <li><a href="/w/index.php?title=LG-001447&action=edit&redlink=1" class="new" title="LG-001447 (page does not exist)">LG-001447</a></li> <li><a href="/w/index.php?title=LG-100127&action=edit&redlink=1" class="new" title="LG-100127 (page does not exist)">LG-100127</a></li> <li><a href="/w/index.php?title=LG-100128&action=edit&redlink=1" class="new" title="LG-100128 (page does not exist)">LG-100128</a></li> <li><a href="/w/index.php?title=LG-120830&action=edit&redlink=1" class="new" title="LG-120830 (page does not exist)">LG-120830</a></li> <li><a href="/w/index.php?title=LG-121046&action=edit&redlink=1" class="new" title="LG-121046 (page does not exist)">LG-121046</a></li> <li><a href="/wiki/Valproic_acid" class="mw-redirect" title="Valproic acid">Valproic acid</a></li> <li><a href="/w/index.php?title=ZM-150271&action=edit&redlink=1" class="new" title="ZM-150271 (page does not exist)">ZM-150271</a></li> <li><a href="/w/index.php?title=ZM-172406&action=edit&redlink=1" class="new" title="ZM-172406 (page does not exist)">ZM-172406</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Membrane_progesterone_receptor" title="Membrane progesterone receptor"><abbr title="Membrane progesterone receptor">mPR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Membrane progesterone receptor</span><br />(<a href="/wiki/Progestin_and_adipoQ_receptor" title="Progestin and adipoQ receptor"><abbr title="Progestin and adipoQ receptor">PAQR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Progestin and adipoQ receptor</span>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">5α-Dihydroprogesterone</a></li> <li><a href="/wiki/5%CE%B2-Dihydroprogesterone" title="5β-Dihydroprogesterone">5β-Dihydroprogesterone</a></li> <li><a href="/wiki/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycortisone (21-hydroxyprogesterone)</a></li> <li><a href="/wiki/11-Deoxycortisol" title="11-Deoxycortisol">11-Deoxycortisol (17α,21-dihydroxyprogesterone)</a></li> <li><a href="/wiki/17%CE%B1-Hydroxyprogesterone" title="17α-Hydroxyprogesterone">17α-Hydroxyprogesterone</a></li> <li><a href="/wiki/Allopregnanolone" title="Allopregnanolone">Allopregnanolone</a></li> <li><a href="/wiki/Mifepristone" title="Mifepristone">Mifepristone</a></li> <li><a href="/wiki/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li> <li><a href="/wiki/Progesterone" title="Progesterone">Progesterone</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Mifepristone" title="Mifepristone">Mifepristone</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div> <dl><dt>See also</dt> <dd><a href="/wiki/Template:Receptor_modulators" title="Template:Receptor modulators">Receptor/signaling modulators</a></dd> <dd><a href="/wiki/Template:Progestogens_and_antiprogestogens" title="Template:Progestogens and antiprogestogens">Progestogens and antiprogestogens</a></dd> <dd><a href="/wiki/Template:Androgen_receptor_modulators" title="Template:Androgen receptor modulators">Androgen receptor modulators</a></dd> <dd><a href="/wiki/Template:Estrogen_receptor_modulators" title="Template:Estrogen receptor modulators">Estrogen receptor modulators</a></dd> <dd><a href="/wiki/List_of_steroidal_progestogens" class="mw-redirect" title="List of steroidal progestogens">List of progestogens</a></dd></dl> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Xenobiotic-sensing_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Xenobiotic-sensing_receptor_modulators" title="Template:Xenobiotic-sensing receptor modulators"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Xenobiotic-sensing_receptor_modulators" title="Template talk:Xenobiotic-sensing receptor modulators"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Xenobiotic-sensing_receptor_modulators" title="Special:EditPage/Template:Xenobiotic-sensing receptor modulators"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Xenobiotic-sensing_receptor_modulators" style="font-size:114%;margin:0 4em"><a href="/wiki/Xenobiotic-sensing_receptor" title="Xenobiotic-sensing receptor">Xenobiotic-sensing receptor</a> <a href="/wiki/Receptor_modulator" title="Receptor modulator">modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Constitutive_androstane_receptor" title="Constitutive androstane receptor"><abbr title="Constitutive androstane receptor">CAR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Constitutive androstane receptor</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/w/index.php?title=6,7-Dimethylesculetin&action=edit&redlink=1" class="new" title="6,7-Dimethylesculetin (page does not exist)">6,7-Dimethylesculetin</a></li> <li><a href="/wiki/Amiodarone" title="Amiodarone">Amiodarone</a></li> <li><a href="/wiki/Artemisinin" title="Artemisinin">Artemisinin</a></li> <li><a href="/w/index.php?title=Benfuracarb&action=edit&redlink=1" class="new" title="Benfuracarb (page does not exist)">Benfuracarb</a></li> <li><a href="/wiki/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li> <li><a href="/wiki/Carvedilol" title="Carvedilol">Carvedilol</a></li> <li><a href="/wiki/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li> <li><a href="/wiki/Chrysin" title="Chrysin">Chrysin</a></li> <li><a href="/w/index.php?title=CITCO_(drug)&action=edit&redlink=1" class="new" title="CITCO (drug) (page does not exist)">CITCO</a></li> <li><a href="/wiki/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li> <li><a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li> <li><a href="/wiki/Cypermethrin" title="Cypermethrin">Cypermethrin</a></li> <li><a href="/wiki/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (<a href="/wiki/Prasterone" title="Prasterone">prasterone</a>)</li> <li><a href="/wiki/Efavirenz" title="Efavirenz">Efavirenz</a></li> <li><a href="/wiki/Ellagic_acid" title="Ellagic acid">Ellagic acid</a></li> <li><a href="/wiki/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li> <li><a href="/wiki/Methoxychlor" title="Methoxychlor">Methoxychlor</a></li> <li><a href="/wiki/Mifepristone" title="Mifepristone">Mifepristone</a></li> <li><a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a></li> <li><a href="/wiki/Nevirapine" title="Nevirapine">Nevirapine</a></li> <li><a href="/wiki/Nicardipine" title="Nicardipine">Nicardipine</a></li> <li><a href="/w/index.php?title=Octicizer&action=edit&redlink=1" class="new" title="Octicizer (page does not exist)">Octicizer</a></li> <li><a href="/wiki/Permethrin" title="Permethrin">Permethrin</a></li> <li><a href="/wiki/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li> <li><a href="/wiki/Phenytoin" title="Phenytoin">Phenytoin</a></li> <li><a href="/wiki/5%CE%B2-Dihydroprogesterone" title="5β-Dihydroprogesterone">Pregnanedione (5β-dihydroprogesterone)</a></li> <li><a href="/wiki/Reserpine" title="Reserpine">Reserpine</a></li> <li><a href="/w/index.php?title=TCPOBOP&action=edit&redlink=1" class="new" title="TCPOBOP (page does not exist)">TCPOBOP</a></li> <li><a href="/wiki/Telmisartan" title="Telmisartan">Telmisartan</a></li> <li><a href="/wiki/Tolnaftate" title="Tolnaftate">Tolnaftate</a></li> <li><a href="/wiki/Troglitazone" title="Troglitazone">Troglitazone</a></li> <li><a href="/wiki/Valproic_acid" class="mw-redirect" title="Valproic acid">Valproic acid</a></li></ul> <ul><li><i>Antagonists:</i> <a href="/w/index.php?title=3,17%CE%B2-Estradiol&action=edit&redlink=1" class="new" title="3,17β-Estradiol (page does not exist)">3,17β-Estradiol</a></li> <li><a href="/w/index.php?title=5%CE%B1-Androstan-3%CE%B1-ol&action=edit&redlink=1" class="new" title="5α-Androstan-3α-ol (page does not exist)">3α-Androstanol</a></li> <li><a href="/wiki/5%CE%B1-Androst-16-en-3%CE%B1-ol" class="mw-redirect" title="5α-Androst-16-en-3α-ol">3α-Androstenol</a></li> <li><a href="/w/index.php?title=5%CE%B1-Androstan-3%CE%B2-ol&action=edit&redlink=1" class="new" title="5α-Androstan-3β-ol (page does not exist)">3β-Androstanol</a></li> <li><a href="/w/index.php?title=5%CE%B1-Androstan-17-ol&action=edit&redlink=1" class="new" title="5α-Androstan-17-ol (page does not exist)">17-Androstanol</a></li> <li><a href="/wiki/Allyl_isothiocyanate" title="Allyl isothiocyanate">AITC</a></li> <li><a href="/wiki/Ethinylestradiol" title="Ethinylestradiol">Ethinylestradiol</a></li> <li><a href="/wiki/Meclizine" title="Meclizine">Meclizine</a></li> <li><a href="/w/index.php?title=Nigramide_J&action=edit&redlink=1" class="new" title="Nigramide J (page does not exist)">Nigramide J</a></li> <li><a href="/wiki/Okadaic_acid" title="Okadaic acid">Okadaic acid</a></li> <li><a href="/wiki/PK-11195" class="mw-redirect" title="PK-11195">PK-11195</a></li> <li><a href="/w/index.php?title=S-07662&action=edit&redlink=1" class="new" title="S-07662 (page does not exist)">S-07662</a></li> <li><a href="/w/index.php?title=T-0901317&action=edit&redlink=1" class="new" title="T-0901317 (page does not exist)">T-0901317</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Pregnane_X_receptor" title="Pregnane X receptor"><abbr title="Pregnane X receptor">PXR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Pregnane X receptor</span></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/17%CE%B1-Hydroxypregnenolone" title="17α-Hydroxypregnenolone">17α-Hydroxypregnenolone</a></li> <li><a href="/wiki/17%CE%B1-Hydroxyprogesterone" title="17α-Hydroxyprogesterone">17α-Hydroxyprogesterone</a></li> <li><a href="/wiki/%CE%944-Androstenedione" class="mw-redirect" title="Δ4-Androstenedione">Δ<sup>4</sup>-Androstenedione</a></li> <li><a href="/wiki/%CE%945-Androstenediol" class="mw-redirect" title="Δ5-Androstenediol">Δ<sup>5</sup>-Androstenediol</a></li> <li><a href="/wiki/%CE%945-Androstenedione" class="mw-redirect" title="Δ5-Androstenedione">Δ<sup>5</sup>-Androstenedione</a></li> <li><a href="/w/index.php?title=AA-861&action=edit&redlink=1" class="new" title="AA-861 (page does not exist)">AA-861</a></li> <li><a href="/wiki/Allopregnanediol" title="Allopregnanediol">Allopregnanediol</a></li> <li><a href="/wiki/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">Allopregnanedione (5α-dihydroprogesterone)</a></li> <li><a href="/wiki/Allopregnanolone" title="Allopregnanolone">Allopregnanolone (brexanolone)</a></li> <li><a href="/wiki/Alpha-Lipoic_acid" class="mw-redirect" title="Alpha-Lipoic acid">Alpha-Lipoic acid</a></li> <li><a href="/wiki/Ambrisentan" title="Ambrisentan">Ambrisentan</a></li> <li><a href="/wiki/AMI-193" class="mw-redirect" title="AMI-193">AMI-193</a></li> <li><a href="/wiki/Amlodipine_besylate" class="mw-redirect" title="Amlodipine besylate">Amlodipine besylate</a></li> <li><a href="/wiki/Antimycotic" class="mw-redirect" title="Antimycotic">Antimycotics</a></li> <li><a href="/wiki/Artemisinin" title="Artemisinin">Artemisinin</a></li> <li><a href="/wiki/Aurothioglucose" title="Aurothioglucose">Aurothioglucose</a></li> <li><a href="/wiki/Bile_acid" title="Bile acid">Bile acids</a></li> <li><a href="/wiki/Bithionol" title="Bithionol">Bithionol</a></li> <li><a href="/wiki/Bosentan" title="Bosentan">Bosentan</a></li> <li><a href="/w/index.php?title=Bumecaine&action=edit&redlink=1" class="new" title="Bumecaine (page does not exist)">Bumecaine</a></li> <li><a href="/wiki/Cafestol" title="Cafestol">Cafestol</a></li> <li><a href="/wiki/Cephaloridine" title="Cephaloridine">Cephaloridine</a></li> <li><a href="/wiki/Cephradine" class="mw-redirect" title="Cephradine">Cephradine</a></li> <li><a href="/wiki/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li> <li><a href="/wiki/Ciglitazone" title="Ciglitazone">Ciglitazone</a></li> <li><a href="/wiki/Clindamycin" title="Clindamycin">Clindamycin</a></li> <li><a href="/wiki/Clofenvinfos" class="mw-redirect" title="Clofenvinfos">Clofenvinfos</a></li> <li><a href="/wiki/Chloroxine" title="Chloroxine">Chloroxine</a></li> <li><a href="/wiki/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li> <li><a href="/wiki/Colforsin" class="mw-redirect" title="Colforsin">Colforsin</a></li> <li><a href="/wiki/Corticosterone" title="Corticosterone">Corticosterone</a></li> <li><a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li> <li><a href="/wiki/Cyproterone_acetate" title="Cyproterone acetate">Cyproterone acetate</a></li> <li><a href="/wiki/Demecolcine" title="Demecolcine">Demecolcine</a></li> <li><a href="/wiki/Dexamethasone" title="Dexamethasone">Dexamethasone</a></li> <li><a href="/wiki/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (<a href="/wiki/Prasterone" title="Prasterone">prasterone</a>)</li> <li><a href="/wiki/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA-S</a> (<a href="/wiki/Prasterone_sulfate" title="Prasterone sulfate">prasterone sulfate</a>)</li> <li><a href="/wiki/Dibunate_sodium" class="mw-redirect" title="Dibunate sodium">Dibunate sodium</a></li> <li><a href="/wiki/Diclazuril" title="Diclazuril">Diclazuril</a></li> <li><a href="/wiki/Dicloxacillin" title="Dicloxacillin">Dicloxacillin</a></li> <li><a href="/wiki/Dimercaprol" title="Dimercaprol">Dimercaprol</a></li> <li><a href="/w/index.php?title=Dinaline&action=edit&redlink=1" class="new" title="Dinaline (page does not exist)">Dinaline</a></li> <li><a href="/wiki/Docetaxel" title="Docetaxel">Docetaxel</a></li> <li><a href="/wiki/Docusate_calcium" class="mw-redirect" title="Docusate calcium">Docusate calcium</a></li> <li><a href="/wiki/Dodecylbenzenesulfonic_acid" class="mw-redirect" title="Dodecylbenzenesulfonic acid">Dodecylbenzenesulfonic acid</a></li> <li><a href="/wiki/Dronabinol" title="Dronabinol">Dronabinol</a></li> <li><a href="/wiki/Droxidopa" title="Droxidopa">Droxidopa</a></li> <li><a href="/wiki/Eburnamonine" class="mw-redirect" title="Eburnamonine">Eburnamonine</a></li> <li><a href="/wiki/Ecopipam" title="Ecopipam">Ecopipam</a></li> <li><a href="/wiki/Enzacamene" title="Enzacamene">Enzacamene</a></li> <li><a href="/wiki/Epothilone_B" class="mw-redirect" title="Epothilone B">Epothilone B</a></li> <li><a href="/wiki/Erythromycin" title="Erythromycin">Erythromycin</a></li> <li><a href="/wiki/Famprofazone" title="Famprofazone">Famprofazone</a></li> <li><a href="/w/index.php?title=Febantel&action=edit&redlink=1" class="new" title="Febantel (page does not exist)">Febantel</a></li> <li><a href="/wiki/Felodipine" title="Felodipine">Felodipine</a></li> <li><a href="/wiki/Fenbendazole" title="Fenbendazole">Fenbendazole</a></li> <li><a href="/wiki/Fentanyl" title="Fentanyl">Fentanyl</a></li> <li><a href="/wiki/Flucloxacillin" title="Flucloxacillin">Flucloxacillin</a></li> <li><a href="/wiki/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li> <li><a href="/wiki/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li> <li><a href="/wiki/Guggulsterone" title="Guggulsterone">Guggulsterone</a></li> <li><a href="/wiki/Haloprogin" title="Haloprogin">Haloprogin</a></li> <li><a href="/wiki/Hetacillin_potassium" class="mw-redirect" title="Hetacillin potassium">Hetacillin potassium</a></li> <li><a href="/wiki/Hyperforin" title="Hyperforin">Hyperforin</a></li> <li><a href="/wiki/Hypericum_perforatum" title="Hypericum perforatum"><i>Hypericum perforatum</i> (St John's wort)</a></li> <li><a href="/wiki/Indinavir_sulfate" class="mw-redirect" title="Indinavir sulfate">Indinavir sulfate</a></li> <li><a href="/wiki/Lasalocid_sodium" class="mw-redirect" title="Lasalocid sodium">Lasalocid sodium</a></li> <li><a href="/wiki/Levothyroxine" title="Levothyroxine">Levothyroxine</a></li> <li>Linolenic acid: <a href="/wiki/%CE%91-Linolenic_acid" title="Α-Linolenic acid">α-Linolenic acid</a> and <a href="/wiki/Gamma-Linolenic_acid" class="mw-redirect" title="Gamma-Linolenic acid">γ-linolenic acid</a></li> <li><a href="/w/index.php?title=LOE-908&action=edit&redlink=1" class="new" title="LOE-908 (page does not exist)">LOE-908</a></li> <li><a href="/wiki/Loratadine" title="Loratadine">Loratadine</a></li> <li><a href="/wiki/Lovastatin" title="Lovastatin">Lovastatin</a></li> <li><a href="/wiki/Meclizine" title="Meclizine">Meclizine</a></li> <li><a href="/wiki/Metacycline" title="Metacycline">Metacycline</a></li> <li><a href="/wiki/Methylprednisolone" title="Methylprednisolone">Methylprednisolone</a></li> <li><a href="/wiki/Metyrapone" title="Metyrapone">Metyrapone</a></li> <li><a href="/wiki/Mevastatin" title="Mevastatin">Mevastatin</a></li> <li><a href="/wiki/Mifepristone" title="Mifepristone">Mifepristone</a></li> <li><a href="/wiki/Nafcillin" title="Nafcillin">Nafcillin</a></li> <li><a href="/wiki/Nicardipine" title="Nicardipine">Nicardipine</a></li> <li><a href="/wiki/Nicotine" title="Nicotine">Nicotine</a></li> <li><a href="/wiki/Nifedipine" title="Nifedipine">Nifedipine</a></li> <li><a href="/wiki/Nilvadipine" title="Nilvadipine">Nilvadipine</a></li> <li><a href="/wiki/Nisoldipine" title="Nisoldipine">Nisoldipine</a></li> <li><a href="/wiki/Norelgestromin" title="Norelgestromin">Norelgestromin</a></li> <li><a href="/wiki/Omeprazole" title="Omeprazole">Omeprazole</a></li> <li><a href="/wiki/Orlistat" title="Orlistat">Orlistat</a></li> <li><a href="/wiki/Oxatomide" title="Oxatomide">Oxatomide</a></li> <li><a href="/wiki/Paclitaxel" title="Paclitaxel">Paclitaxel</a></li> <li><a href="/wiki/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li> <li><a href="/wiki/Piperine" title="Piperine">Piperine</a></li> <li><a href="/wiki/Plicamycin" title="Plicamycin">Plicamycin</a></li> <li><a href="/wiki/Prednisolone" title="Prednisolone">Prednisolone</a></li> <li><a href="/wiki/Pregnanediol" title="Pregnanediol">Pregnanediol</a></li> <li><a href="/wiki/5%CE%B2-Dihydroprogesterone" title="5β-Dihydroprogesterone">Pregnanedione (5β-dihydroprogesterone)</a></li> <li><a href="/wiki/Pregnanolone" title="Pregnanolone">Pregnanolone</a></li> <li><a href="/wiki/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li> <li><a href="/wiki/Pregnenolone_16%CE%B1-carbonitrile" title="Pregnenolone 16α-carbonitrile">Pregnenolone 16α-carbonitrile</a></li> <li><a href="/wiki/Proadifen" title="Proadifen">Proadifen</a></li> <li><a href="/wiki/Progesterone" title="Progesterone">Progesterone</a></li> <li><a href="/wiki/Quingestrone" title="Quingestrone">Quingestrone</a></li> <li><a href="/wiki/Reserpine" title="Reserpine">Reserpine</a></li> <li><a href="/wiki/Reverse_triiodothyronine" title="Reverse triiodothyronine">Reverse triiodothyronine</a></li> <li><a href="/wiki/Rifampicin" title="Rifampicin">Rifampicin</a></li> <li><a href="/wiki/Rifaximin" title="Rifaximin">Rifaximin</a></li> <li><a href="/wiki/Rimexolone" title="Rimexolone">Rimexolone</a></li> <li><a href="/wiki/Riodipine" title="Riodipine">Riodipine</a></li> <li><a href="/wiki/Ritonavir" title="Ritonavir">Ritonavir</a></li> <li><a href="/wiki/Simvastatin" title="Simvastatin">Simvastatin</a></li> <li><a href="/wiki/Sirolimus" title="Sirolimus">Sirolimus</a></li> <li><a class="mw-selflink selflink">Spironolactone</a></li> <li><a href="/wiki/Spiroxatrine" title="Spiroxatrine">Spiroxatrine</a></li> <li><a href="/w/index.php?title=SR-12813&action=edit&redlink=1" class="new" title="SR-12813 (page does not exist)">SR-12813</a></li> <li><a href="/w/index.php?title=Suberoylanilide&action=edit&redlink=1" class="new" title="Suberoylanilide (page does not exist)">Suberoylanilide</a></li> <li><a href="/wiki/Sulfisoxazole" class="mw-redirect" title="Sulfisoxazole">Sulfisoxazole</a></li> <li><a href="/wiki/Suramin" title="Suramin">Suramin</a></li> <li><a href="/wiki/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li> <li><a href="/w/index.php?title=Tenylidone&action=edit&redlink=1" class="new" title="Tenylidone (page does not exist)">Tenylidone</a></li> <li><a href="/wiki/Terconazole" title="Terconazole">Terconazole</a></li> <li><a href="/wiki/Testosterone_isocaproate" title="Testosterone isocaproate">Testosterone isocaproate</a></li> <li><a href="/wiki/Tetracycline" title="Tetracycline">Tetracycline</a></li> <li><a href="/wiki/Thiamylal_sodium" class="mw-redirect" title="Thiamylal sodium">Thiamylal sodium</a></li> <li><a href="/wiki/Thiothixene" class="mw-redirect" title="Thiothixene">Thiothixene</a></li> <li><a href="/wiki/Thonzonium_bromide" title="Thonzonium bromide">Thonzonium bromide</a></li> <li><a href="/wiki/Tianeptine" title="Tianeptine">Tianeptine</a></li> <li><a href="/wiki/Troglitazone" title="Troglitazone">Troglitazone</a></li> <li><a href="/wiki/Troleandomycin" title="Troleandomycin">Troleandomycin</a></li> <li><a href="/w/index.php?title=Tropanyl_3,5-dimethulbenzoate&action=edit&redlink=1" class="new" title="Tropanyl 3,5-dimethulbenzoate (page does not exist)">Tropanyl 3,5-dimethulbenzoate</a></li> <li><a href="/wiki/Zafirlukast" title="Zafirlukast">Zafirlukast</a></li> <li><a href="/wiki/Zeranol" title="Zeranol">Zeranol</a></li></ul> <ul><li><i>Antagonists:</i> <a href="/wiki/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li> <li><a href="/wiki/Sesamin" title="Sesamin">Sesamin</a></li></ul> </div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div> <dl><dt>See also</dt> <dd><i><a href="/wiki/Template:Receptor_modulators" title="Template:Receptor modulators">Receptor/signaling modulators</a></i></dd></dl> </div></td></tr></tbody></table></div></div></td></tr></tbody></table></div> <style data-mw-deduplicate="TemplateStyles:r1130092004">.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;justify-content:center;align-items:baseline}.mw-parser-output .portal-bar-bordered{padding:0 2em;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em auto 0}.mw-parser-output .portal-bar-related{font-size:100%;justify-content:flex-start}.mw-parser-output .portal-bar-unbordered{padding:0 1.7em;margin-left:0}.mw-parser-output .portal-bar-header{margin:0 1em 0 0.5em;flex:0 0 auto;min-height:24px}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;flex:0 1 auto;padding:0.15em 0;column-gap:1em;align-items:baseline;margin:0;list-style:none}.mw-parser-output .portal-bar-content-related{margin:0;list-style:none}.mw-parser-output .portal-bar-item{display:inline-block;margin:0.15em 0.2em;min-height:24px;line-height:24px}@media screen and (max-width:768px){.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;flex-flow:column wrap;align-items:baseline}.mw-parser-output .portal-bar-header{text-align:center;flex:0;padding-left:0.5em;margin:0 auto}.mw-parser-output .portal-bar-related{font-size:100%;align-items:flex-start}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:center;flex:0;column-gap:1em;border-top:1px solid #a2a9b1;margin:0 auto;list-style:none}.mw-parser-output .portal-bar-content-related{border-top:none;margin:0;list-style:none}}.mw-parser-output .navbox+link+.portal-bar,.mw-parser-output .navbox+style+.portal-bar,.mw-parser-output .navbox+link+.portal-bar-bordered,.mw-parser-output .navbox+style+.portal-bar-bordered,.mw-parser-output .sister-bar+link+.portal-bar,.mw-parser-output .sister-bar+style+.portal-bar,.mw-parser-output .portal-bar+.navbox-styles+.navbox,.mw-parser-output .portal-bar+.navbox-styles+.sister-bar{margin-top:-1px}</style><div class="portal-bar noprint metadata noviewer portal-bar-bordered" role="navigation" aria-label="Portals"><span class="portal-bar-header"><a href="/wiki/Wikipedia:Contents/Portals" title="Wikipedia:Contents/Portals">Portal</a>:</span><ul class="portal-bar-content"><li class="portal-bar-item"><span class="nowrap"><span typeof="mw:File"><span><img alt="icon" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/8px-WHO_Rod.svg.png" decoding="async" width="8" height="19" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/12px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/16px-WHO_Rod.svg.png 2x" data-file-width="107" data-file-height="250" /></span></span> </span><a href="/wiki/Portal:Medicine" title="Portal:Medicine">Medicine</a></li></ul></div> <!-- NewPP limit report Parsed by mw‐web.codfw.main‐57488d5c7d‐8wfcm Cached time: 20241128015635 Cache expiry: 2592000 Reduced expiry: false Complications: [vary‐revision‐sha1, show‐toc] CPU time usage: 3.878 seconds Real time usage: 4.355 seconds Preprocessor visited node count: 26685/1000000 Post‐expand include size: 1398940/2097152 bytes Template argument size: 209489/2097152 bytes Highest expansion depth: 18/100 Expensive parser function count: 12/500 Unstrip recursion depth: 1/20 Unstrip post‐expand size: 1347603/5000000 bytes Lua time usage: 2.093/10.000 seconds Lua memory usage: 19237893/52428800 bytes Lua Profile: ? 660 ms 27.3% MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::callParserFunction 240 ms 9.9% dataWrapper <mw.lua:672> 160 ms 6.6% MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::getExpandedArgument 140 ms 5.8% recursiveClone <mwInit.lua:45> 120 ms 5.0% <mw.lua:694> 100 ms 4.1% MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::find 100 ms 4.1% (for generator) 100 ms 4.1% MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::preprocess 80 ms 3.3% MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::match 80 ms 3.3% [others] 640 ms 26.4% Number of Wikibase entities loaded: 1/400 --> <!-- Transclusion expansion time report (%,ms,calls,template) 100.00% 3525.216 1 -total 55.89% 1970.083 1 Template:Reflist 27.59% 972.768 180 Template:Cite_journal 16.63% 586.246 94 Template:Cite_book 14.13% 498.019 1 Template:Infobox_drug 11.80% 415.826 1 Template:Infobox 4.66% 164.225 23 Template:Navbox 4.42% 155.762 2 Template:Navboxes 3.32% 117.192 4 Template:Lang 2.88% 101.615 18 Template:Cite_web --> <!-- Saved in parser cache with key enwiki:pcache:idhash:732656-0!canonical and timestamp 20241128015635 and revision id 1256728327. Rendering was triggered because: page-view --> </div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="https://login.wikimedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" width="1" height="1" style="border: none; position: absolute;"></noscript> <div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Spironolactone&oldid=1256728327">https://en.wikipedia.org/w/index.php?title=Spironolactone&oldid=1256728327</a>"</div></div> <div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Spironolactone" title="Category:Spironolactone">Spironolactone</a></li><li><a href="/wiki/Category:3%CE%B2-Hydroxysteroid_dehydrogenase_inhibitors" title="Category:3β-Hydroxysteroid dehydrogenase inhibitors">3β-Hydroxysteroid dehydrogenase inhibitors</a></li><li><a href="/wiki/Category:5%CE%B1-Reductase_inhibitors" title="Category:5α-Reductase inhibitors">5α-Reductase inhibitors</a></li><li><a href="/wiki/Category:11%CE%B2-Hydroxylase_inhibitors" title="Category:11β-Hydroxylase inhibitors">11β-Hydroxylase inhibitors</a></li><li><a href="/wiki/Category:17%CE%B2-Hydroxysteroid_dehydrogenase_inhibitors" title="Category:17β-Hydroxysteroid dehydrogenase inhibitors">17β-Hydroxysteroid dehydrogenase inhibitors</a></li><li><a href="/wiki/Category:21-Hydroxylase_inhibitors" title="Category:21-Hydroxylase inhibitors">21-Hydroxylase inhibitors</a></li><li><a href="/wiki/Category:Acetate_esters" title="Category:Acetate esters">Acetate esters</a></li><li><a href="/wiki/Category:Aldosterone_synthase_inhibitors" title="Category:Aldosterone synthase inhibitors">Aldosterone synthase inhibitors</a></li><li><a href="/wiki/Category:Anti-acne_preparations" title="Category:Anti-acne preparations">Anti-acne preparations</a></li><li><a href="/wiki/Category:Antimineralocorticoids" title="Category:Antimineralocorticoids">Antimineralocorticoids</a></li><li><a href="/wiki/Category:Cholesterol_side-chain_cleavage_enzyme_inhibitors" title="Category:Cholesterol side-chain cleavage enzyme inhibitors">Cholesterol side-chain cleavage enzyme inhibitors</a></li><li><a href="/wiki/Category:CYP17A1_inhibitors" title="Category:CYP17A1 inhibitors">CYP17A1 inhibitors</a></li><li><a href="/wiki/Category:Hair_loss_medications" title="Category:Hair loss medications">Hair loss medications</a></li><li><a href="/wiki/Category:Hair_removal" title="Category:Hair removal">Hair removal</a></li><li><a href="/wiki/Category:Lactones" title="Category:Lactones">Lactones</a></li><li><a href="/wiki/Category:Pregnane_X_receptor_agonists" title="Category:Pregnane X receptor agonists">Pregnane X receptor agonists</a></li><li><a href="/wiki/Category:Pregnanes" title="Category:Pregnanes">Pregnanes</a></li><li><a href="/wiki/Category:Prodrugs" title="Category:Prodrugs">Prodrugs</a></li><li><a href="/wiki/Category:Progestogens" title="Category:Progestogens">Progestogens</a></li><li><a href="/wiki/Category:Selective_estrogen_receptor_modulators" title="Category:Selective estrogen receptor modulators">Selective estrogen receptor modulators</a></li><li><a href="/wiki/Category:Spiro_compounds" title="Category:Spiro compounds">Spiro compounds</a></li><li><a href="/wiki/Category:Spirolactones" title="Category:Spirolactones">Spirolactones</a></li><li><a href="/wiki/Category:Steroidal_antiandrogens" title="Category:Steroidal antiandrogens">Steroidal antiandrogens</a></li><li><a href="/wiki/Category:Thioesters" title="Category:Thioesters">Thioesters</a></li><li><a href="/wiki/Category:World_Health_Organization_essential_medicines" title="Category:World Health Organization essential medicines">World Health Organization essential medicines</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_DOI_inactive_as_of_November_2024" title="Category:CS1 maint: DOI inactive as of November 2024">CS1 maint: DOI inactive as of November 2024</a></li><li><a href="/wiki/Category:All_articles_with_dead_external_links" title="Category:All articles with dead external links">All articles with dead external links</a></li><li><a href="/wiki/Category:Articles_with_dead_external_links_from_January_2023" title="Category:Articles with dead external links from January 2023">Articles with dead external links from January 2023</a></li><li><a href="/wiki/Category:Articles_with_permanently_dead_external_links" title="Category:Articles with permanently dead external links">Articles with permanently dead external links</a></li><li><a href="/wiki/Category:CS1_German-language_sources_(de)" title="Category:CS1 German-language sources (de)">CS1 German-language sources (de)</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_October_2021" title="Category:Use dmy dates from October 2021">Use dmy dates from October 2021</a></li><li><a href="/wiki/Category:Drugs_with_non-standard_legal_status" title="Category:Drugs with non-standard legal status">Drugs with non-standard legal status</a></li><li><a href="/wiki/Category:ECHA_InfoCard_ID_from_Wikidata" title="Category:ECHA InfoCard ID from Wikidata">ECHA InfoCard ID from Wikidata</a></li><li><a href="/wiki/Category:Drugboxes_which_contain_changes_to_watched_fields" title="Category:Drugboxes which contain changes to watched fields">Drugboxes which contain changes to watched fields</a></li><li><a href="/wiki/Category:All_articles_lacking_reliable_references" title="Category:All articles lacking reliable references">All articles lacking reliable references</a></li><li><a href="/wiki/Category:Articles_lacking_reliable_references_from_July_2024" title="Category:Articles lacking reliable references from July 2024">Articles lacking reliable references from July 2024</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2024" title="Category:Articles with unsourced statements from July 2024">Articles with unsourced statements from July 2024</a></li><li><a href="/wiki/Category:All_articles_with_failed_verification" title="Category:All articles with failed verification">All articles with failed verification</a></li><li><a href="/wiki/Category:Articles_with_failed_verification_from_July_2024" title="Category:Articles with failed verification from July 2024">Articles with failed verification from July 2024</a></li><li><a href="/wiki/Category:Articles_containing_Latin-language_text" title="Category:Articles containing Latin-language text">Articles containing Latin-language text</a></li><li><a href="/wiki/Category:Articles_containing_German-language_text" title="Category:Articles containing German-language text">Articles containing German-language text</a></li><li><a href="/wiki/Category:Articles_containing_Spanish-language_text" title="Category:Articles containing Spanish-language text">Articles containing Spanish-language text</a></li><li><a href="/wiki/Category:Articles_containing_Italian-language_text" title="Category:Articles containing Italian-language text">Articles containing Italian-language text</a></li><li><a href="/wiki/Category:Wikipedia_medicine_articles_ready_to_translate" title="Category:Wikipedia medicine articles ready to translate">Wikipedia medicine articles ready to translate</a></li></ul></div></div> </div> </main> </div> <div class="mw-footer-container"> <footer id="footer" class="mw-footer" > <ul id="footer-info"> <li id="footer-info-lastmod"> This page was last edited on 11 November 2024, at 08:34<span class="anonymous-show"> (UTC)</span>.</li> <li id="footer-info-copyright">Text is available under the <a href="/wiki/Wikipedia:Text_of_the_Creative_Commons_Attribution-ShareAlike_4.0_International_License" title="Wikipedia:Text of the Creative Commons Attribution-ShareAlike 4.0 International License">Creative Commons Attribution-ShareAlike 4.0 License</a>; additional terms may apply. By using this site, you agree to the <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Terms_of_Use" class="extiw" title="foundation:Special:MyLanguage/Policy:Terms of Use">Terms of Use</a> and <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy" class="extiw" title="foundation:Special:MyLanguage/Policy:Privacy policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a rel="nofollow" class="external text" href="https://wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li> </ul> <ul id="footer-places"> <li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li> <li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li> <li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li> <li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li> <li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Universal_Code_of_Conduct">Code of Conduct</a></li> <li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li> <li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li> <li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li> <li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Spironolactone&mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li> </ul> <ul id="footer-icons" class="noprint"> <li id="footer-copyrightico"><a href="https://wikimediafoundation.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/static/images/footer/wikimedia-button.svg" width="84" height="29" alt="Wikimedia Foundation" loading="lazy"></a></li> <li id="footer-poweredbyico"><a href="https://www.mediawiki.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/w/resources/assets/poweredby_mediawiki.svg" alt="Powered by MediaWiki" width="88" height="31" loading="lazy"></a></li> </ul> </footer> </div> </div> </div> <div class="vector-settings" id="p-dock-bottom"> <ul></ul> </div><script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw-web.codfw.main-57488d5c7d-zg5wc","wgBackendResponseTime":207,"wgPageParseReport":{"limitreport":{"cputime":"3.878","walltime":"4.355","ppvisitednodes":{"value":26685,"limit":1000000},"postexpandincludesize":{"value":1398940,"limit":2097152},"templateargumentsize":{"value":209489,"limit":2097152},"expansiondepth":{"value":18,"limit":100},"expensivefunctioncount":{"value":12,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":1347603,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 3525.216 1 -total"," 55.89% 1970.083 1 Template:Reflist"," 27.59% 972.768 180 Template:Cite_journal"," 16.63% 586.246 94 Template:Cite_book"," 14.13% 498.019 1 Template:Infobox_drug"," 11.80% 415.826 1 Template:Infobox"," 4.66% 164.225 23 Template:Navbox"," 4.42% 155.762 2 Template:Navboxes"," 3.32% 117.192 4 Template:Lang"," 2.88% 101.615 18 Template:Cite_web"]},"scribunto":{"limitreport-timeusage":{"value":"2.093","limit":"10.000"},"limitreport-memusage":{"value":19237893,"limit":52428800},"limitreport-profile":[["?","660","27.3"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::callParserFunction","240","9.9"],["dataWrapper \u003Cmw.lua:672\u003E","160","6.6"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::getExpandedArgument","140","5.8"],["recursiveClone \u003CmwInit.lua:45\u003E","120","5.0"],["\u003Cmw.lua:694\u003E","100","4.1"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::find","100","4.1"],["(for generator)","100","4.1"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::preprocess","80","3.3"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::match","80","3.3"],["[others]","640","26.4"]]},"cachereport":{"origin":"mw-web.codfw.main-57488d5c7d-8wfcm","timestamp":"20241128015635","ttl":2592000,"transientcontent":false}}});});</script> <script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Spironolactone","url":"https:\/\/en.wikipedia.org\/wiki\/Spironolactone","sameAs":"http:\/\/www.wikidata.org\/entity\/Q422188","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q422188","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-06-17T17:03:50Z","dateModified":"2024-11-11T08:34:12Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/9\/98\/Spironolactone.svg","headline":"medication that is primarily used to treat fluid build-up due to heart failure, liver scarring, or kidney disease"}</script> </body> </html>